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Summary
Bunyamwera virus is the prototype of the family Bunyaviridae and has a tripartite 
negative-sense RNA genome. The largest RNA segment (L) contains 6875 nucleotides 
and encodes a high molecular weight protein (259K) also termed L. The L protein is 
presumed to be the virion-associated transcriptase or RNA polymerase, although direct 
proof of this is lacking. The large size of the L protein suggests it is multifunctional and 
most probably catalyzes initiation, elongation, and termination of RNA synthesis and 
perhaps also plays a role in events which generate the host-derived primers for 
transcription, such as cap-binding and endonuclease activities. With the long-term aim 
of defining the functional domains within the bunyavirus L protein, the available cloned 
cDNAs were exploited to establish systems in which the L protein can be expressed.
As a prelude to characterizing the expressed L protein, monospecific antisera to 
portions of the L protein fused to B-galactosidase were prepared. Five fusion proteins 
were expressed using the bacterial expression vector pUEX, and two antisera raised 
against the C and N termini of the L protein specifically recognized the L protein.
A full-length cDNA to the L gene of Bunyamwera virus was constructed from the 
existing cDNA subclones and synthetic oligonucleotides. The assembled L gene cDNA 
was subsequently cloned into various expression vectors and several expression systems 
were explored in order to obtain a biologically active L protein for domain mapping.
The full-length cDNA to the L gene was cloned into two vaccinia virus expression 
systems. In the first, the L gene is under control of vaccinia virus p7.5 promoter by 
using the plasmid transfer vector pSCl 1; in the second, the L gene is under control of the 
bacteriophage T7 010 promoter by using the plasmid transfer vector pTF7-5, and 
expression of the L gene requires coinfection with a second recombinant vaccinia virus 
vTF7-3 which synthesizes T7 RNA polymerase. Both systems expressed a protein 
which is the same size as the Bunyamwera virus L protein and was recognized by the 
monospecific L anti sera. The L protein was also transiently expressed by transfection of 
vTF7-3 infected cells with recombinant plasmid DNAs which contained the cDNA for 
the L gene under control of the T7 promoter.
Expression of the L protein in a cell free system (rabbit reticulocyte lysate) by 
translation of an in vitro transcribed L gene was performed. Minor amounts of an L 
sized protein waft synthesized, but many prematurely terminated polypeptides were also 
produced.
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The L gene was also cloned under the T7 promoter in a bacterial expression vector 
(pET8c) to express the L protein in E. coli. However, no L protein was expressed by 
either IPTG induction or infection of the culture with a bacteriophage (CE6) to provide 
the T7 RNA polymerase.
To test the functionality of the L protein expressed by the recombinant vaccinia 
viruses, three assay systems were explored: complementation of bunyavirus ts L gene 
mutants; in vitro transcription assay; and the ability of the expressed L protein to replicate 
an RNA template in infected cultured cells.
The transcriptase activity of the expressed L protein present in cytoplasmic extracts 
from the recombinant vaccinia virus infected cells was assayed in vitro using 
Bunyamwera virus intracellular nucleocapsids as templates. However, the activity of the 
authentic L protein which was associated with the RNP was stimulated by mock infected 
cell extracts. Thus, the intracellular nucleocapsid was not an appropriate template for this 
assay. The attempts to complement bunyavirus ts mutants led to noninterpretable results. Efforts t 
reconstitute a synthetic RNA template containing the 5' and 3' end sequences of the 
Bunyamwera virus S RNA were also made. Linearized recombinant plasmid pUC- 
BUNS292 containing bases 1-99 and 768-961 nucleotides of the S RNA under control 
of the T7 promoter, was transfected into vTF7-3 infected cells, and positive-sense RNA 
should have been transcribed. The cells also expressed N protein, either transiently or 
from Bumyamwera virus infection, to encapsidate any short S-like RNA. However, it 
was observed that the transfected linearized shorter S cDNA was not transcribed by the 
T7 RNA polymerase in vTF7-3 infected cells.
The L protein, expressed from either of the two vaccinia virus systems or transiently 
expressed, was demonstrated to be functional by its capability of replicating viral S RNA 
in a nucleocapsid (RNP) transfection assay. Recombinant vaccinia virus-infected cells 
were transfected with purified Bunyamwera virus nucleocapsids, and subsequently total 
cellular RNA was analyzed by Northern (RNA) blotting or the cells were labelled with 
35s-methionine to analyze viral protein synthesis. No Bunyamwera virus RNA or 
proteins were detected in the cells transfected with the RNP alone, but in cells which had 
previously been infected with recombinant vaccinia viruses or had been transfected with 
recombinant plasmid with the L gene under control of the T7 promoter, Bunyamwera 
virus S RNA of both polarities was detected. Bunyamwera virus N protein was also 
detected in the transfected cells which had the L protein expressed. These results 
indicated that the expressed L protein had replicated the S RNA supplied by the 
transfected RNP and hence the newly synthesized positive-sense S RNA was translated 
into the N protein. The functionality of the recombinant L protein was further confirmed 
by demonstrating its ability to replicate the S RNA of DI particles generated from 
Bunyamwera virus persistently infected mosquito cells.
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Site-directed mutagenesis of the L gene cDNA was performed to begin mapping the
RNA polymerase domain within the L protein, and some preliminary data are presented
in this thesis. Four conserved amino acids in the four predicted RNA polymerase motifs
were chosen for specific amino acid substitution. Sixteen L mutants involving amino
acids substitution of the conserved aspartic acid (D) residue at position 1037 and the D
residue at position 1165 of the L protein were obtained. One mutant (L-A-1037, with
substitution by alanine) was shown to exhibit RNA polymerase activity in the RNP
either no or much reduced 
transfection assay. All the other substitution mutants showea ^activity in mis assay.
A deletion mutant, which was generated by deleting 166 amino acid residues at the C-
terminus of the L, lost activity in the RNP assay, indicating that the intactness of the L is
important for its functionality.
The work described in this thesis directly proves that the L protein encoded by the 
largest RNA segment of a bunyavirus is the viral RNA polymerase. The functional 
assay system developed will be useful for further probing the protein requirements for 
bunyavirus RNA replication and for understanding the mechanism of viral RNA genome 
replication. Site-directed mutagenesis of the L protein could identify possible targets for 
developing antiviral chemotherapy in the future.
m
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1Chapter 1
Review of the literature
1.1. Introduction
The Bunyaviridae is the largest known family of animal viruses. More than 300 
viruses, which are characterized by a tripartite negative-strand or ambisense RNA 
genome and are mostly arthropod-borne (Bishop and Shope, 1979), are classified into 
this family (Karabatsos, 1985). Some viruses in the family are of medical and veterinary 
significance, causing severe or fatal infections in human and animals. Examples of 
serious human diseases caused by the Bunyaviridae are Rift Valley fever, Crimean- 
Congo haemorrhagic fever, California encephalitis and haemorrhagic fever with renal 
syndrome (Table 1.2). In addition, the Bunyaviridae also display some unique features 
in aspects of their molecular biology such as genome structures and genome expression 
strategies, which make them of interest to study. Our knowledge of the molecular 
biology of the Bunyaviridae is limited and not balanced: the Bunyaviridae has such a 
large diversity in serology, pathogenicity and biological properties that some genera have 
attracted more attention than others.
Bunyamwera virus is the prototype virus of the family and is the first member 
whose genome sequence has been completely determined (Lees et al.y 1986; Elliott, 
1989a and b). The research project presented in this thesis concerns expression of the 
Bunyamwera virus L gene and analysis of its role in RNA synthesis. In this chapter, a 
general overview of the Bunyaviridae is provided, and the virus gene expression, RNA 
synthesis and the polymerase protein will be discussed in more detail. Other aspects of 
the biology of the family, not directly related to this area, have to be dealt with only 
briefly.
Chapter 1 Review o f the literature 2
The Bunyaviridae is classified as a family of negative-strand RNA viruses and 
shares some common features with the other negative-strand RNA viruses in its 
replication mechanism. Negative-strand RNA viruses include six families: Arenaviridae, 
Bunyaviridae, Filoviridae, Orthomyxoviridae, Paramyxoviridae and Rhabdoviridae. 
These six families are to some extent differentiated by morphology and fall into two 
distinct categories in terms of genome structure (Pringle, 1991), which are summarized in 
Table 1.1. The Arenaviridae, Bunyaviridae and Orthomyxoviridae have segmented 
genomes, whereas the Filoviridae, Paramyxoviridae and Rhabdoviridae have linear 
undivided genomes. Studies on other groups of RNA viruses with negative-sense 
genomes will no doubt help our understanding of the Bunyaviridae. Therefore, 
references will be made to various negative-strand RNA viruses throughout the thesis.
Table 1.1 Classification of Negative-strand RNA Viruses
Family Genus Representative virus Genome size No of RNA
(kb) segments
Arenaviridae Arenavir us Old world, e.g. Lassa , ^  ,
New world, e.g. Tacaribe 2
Bunyaviridae Bunyavirus Bunyamwera
Hantavirus Hantaan
Nairovirus Crimean Congo
haemorrhagic fever 12-17 3
Phlebovirus Sandfly fever
(Uukuvirus) Uukuniemi 
Tospovirus Tomato spotted wilt
Filoviridae Filovirus Marburg
Ebola 12.7
Rhabdoviridae Vesiculovirus Vesicular Stomatitis 
Lyssavirus Rabies
11.2
11.9
Paramyxoviridae Morbillivirus Measles
Paramyxovirus Parainfluenza virus type 3 15.2 - *|
Sendai 15.9
Mumps
Pneumovirus Respiratory syncytial virus
Orthomyxoviridae Influenzavirus Influenza virus type A 13.5 8
B 14.0 8
C 14.0 7
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1.2. Bunyaviridae
1.2.1. Classification and taxonomy
The classification of the viruses in the family Bunyaviridae was originally based on 
their serological relationships and the data have been further supplemented and largely 
supported by biochemical analyses. At present, five genera are recognized within the 
family Bunyaviridae: Bunyavirus, Hantavirus, Nairovirus, Phlebovirus, (Bishop et al, 
1980; Schmaljohn and Daliymple, 1983) and the recently established Tospovirus. The 
Tospovirus genus contains only one plant-infecting member of the Bunyaviridae, tomato 
spotted wilt virus (TSWV, Milne and Francki, 1984; de Haan et al., 1990), and ICTV 
has approved its inclusion in the Bunyaviridae recently (Peters, 1991). Uukuvirus had 
been an independent genus in the family, however, most recently ICTV has approved its 
inclusion in Phlebovirus genus. In addition, at least 10 serogroups containing 28 
viruses, as well as some 27 other viruses are considered to be possible members of the 
family (Bishop, 1990).
The classification of the Bunyaviridae is summarized in Table 1.2. The essential 
characteristics of viruses assigned to the Bunyaviridae, as defined by Bishop and Shope 
(1979) are as follows:
(1). The viruses are spherical (90-100 nm in diameter) and enveloped with 
glycoprotein surface projections.
(2). The virions contain three unique segments of negative sense single-stranded 
RNA (S, M, and L) in the form of circular ribonucleoprotein complexes (nucleocapsids) 
and a transcriptase enzyme.
(3). The viruses mature by budding into intracytoplasmic vesicles associated with 
the Golgi apparatus.
(4). The viruses have the capacity to interact genetically with certain other closely 
related viruses and produce recombinant viruses by genome segment reassortment.
(5). The viral RNA species have a negative-sense coding strategy except the S 
segment of phleboviruses and tospovirus has an ambisense strategy.
In general, viruses within a genus share complement fixation antibodies and are 
subdivided into different serogroups on the basis of neutralization and haemagglutination- 
inhibition reactions. Phleboviruses are exceptions in that the complementation fixation 
test is specific and the haemagglutination-inhibiton reaction is cross-reactive (Calisher & 
Karabatsos, 1988).
The majority of viruses in the Bunyaviridae are transmitted to vertebrate hosts by 
arthropods. There is no evidence for insect vector transmission for hantaviruses and it is
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suggested that each hantavirus is perpetuated within a single (or a few) rodent species 
(LeDuc et al., 1982). Hantaviruses cause asymptomatic persistent infections of rodents, 
and rodent-rodent, and rodent-human infections are caused by aerosolized rodent 
excretions. Human diseases have been associated with representatives of all genera 
except Tospovirus.
Table 1.2 Classification of the Bunyaviridae
Genus No. of 
serogroups
No. of 
viruses
Examples of viruses associated Principal arthropod 
with human disease vectors
Bunyavirus 16 156 La Crosse
California encephalitis 
Tahyna
Jamestown Canyon 
Oropouche
Mosquitoes
Gnats
Hantavirus 1 9 Hantaan
Puumula
Seoul
None (rodents)
Nairovirus 6 32 Crimean-Congo 
haemorrhagic fever
Ticks
Phlebovirus 1 (8)* 39 Sandfly fevers
Toscana
Rift Valley fever
Sandflies
Gnats
(Uukuvirus)** 1 12 none Ticks
Tospovirus 1 1 none Thrips
* Phleboviruses comprise a single serogroup (Phlebotomus fever) divided into eight 
antigenic complexes. ** Uukuvirus is now included in Phlebovirus genus. This 
table is modified from Elliott (1990).
1.2.2. Virus morphology
Bunyaviridae particles in general are spherical, 80-120 nm in diameter and display 
surface glycoprotein projections of 5-10 nm which are embedded in a lipid bilayered 
envelope apparently 5 nm thick as observed under the electron microscope. There are 
some morphological varieties among viruses in a-ll genera and unique external features 
have been described for representatives of each genus. The surface structures of 
uukuvirus are defined by clustered glycoproteins which form hollow cylindrical 
morphological units (von Bonsdorff & Pettersson, 1975). Bunyaviruses have distinct,
Chapter 1 Review o f the literature 5
regular sharply defined round surface structures about 10 nm in diameter (Martin et al.,
1985). However, the surface structure of nairoviruses exhibits less distinct, small 
morphological surface units (Donets et al., 1977). Hantaviruses sometimes display an 
unusual gridlike pattern on their surfaces and elongated particles (110-210nm long) are 
often observed (Hung et al., 1985). Phleboviruses exhibit knotlike morphological units 
with no distinct pattern (Martin et al., 1985). It is possible that the morphological 
differences between genera reflect altered interaction of the stain with the surface 
proteins, or different arrangement of the surface proteins on the particle.
The chemical composition of virus has been determined only for Uukuniemi virus 
and found to be about 2% RNA, 58% protein, 33% lipid and 7% carbohydrate (Obijeski 
& Murphy, 1977). The virus particle of the Bunyaviridae contains four structural 
proteins (Gl, G2, L and N) and the RNA genome.
1.2.3. RNA genome structure
The genome of the Bunyaviridae comprises three unique single stranded RNA 
segments (L, M and S) of negative or ambisense polarity.
Each RNA genome segment is intimately associated with the N (2100 molecules per 
particle) and the L (25 molecules per particle) proteins to form a nucleocapsid (Obijeski et 
al., 1976). The nucleocapsids can be released from virions by disruption with nonionic 
detergents and purified by CsG gradient centrifugation. All three nucleocapsids species 
are sufficiently stable in the high salt solution to band at a buoyant density of 1.31 g/ml in 
CsCl, whereas mRNAs are pelleted (Obijeski et al., 1976). The buoyant density of the 
Bunyaviridae nucleocapsids in CsCl is very similar to those of rhabdoviruses and 
paramyxoviruses, as well as tobacco mosaic virus. The association of RNA with the N 
protein renders the nucleocapsids resistant to RNase digestion to some extent.
The three RNA segments are designated on the basis of their size class (summarized 
in Table 1.3) and arc usually not present in equimolar amounts, the S species usually 
predominates (Obijeski et al., 1976; Gentsch et al., 1977). As can be seen from Table
1.3, the S segments of bunyaviruses are considerably smaller than those of other genera; 
the L RNA segments of nairoviruses are much larger than the others; differences of the 
M RNA segments among the genera arc relatively less apparent
When viewed in the electron microscope, all three RNA segments were found to be 
circular (Petterson & von Bonsdorff, 1975; Samso et al., 1975). Panhandle structures of 
varying lengths have been observed in RNA preparations of Uukuniemi virus (Hewlett et 
al., 1977) and Germiston virus (Pardigon et al., 1982), in addition to circular forms. 
Such circular or panhandle structures can be rendered linear under denaturing conditions 
(Hewlett et al., 1977). It was found that genomic RNA contains free 5' termini (pppA)
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and 3’ hydroxyl ends (Obijeski et a l, 1976), indicating that the circular RNA species are 
not closed by covalent linkage between the 3' and 5' ends. More recently, psoralen 
cross-linking studies on nucleocapsids showed that the ends of the RNA within 
nucleocapsids are capable of base pairing to form dsRNA, as they are in the naked RNA 
(Raju and Kolakofsky, 1989). Therefore, it appears that in the nucleocapsids the N 
protein must have been locally displaced from the RNA to allow RNA molecules to base 
pair.
Table 1.3 Sizes of RNA segments of the Bunyaviridae
Genus L M S
Bunyavirus 6,875 4,458-4,534 850-984
Hantavirus 6,530-6,550 3,616-3,682 1,696
Nairovirus 11,000-14,000* 4,400-6,300* 1,712
Phlebovirus 6,500-8,200* 3,884-4,330 1,690-1,904
(Uukuvirus) 6,423 3,231 1,720
Tospovirus $897 5,000-5,400 2,916
* The length of the RNA segments were estimated by gel analysis. Others were 
determined by nucleotide sequence analysis.
The 3' and 5' terminal sequences of the individual genome segments are 
complementary, which presumably accounts for the observation of circular and/or 
panhandle forms of the RNA segments. The terminal 9-15 nucleotides are conserved 
within each genus (Elliott, 1990); the conserved sequences of bunyaviruses and 
hantaviruses are similar and those of phleboviruses and uukuviruses are identical (Table 
1.4). The terminal base-paired structures may have functional roles in viral RNA 
synthesis and will be discussed later.
1.2.4. Replication cycle
The replication cycle of Bunyaviridae involves virus attaching and entering cells, 
genome transcription and translation, genome replication and virus maturation.
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Table 1.4. 3-terminal nucleotide sequences of Bunyaviridae RNA segments
Genus Virus 1Genome segment 3'terminus
Bunyavirus Bunyamwera S
M
L
UCAUCACAUGAGGU
UCAUCACAUGAUGG
UCAUCACAUGAGGA
Hantavirus Hantaan S
M
L
AUCAUCAUCUGAGGG
AUCAUCAUCUGAGGC
AUCAUCAUCUGAGGG
Nairovirus Qalyub S
M
L
AGAGAUUCUGCCUGC
AGAGAUUCUUUAUGA
AGAGAUUCUUUAAUU
Phlebovirus Rift Vally fever S
M
L
UGUGUUUCGG
UGUGUUUCUG
UGUGUUUCUG
(Uukuvirus) Uukuniemi S
M
L
UGUGUUUCUGGA
UGUGUUUCUGCC
UGUGUUUCUGGA
1.2.4.1. Attachment and entry
The life cycles of viruses in the Bunyaviridae family can involve replication 
alternately in vertebrates and arthropods. The nature of the Bunyaviridae receptor(s) 
either in vertebrate or in invertebrate is not known. It is assumed that the external 
glycoproteins on virions mediate virus attachment to host cell receptors. James and 
Millican (1986) isolated some virus mutants by repeated passages of Bunyamwera virus 
through mosquito cells and it was found that those mutants were better adapted to 
replicate in the invertebrate cells than the initial virus. Meanwhile, these mutants lost 
their reactivity to G1 specific monoclonal antibodies raised against the parental virus, 
suggesting that the relative resistance of insect cell-passaged virus to neutralizing 
antibodies results from genetic changes not post-translational modification of
viral proteins. Treatment of virions with trypsin or pronase, which removed most of Gl, 
renders the virus completely noninfectious in vertebrate cells (Kingsford & Hill, 1981), 
suggesting that Gl is involved in the attachment process. Ludwig et al. (1989) 
demonstrated that G2 was required for efficient attachment and infection of mosquito 
cells. When they treated La Crosse virus with pronase and trypsin to remove Gl but 
leaving G2 intact, it was found that enzyme treated virions had less infectivity in
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vertebrate cells, but the infectivity was either unaffected or increased in invertebrate cells. 
They proposed that the major determinants for attachment to mosquito cells are on G2 
and are usually masked by G l, and digestion of G1 by proteases in the insect midgut 
renders efficient attachment and infection of mosquito midgut cells. This also explains 
the molecular basis for midgut infection barriers and species susceptibility to arbovirus 
infection in nature.
Fusion of infected cells at acidic pH values has been reported for viruses in the 
Bunyaviridae (Gonzalez-Scarano et al., 1985) as well as numerous other enveloped 
viruses. The membrane fusing activities of these viruses become manifest only upon 
exposures to acid pH, which appears to induce a conformational change in the virus 
surface components. Viral mutants with a defective fusion function have been selected 
and it appears that Gl protein of bunyavirus mediates such fusion (Gonzalez-Scarano et 
al., 1985). However, it was suggested that the large hydrophobic domain in the 
bunyavirus G2 (residues 187-245) was responsible for fusion activity and the role of Gl 
concerned with the cell surface receptor rather than directly with the lipid bilayer 
(Pobjecky et al., 1989). The molecular mechanism involved in bunyavirus mediated cell 
fusion has yet to be elucidated.
1.2.4.2. Transcription and translation
After uncoating of the viral genome, transcription of a negative-strand virus RNA 
genome to mRNA is believed to occur by the virion associated RNA polymerase. 
Transcriptase activity has been detected in detergent-disrupted virion preparations of 
several members of the Bunyaviridae (Ranki & Pettersson, 1975; Bouloy & Hannoun, 
1976; Schmaljohn & Dalrymple, 1983; Patterson et al., 1984; Gerbaud et al., 1987a). 
The features of the Bunyaviridae RNA synthesis are outlined below and will be discussed 
more extensively in section 1.5.
It is observed that viral mRNA is not polyadenylated; it is 60-100 nucleotides 
shorter at 3 ' end than the full length genome; there is a host derived capped methylated 
primer present at 5' end of the mRNA (for review, see Elliott et al, 1991; Kolakofsky & 
Hacker, 1991). Bunyavirus transcription is not affected by actinomycin D or a-amanitin 
(Vezza et al., 1979) and takes place in the cytoplasm of infected cells (Rossier et al., 
1986; Kolakofsky et a l, 1987). For some viruses, continual protein synthesis is 
required for mRNA synthesis (Abraham & Pattnaik, 1983; Patterson & Kolakofsky, 
1984).
Viral polypeptides are synthesized shortly after infection although the relative rate 
of synthesis varies with the virus, host-cell type and multiplicity of infection (McPhee & 
Westaway, 1981; Struthers et al., 1984; Watret et al., 1985). At a high multiplicity of
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infection, N and NSs proteins of RVF phlebovims can be detected as early as 2 hr of 
postinfection and the glycoprotein shortly afterwards (Parker et al., 1984). Hantaviruses 
and uukuviruses exhibit a slower rate of protein synthesis and the viral proteins can not 
be detected until about 6 hours after infection.
During translational process, some of the viral polypeptides undergo several 
maturation changes sucli as cotranslational cleavage, glycosylation of the glycoprotein, 
and in the case of RVFV, phosphorylation of the NSs protein (Strothers & Swanepoel, 
1982; Strothers et al., 1984).
1.2.4.3. Genome replication
For negative-strand RNA viruses, the change from primary transcription to genome 
replication requires a switch from mRNA synthesis to the synthesis of full length 
antigenomic RNA and then viral genomic RNA. Both genomic and antigenomic RNA 
are encapsidated by the N proteins, in contrast to mRNA which is naked. Therefore, it 
appears that the N protein may play an important role in genome replication.
The factors involved in the switch from primary transcription to genome replication 
have not been defined for any member of the Bunyaviridae family. Presumably, some 
viral factor(s) is required to signal a suppression of the transcription termination signal 
responsible for generation of truncated mRNA and also to prevent the addition of host 
derived primers to the S' termini of antigenomic RNA. It is speculated that the NSs 
proteins (where they exist) might be involved in the switch through their interaction with 
the N protein and/or the viral RNA polymerase (Schmaljohn & Patterson, 1990).
1.2.4.4. Virus maturation
A feature of the Bunyaviridae is virus maturation which occurs by a budding 
process at intracellular smooth membranes, principally in the Golgi complex (Kuismanen 
et al., 1982, 1984; Smith & Pifat, 1982). However, in one report, virus maturation was 
observed at the cell surface of RVFV infected primary rat hepatocytes (Anderson and 
Smith, 1987). Viruses in the Bunyaviridae family lack a matrix (M) protein which is 
responsible for bridging the gap between the integral viral envelope proteins and 
nucleocapsids of other negative-strand RNA viruses. Therefore, the early events of 
assembly must include an interaction between viral nucleocap&ds and glycoproteins, 
which have been observed at smooth membrane vesicles, and predominantly at 
membranes in or adjacent to Golgi complex (Smith & Pifu, 1982).
The Golgi-targeting property of the Bunyaviridae glycoproteins has been shown for 
Uukuniemi, Rift Valley fever, Hantaan and Bunyamwera viruses to be independent of 
viral replication and other viral gene products (Gahmberg et al.,1986; Wasmonen et al..
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1988, Pensiero et al., 1988; Nakitare & Elliott, unpublished data). These observations 
suggest that Golgi localization and/or retention signals are contained within the viral 
glycoproteins themselves, but these have not yet been delineated.
1.2.5. Genetics of Bunyaviridae
1.2.5.1. Genome reassortment
As with other segmented genome viruses, the tripartite genomes of the 
Bunyaviridae can exchange RNA segments resulting in reassortant viruses. Reassortant 
bunyaviruses have been isolated from mosquitoes collected in nature (Klimas et al.,
1981), and in mosquitoes which have been dually infected via intrathroacic inoculation, 
simultaneous feeding or interrupted feeding (Beaty et al., 1981; Beaty et al., 1985; Beaty 
& Bishop, 1988; Chandler et al., 1990). Furthermore, Bunyaviridae reassortment has 
also been demonstrated in vitro and only occurs between closely related viruses, not 
between viruses in different genera, nor between viruses in different serogroups of the 
same genus. Even within a serogroup some viruses appear to be incompatible with each 
other (Gentsch & Bishop, 1976; Gentsch et al., 1977, 1979; Iroegbu & Pringle, 1981; 
Ozden & Hannoun, 1978,1980; Rozhon etal., 1981; Pringle e ta i,  1984; Janssen etal.,
1986).
Reassortment in nature may be of significance as a means of evolution for viruses 
with segmented genomes. Genome reassortment has been used to assign the viral 
proteins to genome segments, which will be discussed in section 1.4.
1.2.5.2. ts mutants
Genetic studies of the Bunyaviridae family have been largely due to isolation of 
temperature sensitive (ts) mutants, mostly derived by chemical mutagen induction and a 
few spontaneous mutants. More than 200 ts mutants of 10 bunyaviruses and Uukuniemi 
virus have been produced (Gentsch et al., 1979; Bishop, 1979; Ozden & Hannoun, 
1978, 1980; Iroegbu & Pringle, 1981; Gahmberg, 1984). It is an anomaly that despite 
the tripartite nature of the Bunyaviridae genome, the vast majority fall into two 
recombinant/reassortment groups, except for a single mutant, Maguari virus ts 23 which 
defines a third group (Iroegbu & Pnngle, 1981). Recently, the S RNA segment of 
Maguari virus ts 23 has been sequenced (Pritlove & Elliott, unpublished data) and a point 
mutation which would cause amino acid substitution in both N and NSs proteins was 
found. Thus in contrast to the suggestion of Murphy & Pringle (1987), Maguari virus ts 
23 might be assigned to the S segment though more investigation is needed to confirm 
this. Since the RNA template of negative-strand RNA viruses is in a nucleocapsid foim,
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mutation of the N protein might affect its RNA binding function and further affect virus 
genome replication. Further, the ORFs of the N and NSs overlap so that in the 
overlapping region a mutation yielding a ts protein for one may concomitantly produce an 
inactive (lethal) protein for the other (Bishop, 1990). These might be the reason why the 
S mutants have not been isolated for most viruses in the family. In addition, Maguari 
virus ts 23 mutant shows very poor growth characteristics at the permissive temperature. 
Group I and II have been assigned to M segment and L segment respectively by 
recombination studies (Iroegbu & Pringle, 1981; Bishop, 1979). One of the bunyavirus 
ts mutant in Group II, BUN ts 7 has a faster migrating Gl in SDS-polyacrylamide gels. 
The plaque morphology and plaque size of progeny recombinants derived from 
recombination of parental ts mutants are determined by ts mutants in Group I, whereas 
plaque opacity is taken from Group II. Group II mutants of Bunyamwera virus have 
been assigned to the M segment, Group I mutants are presumed to have defect in the L 
segment (Pringle, personal communication). On the other hand, Group II ts mutants in 
California encephalitis serogroup are located in the L RNA segment and Group I ts 
mutants are in the M RNA segment, which have been confirmed by RNase fingerprinting 
and in vitro transcripts assay of the mutants (Vezza et a/., 1979).
Homologous and heterologous recombination among the ts mutants have been 
performed and in most combinations, heterologous recombination is less efficient than 
homologous recombination (Iroegbu and Pringle, 1981). There is no genetic barrier to 
the exchange of genetic material between Batai, Bunyamwera and Maguari viruses in 
vitro. Complemen-iation between Bunyamwera ts mutants and those of La Crosse virus 
(California encephalitis group) have been unsuccessful (Iroegbu and Pringle, 1981) and 
the molecular basis for this restriction has not been established.
1.2.6. Persistent infection and defective interfering 
particles
Viruses in all genera, except the Hantavirus genus, are capable of alternately 
replicating in vertebrates and arthropods. In general, viruses are cytopathogenic in their 
vertebrate hosts whereas persistent infection is readily established in their invertebrate 
host. Persistent infections can be established in vitro in mosquito cell cultures. Mosquito 
cells persistently infected with Bunyamwera, La Crosse, Marituba bunyaviruses and 
Toscana phlebovirus showed no differences in their metabolic activities, but continued to 
shed infectious virus (Newton et al., 1981; Nicoletti & Verani, 1985, Carvalho et al., 
1986; Elliott & Wilkie, 1986; Rossieretal., 1988; Scallan & Elliott, 1991). Features of 
bunyavirus persistent infection include (Elliott & Wilkie, 1986): (1) both viral antigens 
and RNA can be detected in the persistent infected cells; (2) the cells are resistant to
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superinfection by homologous or closely related viruses; (3) the cells continue to shed 
infectious virus after prolonged passages; (4) the persistent state is accompanied by 
genetic and phenotypic changes in the viruses, including plaque morphology, ts 
phenotype and generation of defective interfering particles (DI).
The molecular mechanisms involved in the establishment and maintenance of 
persistent infection have not been fully elucidated. However, some possibilities have 
been suggested. In La Crosse virus (LAC) infected mosquito cells, viral mRNA is 
encapsidated by the N protein late in infection, thereby rendering the mRNA 
untranslatable (Hacker et al., 1989). Therefore, it is suggested that the self-limiting 
nature of the infection of mosquito cells is related to the control of the N protein 
translation (Kolakofsky and Hacker, 1991, Hacker et al., 1989). Generation of DI 
particles may also be involved in persistent infection. DI particles from Bunyamwera 
virus infected carrier cultures appear to contain only S segment RNA (Elliott & Wilkie, 
1986; Scallan and Elliott, 1991). More typical DI RNAs, derived from the L RNA 
segment, have been observed in Germiston bunyavirus-infected cells (Cunningham & 
Szilaggi, 1987). Recently, Scallan and Elliott (1991) reported defective RNAs derived 
from the L RNA segment in Bunyamwera virus persistently infected mosquito cells but 
these RNAs were not packaged into virus particles. Another possible mechanism of 
persistent infection might be because the viral transcriptase and endonuclease activity of 
the L protein is less active in arthropod than in mammalian cells (Schmaljohn & 
Patterson, 1990).
1.3. Viral proteins and protein function
1.3.1. Structural proteins
Four structural proteins are present in the Bunyaviridae virions: two internal 
proteins, the N (nucleoprotein) and the L proteins which are associated with the RNA 
segments to form nucleocapsids, and two external glycoproteins, termed Gl and G2, 
which are inserted into the virus membrane. Some nairoviruses may contain three 
glycoproteins (Foulke et al., 1981).
1.3.1.1. Glycoproteins G 1 and G2
Glycoproteins Gl and G2 are named according to their protein size. Both proteins 
appear to be located on the external side of the lipid membrane as evidenced by their 
sensitivity to protease digestion. The protease treated vims preparations had spike-less 
panicles and showed decreased infectivity (Obijesld et al., 1976). Various analyses have 
been undertaken to characterize the structural features of the glycoproteins: direct amino
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acid sequencing analysis, specific peptide antibodies mapping (Fazakerley e ta l., 1988), 
nucleotide sequence determinations of cloned cDNAs and gene expression analysis.
Some structural features of bunyavirus glycoproteins have been revealed by 
comparison of the glycoprotein precursors of four bunyaviruses, snowshoe hare (SSH), 
La Crosse (LAC), Bunyamwera and Germiston viruses (Lees eta l., 1986; Elliott, 1990). 
Gl and G2 are rich in cysteine residues (Elliott, 1990) which have the potential of 
forming disulfide bonds and a very complex tertiary structure. Gl has a single 
hydrophobic domain close to its carboxy terminus which is proposed as a transmembrane 
and anchor domain. An overall amino acid homology of about 40% is revealed among 
these four Gl molecules, with more similarity in the carboxy half than the amino half of 
the molecule. It is suggested that G 1 is oriented with its amino terminus external to the 
viral envelope and its carboxy terminus internal to the envelope. The amino acids in the 
N-terminus of Gl is more variable, indicating the external amino half of Gl may 
determine the antigenicity of the individual viruses in the Bunyavirus genus. G2 has 
higher amino acid homology of about 66%. The hydropathy profiles of the four 
polypeptides shows that G2 has a rather long single hydrophobic sequence (residues 
187-245) constituting about 20% of the molecule. The large hydrophobic region is 
longer than a single transmembrane domain and is followed by a highly charged stop- 
transfer sequence (residue 246-252). The orientation of G2 relative to the viral envelope 
is not known yet (Fazakerley et al., 1988).
Bunyavirus glycoproteins have few oligosaccharide side-chains (Cash et al., 1980; 
Lees et al., 1986; Pardigon et al., 1988). The glycans are mostly of the endoglycosidase 
H complex type (Madoff & Lenard, 1982). Some endo H-sensitive high-mannose and 
some small endo H-sensitive intermediate type glycans are also found. Four predicted re­
linked glycosylation sites have been found to be conserved in glycoproteins in the form 
of Asn-Xxx-Ser/Thr. Two are strictly conserved in G2, a single strictly conserved site in 
Gl and a second conserved between viruses in the same serogroup of the four 
bunyaviruses compared (Elliott, 1990). When Bunyamwera virus infected BHK cells 
were labelled with 35S-methionine or 35S-cysteine in the presence of the glycosylation 
inhibitor tunycamycin, the Gl showed a faster migrating ability (Lees et al., 1986). Both 
Gl and G2 of Inkoo bunyavirus can be labelled with sugar precursors e.g., 3H- 
mannose, which has not been found in the unglycosylated N protein (Pesonen et al.,
1982). The glycoproteins Gl and G2 have been found to relate with viral virulence, 
neutralization, haemaglutination and cell fusion (for review, see Elliott, 1990).
The Gl and G2 proteins of Uukuniemi virus are present in nearly equimolar 
amounts in purified virions and may form a dimer to compose the structural units on the 
virus surface (Pettersson and Bonsdorff, 1987). Virion structural units are arranged in a 
T=12, P=3 icosahedral surface lattice as viewed by negative staining and freeze-etching,
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implying that the surface is formed by 110 hexamers and 12 pen tamers, i.e. 720 structure 
units.
1.3.1.2. The N protein
The nucleoprotein (N protein) is found to be associated with the RNA genome both 
in the virion and infected cells. By analysis of the distribution of ^ H-labelled LAC virus 
RNA species after oxidation and reduction with ^H-sodium borohydride, the 
approximate number of N protein molecules per RNA strand of LAC bunyavirus has 
been estimated by Obijeski et al. (1976). It was calculated that 1209 N protein molecules 
are associated with the L RNA segment, 750 N with the M and 167 N with the S 
segment. Thus, in the nucleocapsids of bunyavirus, one N protein would associate with 
6 nucleotides.
The N proteins of viruses in the Bunyavirus, Phlebovirus, and Tospovirus genera 
are of similar size ranging from 19K to 30K. Nairoviruses and hantaviruses have larger 
N proteins of Mr 48K-54K (Watret and Elliott, 1985a; Elliott, 1989b). The N protein 
sequences of six viruses of Bunyavirus genus have been compared (Elliott, 1989b): 
Bunyamwera (Elliott, 1989b), Maguari (Elliott & McGregor, 1989) and Germiston 
(Gerbaud, 1987a, b) of Bunyajwera serogroup, snowshoe hare (Bishop et al., 1982) and 
La Crosse viruses (Akashi & Bishop, 1983; Cabradilla et al., 1983) of the California 
serogroup and Aino virus of Simbu serogroup (Akashi et al., 1984). The six way 
alignment of the N proteins shows that the N protein has overall 40% similarity between 
serogroups and 80% or greater similarity within a serogroup. Certain regions of the N 
protein are well conserved, particularly between residues 62-102, residues 123-169 and 
the carboxy-terminal 15 residues. The conserved regions may reflect their functional 
significance, presumably binding to the viral RNA, and may also account for the cross- 
reactivity throughout the Bunyavirus genus (Shope,1985).
1.3.1.3. The L protein
The large (L) protein of the Bunyaviridae is also associated with RNA genome and 
is considered to be the viral RNA polymerase. The transcriptase activity of the L protein 
was first detected in purified Lumbo bunyavirus preparations by Bouloy and Hannoun 
(1976) and further confirmed in a number of other bunyaviruses (Gerbaud et al., 1987a; 
Patterson et al., 1984). Patterson et al. (1984) demonstrated that LAC virion associated 
polymerase synthesized (+) transcripts in vitro and the polymerase activity can be 
stimulated by dinucleotides (e.g. ApG), cap analogues (e.g. mGpppAm) and natural 
mRNAs (e.g. alfalfa mosaic virus RNA 4). An endonuclease activity which cleaved 
methylated capped mRNAs in vitro was also detected. Their results imply that the L
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protein present in the virion is responsible for the polymerase and endonuclease activities 
although more direct evidence is lacking.
The L proteins of the viruses in the Bunyaviridae are very similar in size with Mr of 
more than 200K. The L protein of Bunyamwera virus has Mr 259K and the L protein of 
hantaviruses has Mr 247K. Considering such a large size of the L protein, some other 
functions may also be associated with it and it may be a multifunctional protein. The L 
protein has been implicated in some biological properties of the virus, such as virulence 
which was demonstrated by the studies of ts mutants (Beaty et a l ,  1981; Rozhon et a l,  
1981) and reassortant viruses (Janssen et a l ,  1986).
1.3.2. Virus-coded nonstructural proteins
Two nonstructural proteins have been found in cells infected with some members of 
Bunyaviridae and are designated as NSs and NSm according to their coding strategies 
(see later). NSs proteins have been detected in bunyavirus, phlebovirus, tospovirus 
(TSWV) and uukuvirus infected cells, whereas NSm proteins have only been identified 
in bunyavirus and phlebovirus infected cells.
1.3.2.1 N Ss
The NSs protein detected in bunyavirus infected cells has a molecular weight of 
10K-13K (Fuller and Bishop, 1982; Short et a l., 1982; Bouloy et a l ,  1984; Elliott, 
1985; Watret et a l ,  1985; Elliott & McGregor, 1989). Phleboviruses induce the 
synthesis of an NSs protein of Mr 29K-32K (Struthers and Swanepoel, 1982; Watret et 
a l ,  1985; Overton et a l ,  1987). The NSs protein encoded by TSWV is significantly 
larger and has Mr 52.4K (Kormelink et a l ,  1991).
Conflicting data have been reported on the presence of nonstructural proteins in 
virus particles. Overton et a l  (1987) reported that the NSs protein can be detected in 
purified virion and intracellular nucleocapsid preparations of PT phlebovirus. However, 
Simons et a l  (1990) could not demonstrate NSs in highly purified Uukunijmi virions. 
Kormelink et al. (1991) also reported that NSs protein of TSWV can not be detected in 
purified virions by Western blot analysis. Thus, the specific association of NSs protein 
with the nucleocapsid structure needs more extensive investigation. Struthers et a l  
(1984) clearly showed that the NSs of RVFV is phosphorylated, which is the only case 
of a Bunyaviridae specific phosphoprotein reported to date. The other unique feature of 
RVFV NSs is that it is present in the nuclei of the infected cells, which might be 
responsible for the formation of the intracellular inclusions observed in RVFV infected 
cells (Struthers and Swanepoel, 1982). The NSs protein of TSWV was demonstrated to 
be dispersed throughout the cytoplasm or associated with fibres in infected cells using an
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immunogold labelling technique. The amount of NSs protein has also been observed to 
be related with the severity of disease symptoms induced (Kormelink et al., 1991). NSs 
has been suggested to be involved in the viral RNA synthesis process (Bishop, 1985) 
and its function remains to be elucidated.
1.3.2.2. N Sm
The NSm proteins have been detected in bunyavirus and phlebovirus infected cells. 
The NSm proteins of bunyavirus are of Mr 11K-16K (Fuller and Bishop, 1982; Elliott, 
1985; Lees et a l ., 1986). Inspection of the amino acid sequence of four bunyavirus NSm 
proteins (Elliott, 1990) shows that NSm is highly hydrophobic, suggesting it is a 
membrane-associated protein.
In the Phlebovirus genus, the NSm of Punta Toro (PT) virus has different 
molecular weight (30K) to that of RVFV (14K). In addition to the 14K nonstructural 
protein, a 78K protein was also detected in RVFV infected cells (Kakach et al.t 1988). 
Subsequent studies (Wasmonen et a/., 1988) indicated that the 78K protein is the 
precursor polypeptide of preglycoprotein and G2.
Hydrophobic profile analysis of NSm implied that it may function as a signal 
peptide during translation and processing of the glycoproteins (Lees et a l., 1986). 
However, using ^ vaccinia virus expression system, the 78K and 14K proteins of RVFV 
do not appear to be necessary for glycoprotein synthesis, processing, modification or 
Golgi distribution. Thus, the role of NSm in the virus life cycle remains to be 
established.
1.4. Gene expression strategies
The coding relationship between the genomic RNA segments and the polypeptide 
gene products has been established through genetic and biochemical studies of the 
viruses. As segmented RNA genome, members of Bunyaviridae have the capacity to 
produce recombinant viruses by genome reassortment. By comparison of the 
polypeptide profiles of parental and recombinant viruses, the N protein was mapped to 
the S RNA segment (Gentsch and Bishop, 1978); the glycoproteins (Gl and G2) were 
mapped to the M RNA segment (Gentsch and Bishop, 1979); the L protein was mapped 
to the L RNA segment (Endres et al., 1989; Elliott, 1989a); and the nonstructural proteins 
NSs to the S segment and NSm to the M segment (Elliott, 1985; Fuller et al.t 1982).
These results have been confirmed by virus RNA genome nucleotide sequencing 
data which have also revealed the expression strategies of the individual genome 
segments. As the Bunyaviridae family contains such a large numbers of viruses (>300), 
there is significant diversity of viruses in genome structures and expression strategies.
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Based on the available information, the coding strategies of the Bunyaviridae genomes 
will be discussed in more detail regarding individual cases.
1.4.1. L RNA segment
It has been assumed that the L RNA segment encodes the L protein which functions 
as the viral polymerase. Although the L protein has been observed in representative 
viruses of all genera, direct evidence has only been obtained recently (Elliott, 1989a; 
Endres et al., 1989; Antic etal., 1991; Schmaljohn, 1990; Stohwasser et al., 1991). By 
making genome reassortment viruses in conjugation with viral protein migrating 
analyses, Endres et al. (1989) mapped the L protein of viruses in California serogroup to 
the L RNA segment. By a similar approach, Elliott (1989a) assigned the L protein of 
Bunyamwera virus to the L RNA segment.
The sequence data of the L RNA segment have been available for the Bunyamwera virus 
(Elliott, 1989a), hantaviruses (Antic e ta l,  1991; Schmaljohn, 1990; Stohwasser et al., 
1991), TSWV (de Haan et al., 1991), and Uukuniemi virus (Elliott et al., unpublished 
data). A long single open reading frame is identified in the viral complementary RNA 
with potential of encoding a protein of Mr >200K (Table 1.5 and Fig. 1.1). The L RNA 
segments and the encoded L proteins are very similar in size except that the nairovirus L 
segment is considerably larger (about twice size of other L RNA segments). Therefore, it 
appears that the coding potential of the nairovirus L RNA segment is grossly under 
utilized; sequence data are needed to elucidate its coding potential. All the L segments are 
rich in A and U residues(53-66.7%) and show economical use of the genomic RNA: 
97.7-98.86% nucleotides of the segment are used to encode the L protein. AUG-initiated 
ORFs in both (-) and (+) sense of the L segment have been screened and, in addition to 
the unique L ORF in the (-) sense, some short ORFs have been found in the (+) sense of 
Bunyamwera and Hantaan viruses (Elliott, 1989a; Schmaljohn, 1990). The longest ORF 
in (+) sense of Bunyamwera virus L segment is in position of nucleotides 6772-6383 and 
has 129 codons with potential of encoding a protein of Mr 14.7K. In Hantaan virus L 
segment the similar ORF (6302-5637) which could encode a polypeptide of 24 K was 
detected. However, no homology could be detected between the polypeptides encoded 
by these two ORFs (Schmaljohn, 1990). Preliminary data indicate that these proteins are 
not present in the virus infected cells, nor has the subgenomic transcript originating from 
these ORFs been detected by Northern blotting analysis (Elliott, 1989a). A small ORF 
has also been reported at the 3’ end of the L segment of Tacaribe arenavirus and the 
encoded 1 IK protein can be detected in the virus infected cells. This protein contains a 
potential metal binding domain and has been identified as a zinc finger protein 
(lapalucci et a l, 1989). "Zinc finger" sequences are generally rich in Cys residues, and
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Bunyavirus
BUN
3' 6875nt
L (259k)
5'
Hantavirus
HTN
3' 6530nt
L (247k)
5'
Phlebovirus
UUK
3' 6312nt 5'
L (241k)
Tospovirus
TSW
3' 8897nt 5 ’
L (332k)
Fig. 1.1. Gene expression strategy of the Bunyaviridae L RNA segment. Genomic 
RNAs are represented by thin lines, mRNAs by arrows (5’ end and 3' ends are 
indicated) and gene products are designated by stippled boxes (not to scale). This 
figure is from Elliott (1991).
are well known for their role in the recognition of specific sequences in dsDNA (Berg, 
1988) and specific recognition of RNA as found in moloney murine leukemia virus 
(Gorelick et a l ,  1988). Therefore, the significance of the ORFs in the viral sense L RNA 
segment requires to be investigated in more detail.
1.4.2. M RNA segment
The complete nucleotide sequence data of M RNA segments representing four 
genera in the family are available and are summarized in Table 1.6. The M RNA 
segments of all the viruses in the Bunyaviridae family encode glycoproteins Gl and G2. 
In addition, bunyaviruses and phleboviruses M segments also encode nonstructural 
protein(s) even though their gene orders are different. The gene order of the 
bunyaviruses M RNA segment is 5' G2-NSm-Gl 3’, hantaviruses and uukuviruses have
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the gene order of 5' G1-G2 3', and phleboviruses have 5’ NSm-Gl/G2-G2/Gl 3’ (Fig 
1.2). Thus, the gene expression strategies of viruses in each genus are apparently 
different and are discussed individually as follows:
Bunyavirus: The bunyavirus M segment encodes, in the viral complementary 
RNA, two virion glycoproteins Gl (Mr 100K-120K) and G2 (Mr 29K-41K), and a 
nonstructural protein termed NSm (Mr 11K-18K, Gentsch and Bishop, 1979; Fuller and 
Bishop, 1982; Elliott, 1985).
The M segments of bunyaviruses have very similar length, ranging from 4458 to 
4534 nucleotides, and have a single open reading frame of 1433-1441 amino acids 
(Elliott, 1990). The precursor polypeptide corresponding to this ORF has not been 
detected in infected cells. Attempts to translate bunyavirus M segment specific mRNA in 
vitro have also been unsuccessful (Abraham & Pattnaik, 1983; Elliott, 1985). The M 
RNA segment of Bunyamwera virus has been cloned into vaccinia virus^and Gl and 
NSm proteins have been produced (G2 was not labelled well enough for detection), 
and no precursor protein can be detected (Nakitare and Elliott, unpublished data). Thus, 
it appears that the polypeptide cleavage is probably a cotranslational event (Pennington et 
a l , 1977; Lees etal., 1986).
Using direct amino acid sequencing and specific peptide antibodies, Fazakerly et al. 
(1988) were able to determine the gene order of SSH M segment to be 5’ G2-NSm-Gl 3’ 
in the complementary RNA. The polypeptide sequences of the other three bunyavirus M 
segment precursor proteins have been aligned with that of SSH by Elliott (1990), which 
revealed a putative signal peptide of 13-21 residues at the amino terminus of the 
precursor. G2 is generated by cleavage after a conserved Arg residue; cleavage of G1 
from NSm may occur after a common Ala residue; there is a major trypsin sensitive site 
in Gl around residue 761 (Fazakerley etal., 1988; Gonzalez-Scarano, 1985).
Hantavirus: Hantavirus M segment encodes two virion associated glycoproteins 
Gl (68K-72K) and G2 (56K-57K) with the gene order of 5* G1-G2 3'(Fig.l.2). There 
is an 18-residue signal peptide preceding Gl and a small peptide of Mr 5.9K encoded 
between Gl and G2. The 5.9K peptide has not been detected in the virus infected cells 
and may only act as a signal sequence for G2 (Schmaljohn et al., 1987).
The M RNA segments of the three sequenced hantaviruses are very similar in size 
(3616-3682 nt). Two potential translation initiation codons are present in the sequence 
preceding the coding region for the Gl protein. The first AUG is conserved in the ORFs 
of all three hantaviruses and its exclusive use is also supported by the presence of more 
favourable flanking sequences. It is 18 codons away from the amino terminus of HTN 
Gl and 16 codons from that o f  S R - 1 1 Gl. This 16-18 amino acid stretch would 
constitute an efficient signal sequence (von Heijne, 1983; Schmaljohn et al., 1987) as in 
the case of bunyaviruses.
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3’ 4458nt
Bunyavirus
BUN
G2 NSm 
32k 18k
G l
110k
3'
Hantavirus
HTN
3616nt
G l
70k
G2
55k
3'
Phlebovirus
RFV
m 
14k
3 ’
Phlebovirus
UUK
3884nt
G2
55k
G l
62k
3231m 5'
G l
72k
G2
67k
Fig. 1.2. Coding strategies of the Bunyaviridae M genome segment. Genomic RNAs 
are repressed by thin lines, mRNAs by arrows (5' end and 3' ends are indicated) and 
gene products are designated by stippled boxes (not to scale). This figure is from 
Elliott (1991).
No precursor protein has been detected in hantavirus infected cells, suggesting
iA
either very rapid post-translational cleavage or/co-translational cleavage event. The exact 
cleavage site has not been mapped, neither have the factors affecting the cleavage. The 
G2 protein may also be synthesized through an internal initiation codon which precedes 
sequences encoding the G2 proteins of HTN virus and SR-11 virus (Schmaljohn et al., 
1987; Arikawa et al., 1990). This AUG can be efficiently used to produce HTN G2 by 
both recombinant baculovirus and vaccinia virus expression systems (Schmaljohn et al., 
1989, 1990), though its use in Hantaan virus infected cells remains to be determined.
P hlebovirus: The M segment of phlebovirus encodes Gl, G2 and NSm, with 
NSm preceding Gl or G2. The M segmenuof two phleboviruses, Punta Toro (PT) virus
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and Rift Valley fever virus (RVFV), hai/ebeen sequenced and are 4330 bases and 3884 
bases in length respectively. The gene order is 5' NSm-Gl-G2 3’ for PT virus and 5' 
NSm-G2-Gl 3' for RVFV M segment. The Gl protein of PT virus shows 35% 
similarity with the G2 protein of RVFV, and the G2 protein of PT virus has 49% 
similarity with the Gl protein of RVFV (Ihara et al., 1985b). This reflects the 
nomenclature system for the glycoproteins, whereby the slowest migrating protein on 
SDS-polyacrylamide gel is designated as Gl. The sizes of nonstructural proteins encoded 
by PT virus and RVFV are significantly different. PT virus M segment encodesjNSm of 
Mr 30K ( I h a r a  et ai t 1985b), whereas RVFV M segment encodes a 14K protein as well 
as a 78K protein (Fig. 1.3), all of which have been detected in virus infected cells.
1 G2 Gl 3885nt
5 ' 1  ....... .— L m — ■ » — —  3'T T ▼ T ▼ T
78k
14k
G2 Gl
Fig. 1.3. Expression strategy of RVFV M RNA segment. At the top is shown 
the RNA with the coding region indicated. AUG codons are shown as I and N- 
linked glycosylation sites as \  The four protein products detected in infected 
cells (solid boxes - structural protein, stippled boxes - nonstructural proteins) are 
indicated below. This figure is modified from Elliott (1990).
The large precursor protein has not been detected in phlebovirus infected cells. A 
common cleavage event by an alanine-specific protease may be used by phlebovirus to 
cleave Gl and G2 (Ihara et a l., 1985b), as happens in the cleavage of the bunyavirus 
glycoprotein precursor to generate Gl. The 78K protein translated from^RVFV M 
segment probably contains an unprocessed polyprotein of NSm and G2 sequences. It is 
unclear why the cleavage site between the 14K (NSm) and G2 is not used in the 78K 
protein. It is speculated that glycosylation may have some role in the cleavage of this 
site, as it is shown that the 78K protein is glycosylated at both the preglycoprotein site 
which is not utilized in the 14K protein and the site that it shares with glycoprotein G2
(Kakach e ta l ., 1989).
The coding capacity and gene expression strategy of phlebovirus M RNA segment 
is very complicated and has been studied in detail in the case of RVFV (Fig. 1.3). There 
are five inframe AUG codons upstream of the amino terminus of the first glycoprotein 
(G2). Four proteins G l, G2 and two additional products, a glycosylated 78K protein 
and a nonglycosylated 14K protein (Kakach et al., 1989; Wasmonen et al., 1988) are
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derived from the single large ORF. The sequences represented in the 78K protein begin 
from the first AUG of the ORF and extend to the carboxy end of G2. The 14K protein 
initiates at the second AUG (37 amino acids downstream from the first AUG) and 
contains only^pre-02 sequence (Suzich & Collett, 1988; Suzich e ta l ,  1990). Efficient 
synthesis of G2 requires a translation start site within the preglycoprotein region and 
appears to use the second AUG codon as the 14K protein. By site-directed mutagenesis 
and recombinant vaccinia virus expression analyses, Suzich et al. (1990) found that about 
half the production of the Gl was synthesized by a mechanism independent of all in- 
phase methionine codons in the preglycoprotein region and suggested that an internal 
translation initiation may be responsible for this. Translation initiation at the first AUG 
results in utilization of the glycosylation site at position 285 in the 78K protein which is 
not used in the 14K protein and the lack of cleavage at the junction of the preglycoprotein 
and G2 of the 78K protein. Therefore, the sequence between AUG codon 1 and 2 is 
implicated in exerting a profound influence on subsequent protein glycosylation and 
proteolytic processing.
The M segment sequence of Uukuniemi virus has been determined. It is 3231 
bases long and encodes Gl and G2 in a single ORF on the viral complementary RNA.^ ^  
A large precursor protein (110K) has been detected by translation in vitro of,M 
segment specific mRNA extracted from infected cells, and the in vitro produced 110K 
polypeptide was cleaved roughly in the middle in the presence of microsomal membranes 
to generate Gl and G2 (Ulmanen et al., 1981). The cleavage site between Gl and G2 
and the factors affecting the cleavage (presumably microsome associated) have not been 
determined.
The gene order of the uukuvirus M segment is 5' G1-G2 3' and no preglycoprotein 
coding region has been found. The amino terminus of Gl is located 17 amino acids 
downstream of the AUG (Ronnholm & Pettersson, 1987). Both Gl and G2 are 
preceded by stretches of predominantly hydrophobic amino acids which might act as 
signal sequences.
1.4.3. S RNA segment
The expression strategies of S RNA segment have been examined in detail because 
of the availability of more sequence data and are summarized in Fig. 1.4 and Table 1.7.
Th * S segments of bunyaviruses are very similar in size (850-961 bases in length) 
d th< oded proteins N (233-235 aa) and NSs (91-101 aa) are also very similar.
• N *>K) and NSs (10K-12K) arc encoded in overlapping reading frames in the
c ntary RNA. A single mRNA species appears to be used for translation of
resulting from alternative initiation of translation (Bishop et al., 1982;
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Elliott & McGregor, 1989). There also appears a third AUG-initiated ORF(ORF3) in the 
S RNA segments of Gemruston and Maguan viruses which is in the same frame as and 
downstream of the NSs ORF. ORF3 of Maguari virus can be translated in vitro into a 
9.3 K protein from mRNA transcribed from its cDNA, but this protein has not been 
found in virus infected cells and its significance is questionable (Elliott & McGregor,
1989).
The S RNA segment expression strategies of Hantavirus and Nairovirus are very 
similar. The segments of both viruses have similar length, 1675 to 1785 nucleotides for 
hantaviruses and 1712 nucleotides for Dugbe nairovirus. There is a single ORF encoding 
the N protein (48-49K) in the viral complementary RNA (for references, sec Table 1.7). 
No evidence for an NSs encoded by the S RNA has been found. Interestingly, a small 
ORF which could code for a 5.9K polypeptide was identified in the same reading frame 
immediately following the termination codon of two strains of Hantaan viruses but not in 
SR-11, NE and PH viruses and Dugbe nairovirus (Schmaljohn et a l., 1986; Ward et al.,
1990). This 5.9K protein has not been detected in virus infected cells and the reading 
frame is not conserved in the S segments of the four sequenced hantaviruses. Therefore, 
its significance remains to be determined but it does not appear to be equivalent to the 
NSs protein of bunyaviruses.
The S segment of phleboviruses and tospovirus uses a novel ambisense expression 
strategy (for references, see Table 1.7). The S RNA segments of phleboviruses are very 
similar in length (1690-1746 bases) and are about twice the size of the bunyavirus S 
segment. Thus, they have more than sufficient potential coding information for both N 
(27K-28.5K) and NSs (30K-32k) proteins. The S segment of TWSV is even larger 
(2916 bases long) and also encodes both N (28.8K) and NSs (54.2K) proteins. The N 
protein of these viruses is encoded in a complementary plus sense RNA corresponding to 
the 3' half of the genomic S RNA, whereas NSs is encoded in the 5' half of the genomic 
RNA (Fig. 1.4). The N and NSs Proteins are translated from separate subgenomic 
mRNAs (Ihara et a l ,  1984, 1985a). This ambisense strategy of encoding two proteins 
from non overlapping regions of virion sense and anti-virion sense RNAs has also been 
identified in the Sfend L segments of arenaviruses. Another unique feature of these three 
different viruses is the presence of an intergenic region (IR) between the ORFs for N and 
NSs. However, the lengths of the IR are dramatically different, ranging from 62 to 508 
nucleotides (Table 1.7). PT virus S segment IR is A+U rich and can potentially foim an 
energetically stable hairpin structure involving 200 nucleotides (Emery^and Bishop,
1987), and such an RNA secondary structure might be involved in^transcnption 
termination process. The IRs of Uukuniemi virus and TSWV are also A+U rich and are 
predicted to form a stem-loop structure (Simons et al., 1991; De Haan et al., 1990). In
Chapter 1 Review of the literature 26
contrast, the S RNA of SSF virus has a predominantly C-rich IR and cannot be folded 
into a base-paired structure (Marriott et al., 1989).
3' 961 nt 5'
Bunyavirus
Nairovirus
BUN EL..:...:....,.:.................. ............................. : ^
N (26k)
NSs (Ilk)
^ 1696nt ^
Hantavirus
HTN
N (48k)
3' 1712nt 5'
■  ►
DUG r / - ................. ... . .......... 1
N (50k)
3 ’ 1720nt 5 ’
Phlebovirus
UUK h r n ^ r n m ^ m m
N (28k)
B B S  
NSs (32k)
3' 2916nt 5'
Tospovirus
TSW N (29k)
NSs (52k)
Fig 1 4 Coding strategies of the Bunyaviridae S genome segment. Genomic RNAs 
are repressed by thin lines, mRNAs by arrows (5' end and 3’ ends are indicated) and 
gene products are designated by stippled boxes (not to scale). This figure is from
Elliott (1991).
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1.5. RNA synthesis
All negative-strand RNA viruses require active transcription of their genomic RNA 
following penetration into a susceptible host cell as a prerequisite for replication of their 
genomes and the Bunyaviridae is no exception. The minus-strand genomes are templates 
for two kinds of RNA synthesis, that of mRNAs and antigenomes. Following 
translation of the primary mRNA transcripts, genome replication and amplification by 
secondary transcription of mRNA then occur. Antigenomic RNA is encapsidated by the 
N protein and acts as a replicative intermediate, whereas mRNA is naked which ensures 
its translational properties. The RNA synthesis process of viruses in Bunyaviridae is not 
fully understood. Data on mRNA synthesis are mainly based on the studies of 
Bunyavirus genus and little is known about the genome replication process.
1.5.1. RNA templates
The functional template for both transcription and replication of all the RNA viruses 
with negative-strand genome is a ribonucleoprotein complex (nucleocapsid) with RNA 
completely encapsidated by the N protein. The genome segments (L, M and S) of 
bunyaviruses are found as viral nucleocapsids both in virions and in infected cells which 
have been described in section 1.2.3.
The first 11 bases of 5’ and 3' end structures of the three segments of bunyaviruses 
are strictly conserved and can form panhandle structure by base pairing. Recently, Raju 
& Kolakofsky (1989) have shown that the ends of the full-length (-) and (+) strands are 
base-paired in the viral nucleocapsid. They reiterated the importance of unmatched and 
mismatched bases within double strand regions of RNA for recognition by proteins 
(Wickens & Dahlberg, 1987). They stressed that the ends of the (-) and (+) RNAs 
would have significantly different structures as the G:U pairs in genomic RNA are 
allowed pairs but the corresponding A:C pairs in antigenome would break the helical 
stack. Therefore, it is speculated that the G:U pairs in genomic and A:C pairs in 
antigenomic RNA can be recognised by proteins differently. The ability of proteins to 
distinguish these structures may be the basis by which genomes and antigenomes are 
differently transcribed, and genomic RNA packaged into virions.
It has been realized that the larger the segment, the longer and stronger the 
panhandle structure (Kolakofsky and Hacker, 1991). The longer segment has also less 
mRNA and anti-mRNA made per template (Hacker et a l., 1990), presumably because it 
is relatively more difficult to open the longer end structure for mRNA synthesis. In fact, 
the amounts of the three RNA species are not equimolar and S is usually the predominant
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Fig. 1.5. Complementary sequences and possible base-paired structures between Me 
3’ and 5' termini of Bunyamwera virus genomic RNA segments. The termini 11 
nucleotides are conserved in all genome segments; shaded regions, nucleotides which 
are conserved on a segment specific basis in all available sequenced bunyavirus RNA 
segments. This figure is from Elliott et al. (1991).
species. In attempts to measure the relative amounts of the three mRNA species, Rossier 
et al. (1988) used slot blot hybridization. mRNA from LAC virus infected BHK cells 
was pelleted through a CsCl gradient and hybridized to riboprobes specific for each 
segment The riboprobes were of similar length (400-600 nt) to minimize differences in 
their annealing characteristics. It was found that the S mRNAs (5 per S genome 
segment) were approximately 10-fold more abundant than M mRNAs (0.5 per M 
genome) and 100-fold more abundant than L mRNAs (0.05 per L genome). Therefore, 
the three genome segments appear to transcribe their mRNAs at very different rates 
depending on the requirements for their individual gene products. The exact mechanism 
regulating the transcription of each of the three genome segments is not known yet
The mechanism by which the N proteins encapsidate viral RNAs is not fully 
understood yet. Recently, Raju and Kolakofsky (1987) have observed two unusual 
transcripts in LAC virus-infected BHK cells. By Northern blot and primer extension 
analyses of S RNA species, two S mRNA-like species were detected in the banded
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intracellular nucleocapsid preparations. One had nucleotides 1-886 of the S RNA, which 
terminated to the mRNA termination site. The other had nucleotides (-) 15-983, which 
had the 3' genomic end but contained host-derived primers at 5' end. Since both were 
encapsidated with the N protein, it was suggested that the encapsidation site is located at 
the 5’ end of the genome and antigenome. Later, Hacker et a/.(1989) reported that in 
LAC bunyavirus infected mosquito cells, the S mRNAs of LAC were encapsidated by the 
N protein. Analysis of the micrococcal nuclease sensitivity of encapsidated S RNA 
showed that the nontemplated primers were also encapsidated. On the other hand, little 
or no cellular mRNA was found to be even partially assembled. It appears that 
nucleocapsid assembly occurs bidirectionally and the N protein recognizes a specific viral 
sequence or structure at the 5’ end of mRNA. Therefore, it can be concluded that the 
assembly site is initiated from the conserved 5' ends of the genome and antigenome 
chains.
The RNA binding site of the N protein has not been investigated. Inspection of the 
charge distribution along the amino acid sequence of the N proteins revealed that the N 
proteins of phleboviruses possess a 70 residue region with distinctly basic character 
preceded by a 30 residues acidic amino-terminal domain (Elliott et al., 1991). This 
stretch of basic amino acid region may contain the RNA binding site.
1.5.2. Initiation
The length of mRNA is different from the genomic or antigenomic RNA. It is 
about 100 bases shorter at 3' end and has extra bases at 5' end. Plus-sense antigenomic 
RNA is a full length copy of the genome, which is encapsidated with the N protein and 
acts as a replicative intermediate. The initiation of mRNA and antigenomic RNA 
synthesis is different and will be discussed separately.
1.5.2.1. Initiation of mRNA synthesis
Sequence analyses of the 5' end of virus mRNA have been undertaken in order to 
determine the transcription initiation mechanism and the data have been available for five 
viruses in the family." LAC (Patterson & Kolakofsky, 1984), SSH (Bishop et al., 1983, 
Eshita et al., 1985), GER (Bouloy et al., 1990; Gerbaud et al., 1987a) of Bunyavirus 
genus, UUK (Simons & Pettersson, 1991)^and FT (Collett, 1986; Ihara et al., 1985a) 
of Phlebovirus genus. All the viral mRNA species analysed possess a 12-18 nt long 
heterogeneous nonviral sequence which may be derived from host mRNAs and used to 
prime mRNA syntheses, a mechanism remarkably similar to that of influenza virus (for a 
review, see Krug, 1981, Krug et al., 1989). The speculation has been supported by 
further analysis of polymerase activity of a purified LAC virion preparation (Patterson et
Chapter 1 Review of the literature 31
al., 1984). It was demonstrated that the LAC virion associated polymerase activity can 
be stimulated by oligonucleotides such as (A)nG which can be incorporated into the in 
vitro synthesized transcripts, cap analogs such as mGpppG and natural mRNAs such as 
alfalfa mosaic virus RNA4 (ALMV RNA4). An endonuclease activity was also detected 
in purified LAC virions and 12-18 nucleotides can be cleaved from the cap group of 
ALMV RNA4. This endonuclease activity may be responsible for the mRNA instability 
in mammalian cells induced by bunyavirus infection (Raju and Kolakofsky, 1988). 
Again, analogous to the influenza virion endonuclease, the LAC endonuclease do ts not 
cleave unmethylated ALMV RNA4. The capped sequences present in the LAC virus S 
mRNA could be specifically selected by anti-cap antibodies (Hacker et al., 1990). Thus, 
these data strongly suggest that bunyaviruses initiate the synthesis of their mRNAs by 
capturing the 5' end sequence of a host mRNA and using it as a primer.
The influenza virus genome is transcribed in the nucleus of the host cell; the primers 
required for influenza virus RNA transcription initiation are cleaved from the cellular 
mRNA precursors and influenza virus RNA needs to undergo maturation processes, 
such as splicing and polyadenylation which are catalyzed by host nuclear enzymes (Krug 
et al., 1989). In contrast, bunyaviruses do not have spliced mRNAs and appear to 
replicate solely in the cytoplasm (Rossier et al., 1986). It was reported that 
California encephalitis bunyavirus could produce progeny in enucleated cells (Goldman et 
al., 1977). By pulse-labelling of infected cells for various times and determination of the 
amount of the labelled S mRNA in both the cytoplasmic and nuclear fractions, Rossier et 
al. (1986) were able to examine the cellular site of LAC virus S mRNA synthesis. They 
demonstrated that the majority of the pulselabelled LAC S mRNA (85-87%) were 
detected in the cytoplasmic fraction and suggested that LAC virus S genome transcription 
appeared to be in the cytoplasm. Moreover, unlike influenza virus, bunyavirus 
replication is not affected by actinomycin D, a drug which inhibits DNA dependent-RNA 
polymerase such as host cell RNA polymerase II (Obijeski & Murphy, 1977). It is 
therefore believed that bunyaviruses acquire the primers needed for transcription 
initiation from a cytoplasmic pool rather than from newly synthesized nuclear
transcripts.
Bouloy et al. (1990) found that the primers present at the 5' end of the M and S 
Germiston mRNA had a high C and G content which was never less than 50% (Fig. 1.6). 
With one exception, the penultimate base at position -1 was either U or C, with U being 
the preferred base (13 cases of 18), indicating that the nucleolytic activity of the 
endonuclease of bunyavirus should be U or C specific. This observation was also 
confirmed for the 5' ends of the N mRNAs and 5' ends of the NSs mRNAs of 
Uukuniemi virus (Simons & Pettersson, 1991).
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3 ' UCAUC ACAU. . .v  RNA 
5' A G U A G ll G U A . . .c RNA
CGCGAGU AG.............................
C U U C A G C U  AG.............................
CG CCGUCGUU AG.............................
AUCCGGAGCC A G ............................
A A A C C U CG CC C  A G ...........................
CGCAGAGGAGU A G  .....................
C C C U C U GC GG U  A G ............................
C U C C C A A G A U G  G ............................
C U C U U U C C A G C C  AG..............................
UC CC CA GA CG GU AG.............................
AC CC U C AG UC C GU  AG.............................
U A CC U G C G C C UC C  G ............................
CACU U CCCCCGCU G.............................
C C AG GG AA ACC AC  G ............................
CCAUGUCG GG CGGU AG.............................
C U C U C U U C A C C A G U  AG.............................
AC CGG AUG UG UCC U AG............................
ACUCGCGGCGGGGU AG..............................
CC UC U GC C AC U C UU GU  AG
Fig. 1.6. Sequences of the 5' region of several S mRNA molecules of Germiston 
virus. Nineteen recombinant plasmids with S-specific inserts were sequenced and 
the nonviral sequence of the 5' end of the insert is indicated. The sequence of the 
3' end of the virion RNA and its copy representing the 5' end of the mRNA are 
shown on the top lines. This figure is from Bouloy et al. (1990).
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Recently, studies on Tacaribe arenavirus .end structures (Garcin & Kolakofsky,
(K
1990) reveal thatjnontemplated heterogeneous capped base is also present at the 5' ends 
of the N mRNAs of Tacaribe virus. Therefore, it appears that all the three negative- 
strand RNA virus families with segmented genomes, Arenaviridae, Bunyaviridae and 
Orthomyxoviridae, employ a similar initiation mechanism by using specifically capped 
RNA fragments derived from host cell RNAs.
The promoter sequence in the influenza virus genome has been investigated by an in 
vitro transcription assay of reconstituted nucleocapsid templates containing only the 3' 
end of genomic RNA. The evidence suggested that the promoter of influenza virus RNA 
lay within 15 nucleotide*of|^-terminus (Parvin et a l., 1989). Yamanaka et al. (1991) 
further defined the important promoter signal of influenza virus to reside at position of 6- 
14 of the 3' terminus using a transfection system with a synthetic genetically engineered 
RNA. The chloramphenicol acetyltransferase (CAT) gene was inserted between the non 
coding region sequences of the influenza virus RNA genome segment 8 and negative 
sense CAT RNA was synthesized in vitro by T7 RNA polymerase. This RNA was then 
complexed with influenza viral RNA polymerase and NP proteins and introduced into 
cells infected with a helper virus. Transcription of the engineered RNA was monitored 
by CAT assay. Site directed nutagenesis of the terminal sequences was performed and it 
was found that mutations of the 3' terminal base hardly affected transcription, whereas 
mutations at positions 6-14 from the 3' end significantly reduced transcription, 
suggesting that the 6-14 bases of the 3' end of the influenza virus RNA are important in 
the promoter sequence. It is most likely that the promoter sequence of bunyavirus is also 
located within the conserved end sequence.
It has been considered that viral mRNA synthesis only initiates on a genome sense 
RNA template. Recently, Hacker et al. (1990) reported that mRNA-like transcripts were 
also synthesized from antigenome templates of LAC virus as examined by Northern 
blotting using strand-specific riboprobes and primer extension analysis. These mRNA- 
like transcripts were thus termed as anti-mRNA and were characterized by possession of 
a similar range of capped nontemplated sequences at their 5’ ends which were precipitated 
by anti-cap antibodies. Therefore, the initiation of anti-mRNA is probably the same 
as that for mRNA, and the viral RNA polymerase may recognize the 3’ end sequences of 
antigenomes to synthesize anti-mRNA. However, the role of these anti-mRNAs during 
virus infection is unclear.
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1.5.2.2. Initiation of genome replication
Genomes and antigenomes initiate with ATP at the precise 3' end of the templates 
(Obijeski et a l., 1980), clearly by a different mechanism to that of mRNA synthesis. It is 
known that protein synthesis is required for bunyavirus replication to occur, although it is 
not determined which viral proteins are required. Since both genomes and antigenomes 
are found only as nucleocapsids and the sites for the N protein assembly appear to start 
at the 5' ends of these chains, it is logical to speculate that RNA synthesis and assembly 
take place concurrently (Kolakofsky and Hacker, 1991). It appears that the presence of 
assembling N protein participates in the initiation of genome replication. The switch 
between transcription and replication is most likely to occur at the level of chain initiation 
though the factors controlling this switch are not well understood. In addition to the N 
protein, the most likely candidates are modification of the L protein, or possibly the NSs 
protein where it exists.
The NS protein (now referred to as P protein) of VS V has been proposed to play an 
important role in the switch between transcription and replication of VSV (Wertz et a/., 
1987). Three functional domains of VSV NS protein have been identified (Banerjee,
1987). The template binding domain is located in the carboxy-terminal basic region (Gill 
et a l., 1986); the L protein binding domain which is close to the template binding domain 
is directly involved in binding with the L protein to form the active RNA polymerase 
complex (Chattopadhyay & Baneijee, 1987a, b); and an ancillary domain at the N 
terminus might be responsible for the chain elongation (Chattopadhyay & Baneijee,
1988). It appears that the NS protein of VSV regulates replication by controlling the 
availability of the N protein, thereby controlling the balance between RNA replication and 
transcription (Wertz et a l., 1987). More detailed studies of the NSs protein of 
bunyaviruses are required to elucidate its function in the RNA synthesis process and to 
see whether it functions similarly to the VSV NS protein.
1.5.3. Termination
The mRNAs of viruses in the Bunyaviridae are about 60-120 nucleotides 
shorter than full-length transcripts and there appears to be a termination site(s) near the 5' 
end of the genome to prevent the polymerase reading through. A few termination sites 
have been mapped for some of the viruses by analyses of the 3' end sequences of viral 
mRNA species (Patterson & Kolakofsky, 1984; Eshita et a l., 1985; Emery & Bishop, 
1987; Bouloy et a/., 1990; Simons & Pettersson, 1991). It has been found that all the 
stop signals are usually located in a sequence rich in Us and contain a G residue. RVF 
phlebovirus is an exception in that the proposed termination site is C rich (Collett, 1986).
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Germiston M and S mRNA have transcription stop sequence of UUUUUGUUU and 
UUUGUU respectively (Bouloy et al., 1990), LAC virus S mRNA has GUUUUU and 
Bunyamwera virus M mRNA has the sequence GUUUUUUG after the translational stop 
codon. These U rich sequences are similar to the termination signal of influenza viruses 
which also consists of a stretch of 5-7 uridine residues (Hay et al., 1977; Krug et al., 
1989). Because other similar U rich sequences are also present in the virus 
genome, especially upstream from the termination site, it is possible that flanking 
sequences are also involved to enable the transcriptase to recognize the termination signal 
(Bouloy et al., 1990). Further mapping studies are required to delineate these in detail.
For phleboviruses having an ambisense expression strategy, the internal repeat 
regions of RNA genome may be involved in the terminal signal recognition. Northern 
blot analysis of PT virus infected cellular mRNA with 32p_iat>euecj synthetic 
oligonucleotide probes has enabled the 3' termini of both the N and NSs mRNA species 
to be mapped to a common region of the PT S RNA segment genome between 
nucleotides 977 and 1017 (Emery and Bishop, 1987). Secondary structure analysis of 
the intergenic region reveals an energetically stable A:U rich hairpin structure extending 
from nucleotide 886 to 1090 with its peak at 996 which correlates with the region 
involved in termination of mRNA transcription. However, some phleboviruses such as 
sandfly fever Sicilian virus have a C-rich intergenic region which can not be folded into a 
large base paired structure (Marriott et al., 1989). Most recently, Simons & Petterson 
(1991) reported that the 3' ends of the N and NSs mRNAs of Uukuniemi virus overlap 
each other by about 100 nucleotides. The 3' end of the NSs mRNA extends into the 
coding sequence of the N mRNA, whereas the N mRNA is terminated just prior to the 
stop codon of NSs. Therefore, the role of the intergenic region in the termination of 
phlebovirus mRNA transcription remains to be determined.
An important consequence of the missing sequence at the end of the mRNAs has 
been speculated to have some significant role in ^ translation process. Unlike the 
antigenomic and genomic RNA, the endsof mRNA are no longer complementary and can 
not form circular or panhandle structures which might interfere with their translation 
(Kolakofsky and Hacker, 1991).
1.5.4. Elongation: translational requirement of mRNA 
synthesis
Conflicting data concerning the requirement for ongoing host protein synthesis of 
virus primary transcription have been reported in the B unyavirus genus. Protein 
synthesis inhibitors have been found to have no effect on primary transcription in other 
negative-strand RNA virus families such as the Orthomyxoviridae (Bean & Simpson,
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1973), Rhabdoviridae (Marcus et al., 1971) and Paramyxoviridae (Robinson, 1971). 
Very low levels of primary transcripts have been detected in Bunyamwera or snowshoe 
hare virus infected cells in the presence of drugs that inhibit host cell protein synthesis 
(Kascsak & Lyons, 1977; Vezza et al., 1979). Using cDNA hybridization probes for 
analysis of the mRNA species in snowshoe hare virus infected cells which had been 
treated with puromycin, only S mRNA was detected (Eshita et al., 1985). Furthermore, 
in vitro studies showed that full-length S transcripts of Germiston virus could be obtained 
in an in vitro transcription system (Gerbaud et al., 1987a), although Germiston S 
segment mRNA synthesis was inhibited in cell culture by either anisomycin or 
cycloheximide.
Some evidences indicate that bunyavirus mRNA synthesis is sensitive to drugs that 
disrupt protein synthesis. This finding was first reported for Bunyamwera virus 
(Abraham & Pattnaik, 1983) and Akabane bunyavirus (Pattnaik & Abraham, 1983), and 
has been confirmed for LAC (Raju & Kolakofsky, 1986b) and Germiston virus 
(Gerbaud et al., 1987a). These results have no precedence among other negative-strand 
RNA viruses and are contradictory to the results mentioned above.
/A detailed examination of the translational requirement of bunyavirus mRNA 
synthesis has thus been performed on the S segment of LAC virus in both in vitro and in 
vivo systems (Raju & Kolakofsky, 1986a; Bellocq et al., 1987; Raju et al., 1989). In 
the absence of a reticulocyte lysate, transcription in vitro from the S segment genome by 
the virion associated polymerase produced two incomplete transcripts, 110 and 205 
nucleotides in length, whereas full length S mRNA (900 nt) was predominantly made 
when the lysate was added. The drugs puromycin, cycloheximide and pactamycin, were 
then added to the system to test their effect on LAC transcription. It appears that all these 
drugs caused S transcription to terminate prematurely at the defined sites. The data 
suggest that the requirement for ongoing protein synthesis for productive transcription in 
vitro is not at the level of chain initiation but at the level of the nascent RNA chain 
elongation beyond the termination sites (Bellocq et al., 1987). Further studies indicate 
that the translational requirement for complete LAC mRNA synthesis is cell-type 
dependent (Raju et al., 1989). Total cellular mRNAs from LAC virus infected cells 
which had been exposed to various translational inhibitors for 4 hours were analysed by 
solution hybridization to strand specific riboprobes which represent three different 
regions of LAC S RNA. The hybrids were further assayed by RNase mapping 
techniques. Small amountsof shorter S plus-strand RNA (approximately 154 nt in length) 
were found in virus infected BHK cells. These shorter transcripts were also detected in 
HEL and Vero mammalian cells infected with LAC virus in the presence of protein 
synthesis inhibitors. On the other hand, in the mosquito cell line, C6/36, infected with 
the virus in the presence of cycloheximide, virus RNAs were found to resist RNase
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digestion. Surprisingly, in the mosquito cells, secondary transcription of S RNA of LAC 
was not affected by the drug either.
Using either BHK or C6/36 cell extracts for reconstitution studies in vitro Raju et 
al. (1989) suggested that the translational requirement was due to a factor(s) present in 
BHK, but not in C6/36 cells. When uninfected BHK cell extracts were added to the in 
vitro  transcription system programmed with virus genomes prepared from LAC virus 
infected mosquito cells, the extract recreated the translational requirement of mRNA 
synthesis. Further, by pelleting mRNA prepared from LAC virus infected cells through a 
sucrose cushion to remove cellular protein components, the ability of S mRNA 
transcription to read through the termination sites was increased.
Since premature termination of LAC S mRNA synthesis takes place efficiently 
when purified virions alone were used (Bellocq et a l., 1987), it is unlikely that a host 
termination factor is involved in the in vitro system. Thus, the possible role of 
RNA:RNA interactions in transcription premature termination was then proposed 
(Kolakofsky et al., 1987). It had been reported that substitution of inosine for guanosine 
would weaken possible RNArRNA interactions (Lee & Yanofsky, 1977). When GTP 
was progressively replaced with ITP in the absence of reticulocyte lysate in the LAC 
virion polymerase reaction, the synthesis of complete S mRNA become more 
predominant (Kolakofsky et al., 1987). BrUTP incorporation has been suggested to 
strengthen base pairing and its incorporation into the nascent LAC S mRNA chain 
counteracted the effect induced by inosine incorporation. Thus, it is possible that the 
nascent chain can interact with its template cause premature termination and therefore, 
concurrent translation of the nascent chain is required to break these interactions.
Based on the observations described above, Kolakofsky et al. (1987) have 
proposed a model to explain the curious coupling of translation to the primary 
transcription. The model suggests that interaction between the nascent chain and its 
template causes the polymerase to pause and terminate, thus generating the incomplete 
transcripts. In the presence of concomitant protein synthesis, ribosomes moving along 
the nascent mRNA behind the polymerase prevent the mRNA from hybridizing to its 
template and enable the polymerase to read through the major termination sites (Bellocq & 
Kolakofsky, 1987; Kolakofsky et a l., 1987). Such a translational requirement 
mechanism would then be similar to that in certain bacterial systems (Platt, 1986, von 
Hippel et al., 1984), whereby ribosomes prevent RNArRNA interactions and thus 
premature termination. Whether this hypothesis only applies to LAC virus or to all the 
viruses in the family remains a question and investigation of more primary transcription 
process^of all three RNA segments of the viruses in the family should help clarify this 
issue. A functional analysis ofjyiral RNA polymerase from molecularly cloned and 
expressed L gene segment is also required to explain this.
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RNA polymerase is the key enzyme for RNA viruses to transcribe and replicate 
their RNA genomes. Most RNA viruses replicate outside the nucleus of the host cells 
and thus are independent of cellular replication functions. Some positive-strand RNA 
viruses, such as picomaviruses, have evolved to encode the RNA polymerase in their 
genomic sense RNA which can be translated right after entering the cells. The negative- 
strand RNA viruses, on the other hand, due to their genomic RNAs being unable to 
directly translate this unique RNA polymerase, have to package the enzyme within the 
virion during viral morphogenesis. The virion associated RNA polymerase, in turn, 
plays a unique role in initiating infection by carrying out primary transcription of the 
genome when the virus infects gl cell • Except orthomyxoviruses, all negative-strand 
RNA viruses encode a large (L) polymerase protein in their complementary RNA, with 
similar molecular weight of >200 K (Fig. 1.7 and Table 1.8), despite the diversity of their 
genomes. The polymerase of orthomyxoviruses comprises three proteins, PB1, PB2 and 
PA, which are encoded by three different segments. However, the combined length 
(6915 bases) of these three polymerase genes is very similar to the L gene of other 
negative-strand RNA viruses and the combined molecular weight of the three P proteins 
is 246-285 K (Lamb, 1989) which is also very similar to that of the L proteins.
The polymerase of negative-strand RNA viruses is unique in that it can not directly 
utilize the naked RNA as its template. Rather, it recognizes the viral genome only in the 
context of the nucleocapsid core. The N protein confers a helical structure on the 
nucleocapsid and is essential for the recognition of the genomic template RNA by the 
virus polymerase. By virtue of its large size and its presence in very low amounts in the 
virion of the L protein, the majority of the enzymatic activities involved in transcription 
and replication are thought to reside in the L protein and hence this large protein is 
presumably multifunctional.
Through genetic and biochemical studies, several enzyme activities have been found 
to be associated with the L protein of vesicular stomatitis virus (VSV), such as viral 
mRNA capping (Banerjee, 1987), methyltransferase (Hercyk et al., 1988), poly(A) 
polymerase (Hunt et al., 1984) and protein kinase (Sanchez et al., 1985) activities. For 
VSV transcription, the L protein alone is unable to perform RNA synthesis and the 
phosphorylated NS protein plays a crucial role in the transcription process by complcxing 
with the L protein to maintain its functional conformation (Baneijee, 1987). It is not 
known if the L protein of bunyaviru%j>erforms all the polymerase functions or if some 
other protein is also required.
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To map the various functional domains within the L protein, it is necessary to 
determine the relationship between its primary structure and its role in RNA transcription 
and replication. The determination of the complete nucleotide sequence of the L RNA 
segment represents the first important step for analysis of the virus polymerase function 
and further elucidation of the mechanism of RNA transcription and replication.
Morbillivirus
(measles)
Vesiculovirus 
(VSV)
Bunyavirus
(Bunyamwera)
Arenavirus 
(Tacaribe)
Orthomyxovirus 
(Influenza)
[Core genes] Envelope genes | polymerase genes |
Fig. 1.7. Gene alignment of the genomes of negative-strand RNA viruses. This figure
diagram is modified from Pringle (1991) and Peters (1991).
1.6.1 Sequence analysis of the L gene
The complete nucleotide sequence of the L segment has been determined for six 
viruses in the Bunyaviridae: Bunyamwera (Elliott, 1989a) of the Bunyavirus genus, 
Hantaan (Schmaljohn, 1990), Seoul 80-39 (Antic et a l ,  1991) and nephropathia 
epidemica viruses (Stohwasser et a l., 1991) of the Hantavirus genus, TSWV (de Haan et 
a l., 1991) of the Tospovirus genus and Uukuniemi virus (Elliott et a l, unpublished data)
of the Phlebovirus genus.
The properties of the amino acids in the predicted L protein of NE virus have been 
studied and the NE L protein displays an acidic character at its carboxy terminus, and 
within this acidic domain, a stretch of 80 amino acids (residue 1948-2027) is mainly 
composed of four hydrophilic amino acids. In addition, there is a slightly acidic cluster 
in the central region and close to it exists a strongly basic domain between residues 900- 
1000 (Stohwasser et al., 1991).
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Table 1.8. Comparison of the polymerase genes and deduced proteins 
of negative-strand RNA viruses
Family Virus Polymerase Gene 
(nt)
Deduced Protein 
Residues Mr (kDa)
Paramyxoviridae RSV 6575 2165 250
MEV 6639 2183 248
PIV3 6755 2233 256
NDV 6704 2204 279
SeV 6800 2228 253
Rhabdoviridae RaV 6475 2142 244
VSV 6380 2109 241
Arenaviridae LCMV 6677 2210 254
TV 6698 2210 252
Bunyaviridae BUN 6875 2238 259
HTN 6530 2150 247
SEO 6530 2150 247
NE 6550 2156 246
UUK 6423 2103 241
TSW 8897 2876 331
Orthomyxoviridae Influ A 2320 (PB1) 757 87
2320 (PB2) 759 88
2211 (PA) 716 82
RSV: Respiratory syncytial virus (Stec et al., 1991),
MEV: Measles virus (Blumberg et al., 1988),
PIV3: Parainfluenza virus (Galinski et al., 1988),
NDV: Newcastle disease virus (Yusoff et al., 1987),
SeV: Sendai virus (Shioda et al., 1986),
RaV: Rabies virus (Tordo et al., 1988),
VSV: Vesicular stomatitis virus (Schubert et al., 1984),
LCMV: Lymphocytic choriomeningitis virus (Salvato et al., 1989),
TV: Tacaribe virus Oapalucci et al., 1989),
BUN: Bunyamwera virus (Elliott, 1989b),
HTN: Hantaan virus (Schmaljohn, 1990),
SEO: Seoul 80-39 virus (Antic et al., 1990),
NE: Nephropathia epidemica virus (Stohwasser et al., 1991),
UUK: Uukuniemi virus (Elliott et al., unpublished)
TSW: Tomato spotted wilt virus (de Haan et al., 1991),
Influ A: Influenza A virus (Lamb, 1989).
Comparison of the deduced amino acid sequences from NE hantavirus and 
Bunyamwera virus L proteins revealed a high degree of diversity with overall amino acid 
identity of only 17%, even though three clusters of 30-40% amino acid identity can be 
detected between these two L genomes (Stohwasser et a l ., 1991). This is not so
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surprising as the Bunyaviridae is such a diverse family. No other complete bunyavirus L 
segment has been reported, though Clerk-van Haaster et al. (1982) have sequenced 200 
bases at the 3’ termini of the L RNA segments from LAC and SSH viruses of California 
serogroup of the Bunyavirus genus. Elliott (1989a) compared the amino acid sequences 
of these ORFs with the N-terminal residues of the Bunyamwera virus L protein and 
found that these predicted proteins are strongly homologous, with 29/46 residues (63%) 
being identical, suggesting that the L protein may have a high degree of conservation 
within the genus.
Most recently the L protein of the Seoul 80-39 hantavirus has been compared with 
the L protein of other negative-strand RNA viruses, which revealed 44% homology with 
pan of the Bunyamwera virus L protein and a very weak homology (17%) with the 
influenza virus PB1 protein (Antic et al., 1991). The same comparison has also been 
made for the NE L protein by Stohwasser et al. (1991). The highest degree of similarity 
was found in the region of BUN L (1070-1286), NE L (1017-1242) and PB1 (356-561), 
showing a total of 38% homology. Several clusters of higher homology within these 
central regions which contains the polymerase motifs were also evident, de Haan et al. 
(1991) revealed a significant amino acid sequence homology in an internal region 
(approximately 1000 amino acids long) between the L proteins of Bunyamwera virus and 
TSWV. However, homology between TSWV and Hantaan virus is lower and restricted 
to a shorter internal stretch of about 200 to 250 residues long. Comparisons of RNA 
polymerases from TSWV, Bunyamwera virus, Hantaan and influenza viruses also reveal 
the presence of amino acids sequence motifs that are present in all RNA polymerase 
proteins.
1.6.2. Sequence relationships of RNA-dependent RNA 
polymerases
By extensive and sophisticated computer analysis of 80 RNA-dependent 
polymerases from diverse sources of positive, negative and double-strand RNA viruses, 
as well as RNA dependent DNA polymerases encoded by retroid elements (reverse 
transcriptase), Poch et al. (1989) have identified four motifs in the same linear 
arrangement in all the polymerase proteins. The four motifs span a region of 120-210 
amino acids which contains four strictly and 18 conservatively maintained amino acids. 
Each motif has invariant amino acid(s) roughly centred between the conserved amino 
acids (Fig. 1.8). Motif C (S/GDD) corresponds to the YGDD span previously described 
by Kamer and Argos (1984) as being conserved among many RNA polymerases. 
However, more extensive analysis of Poch et al. reveals that only the DD dipeptide is 
universally maintained and may be a key functional domain in RNA-dependent
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polymerases. One important exception is that all the polymerase proteins of unsegmented 
negative-strand RNA viruses have GDN in motif C. In contrast, all the segmented 
negative-strand RNA viruses analysed, such as orthomyxoviruses and arenaviruses, have 
SDD in this motif. The only other instance of the DN dipeptide is in the putative reverse 
transcriptase of a Chlamydomonas species. The difference in the S and the second D 
between segmented (SDD) and unsegmented (GDN) RNA polymerases might represent 
important elements of the active site different for these two virus groups (Poch et a l.,
1989).
The linearity of the polymerase motifs in all these divergent RNA polymerase 
molecules suggests they may cooperate to form an ordered functional domain after 
folding of the protein. Secondary structure predictions suggest that the invariant amino 
acids are in, or close to, tight turns and perhaps the orientation of these residues is crucial 
for template recognition in a catalytic event. The predicted domains of RNA polymerases 
given by Poch et al. can be dissected in fine detail by site-directed mutagenesis of the 
polymerase proteins.
Site directed mutagenesis experiments have recently been performed on a region of 
the reverse transcriptase of HIV1 encompassing the four conserved motifs (Larder et a l., 
1987). Within all the mutated amino acids, just two mutations totally destroyed the 
polymerase activity. They involve the invariant D residue of motif A and the first 
invariant D residue of motif C. Within the other amino acids mutated, drastic loss of 
activity was observed when the Y residue (position 4 of motif C) was mutated, while the 
other mutations (D and A in position 12 and 13 of motif A respectively, and G in position 
11 of motif C) had limited effects. These site-directed mutagenesis experiments were not 
exhaustive and in particular do not involve the invariant G residue in motif B and the K in 
motif D. Hizi et al. (1988 and 1989) reported that insertion of amino acids at position 3 
or 10 of motif B induced the loss of reverse transcriptase activity of the HIV enzyme. As 
far as motif C is concerned, the key functional role of this motif is further highlighted by 
mutation experiments within the replicase of a plus-strand RNA virus, the QB 
bacteriophage, in which substitution of the G of the YGDD sequence by A, S, M, or V 
residues totally destroyed the activity (Inokuchi and Hirashima, 1987).
More recently, Poch et al. (1990) made a more extensive comparison of five 
polymerases (L proteins) of rhabdoviruses and paramyxoviruses. The five L proteins 
exhibit a high degree of homology along most of their length, with strongly invariant 
amino acids embedded in 6 conserved blocks separated by variable regions. The relative 
frequency of G (15.3%) and W (3.8%) residues among the invariant amino acids is 
remarkably higher (2.5- to 3-fold) than their average abundance in the L protein, 
suggesting that these residues are especially important for the L protein. In addition to 
the possible active polymerase sites, some other functional sites which may assure the
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polymerase activity are also tentatively identified. One of the conserved blocks, which 
contains basic and hydrophobic amino acids constituting a positively charged region, has 
been suggested as the template recognition site of the L protein. Two substrate dNTP- 
binding sites have been experimentally located in the Moloney murine leukaemia virus 
reverse transcriptase, targeted within the residues flanking the putative site for 
polymerization (Basu et al., 1988). In the L proteins sequenced, there are many invariant 
K residues surrounding the active site GDN which may be involved in dNTP binding.
Stec et al. (1991) determined the L gene sequence of human respiratory syncytial 
virus (RSV) and compared the L protein of RSV to that of four other paramyxoviruses 
and two rhabdoviruses by data base search, dot matrix alignments and other alignment 
methods. Although homology was detected among all the L proteins compared, the five 
L proteins of paramyxoviruses were more closely related to each other than to those of 
the rhabdoviruses, indicating the evolutionary relationship between the two families.
The RNA polymerase motifs identified by Poch et al. have also been detected in the
L protein of the Bunyaviridae family (Fig. 1.8). Elliott (1989a) compared the
Bunyamwera virus L protein with several L proteins of nonsegmented negative-strand
RNA viruses and influenza virus PB1, PB2 and PA proteins, and revealed an area
(residues 950-1220) of weak homology with part of the influenza virus PB1 protein.
PB1 has been identified as the polypeptide responsible for RNA polymerization (Braam
et a l ,  1983; Krug et al., 1989). This area contains the four proposed polymerase motifs
between residue 1030-1210. The N residue at position 1119 of the Bunyamwera virus L
. ^protein aligns with the invariant G residue in motif B. It is not clear if this N is^important 
residue in polymerization activity or the G residue at position 1123 serves as the similar 
function as the invariant G residue in motif B.
Despite the similar size of the L proteins between Bunyaviridae and nonsegmented 
RNA viruses, the L proteins of Bunyaviridae have invariant amino acids SDD in motif C 
instead of GDN. This further confirmed the observation of Poch et al. (1989) that 
polymerase proteins of all the segmented RNA viruses have common invariant amino 
acids SDD in motif C (Fig. 1. 8).
1.6.3. Functional analysis of RNA polymerase
Although sequence analysis has revealed the RNA polymerase motifs in the L 
protein, the functional domains of the bunyavirus L protein involved in initiation (cap 
recognition and endonuclease activity), elongation and termination of RNA transcription 
and Jreph cation process are entirely undetermined.
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To map the various domains within the L proteins, it is essential to obtain biologically 
active RNA polymerase proteins and suitable RNA templates for the assay. It has been 
possible to purify functional RNA polymerase of some negative-strand RNA viruses 
from virion or intracellular nucleocapsids. More recently, with the molecular cloning of 
the RNA polymerase genes in several virus families, the recombinant polymerase 
proteins have proved to be useful in analyzing polymerase functions. Therefore in 
this section, analyses developed to dissect the polymerase functions of other negative- 
strand RNA viruses will be discussed so that some possible approaches can be exploited 
to delineate the polymerase protein of bunyaviruses.
1.6.3.1. R N A  polym erase from virus
Various efforts have been made to purify RNA polymerase proteins either from 
virus infected cells or purified virions. It is known that the RNA polymerase of VSV 
comprised of the L and NS proteins which are associated with the nucleocapsids. The 
method for isolating and purifying these two protein molecules from the purified virions 
has been reported by De & Baneijee (1984). VSV was disrupted with 1.85% Triton X- 
100 in the presence of 0.4 M NaCl to release the RNP, and the L and NS proteins were 
released from the RNP by 0.8 M NaCl treatment. The preparation was centrifuged 
through a 30% glycerol and 100% glycerol noncontinuous gradient to separate the L and 
NS proteins from N-templates. The N-templates were pelleted on the 100% glycerol 
cushion and the released L and NS proteins were recovered from the top of the tube. The 
NS protein was further separated from the L protein by phosphocellulose 
chromatography purification, since the NS protein does not bind to the column and 
therefore can be recovered free of the L protein. The L and NS proteins purified by the 
above method were biologically active since they specifically transcribed the VSV N- 
template when added to the reconstituted transcription assay (De & Baneijee, 1984; 
1985). In heterogeneous reconstitution reactions in vitro, the purified L and NS proteins 
of VSV(NJ) did not transcribe N-RNA template purified from VSV(IND), but mRNA 
synthesis ensured when purified homologous NS (IND) was added (De & Baneijee, 
1984). This suggests that specific interaction of homologous L and NS proteins with the 
N-template is important in RNA synthesis.
Influenza virus RNA polymerase contains three P proteins (PB1, PB2 and PA) 
which are associated together as P-protein complex on the nucleocapsids. Parvin et 
<i/.( 1989) reported that the influenza virus polymerase proteins can be purified from 
virions. Purified influenza virions (2-3 mg) were disrupted by incubation in the buffer 
containing 1.5% Triton X-100, 10 mg/ml lysolecithin, 5% glycerol and 1.5 mM DTT. 
The RNP cores were fractionated on 30-70% (w/v) glycerol step gradient followed by a
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second gradient consisting of CsCl and glycerol. The polymerase proteins were 
recovered from the region of the gradient correlating with 1.5 to 2.0 M CsG and dialyzed 
against DTT and glycerol containing buffer. The polymerase preparation was shown to 
be free of viral RNA and used to copy short synthetic RNA templates. The synthetic 
RNA templates, which were transcribed from cDNA corresponding to the 3'-terminal 
sequences of genomic RNA, were efficiently copied by the purified polymerase. The 
polymerase was also shown to be able to transcribe full-length influenza virus genome in 
vitro. Unexpectedly, the virion-derived polymerase preparation copied complementary 
RNA templates inefficiently. Thus, it is speculated that the influenza virus polymerase 
may be modified in cells during infection to recognize the slightly different promoter 
sequence at the 3' terminus of positive sense RNA. This speculation was confirmed by 
Akkina et al. (1991) who reported that, in influenza A virus infected cells, there exist 
two heterogeneous forms of the PB1 (85K and 70K) and PA (60K and 62K) proteins. 
These additional proteins were only associated with intracellular RNP and could not be 
detected in purified virus. Peptide mapping analysis revealed they are subsets of their 
normal counterparts and might participate in virus replication in infected cells.
Szewczyk et al. (1988) reported reconstitution of the influenza virus transcriptase 
simply by renaturing the NP and P-proteins by E. coli thioredoxin. The proteins in 
virion nucleocapsids were separated by SDS polyacrylamide gel electrophoresis and 
blotted onto a polyvinylidine difluoride membrane. Individual protein bands (PB1, PB2, 
PA and NP) were eluted from the membrane with Triton X-100 at pH 9.0. The four 
proteins were then mixed with purified influenza virion RNA in the presence of E. coli 
reduced thioredoxin to renaturc the proteins. In the presence of a primer, the renatured 
RNA polymerase thus synthesized plus-strand RNA products which were apparently of 
relatively large size (900-1800 nt in length). The data indicate that NP is able to bind to 
naked vRNA to form a functional template and the three P proteins form a functional 
enzyme complex to initiate and elongate mRNA chains. This is a potentially exciting 
result which may become a simple practical means to obtain reasonable amounts of active 
RNA polymerase.
The approach for purification of the Sendai virus L protein was developed by 
Einberger et al. (1990) using hydrox l^apatite column chromatography of SDS-solubilized 
Sendai virus proteins. Purified Sendai virions (60 mg) were disrupted with 3% SDS and 
the soluble fraction was applied to a hydro^lapatite column. The L protein was 
completely separated from all other viral and cellular proteins by eluting with^linear 
gradient (0.01-0.5 M)jtodium phosphate buffer. The SDS was removed from the L 
protein preparation by dialysis and acetone precipitation. The L protein was then 
renatured by dialyzing against a DTT containing buffer and further purified by
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immunoprecipitation. The L protein preparation was shown to contain kinase enzyme 
activity, although the polymerase assay was not performed.
1.6.3.2. R N A  polym erase expressed from cDNA
Functional RNA polymerase has been expressed from the recombinant DNA for 
some members of negative-strand RNA viruses: VSV (Schubert e ta l ., 1985; Pattnaik and 
Weitz, 1990), influenza virus (Krystal e ta l., 1986), Sendai virus (Gotoh e ta l., 1989) 
and measles virus (Ballart et al., 1990). But it has not been possible to purify the 
expressed RNA polymerase proteins of negative-strand RNA viruses for in vitro 
transcriptase assays Therefore, alternative assays have been developed, such as 
complementation of a ts mutant and replication of a suitable template in vivo using the 
expressed RNA polymerase.
The VSV L gene cDNA was inserted into the simian virus 40 transient expression 
vector pJCl 19 and the 241 K L protein expressed in the recombinant plasmid transfected 
COS cells (Schubert et al., 1985). The expressed VSV L protein was found to be 
biologically active, since it efficiently complemented and rescued VSV temperature 
sensitive (ts) polymerase mutants at the nonpermissive temperature. It appeared that the 
efficiency of complementation was dependent on the level of the L protein expressed, as 
it was observed that the cells with high levels of L protein expression never showed 
immunofluorqcent staining for the N protein, whereas cells with low levels of the L 
protein did. Schubert et al. (1985) suggest that high levels of the L protein or the L 
message may aiTest transcription or replication of the ts mutants. The observation was 
further confirmed by Meier et al. (1987). It was found that high levels of the L protein 
expression not only greatly inhibited complementation, but also inhibited wild type virus 
replication. These results suggest that the requirement of the L protein in transcription 
and/or replication is catalytic. It also suggests that the unsegmented RNA viruses could 
have evolved in a manner such that the location of the L gene at the extreme 5' end of the 
genome RNA is transcribed least frequently, yielding low quantities of L protein in 
infected cells (Fig.1.6). Baneijee (1987) revealed that the truncated L proteins expressed 
in COS cells did not show their functionality. Therefore, truncation mutation of the L on 
the function of the L protein has yet to be determined.
Using a similar approach, Krystal et al. (1986) tried to test the ability of cells 
expressing influenza virus RNA polymerase proteins to complement ts mutants at the 
nonpermissive temperature. Instead of employing a transient expression system, they 
constructed transformed cell lines expressing the three P proteins. Complementation was 
determined by analysis of virus protein synthesis and infectious virus yield in ts mutant 
infected transformed cell lines at the nonpermissive temperature. Two cell lines
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expressing all three P proteins were isolated. Both cell lines complemented the growth of 
PB2 ts mutants, one of them also complemented PA ts mutants, but none of them 
complemented PB1 ts mutants at the nonpermissive temperature. The complementation 
for each ts mutant varied (3- to 328-fold) for the two cell lines and the reason was not 
clear. However, these complementation data show that the presence in a single cell of all 
three P-proteins produced a synergic effect and the three P-proteins may have formed a 
functional complex in the celh That the three P-proteins form a complex in the absence of 
other virus proteins has been reported by Angelo et al. (1987) using recombinant 
baculoviruses.
Recently, Pattnaik and Wertz (1990) have made more exciting progress by showing 
that VSV proteins expressed from vectors containing cloned virus cDNAs support 
replication and amplification of VSV DI particle RNAs. They used a recombinant 
vaccinia virus-T7 RNA polymerase expression system developed by Fucrst et al. (1986, 
1987) to synthesize individual VSV proteins (N, NS and L) in cells. Plasmid DNAs that 
contain cDNA copies of the VSV genes downstream of the T7 RNA polymerase 
promoter were transfected into cells infected with a recombinant vaccinia virus which 
produces T7 RNA polymerase. In that way, they were able to examine the ability of 
VSV proteins, individually and in combination, to support DI particle RNA replication. 
Rapid efficient replication and amplification of DI particle RNA only occurred in cells 
expressing the N, NS and L proteins of VSV. Omission of any one of the three viral 
proteins abrogated the replication. They demonstrated that both (+) and (-) sense DI 
panicle RNA were synthesized and the newly synthesized DI RNA was encapsidated by 
the N protein supplemented from plasmid DNA transfection, as judged by 
immunoprecipitation of ^H-uridine labelled nucleocapsids. The data strongly suggest 
that functional proteins expressed from the input templates were assembled with newly 
synthesized RNAs to form active nucleocapsid templates that were able to undergo 
multiple rounds of replication, and the expressed proteins (L and NS) function as the 
polymerase to transcribe and replicate the DI RNA.
Pattnaik and Wertz (1991) further exploited this replication system and successfully 
expressed all five VSV proteins (N, NS, L, M and G) simultaneously when cells were 
cotransfected with five recombinant plasmids. When the cells expressing all the five 
VSV proteins were superinfected with the DI particles, DI particle replication, assembly 
and budding were observed and furthermore, infectious DI particles were released into 
the culture fluids. The released DI particles were confirmed by their infectivity in the 
presence of a helper virus and their morphological appearance viewed by electron 
microscopy. Omission of either M or G protein expression resulted in no DI particle 
budding. The system established by these workers provides a powerful approach for
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detailed structural and functional analysis of the virus gene products in each step of the 
viral replicative cycle .
For Sendai virus, the polymerase proteins (L and P/C) have also been expressed by 
a recombinant vaccinia virus system and virus ribonucleoprotein (RNP) was used as 
templates for the polymerase assay (Gotoh et a l ,  1989). It is known that the Sendai 
virus L and P/C proteins are associated with the RNP as observed by immuno-electron 
microscopy assay (Portner et al., 1988), but they can be easily dissociated from the RNP 
during the preparation of the RNP and the RNP is usually noninfectious. Gotoh et al. 
prepared RNP from purified virions by NP-40 disruption and recovered them by 
pelleting onto a 46% (w/w) CsCl cushion through a 2 ml layer of 50% glycerol. The 
RNP preparation was then transfected j(o cells infected with recombinant vaccinia viruses 
expressing the L and P proteins. Culture fluids from the transfected cells were analysed 
for the Sendai virus yields and it was revealed that the infectious Sendai virus was 
rescued from the transfected RNP. A recombinant vaccinia virus with the L gene under 
control of the vaccinia virus TK promoter, which expressed less L protein was far more 
efficient (500-fold) in rescuing Sendai virus than that with the L gene under control of the 
P7.5 promoter (12-fold) which expressed more L protein. This result is consistent with 
the report of Meier et al. (1987) on high level expression of VSV L protein inhibiting 
VSV infection.
From the recombinant RNA polymerase studies described above, it can be seen that 
in the systems involving complementation of virus ts mutants (Meier et al., 1987; Krystal 
et al., 1986) or rescue of infectious virus from RNP (Gotoh et al., 1989), the level of the 
polymerase protein is crucial. In most cases, overexpression of the L protein shows less 
activity or even an inhibitory effect. However, the system used by Pattnaik and Wertz 
(1990 and 1991) which only involved DI particles does not appear to have the similar 
effect.
1.6.3.3. R econstitution o f RNA templates
In vitro  encapsidation of genomic RNA by the N protein with subsequent RNA 
transcription should help unravel the role of the L protein and eventually the mechanism 
of RNA transcription in general. The difficulty in generating biologically active 
nucleocapsids of negative-strand RNA viruses has been a major stumbling block for 
detailed genetic analysis of this group of viruses. The nucleocapsids assembled in vitro 
should satisfy the following criteria as proposed by Mirakhur and Peluso (1988): (1) the 
RNP is resistant to RNase degradation; (2) the nucleocapsids band at the appropriate 
density in CsCl, and display the correct sedimentation rate in sucrose gradients; and (3) 
the viral N protein is found on the nucleocapsids. Only recently, synthetic transcripts
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representing the genomic RNAs of influenza virus (Luytjes et al., 1989), and short 
synthetic templates representing the end sequences of VSV (Moyer et al., 1991), have 
been assembled into biologically active nucleocapsids. These accomplishments hold 
great promise as experimental systems for genetic manipulation of negative-strand RNA 
virus genomes.
For VSV, the use of DI particles has been crucial, as the DI particle has smaller size 
(2.2Kb) and can be easily separated and purified by gradients centrifugation from the 
wild type virus. Mirakhur and Peluso (1988) extracted RNA from the purified DI 
particles and incubated this RNA with VSV infected cytoplasmic extracts which contained 
the N protein to encapsidate the RNA molecules. The reassembled RNP was shown to 
have the same CsCl buoyant density as the authentic RNP, was resistant to RNase 
digestion, and was capable of replicating in cells infected with a helper virus.
More recently, synthetic VSV nucleocapsids have been assembled by Moyer et al. 
(1991) and shown to be a functional template by an in vitro transcription assay. Various 
length cDNAs representing the 3' end of the VSV genome were cloned under the SP6 
RNA polymerase transcription start site and in vitro transcribed RNA encapsidated with 
N protein which had been purified from VSV virions. Optimal encapsidation occurred 
when the concentration of the N protein stock was less than 300 p.g/ml. It appeared that 
as few as 19 nucleotides from the 5' end of positive-strand RNA allowed maximal 
encapsidation and 5' terminal 10 nucleotides allowed partial (50%) encapsidation. The 
synthetic nucleocapsids resisted RNase digestion and had a buoyant density typical of 
wild type VSV nucleocapsids. The in vitro encapsidation produced synthetic VSV 
nucleocapsids were specifically transcribed by the viral RNA polymerase and the 
products are of the correct positive strand sense with the proper 5' nucleotides. It was 
also found that some other factors present in the infected cell extracts, probably poly(A), 
were also needed in the transcription assay, possibly by associating with the N protein to 
prevent its aggregation.
Synthetic influenza virus segment 8 RNP have been successfully reconstituted in 
vitro (Yamanaka et al., 1990) and were structurally similar to the authentic RNP since 
they had the same RNase VI-sensitive sites as authentic virus RNP. In a similar way, 
the influenza virus segment 8 RNA synthesized from its cDNA in vitro was encapsidated 
with the NP protein purified from virions. More recently, Yamanaka et al. (1991) 
reported that the in vitro reconstituted RNAs were functional templates which could be 
transcribed by viral RNA polymerase in vivo upon transfection of these templates into the 
cells. These data suggest that the NP proteins can encapsidate the prcsynthcsized RNA 
and the method could be very useful for reconstituting RNA templates of other negative- 
strand RNA viruses.
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The success of making full length synthetic virus RNA nucleocapsids was claimed 
by Ballart et al. (1990). A full length measles virus cDNA (15894 nucleotides in length) 
was cloned under control of T3 or T7 promoters so that both (+) and (-) sense RNA can 
be transcribed respectively. The recombinant plasmids were linearized just downstream 
of the cDNA, and 'committed' transcripts were made by incubation with T3 or T7 RNA 
polymerase and just two ribonucleoside triphosphates. The complexes were microinjected 
into the helper cells to continue the transcription of the 'committed' complexes using the 
cellular NTP pool. The helper cell line was obtained by cocultivation of brain tissue from 
a SSPE patient with cells persistently infected with measles virus. The cells support 
efficient propagation of the resident genome without releasing infections virus because of 
defects in the envelope genes. It appears that after microinjection, transcription of the 
'committed' complexes continued and the input measles virus genome was replicated by 
the virus RNA polymerase present in the helper cells. Infectious virus was recovered 
from the supernatant of the helper cells and contained specific silent mutations which had 
been introduced into the cDNA by site-directed mutagenesis, indicating that the released 
virus genome was replicated from the input cDNA. The production of the infectious 
measles virus indicates that the N protein available in the helper cells cotranslationally or 
posttranslationally encapsidated the nascent measles virus RNA to produce the functional 
nucleocapsids. However, this paper has been retracted recently (J. Virol. 65:5656, 
1991) and the approach of making infectious virus by microinjection is thus questionable.
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1.7. Aims of the project
The L genome segment of Bunyamwera virus encodes the L protein, which is 
presumed to be the viral polymerase protein. The large size of the L protein suggests it is 
multifunctional and might be involved in initiation, elongation, and termination of RNA 
synthesis. With the long-term aim of defining the functional domains within the L 
protein, it is required to establish a system to attack these areas. Systems used for 
analysing RNA polymerase proteins of other negative-strand RNA viruses, recently 
establised by other workers, have been described in section 1.6. In this project, I 
considered to exploit the available cloned cDNAs to establish systems in which the 
functionally active L protein can be expressed. Thus the aims of the project were 
proposed as follows:
(1) To construct a full-length cDNA to the L gene of Bunyamwera virus from the 
existing cDNA subclones;
(2) To express the L protein in various systems;
(3) To produce monospecific antisera against the L protein in order to characterize the
antigenicity of the expressed L protein;
(4) To assay the RNA polymerase function of the L protein.
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Materials and methods
2.1. Materials
1. Chemicals
Chemicals were obtained from either BDH Ltd. or Sigma Chemical Co. Ltd. except 
for the following:
Ampicillin (Penbritin, Beecham Research Labs. Ltd.); Ammonium persulphate and 
N,N,N'N' tetramethyl ethylenediamine (TEMED, Bio-Rad Labs. Ltd); Enhance 
autoradiography enhancer (Du Pont UK Ltd.); Formamide (Fluka Chemicals Ltd.); 
Absolute alcohol 100 (James Burough (FAD) Ltd); Boric acid and caesium chloride 
(Koch-Light Labs.); Acetic acid (glacial), chloroform, glycerol and hydrochloric acid 
(May and Baker Ltd.); Ribonucleoside 5'-triphosphates, ultra-pure dNTP set, 'universal' 
and T7 promoter sequencing primers, diguanosine triphosphate sodium salt (m^GpppG) 
and Sephadex G-50 (Pharmacia LKB Ltd.).
2. Miscellaneous Materials
Dialysis membrane (Medical International Ltd.)
Nitrocellulose BA85 (Schleicher and Schuell)
RNasin (Promega Corp.)
Tissue culture plastics (Gibco Ltd. and Sterilin Ltd.)
Trypsin (Gibco Ltd.)
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X-ray film for autoradiography (Kodak Ltd.)
3. Enzymes
Restriction endonuclease enzymes, DNA polymerase I, and T4 DNA ligase 
(Bethesda Research Labs, or Boehringer Mamhein); calf intestinal phosphatase 
(Boehringer Mannhein); T4 polynucleotide kinase (New England Biolabs.) and 77 DNA 
polymerase (Pharmjbia LKB Ltd.)
4. Radiochemicals
Radiolabelled compounds were supplied by Amersham International pic. at the 
following specific activities:
■^S-L-methionine approximately 800 Ci/mmol (15 |iCi/|il)
5’-a-32p_dNTPs 3,000 Ci/mmol (10 pCi/pl)
5'-a-35s-dATP > 1,000 Ci/mmol (10 pCi/p.1)
5’-a-32p.GTP 400 Ci/mmol (10 pCi/pl)
5. Synthetic oligonucleotides
Synthetic oligonuceotides were produced using a Biosearch model 8600 DNA 
synthesiser by Dr. J. McLauchlan of this Institute.
6. Plasmids
Cloning vectors pUC18/pUC19, pTZ18/pTZ19, M13mpl8/M13mpl9 (Yanisch- 
Perron et a l., 1985) and pUCl 18/pUCl 19 (Vieira and Messing, 1987) were supplied by 
Dr. R.M. Elliott. Vaccinia virus transfer vactor pTF7-5 was obtained from Dr. B. Moss 
(Lab. of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, 
Maryland, USA), and pSCll obtained from Dr. L. Whitton formerly of this Institute. 
Bacterial 77 expression vector pET8c was obtained from Dr. C. Preston of this Institute. 
TTie pUEX bacterial expression vector series were from Dr. D. P. Leader (Dept, of 
Biochemistry, University of Glasgow).
Recombinant plasmids containing cDNA derived from the Bunyamwera virus L 
segment, cloned into pBR322 have been described by Elliott (1989a). Recombinant 
plasmids containing full length Bunyamwera virus S segment in pUC9 and pUC18 were 
constructed by A. McGregor, Recombinant plasmids containing Bunyamwera virus S
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segment derived cDNA in bacteriophage vectors M13mpl8 and M13mpl9 were supplied 
by M. Scallan of this Institute.
7. Bacterial and bacteriophage strains
E. coli strain DH5 (supE44 hsdR17 recA l endAl gryA96 th i-lre lA l, Hanahan, 
1983) was the usual host for the propagation of many of the recombinant plasmids. E. 
coli strain XL-1 (supE44 hsdR17 recAl endAl gryA46 thirelAl lac~ F~\ Bullock at al., 
1987) was used for the growth of phagemids. E. coli strain TGlCrwpE hsdA5thiA[lac- 
proABJ F'[traD36 proAB+ laclQ lacZAM IS]) was used for the growth of bacteriophage 
M13mpl8 or M13mpl9. E. coli strain LE392.23 (supE44 supF58 hsdR5l4 galK2 
gaXT22 m etB l tryR55 lacY l) was used for the growth of bacteriophage CE6 . E. coli 
strain LE392.23 and the strains described below were obtained from Dr. W. Studier 
(Studier et al., 1990; Biology Dept. Brookhaven, National Lab. NY, USA). E. coli 
strains HMS174 (recA l hsd R r i f )  and BL21 (F'hsdS gal; Studier & Moffatt, 1986) 
were used as hosts for bacterial T7 expression system of recombinant plasmids. The 
lysogens BL21(DE3) and HMS174(DE3) contain a single chromosomal copy of the gene 
for T7 RNA polymerase under control of the lac UV5 promoter. The £. coli strains 
HMS174(DE3)pLysS, HMS174(DE3)pLysE, BL21(DE3)pLysS and BL21(DE3)pLysE 
have plasmid pLysS or pLysE in the cells. Plasmid pLysS contains a fragment which has 
the lysozyme gene cloned under the tet promoter of pACYC184, the fragment has a 03.8 
promoter for T7 RNA polymerase immediately following the lysozyme gene, whereas 
pLysS has the fragment cloned in the opposite orientation.
Bacteriophage CE6 obtained from Studier is a lambda derivative that carries the 
gene for T7 RNA polymerase under control of the phage P l  and P] promoters and also 
has the cI857 thermolabile repressor and the sam7 lysis mutation. Bacteriophage 
M13K07 supplied by Dr. R.M. Elliott is a derivative of bacteriophage M13 that carries a 
mutated version of gene II, a plasmid origin of replication, and the kanamycin resistance 
gene from Tn903 (Vieira and Messing, 1987).
8. Bacterial culture media
The following bacterial culture media were used:
L-Broth (LB): 10 g NaCl, 10 g Bactopeptone, 15 g yeast extract per litre.
L-Broth agar: L-Broth plus 1.5% (w/v) agar.
2 YT broth: 5 g NaCl, 16 g Bactopeptone, 10 g yeast extract per litre.
M9 minimal medium: 0.5 g NaCl, 3 g KH2P04, 6 g Na2HP04, 4 g glucose, 1 ml 1 M
MgSC>4 per litre.
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Ampicillin was added at 100 (ig/ml into the medium where appropriate.
9. Cells and tissue culture media
BHK-21, C l3 cells, a continuous cell line derived from baby hamster kidneys 
(MacPherson and Stoker, 1962), were supplied by the Cytology Unit of this Institute, 
and used for growing Bunyamwera virus in Glasgow modified Eagle's medium 
supplemen ted with 10% new bom calf serum (10% GMEM, Stoker and McPherson, 
1961). GMEM was supplied as a 10 x liquid concentrate. This was diluted in distilled 
water and supplemented with 5 mM L-glutamine, 2.75 g/1 NaHCC>3 , 100 unit/ml
penicillin, 100 pg/ml streptomycin and 10% tryptose phosphate broth. CV-1 monkey 
kidney cells were grown in Dulbecco's modified Eagle's medium containing 5% foetal 
calf serum (5% DMEM). TK"143, Human thymidine kinase deficient (TK") 143 cells 
(Rhim et a l., 1975) were growdn DMEM supplemen ted with 5% foetal calf serum and 
25 pg 5-bromodeoxyuridine per ml.
10. Viruses
Bunyamwera virus originally isolated from a suckling mouse brain homogenate was 
obtained from Dr. N. Karabasos (Vector-borne Diseases Laboratory, Centrofor Disease 
Control, Fort Collin s, Colorado, USA.) and subsequently triple-plaque purified in BS­
C-1 cells by Prof. C. R. Pringle in this Institute. The temperature sensitive mutants of 
Bunyamwera virus (ts5) and Maguari virus (ts7) were isolated by C. U. Iroegbu (Iroegbu 
and Pringle, 1981). The snowshoe hare bunyavirus ts mutants were obtained from Prof.
D. H. L. Bishop (NERCInstitute of Virology and Environmental Microbiology, Oxford, 
U.K.).
vTF7-3, a recombinant vaccinia virus which expresses T7 RNA polymerase was 
obtained from Dr. B. Moss (Fuerst et a l., 1986). Vaccinia virus WR strain was obtained 
from Dr. A. Patel of this Institute.
11. Antiserum
Anti-Bunyamwera virus antiserum (Watrct, 1985) was obtained from Dr. R. M. 
Elliott.
12. Commonly used solutions
Agarose gel loading buffer: 0.25% bromophenol blue, 0.25% xylene cyanol FF, 30% 
glycerol.
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10 x EM buffer: 0.05 M sodium borate, 0.1 M sodium sulfate, 0.01 M EDTA, 0.15 M 
boric acid.
2 x RNA gel sample buffer: 20% glycerol, 0.05% bromophenol blue, 2 x EM buffer.
Carrier DNA: 10 mg/ml salmon sperm DNA, autoclaved and stored at -20°C.
50 x Denhart's solution: 1% polyvinylpyrrolidone, 1% BSA (Pentex fraction V), 1% 
Ficoll.
Giemsa stain: 1.5% Giemsa in glycerol, heated to 50°C for 2 hr and diluted with an equal 
volume of methanol.
5% milk: 5% dried nonfat milk in water and stored at -20°C.
NTE: 100 mM NaCl, 10 mM Tris-HCl, pH 7.5, 1 mM EDTA.
PBS: 170 mM NaCl, 3.4 mM KC1, 10 mM HPO4 , 1.8 mM KH2PO4 , pH 7.2, 6.8 mM 
CaCl2 and 4.9 mM MgCl2-
Protein dissociation mix: 100 mM Tris-HCl, pH 6 .8, 200 mM 13-mercaptoethanol, 4% 
SDS, 0.2% bromophenol blue, 20% glycerol.
RNase A solution: 10 mg/ml pancreatic RNase A in 10 mM Tris-HCl, pH 7.5, 15 mM 
NaCl, heated at 100°C for 15 min, cooled and stored at -20°C.
SM: 0.1M NaCl, 10 mM MgSC>4 , 50 mM Tris-HCl, pH 7.4, 0.01% gelatin.
Sequencing gel mix: 6-12% acrylamide/bisacrylamide (57:3), 8M urea, 1 x TBE.
20 x SSC: 3 M NaCl, 3 M trisodium citrate.
20 x SSPE: 3 M NaCl, 0.18 M NaH2PC>4 , 20 mM EDTA, pH 7.4.
TAE: 40 mM Tris-acetate, pH 8.0, 1 mM EDTA.
TBS+ buffer: 25 mM Tris-HCl, pH 7.4, 135 mM NaCl, 50 mM KC1, 0.01% CaCl2 , 
0.01% f^Cl2.
TBE: 90 mM Tris-HCl, 90 mM boric acid, 1 mM EDTA, pH 8.0.
TE: 10 mM Tris-HCl, pH 7.5, 1 mM EDTA.
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10 x Tris-glycine: 0.25 M Tris, 2.5 M glycine, 1% SDS, pH 8.3.
X-Gal: 20 mg 5-bromo-4-chloro-3-indolyl-B-D-galactoside in 1ml dimethylformamide, 
stored at -20°C.
Chapter 2 Materials & methods 59
2.2. Methods
1. Preparation of plasmid DNA
1.1. G row th o f bacterial cultures
A single colony of the appropriate E. coli strain was picked from an agar plate and 
inoculated into 10 ml of 2 x YT broth plus antibiotics, if necessary, and shaken overnight 
at 37°C.
1.2. Large scale preparation and purification o f plasmid DNA.
The propagation and purification of supercoiled plasmid DNA on caesium 
chloride/ethidium bromide gradients were essentially as described by Maniatis et al. 
(1982). An overnight culture (5 ml) was inoculated into a 2-litre flask containing 400 ml 
of L-broth (with 100 p.g/ml of ampicillin where appropriate) and shaken at 37°C for 20 
hr. The bacterial cells were pelleted by centrifugation at 6000 rpm (Sorval GS3 rotor) for 
20 min at 4°C, washed by resuspending in 10 ml of TE and repelleted in the SS34 rotor at 
6000 rpm for 5 min 4°C. The pellet was resuspended in 8 ml of 50 mM glucose, 250 
mM Tris-HCl, pH8.0 and 12 mM EDTA containing 5 |ig/ml lysozyme. The mixture was 
incubated at RT for 5 min before the addition of 16 ml of freshly made 0.2 N NaOH, 1% 
SDS to allow cell lysis. Following 10 min incubation on ice, 12 ml of ice cold 5M 
potassium acetate, pH4.8, was added to precipitate DNA and the mixture was incubated 
on ice for a further 10 min. After centrifugation at 18,000 rpm (Sorval SS34 rotor) for 
20 min at 4°C, the supernatant was decanted into Corex tubes, the plasmid DNA was 
precipitated by the addition of 0.6 volumes of isopropanol at RT for 15 min, and 
centrifuged at 12,000 rpm for 30 min at 15°C. The DNA pellet was washed with 70% 
ethanol, dried and resuspended in a total volume of 10 ml TE, pH8.0. Ten g of caesium 
chloride was added to the DNA solution to give a final density of 1.55 to 1.60 g/ml. One 
ml of a 10 mg/ml solution of ethidium bromide was then added and the solution 
transferred to a Ti 50 heat-sealable centrifuge tube. An isopycinic caesium chloride 
gradient was formed by centrifugation at 40,000 rpm (Beckman Ti 65 or 50 rotor) for 36 
hr at 15°C. The plasmid DNA was identified as a red band in which the ethidium 
bromide intercalates with the DNA ot-helix. The plasmid DNA was carefully removed
with a syringe through the side of the tube.
Ethidium bromide was removed by successive extractions (usually four times) with 
an equal volume of isoamyl alcohol equilibrated with 5 M NaCl. The DNA was then
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dialysed against TE (pH 8.0) at 4°C overnight, precipitated with 2 volumes of ethanol, 
dissolved in water and stored at -20°C. The concentration of the plasmid DNA 
preparations were determined by measuring their absorbance at 260nm, assuming OD260 
of 1=50 pg/ml with a 1 cm pathlength cuvette.
1.3. Small scale preparation o f plasm id DNA
Single colonies of transformed E. coli strain DH-5 were picked with a cocktail stick 
into 2 ml of 2 x YT broth containing 100 pg/ml of ampicillin. After shaking at 37°C 
overnight, bacterial cells (1.4 ml of culture) were pelleted in 1.5 ml fcppendorf tubes for 1 
min and the supernatant removed by aspiration. The bacterial cell pellet was resuspended 
in 100 pi of an ice-cold solution of 50 mM glucose, 25 mM Tris-HCl, pH 8.0, 10 mM 
EDTA and the cells were lysed by the addition of 200 pi of 0.2 N NaOH, 1% SDS at RT 
for 5 min; 150 pi of 5 M potassium acetate (pH 4.8) was added to the tubes and 
incubated for a further 5 min. After centrifugation for 5 min, the supernatant was 
extracted with phenol/chloroform and plasmid DNA ethanol precipitated. The DNA pellet 
was washed with 70% ethanol, dried under vacuum and dissolved in 40 pi water.
2. Restriction enzyme digestion of DNA
DNA was digested with the appropriate restriction enzyme (normally 1 unit/pg 
DNA) in commercial restriction enzyme buffer (BRL or Boehringer Mannheim). For the 
analysis of small scale plasmid DNA preparation, 5 pi of DNA was digested in a 10 pi 
volume containing 20 pg/ml RNase A for 1 hr at 37°C and DNA fragments separated by 
eletrophoresis on an agarose gel.
3. Electrophoresis of DNA
3.1. N on-denaturing agarose gels
Electrophoresis of DNA was performed on horizontal slab gels (14 x 11 x 0.5 cm, 
BRL gel electrophoresis apparatus Model H5, or 5.7 x 8.3 x 0.3 cm, BRL gel 
electrophoresis Horizon 58) of 1% (w/v) agarose in 1 x TBE or 1 x TAE containing 0.5 
pg/ml ethidium bromide. DNA samples were applied to the gel in 5% (v/v) glycerol, 
0.05% (w/v) bromophenol blue, 0.05% (w/v) xylene cyanol FF. Electrophoresis was 
carried out at 50-100V in 1 x TBE or 1 x TAE containing 0.5 pg/ml ethidium bromide.
3.2. D enaturing polyacrylam ide gels
Polyacrylamide gel electrophoresis was as described by Maniatis et al. (1982). 
Vertical slab gels (257 x 165 x 1 nm) comprised 8% or 12% polyacrylamide sequencing
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gel mix containing 8 M urea in 1 x TBE. Polymerization was catalysed by the addition of 
ammonium persulphate 0.1% (w/v) and TEMED 0.01% (v/v). Samples were loaded in 
5% (v/v) glycerol, 0.05% (w/v) bromophenol blue, 0.04% (w/v) xylene cyanol and 
elecrophoresed at 200-300 V in 1 x TBE buffer until the dye fronts had migrated the 
required distances.
4. Purification of DNA fragments from agarose gels
4.1. E lectroelution
Plasmid DNA was cleaved with the appropriate restriction enzyme(s) and the 
fragments fractionated by electrophoresis on a 1% agarose TBE gel. The DNA bands 
were visualised under long wave UV light and the required DNA band excised from the 
gel. The gel slice was placed in a dialysis bag with 0.2-0.5 ml 0.5 x TBE and immersed 
in a minimal volume of 0.5 x TBE in an electrophoresis tank. After electrophoresis at 
250 V for 2hr, the current was briefly reversed to release the DNA from the wall of the 
dialysis bag. The DNA solution was extracted with phenol/chloroform until protein 
contamination was not visible at the interface, and the DNA was recovered by ethanol 
precipitation from the aqueous phase. The DNA precipitates were pelleted by 
centrifugation for 10 min, washed with 70% ethanol, lyophilised and resuspended in 50 
pi water.
4.2. Silica m atrix adsorption
A commercial kit, Geneclean (BIO 101 Inc, La Jolla, CA), which contains a 
specially formulated silica matrix called glassmilk that binds DNA specifically in the 
presence of sodium iodide (Nal), was used for recovering of DNA fragments from 
agarose gels (Vogelstein & Gillespie, 1979). An agarose gel slice (in TAE buffer) 
containing the DNA of interest was mixed with 3 volumes of Nal solution and the tube 
was incubated at 45-55°C for 5 min until the agarose was completely dissolved. 
Glassmilk was added at concentration of 5 pl/5 pg of DNA and the mixture was 
incubated at 4°C for 5 min to allow the DNA to bind to the glassmilk. Following a short 
spin (about 5 seconds), the pellet was washed three times with NEW wash solution 
(which contains Tris, EDTA, NaCl, ethanol) by repeated suspension and pelleting. The 
DNA was eluted from the glassmilk by resuspending the pellet in 20 pi water and 
incubating at 45-55°C for 1-2 min. After a short centrifugation, the DNA solution was 
removed and stored at -20°C.
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5. DNA cloning
5.1. End repair and DNA ligation
DNA fragments (0.1 pg) were ligated with vector DNA (0.01-0.05 pg), which had 
been digested with^appropriate restriction enzymes, in a volume of 10 pi containing 0.1 
M Tris-HCl, pH7.4, 50 mM MgCl2 ,l mM spermidine, 1 mM ATP, 100 pg/ml BSA and
1 unit of T4 DNA ligase at 16°C for 16 to 24 hr.
For blunt end DNA ligation, DNA fragments with sticky ends were converted to 
blunt ends by incubating the DNA fragment (up to 1 pg) in reaction buffer containing 33 
mM Tris. OAc, pH7.9, 66 mM KOAc, 10 mM MgCl2 ,0.5mM DTT, 0.1 mg/ml BSA, 
0.2 mM of each dNTP, 0.1 mM ATP and 3 units of T4 DNA polymerase at 37°C for 30 
min. After extraction with phenol/chloroform, the DNA was resuspended in 20 pi of /j T 
p-liy o.iimfyAduff; and incubated with 1 unit of Klenow fragment of DNA polymerase 
I at 20°C for 30 min. The DNA was phenol/chloroform extracted, ethanol precipitated and 
resuspended in 20 pi of water. Ligation was carried out as above except that the ATP 
concentration was reduced to 0.05 mM.
5.2. P reparation o f com petent bacterial cells
A 0.5 ml aliquot of an overnight bacterial culture was diluted into 50 ml of 2 x YT 
broth in a 250-ml flask. The culture was shaken at 37°C for approximately 2 hr until the 
OD550 reached 0.2. The bacterial cells were harvested by centrifugation at 3000 rpm for 
10 min. The cell pellet was gently resuspended in 10 ml of 0.1 M CaCl2 and placed on 
ice for at least 20 min. The suspension was centrifuged at 3000 rpm for 5 min and the cell 
pellet resuspended in 3 ml of 0.1 M CaCl2- These competent cells were used directly for 
transformation or could be stored at 4°C for up to 24 hr.
5.3. Transform ation
Half of the ligation region was incubated with 200 pi of competent cells on ice for 
60 min followed by a 1 min 42°C heat shock to allow the ligated DNA to enter the E. coli 
cells. The tube was returned to the ice bath and 0.5 ml of 2 x YT broth was added to the 
tube and the cells incubated at 37°C for a further 60 min. The cells were then plated onto 
LB agar containing the appropriate antibiotics and incubated at 37 C for 12 to 20 hr to 
allow single colonies to form. For vectors containing the LacZ gene, 20 pi of 100 mM 
IPTG and 20 pi of X-Gal was added to the cells before plating out to allow colour 
selection (blue/white) of recombinants.
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6. Purification o f synthetic oligonucleotides
Synthetic oligonucleotides were produced by the phosphoram idite method and 
supplied in ammonium hydroxide which was heated to 55°C for 5 hr to remove the base 
protecting groups, followed by lyophylisation overnight to ensure removal of the 
ammonia. The oligonucleotide pellet was dissolved in 0.2 ml of water and loaded in 10% 
glycerol onto an 8% or 12% polyacrylamide gel containing 8 M urea. After 
electrophoresis, the oligonucleotides were viewed under UV light as a dark shadow 
against a fluorescent thin-layer chromatography plate. The gel slice cont^ning the major 
full length oligonucleotide species was excised with a razor blade and eluted in 1-2 ml of 
water at 42°C overnight with shaking. The supernatant was transferred to a Spin-x 
centrifuge unit (COSTAR) which contains a 0.45 pm cellulose acetate filter in a 
microfuge tube. Acrylamide gel pieces were removed by centrifugation for 2 min in a 
microcentrifuge. The oligonucleotides were precipitated with 3 volumes of ethanol in the 
presence of 0.2 M NaCl at -20°C overnight. The oligonucleotide pellet was washed with
70% ethanol, dried and dissolved in water. The concentration of oligonucleotide was
rquantitated by spectjophotometry, assuming that an OD26O nm of one=20 pg/ml with a 1 
cm pathlengh cuvette.
7. Preparation of DNA templates for sequencing
7.1. P reparation  o f ssD N A  tem plates from  M l3 bacteriophage 
derived vectors
Two ml aliquots of a 1:100 dilution of an overnight culture of E. coli strain TGI in 
2 x YT broth were dispensed into universal bottles. Each universal was inoculated with a 
colourless M13 phage plaque picked with a sterile cocktail stick and shaken at 37°C for 5 
hr. One andjhalf ml of culture were transferred to a microcentrifuge tube and centrifuged 
for 5 min at RT. The supernatant was removed to a fresh tube and 250 pi of 20% 
PEG/2.5 M NaCJ solution added and incubated at RT for 15 min. After centrifugation 
for 5 min, the supernatant was removed by aspiration using a drawn-out f?asteur pipette. 
All the remaining traces of PEG were removed by centrifugation and aspiration. The 
Ml 3 phage pellet was resuspended in 200 pi of TE buffer and extracted with 100 pi of 
TE saturated phenol. The upper phase was transferred to a fresh tube, the DNA was 
ethanol precipitated and dissolved in 25 pi of water.
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7.2. P reparation o f denatured dsDNA tem plates
Forty pi of small scale prepared DNA (10-20 pg) was digested with RNAase A at 
20 pg/ml at 37 C for 30 min. Ten pi of 2 M NaOH was added and the DNA was 
denatured at RT for 10 min. After extraction with phenol/chloroform, the DNA was 
ethanol precipitated, dried and resuspended in 20 pi of water. Ten pi (5-10 pg) of DNA 
was used for one set of sequencing reactions.
8. Dideoxynucleotide sequencing
The dideoxynucleotide chain termination sequencing method (Sanger et al., 1977), 
according to the protocol of Pharmacia LKB, was used to determine the DNA sequence.
Ten pi of DNA (about 2-10 pg), either single stranded or denatured double stranded 
DNA, was mixed with 2 pi of sequencing oligonucleotide primer (0.8 pM) and 2 pi of 
annealing buffer (200 mM Tris-HCl, pH 7.5, 100 mM MgCl2 , 250 mM NaCl). The 
annealing reaction was carried out at 60°C for 10 min followed by incubation at RT for at 
least 10 min. The labelling reaction was performed at RT for 5 min: 6 pi of enzyme 
premix (5 pCi of a-^^p-dATP at 3000 Ci/mmol, or a-^^S-dATP at >1000Ci/mmol,
0.57 pM dGTP, dCTP, dTTP and 3 units of T7 DNA polymerase) was added to the
a
annealed DNA/premix mix. Two and^half pi of termination mix (150 pM each of the 4 
dNTPs, 15 pM one ddNTP) was pipetted into the corresponding well of a 96-well 
microtitre plate labelled as 'G', 'A', T , *C; the plate had been prewarmed at 37°C for 1 
min. Four andjhalf pi of the labelling reaction mix were then added and mixed with each 
of the four sequencing termination mixes by centrifugation at 1000 rpm for 1 min. The 
plate was incubated at 37°C for 5 min; 5 pi of stop solution (95% formamide, 20 mM 
EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF) was added to each well, 
and the plate was heated at 80°C for 2 min immediately before loading onto a 6% 
sequencing gel.
The 6% sequencing gel mix was made by dissolving 480 g urea, 57 g acrylamide, 3 
g bisacrylamide in 800 ml of distilled water and deionised by stirring with Amberlite for 
30 min. The solution was filtered through a Whatman 3MM filter paper, 100 ml of 10 x 
TBE was then added and the volume was adjusted to 1 litre and stored at 4°C. The BRL 
model S2 electrophoresis apparatus (44.5 x 42.2 x 21.6 cm) was used to run sequencing 
reaction samples. One pair of glass plates (one is 2 cm shorter) were siliconized and 
assembled with one spacer (0.4 mm thick) on each side. Seventy ml 6% sequencing gel 
mix was used for one gel and poured beween the sealed plates immediately after having 
added the ammonium persulfate and I t  MED to 0.1%. The smooth interface was formed 
by inserting the flat edge of the sharkstooth comb between the plates to a depth of 2-3 mm
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below the short plate. The gel sandwich was assembled in the gel apparatus and the 
comb inserted between the plates until it just made contact with the surface of the gel. 
Sequencing reactions (2-2.5 pi) were loaded into the appropriate well of the gel. 
Electrophoresis was performed at 60 watts for 2-4 hr and one of the plates was carefully 
removed from the gel; the gel was transferred to a supporting sheet of Whatman 3 MM 
filter paper, covered with "cling film" and dried using a vacuum gel drier. The cling film 
was removed and the gel was exposed to X-ray film for several hours for 32p labelled 
DNA, and 1-3 days for 35$ labelled DNA.
9. Extraction of total cellular RNA
The extraction of total cellular RNA from virus infected or uninfected cell 
monolayers was by a modification of the method described by Chomcznski and Sacchi 
(1987). Cell monolayers in 35 mm dishes were washed once with PBS and lysed in 0.5 
ml GSCN solution (4.2 M guandinium thiocyanate, 0.5% sarcosine, 100 mM 2- 
mercaptoethanol, 0.33% Antifoam A emulsion, 50 mM Tris-HCl, pH 7.5, 2.0 mM 
EDTA). The lysate was then transferred to a microfuge tube. Fifty pi of 2 M NaOAc, 
pH4.0, 500 pi of water saturated phenol, and 100 pi chloroform/isoamylalcohol (49:1) 
were added to the tube. The tube was vortexed for 10 seconds, incubated on ice for 15 
min and centrifuged for 10 min. The RNA containing aqueous phase was precipitated by 
an equal volume of isopropanol at -20°C for 60 min followed by centrifugation for 10 
min at RT. The RNA pellet was resuspended in 300 pi of GSCN solution, mixed with 
300 pi isopropanol and reprecipitated at -20°C for 60 min. After centrifugation for 10 
min, the pellet was dissolved in 200 pi of water by heating at 60°C for 5 min and 
extracted with an equal volume of a 4:1 mixture of chloroform and butan-2-ol. The RNA 
aqueous phase was precipitated with three volumes of ethanol in the presence of 0.3 M 
NaOAc. After centrifugation for 10 min, the RNA pellet was washed with 70% ethanol, 
dried, dissolved in water and stored at -70°C.
10. Electrophoresis of RNA
RNA samples were separated on an agarose gel containing 5 mM methylmercuric 
hydroxide, as described by Perbal (1988). Electrophoresis was performed on a 
horizontal slab gel (14 x 11 x 0.5 cm) of 1% or 1.2% agarose containing 1 x EM buffer 
(5 mM sodium borate, 10 mM sodium sulphate, 1 mM EDTA, 15 mM boric acid) and 5 
mM methylmercuric hydroxide. Agarose was melted in 1 x EM buffer and cooled to 
60°C prior to the addition of methylmercuric hydroxide. RNA samples were mixed with 
an equal volume of 2 x sample buffer (20% glycerol, 0.05% bromophenol blue, 2 x EM 
buffer) and loaded onto the gel. Electrophoresis was earned out in 1 x EM buffer at 75 V
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for 4 hr until the bromophenol blue had migrated to the bottom of the gel. All 
manipulations involving methylmercuric hydroxide were performed under a fume hood.
11. Northern transfer of RNA
RNA samples separated on an agarose gel containing 5 mM methylmercuric 
hydroxide weretransferred to a 0.2 pm nitrocellulose membrane by the standard method 
(Southern, 1975; Maniatis et a/., 1982). Two strips of Whatman 3MM paper were 
wrapped around a glass plate which was put on a rack in a tray containing 20 x SSC. 
The gel was placed upside down on the Whatman 3MM paper and covered with a sheet of 
nitrocellulose membrane which had been prewetted with 20 x SSC. The nitrocellulose 
was then covered by a stack of blotting pads (BRL) about 10 cm high and a weight 
(500g). Transfer was performed overnight, the nitrocellulose membrane was then dried 
in air and baked under vacuum for 2 hr at 80°C before hybridization.
12. Extraction of total cellular DNA
Cell monolayers in a 24-well Linbro tray were washed once with PBS and lysed in 
cell lysis buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 0.6% SDS, 500 pg/ml 
proteinase K) in a 37°C incubator for three hours. The lysate was transferred to 
microfuge tubes, NaCl was added to 0.375 M and the lysate extracted with 
phenol/chloroform (49:1). The DNA containing aqueous phase was precipitated with 2 
volumes of ethanol. The DNA pellet was washed with 70% ethanol, dried and 
resuspended in 100 pi of TE buffer. RNA was removed by digesting with 0.25 pg/ml 
RNAase A and 50 units/ml RNAase TI at 37°C for 30 min. After extraction with 
phenol/chloroform, the DNA was reprecipitated with ethanol, dissolved in water and 
stored at -20°C.
13. Southern transfer of DNA
DNA restriction fragments separated in a TBE agarose gel weredenatured in 1.5 M 
NaCl, 0.5 M NaOH for 1 hr at RT with gentle agitation and neutralised with 1 M Tris- 
HCl, pH8.0, 1.5 M NaCl for 1 hr. The gel was transferred to a 0.45 pm nitrocellulose 
membrane by the same method described for the Northern transfer of RNA (Southern, 
1975; Maniatis e ta l., 1982).
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14. Hybridization of radiolabelled probes to nucleic acids 
immobilized on nitrocellulose filters
When 32P-labelled cd n a  was used as a probe, the nitrocellulose filter was 
prehybridized with 5 x SSPE, 0.5% non-fat milk, 0.2 mg/ml carrier DNA (salmon sperm 
DNA), 50% formamide, in a heat sealable bag at 42°C for 2-4 hr. The solution was then 
replaced by hybridization solution containing 5 x SSPE, 0.1% milk, 0.2 mg/ml carrier 
DNA, 50% formamide. 32P labelled cDNA probes were denatured by boiling at 100°C 
for 5 min, quickly chilled on ice and added to the hybridization bag. The bag was sealed, 
submerged in a water bath and the hybridization was performed at 42°C with agitation for 
12 to 18 hr.
When 32P labelled riboprobes were used, the prehybridization solution was 6 x 
SSPE, 5 x Denhardt's reagent (0.02% each of Ficoll, polyvinylpyrrolidone, bovine 
serum albumen) described by Maniatis et al. (1982), 0.2 mg/ml carrier DNA, 0.1% 
SDS, 50% formamide; the hybridization solution contained 6 x SSPE, 1 x Denhardt's 
solution, 0.1 mg/ml carrier DNA, 0.1 mg/ml yeast tRNA, 50% formamide. The 
hybridization was performed at 42°C as described above.
After hybridization, the filter was removed from the bag and immediately 
submerged in a tray containing 200 ml of 2 x SSC and 1% SDS. The filter was washed 
at RT for 30 min with constant agitation with one change of the wash solution. The filter 
was further washed with 0.1% SSC and 1% SDS for 30 min at RT. The filter was then 
placed on a pad of paper towels to remove most of the liquid, wrapped with "cling film" 
and exposed to X-ray film at -70°C with an intensifying screen.
15. Radiolabelling of nucleic acid as hybridization probes
15.1. N ick translation labelling o f DNA
Plasmid DNA was labelled with 32P in vitro by nick translation as described by 
Maniatis et al. (1982). Plasmid DNA (0.2 - 0.5 pg) in a 50 pi reaction volume, 
comprising NT buffer (100 mM Tris-HCl, pH7.5, 10 mM MgS04, 1 mM DTT, 0.05 
mg/ml BSA), 10 pCi of a -32P-dATP, 10 pCi of a -32P-dTTP, 20 mM each of the four 
unlabelled dNTPs, 1 unit of E. coli DNA polymerase I and 10-3pg/ml of DNase I, was 
incubated at RT for 1 hr. The radiolabelled plasmid DNA was separated from 
unincorporated label by gel filtration chromatography through a Sephadex G-50 column. 
The Sephadex G-50 beads were equilibrated in TE buffer and the column prepared in a 
lml plastic syringe with a siliconized glass wool plug. Orange G dye was added to the 
reaction as an indicator, the DNA was applied to the column followed by elution with
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water. The eluted DNA was collected before the orange G reached the bottom of the 
column. The probes were heated at 90-100°C for 2 min before hybridization.
15.2. R iboprobes from i n  v i t r o  transcription
Recombinant plasmid DNA with a cDNA insert under the control of the T7 
promoter was linearized by digestion with an appropriate restriction enzyme and the DNA 
transcribed using T7 RNA polymerase (Promega Biotech) by the method of Nielsen and 
Shapiro (1986). One pg of the linearized DNA was added to the in vitro transcription 
reaction (total volume 20 pi) which contained 40 mM Tris-HCl, pH 8.0, 25 mM NaCl, 8 
mM MgCl2 , 2 mM spermidine-HCl, 5 mM DTT, 0.5 mM ATP, GTP, UTP, 1.2 pM
CTP, 50 pCi/ml a-^^P-CTP (400Ci/mmol), 40 units of RNasin, 25 units of T7 RNA 
polymerase. The reaction was incubated at 37°C for 60 min followed by the addition of 1 
pi of RQ DNase 1(1 pg/pl) to remove the DNA template; the incubation was continued 
for 15 min at 37°C and the reaction mix was extracted with phenol/chroloform. The RNA 
aqueous phase was precipitated by 3 volumes of ethanol in the presence of 1 M 
ammonium acetate (NH4OAC), dried and the labelled RNA pellet was dissolved in 50 pi 
water; it was either used immediately or stored at -70°C.
15.3. Random  prim er labelling o f DNA
Random primer labelling of DNA with 32p was based on the method developed by 
Feinberg and Vogelstein (1983 and 1984), in which a mixture of random hexanucleotides 
was used to prime DNA synthesis in vitro from a double stranded DNA template. 
Recombinant plasmids containing cDNA derived from Bunyamwera virus S segment, 
cloned into Ml 3 bacteriophage vectors, were obtained from M. Scallan of this laboratory 
and used to make strand specific DNA probes with the multiprime DNA labelling kit 
(Amersham LKB Ltd.). Five pi of DNA (25 ng), denatured at 95-100°C for 2 min and 
chilled on ice. To this denatured DNA, the following reagents were added: 5 pi of 5 x 
labelling buffer, 5 pi each of dGTP and dCTP, and 5 pi of primer, 5 pi of each a-32p- 
dATP and a-32P-dTTP, 5 units of Klenow enzyme. The reaction was incubated at 37°C 
for 30 min and unincorporated label was removed by gel filtration. The eluted labelled 
DNA was denatured at 95-100°C for 2 min and rapidly chilled on ice. The probes were 
used directly in hybridization reactions or stored at -20 C for later use.
16. Metabolic labelling of intracellular proteins
Monolayers of cells in 35 mm dishes were radiolabelled with ^ S - m e t h i o n i n e  j n  ] 
ml of PBS (100 pCi/ml) for 2 hr at 37°C. The radioactive solution was then removed, 
the monolayers washed with cold PBS and the cells lysed in 200 pi of protein
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dissociation mix (0.125 M Tris-HCl, pH 6 .8 , 4% SDS, 10% 2-mercaptoethanol, 20% 
glycerol, 0.1% bromophenol blue). Cell lysates were boiled for 5 min before loading 
onto an SDS containing polyacrylamide gel (see method 18).
17. Immunoprecipitation
Cell monolayers were radiolabelled with -^S-methionine (50 |iCi/ml) in 1 ml 
methionine free minimal essential medium for 2 to 16 hr. The cells were washed with 
cold PBS and 1 ml of cold RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% 
NP-40, 0.5% sodium deoxycholate, 0.02% SDS) was added to each dish to lyse the 
cells. The dishes were incubated on ice for 30 min and the solution was transferred to 
microfuge tubes. Nuclei and other cellular debris were removed by centrifugation for 5 
min and the lysate was precleared by incubation with 10 p.1 of preimmune serum for 30 
min at 4°C followed by a further 30 min incubation at 4°C with 50 pi of a 10% 
suspension of protein A-Sepharose. The protein A*Sepharose beads were removed by 
centrifugation and 0.5 ml of the supernatant were reacted with 5 pi of antiserum for 4-16 
hr at 4°C on a mixing wheel. Immmune complexes were collected by incubation with 50 
pi of protein A-Sepharose for 30 min at 4°C and pelleted by centrifugation for 30 
seconds. The pellet was washed three times with 0.5 M LiCl/0.1 M Tris-HCl, pH 8.0, 
resuspended in 50 pi of protein dissociation mix and boiled for 5 min prior to 
electrophoresis on an SDS polyacrylamide gel.
18. SDS-polyacrylamide gel electrophoresis of proteins
Proteins were fractionated on SDS-containing polyacrylamide gels using the 
discontinuous buffer system of Laemmli (1970). The resolving gel contained 10% or 
12% polyacrylamide in which the acrylamide was cross linked with N, N'-methylene 
bisacrylamide in a ratio of 75:1 (w/w) in resolving gel buffer (0.373 M Tris-HCl, pH 
8 .8 , 0.1% SDS). Ammonium persulphate and TEMED were added to a final 
concentration of 0.1 % (v/v) to polymerize the gel. The gel was overlaid with butan-2-ol 
to ensure a smooth interface on polymerization. The butanol was removed once the gel 
had polymerized and the interface washed once with unpolymerized stacking gel solution. 
The stacking gel solution contained 3.8% polyacrylamide, 62.5 mM Tris-HCl, pH 6 .8, 
0.1% SDS and was layered on top of the resolving gel once the ammonium persulphate 
and TEMED had^added to the solution. Protein samples were boiled for 5 min and 
separated by electrophoresis in tank buffer (53 mM Tris, 53 mM glycine, 0.1% SDS) at 
40 mA per gel until the bromophenol blue had reached the bottom of the resolving gel.
The gel was removed from the glass plates after electrophoresis and either stained 
with 0.2% Coomassie brilliant blue for 30 min followed by destaining with gel fix (7%
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acetic acid, 20% methanol) or processed for fluorography. For fluorography, the gel 
was treated with gel fix for 30-60 min, soaked in EnZhance (Dupont, Boston, USA) for 
30 min and rehydrated in several changes of water for 30 min. The gel was then dried 
under vacuum and placed in contact with Kodak-X-Omat S film at -70°C for at least 18 
hr.
19. Production of antisera against the Bunyamwera virus 
L protein
19.1. E xpression  o f  portions o f  the L  p ro tein  fused to 8- 
galactosidase
The pUEX series of vectors (Brcssan and Stanley, 1987) were used to express lac 
Z gene fusion proteins. These are bacterial expression vectors which can give controlled 
expression in many £. coli strains as a result of the cI857 thermolabile repressor gene 
located in the plasmid. The Bunyamwera virus L cDNA fragments representing different 
regions of the L protein were cloned into pUEXl or pUEX3 and transformed into E. coli 
strain DH5 cells. The recombinant plasmid DNAs were analysed by DNA restriction 
enzyme digestion and DNA sequencing. Single bacterial colonies were inoculated into 10 
ml of 2 YT broth containing 100 M-g/ml of ampicillin and shaken at 30°C overnight. One 
ml of the overnight bacterial culture was diluted to 100 ml with 2 x YT broth containing 
ampicillin at 100 (ig/ml and incubated at 30°C for approximately 3-4 hr at 30°C until the 
OD550 reached 0.2. The culture was transferred to a 42°C water bath for 20 min and then 
incubated at 42°C with shaking for a further 2 hr.
The bacterial cells were harvested by centrifugation of the culture at 3,000 rpm in 
the Sorval SS34 rotor for 10 min. The pellet was resuspended in 4 ml of lysozyme 
solution (50 mM Tris-HCl, pH 8.0, 50 mM EDTA, 15% of sucrose, 0.1 mg/ml of 
lysozyme) and incubated on ice for 40 min. The cells were lysed by incubation with 5 ml 
of 0.2% Triton X-100, 10 mM Tris-HCl, pH 8.0, 1 mM EDTA for 5 min on ice. The 
inclusion bodies were pelleted by centrifugation at 10,000 rpm for 15 min in the Sorval 
SS34 rotor and resuspended in 2.5 ml of 8 M urea, 2% 6-mercaptoethanol. An equal 
volume of protein dissociation mix was added and boiled for 5 min before the proteins 
being fractionated on SDS-polyacrylamide gels.
The fusion proteins were partially purified by separating on 10% polyacrylamide- 
SDS gels. The proteins were visualized by staining with 0.05% Coomassie brilliant blue 
in water for 10 min followed by destaining in water for 10-20 min. The fusion protein 
band, which was the major band visible, was excised from the gel with a scapel and 
stored at -20°C before further processing.
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19.2. Im m unization of rabbits
The SDS-polyacrylamide gel slices containing the fusion proteins were macerated 
by passing through a 20-ml syringe a few times, then through a 21 gauge needle several 
times until the gel pieces were small enough to pass through the needle easily. An equal 
volume of water was added and the suspension, which contained about 0.1 mg of fusion 
protein, was injected subcutaneously into New Zealand white rabbits. The rabbits were 
boosted three times at 10 days intervals with the same amounts of fusion proteins and the 
sera were tested by immunoprecipitation and Western blotting before the final bleed.
20. Western blotting
Proteins separated on an SDS-polyacrylamide gel were transferred to 0.45 pm 
nitrocellulose filter by electroblotting using a LKB2117-250 NovaBlot electrophoretic 
transfer unit at 0.8 mA/cm^ gel area for 1 hr in transfer solution (39 mM glycine, 48 mM 
Tris, 0.0375% SDS, 20% methanol) according to the manufacturer's instructions.
The nitrocellulose filter was air dried and excess protein binding sites were blocked 
by floating the membrane on TBST buffer (10 mM Tris-HCl, pH8.0, 150 mM NaCl, 
0.05% Tween 20) containing 1% BSA at RT for 30 mim with agitation. The blocking 
solution was replaced with TBST containing the appropriate dilution of primary antibody 
(1:50 - 1:200 for polyclonal antisera) and incubated at RT for 30 min. The membrane 
was washed three times for 15 min with TBST buffer, reacted with 1:2500 diluted anti- 
IgG horseradish peroxidase conjugate at RT for 30 min followed by three 5 min washes 
with TBST. The membrane was then transferred to the colour development solution 
which was made by adding 50 pi of 100 mg/ml 4-chloro-l-naphthol to 2 ml methanol and 
mixing with 8 ml of TBS (10 mM Tris-HCl, pH8.0, 150 mM NaCl) and 35 pi of 30% 
hydrogen peroxide. When the colour had developed to the desired intensity, the reaction 
was stopped by rinsing the membrane in water for a few minutes. The membrane was 
dried in air and photographed.
21. Bunyamwera virus growth and titration
BHK-21, clone 13, cells (MacPherson and Stoker, 1962) were useed for growing 
Bunyamwera virus stocks and titration. Confluent BHK-21 cells grown in 10% GMEM 
in 80 oz roller bottles were infected with Bunyamwera virus at multiplicity of 0.01 
pfu/cell and incubated at 31°C for 2-3 days. The culture fluids were harvested and 
clarified by centrifugation at 5,000g for 20 min. The clarified fluids were aliquoted and 
stored at -70°C.
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Virus was titrated by plaque assay (Iroegbu and Pringle, 1981). Ten-fold serial 
dilutions of virus stocks were made in PBS/2% serum. The growth medium was 
removed from confluent BHK monolayers in 50 mm dishes and 0.1 ml of diluted virus 
was added to each dish. The dishes were incubated at 31°C or 37°C for 1 hr to allow the 
virus to absorb to the cells. The inoculum was removed and the cells overlaid with 
Eagle's medium supplemented with 2% calf serum containing 0.6% agarose. The dishes 
were incubated at 31°C for 3-5 days. The monolayers were fixed with 1% glutaraldehyde 
in PBS for a few hours, and plaques were counted after Giemsa staining.
22. Purification of Bunyamwera virus
Clarified Bunyamwera virus infected tissue culture fluids were stirred with 23 g/1 
NaCl and 70 g/1 PEG 6,000 for 4 hr at 4°C (Obijeski et al., 1976). The PEG precipitate 
was collected by centrifugation at 8,000 rpm at 4°C for 20 min in the GSA rotor. The 
crude virus pellet was resuspended in 1 x NTE buffer (10 mM Tris-HCl, pH 7.5, 1 mM 
EDTA, 100 mM NaCl) and sonicated for 1 min before centrifuging out any aggregates at
2.000 rpm for 5 min at 4°C. The crude virus supernatant was layered onto potassium 
tartrate/glycerol gradients. The gradients comprised 5.6 ml^50% (w/w) potassium tartrate 
and 6.4 ml^30% (v/v) glycerol in TST41 tubes. The tubes were centrifuged at 39,000 
rpm for 150 min at 4°C. The virus band was removed with a syringe through the side of 
the tubes, diluted with 1 M NaCl, 10 mM Tris-HCl, pH 7.5 and pelleted through a 3 ml 
cusion of 25% sucrose in 1 M NaCl, 10 mM Tris-HCL, pH 7.5 at 40,000 rpm for 60 
min at 4°C in the TST41 rotor. The virus pellet was then resuspended in 1 M NaCl, 10 
mM Tris, pH 7.5 (0.5 ml per five roller bottles), loaded onto a 13 ml 20-60% (w/v) 
sucrose gradient in 1 M NaCl, 10 mM Tris-HCl, pH 7.5 and centrifuged at 24,000 rpm 
overnight at 4°C in the TST41 rotor. The virus band was collected and stored in 10% 
glycerol at -70°C.
23. Preparation of Bunyamwera virus nucleocapsids
The method was based on Leppert et al. (1979). Bunyamwera virus infected cells 
were scraped into the medium with a rubber policeman and pelleted by centrifugation at
3.000 rpm for 30 min in a 50-ml Falcon tube. The cell pellet was suspended in cold lysis 
buffer (0.15 M NaCl, 0.05 M Tris-HCl, pH 7.5, 0.6% NP-40, 2 ml per roller bottle of 
infected cells) and incubated on ice for 5 min. The suspension was vortexed for 2 min to 
break the cell membranes. Nuclei and cell debris were removed by centrifugation at
4.000 rpm for 10 min at 4°C. The supernatant was made to contain 6 mM EDTA and 3- 
4 ml of extract was loaded onto a CsCl gradient. The gradient was made of 6 ml of 20- 
40% (w/w) CsCl overlaid with 2.0 ml of 5% (v/v) sucrose in 50 mM NaCl, 25 mM Tris-
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HC1, pH 7.5, in a TST41 tube. The nucleocapsids were separated by centrifugation at
32.000 rpm overnight at 12 C in the TST41 rotor. The nucleocapsids band which was 
visible in the middle of the gradient was harvested with a syringe through the side of the 
tube and diluted with NTE buffer three fold. The nucleocapsids were then pelleted at
40.000 rpm for 2 hr at 4°C in the TST41 rotor, resuspended in NTE buffer (0.2 ml per 
roller bottle) and stored at -70°C.
24. Expression of the Bunyamwera virus L protein by T7 
RNA polymerase in E .  c o l i
The plasmid vector pET-8c was used for cloning and expressing the target DNAs 
under the control of T7 promoter (Studier et a l., 1990). Recombinant plasmids 
containing Bunyamwera virus L cDNA were transformed and established in different E. 
c o li strains: BL21; BL21(DE3); BL21(DE3)plysS and BL21(DE3)plysE, or the 
equivalent set of HMS174.
24.1. Expression by IPTG induction
For recombinant plasmids established in E. coli strains BL21(DE3) and 
HMS174(DE3) which contain lysogen DE3 to provide T7 RNA polymerase or in these 
strains containing pLysS or pLysE, expression was induced by IPTG. A fresh 
overnight culture was grown from a single colony obtained from a freshly incubated 
plate. The overnight culture was diluted 1:100 in LB broth and shaken at 37°C in the 
presence of 50 p.g/ml of ampicillin (25 pg chloramphenicol/ml was also added if the 
bacterial strain had the pLysS or pLysE genotype) and the IPTG was added to final 
concentration of 0.4 mM when the culture had reached an OD550 of 0.6-1. After 
induction for 2-3 hr, the bacterial cells were pelleted by centrifugation at 3,000 ipm for 5 
min. The bacterial pellet was resuspended in protein dissociation mix and boiled for 5-10 
min before loading onto an SDS polyacrylamide gel.
24.2. Expression by CE6 phage infection
An alternative way to deliver T7 RNA polymerase to the cell was by infection with 
CE6 phage for the expression of recombinant plasmids in E. coli strain BL21 or 
HMS174. Bacteriophage CE6 is a lambda derivative that carries the gene for T7 RNA 
polymerase under the control of the phage P l  Pi promoters, it also has the cI857 
thermolabile repressor and the Sam? lysis mutation (Studier and Moffatt, 1986).
CE6 phage was grown in host strain E. coli LE392-23 by adding a single plaque to 
50 ml of 2 x YT broth in a 125-ml flask and shaken at 37°C for 6 hr. The bacterial 
cultures were made 0.5 M in NaCl and centrifuged at 10,000 rpm for 10 min at 4°C in the
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SS34 rotor. The phage was further purified by CsCl gradient centrifugation (Maniatis et 
a l ., 1982). The supernatant containing CE6 phage was treated with DNAase I and 
RNAase A at 1 pg/ml for 30 min at RT. Forty g PEG6000 and 14.5 g NaCl wereadded 
to the 50 ml phage supernatant and stirred at 4°C for least 60 min. The suspension was 
centrifuged at 10,000 rpm for 10 min at 4°C. The phage pellet was gently rcsuspended in 
SM solution (0.1 M NaCl, lOmM MgSC>4 , 50 mM Tris-HCl, pH7.5, 0.1% gelatin) and 
extracted with phenol/chloroform to remove the PEG and cell debris. CsCl was added to 
0.75 g/ml, an isopycinic caesium chloride was formed by centrifugjon at 38,000 rpm at 
4°C for 24 hr in the Beckman Ti 50 or Ti 60 rotor. The phage band was harvested with a 
syringe and the purified phage were stored in the CsCl solution at 4°C. Dilutions were 
made in SM solution, and the titre of the CE6 phage was determined by plaque assay. 
One hundred pi of appropriate dilutions of CE6 phage was mixed with 200 pi of fresh 
overnight host E. coli strain LE392.23 in 4 ml of top agar at 42°C and poured onto LB 
agar plates. After overnight incubation at 37°C, plaques were counted for the various 
phage dilutions.
E. coli strain BL21 or HMS174 transformants were grown in LB broth with 
ampicillin at 50 pg/ml until the cultures reached an OD550 of 0.3, then glucose was 
added to a final concentration of 4 mg/ml. After an additional 1-2 hr of growth, MgSC>4 
was added to a final concentration of 10 mM and CE6 phage added to 10  ^pfu/ml, giving 
a multiplicity of 5 pfu/cell. Cells were harvested 2-3 hr after infection, the bacterial cells 
were pelleted by centrifugation and the proteins separated on a 10% polyacrylamide-SDS 
gel. Gels were stained with Coomassie brilliant blue to visualize the expressed proteins.
To monitor protein synthesis by radiolabelling, cells were pelleted after induction 
and resuspended in M9 minimal medium containing 35s_mcthionine (50 pCi/ml) and 
incubated at 37°C for 2h. The proteins were separated by SDS-polyacrylamide gel 
electrophoresis and visualized by fluorography.
25. I n  v i t r o  transcription and translation of recombinant 
plasmids
The bacterial expression vector pTZ contains a T7 promoter and a full lengh 
Bunyamwera virus L cDNA was cloned under control of this promoter. The recombinant 
plasmid DNA was linearized at the 3' end of the coding sequence with an appropriate 
restriction enzy me, and the linearized DNA was phenol/chloroform extracted and ethanol 
precipitated. The DNA concentration was adjusted to 1 pg/pl-
In vitro transcription was performed in a total volume of 50 pi containing 1 pg of 
linearized DNA, 40 mM Tris-HCl, pH 7.5, 6 mM MgCl2 , 2 mM spermine, 5 mM DTT, 
0.4 mM each of ATP, CTP, GTP, UTP, 40 units of RNasin, 25 units of T7 RNA
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polymerase and in some reactions, 0.5 mM m^GpppG (Sutton and Boothroyd, 1986). 
The reaction was incubated at 37°C for 1 hr, and the DNA template was removed by 
incubating with 1 unit RQ DNase I for 15 min at 37°C. The RNA transcripts were 
extracted with phenol/chloroform and precipitated with 3 volumes of ethanol on dry ice 
for 15 min. The RNA pellet was dissolved in 10 pi of water and used immediately or 
stored at -70°C.
RNA transcripts were translated in vitro using the New England Nuclear (NEN) 
reticulocyte lysate translation system or Promega's reticulocyte lysate system according to 
the manufacturer's instructions. A typical reaction (25 pi) using the NEN system was 2 
pi of RNA, 10 pi of rabbit reticulocyte lysate, 5 pi of 35S-methionine, 5.5 pi in vitro 
translation cocktail, 2 pi 1 M KOAc, 0.5 pi 32.5 mM MgOAc2 . The region was 
incubated at 37°C for 90 min. For the Promega system, 2 pi of RNA, 12.5 pi of 
reticulocyte lysate, 4 pi of 35s-methionine, 1 pi of -methionine mix and 1 pi RNasin 
were added together and incubated at 31°C for 60 min. The in vitro translated protein 
products were analysed by electrophoresis on an SDS-polyacrylamide gel directly or after 
immunoprecipitation.
26. Construction of recombinant vaccinia viruses
Two plasmid transfer vectors pTF7-5 (Fuerst et a l., 1987) and pSCl 1 (Chakrabarti 
et a l., 1985) obtained from B. Moss and L. Whitton respectively were used to make 
recombinant vaccinia viruses. pTF7-5 contains a T7 promoter and flanking TK 
sequences of vaccinia virus. pSCl 1 has cloning sites downstream of the vaccinia virus 
early and late promoter P7.5, a lacZ gene under the control of vaccinia virus later 
promoter PI 1, and also the flanking TK sequences. The cDNAs of interest were cloned 
dowstream of T7 promoter of pTF7-5 or under P7.5 promoter of pSCl 1, and the correct 
orientation of the insert determined by restriction endonuclease digestion and confirmed 
by nucleotide sequencing.
Recombinant vaccinia viruses were prepared essentially as described by Mackett et 
a l  (1985). Confluent monolayers of CV-1 cells in 35mm dishes were infected with 
vaccinia virus (WR strain ) at a multiplicity of 0.05 pfu/cell at 37 C for lh. The virus 
inoculum was removed, the monolayer washed once with TBS+ buffer (25 mM Tris- 
HCl, pH 7 .4 , 135 mM NaCl, 50 mM KC1, 0.01% CaCl2 , 0.01% MgCl2 ) and then 
transfected with 5 pg of plasmid DNA by the calcium phosphate method. DNA 
coprecipitates were formed by incubating DNA in 250 pi of HEPES buffered saline (140 
mM NaCl, 5 mM KC1, 0.75 mM NaHPC>4 , 6 mM dextrose, 25 mM Hepes, pH 7.05) 
and 125 mM CaCl2 at RT for 30 min. The DNA was added to the infected monolayer 
and the dishes incubated at RT for 30 min. Two ml of 5% DMEM were added and the
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dishes incubated at 37°C for 3-4 hr. The medium was changed and the incubation was 
continued for a further 48 hr. The transfected cells were scraped into the medium, virus 
released by three cycles of freeze-thawing (dry ice/37°C) and sonication for 5min. 
Recombinant vaccinia viruses were isolated by plaque assay.
TK' recombinant viruses were selected by growth in TK -143 cells in the presence 
of 25 pg/ml BUdR (Mackett et al., 1985). The progeny viruses produced by transfection 
were plaqued on TK" 143 cells using a 1% low melting point agarose overlay containing 
25 pg/ml BUdR and incubated at 37°C for 2 days. The plaques were stained by neutral 
red and for pSCl 1 derivatives, neutral red was replaced by 300 pg/ml X-Gal (5-bromo- 
4-chloro-3-indolyl-6-D-galactopyranoside; BRL). The plaques were picked with a 
$asteur pipette and added to 200 pi of 5% DMEM; half of the plaque was used to infect a 
TK- 143 cell monolayer in 24-well Linbro tray. Virus was adsorbed at 37°C for 60 min 
and the inoculum removed. 5% DMEM supplemented with 25 pg/ml BUdR was added 
and the tray incubated at 37°C for 2 days. The cells were lysed with 100 pi of 0.5 M 
NaOH and 1% SDS at RT for 20 min. To the lysed cells, 50 pi of neutralization buffer 
(1 M NaCl, 0.3 M Na-citrate, 0.5 M Tris-HCl, pH 8.0, 1 M HC1) was added and the 
solution was further diluted with 100 pi of distilled water. Half the amount of DNA was 
applied to a nitrocellulose filter using a 96-well filtration dot blotting apparatus and the 
filter probed with 32p.iabcue<j Bunyamwera virus L gene specific cDNA. After dot blot 
filter hybridization screening, plaques positive for the L gene were purified by three 
rounds of plaque-to-plaque passage. Finally, the genomes of the recombinant viruses 
were analysed by restriction enzyme digestion and Southern blotting as described in 
methods 2 and 13.
27. Preparation and purification of recombinant vaccinia 
virus stocks
Recombinant vaccinia viruses were grown in CV-1 cells and purified as described 
by Mackett at al. (1985). Half of the progeny virus released from a small monolayer 
culture (25 cm2) was diluted to 16 ml with PBS and used to infect 8 large flasks (150 
cm^) of CV-1 cells. Following virus adsorption at 37°C for 1 hr, 40 ml 5% DMEM was 
added and the flasks were incubated at 37°C for 48 hr.
The infected cells were scraped into the medium and the cells were pelleted by 
centrifugation at 3,000 rpm for 5 min. The pellet from each flask was resuspendcd in 2 
ml of 10 mM Tris-HCl, pH 9.0. After three cycles of freeze-thawing, the nuclei were 
removed by centrifugation at 750g for 5 min. The supernatant was then incubated with 
0.1 volume of trypsin (2.5 mg/ml) at 37°C for 30 min with frequent vortexing. The 
mixture was layered onto an equal volume of 36% (w/v) sucrose in 10 mM Tris-HCl,
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pH9.0 in a TST41 tube and centrifuged at 12,000 rpm for 80 min at 4°C. The virus pellet 
was resuspended in 2 ml of 1 mM Tris-HCl, pH9.0 and incubated with 0.1 volume of
2.5 mg/ml trypsin at 37°C for 30 min. Two ml of this virus suspension were then 
overlaid onto a continuous sucrose gradient (15-40% sucrose in 1 mM Tris-HQ, pH9.0) 
in a TST41 tube and centrifuged at 12,000 rpm for 40 min at 4°C. The virus band was 
collected with a syringe, diluted with 1 mM Tris-HCl, pH9.0, and pelleted at 13,000 
rpm for 60 min at 4°C. The virus pellet was resuspended in 1 mM Tris-HCl, pH9.0 and 
stored at -20°C. The titre of the virus was determined by plaque assay.
28. Complementation assay
Bunyamwera virus temperature sensitive (ts) mutants BUN ts5, Maguari virus ts 
mutant MAG ts7 and snowshoe hare virus (SSH) ts mutants were used for 
complememtation assay. The recombinant Bunyamwera virus L protein expressed from 
recombinant vaccinia viruses was assayed for its ability to complement ts mutants with a 
defective L protein. CV-1 cells in 35 mm dishes were infected with the ts mutants at 
multiplicity of 1 pfu/cell. Viruses were allowed to adsorb at RT for 40 min in 0.5 ml of 
medium. The inocula were removed and 2 ml of prewarmed 5% DMEM added. The 
dishes were incubated at the nonpermissive temperature 39.8°C (SSH) or 38.5°C (BUN 
ts5 and MAG ts7) for 2 hr, the cells were infected with recombinant vaccinia viruses 
vSCl 1-BUNL or vTF7-5-BUNL with vTF7-3 at multiplicity of 5 pfu/cell. Adsorption 
was performed at 31°C for 60 min, the infected cell monolayers were washed three times 
with 40°C warmed PBS, and 2 ml of prewarmed 5% MEM was added. Incubation was 
continued at the nonpermissive temperature for 1 or 2 days. The culture fluids were 
harvested and the titres of bunyavirus were determined by plaque assay at 31°C. As the 
culture fluids contained both vaccinia viruses and bunyaviruses, 250 pg/ml of 
phosphonoacetic acid was added to the agarose overlay to inhibit vaccinia virus growth 
without interfering with bunyavirus plaquing.
29. I n  v i t r o  transcriptase assay of the Bunyamwera virus 
L protein
The polymerase activity of the L protein from either detergent disrupted purified 
virions or CsCl gradient purified intracellular nucleocapsids was assayed in vitro. The 
activity of the L protein expressed from recombinant vaccinia viruses were tested by 
adding infected cytoplasmic extracts to the reaction to investigate any stimulation of 
transcriptase activity. The extracts were prepared by a modification of the method 
described by Peluso and Moyer (1983). Mock or virus infected cell monolayers were 
washed twice with 50 mM Hepes, pH 8.1, 0.1 M KC1, 6 mM MgCl2 , 1 mM DTT and
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the cell membranes were penetrated with 200 pg/ml lysolecithin in the same buffer for 1-2 
min. Following a gentle wash with buffer, the monolayers were scraped into 200 pi of 
buffer containing 10 pg/ml of actinomycin D. The suspension was pipetted up and down 
15 to 20 times followed by centrifugation for 2 min to remove the nuclei and cell debris. 
The resulting supernatant (cytoplasmic extract) was either used immediately or stored at - 
70°C in 10% glycerol.
The transcription reaction was performed in a total volume of 25 pi containing 50 
mM Hepes, pH 8.1, 0.1 M KC1, 6 mM MgCl2 , 1 mM DTT, 40 units /ml of RNasin, 1 
mM each of ATP, UTP, CTP, 0.01 mM GTP, 2.5 pi of a -3 2P-GTP, 2.5 pi of 
nucleocapsids (prepared by the method described in method 23), or 2.5 pi of virions 
(prepared by the method described in method 22) disrupted with 1% NP-40 and 10 pi of 
cell extract. The reaction was incubated at 30°C for 2 hr and stopped by the addition of 
50 pi of 10 mM Hepes, pH 8.1, 1% SDS, 1 mM EDTA, 100 mM NaCl. The reaction 
was phenol/chloroform extracted and ethanol precipitated. Half of the sample was loaded 
onto a 1% agarose gel containing 5 mM methylmercuric hydroxide. After 
electrophoresis, the gel was dried and the radiolabelled RNA products were visualized by 
autoradiography.
30. Nucleocapsid transfection assay
The nucleocapsids purified from Bunyamwera virus infected cells (method 23) were 
used as RNA templates and delivered into recombinant vaccinia virus infected cells to 
analyse the RNA polymerase function of the recombinant L protein. The nucleocapsids 
were transfected into the recombinant vaccinia viruses infected cells by the calcium 
phosphate method (Sambrook et a l., 1990). CV-1 cells (10^ per 35 mm dish) were 
infected with recombinant vaccinia viruses at a multiplicity of 5 pfu/cell for 1 hr at 37 C, 
and then washed once with TBS+ buffer. The nucleocapsids transfection mix was added 
and comprised, in a total volume of 250 pi, purified nucleocapsids (10 pi), 140mM 
NaCl, 5 mM KC1, 0.75 mM Na2HP0 4 -2H2 0 , 6 mM dextrose, 25 mM HEPES, pH
7.05 and 125 mM CaCl2 - After 30 min incubation at RT with occasional shaking, 2 ml 
of 5% DMEM was added and incubated at 37°C for 3-4 hr. The supernatant was 
removed and the cells were shocked with TBS+ containing 10% glycerol for 1-2 min. 
After two further washes with TBS+, 2ml of 5% DMEM was added and the incubation 
continued at 37°C for 20 hr. Cell monolayers were then either radiolabelled with 35S- 
methionine to analyse the protein synthesis, or total cellular RNA extracted for Northern 
blotting analysis.
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31. Site-directed mutagenesis
31.1. Preparation o f DNA tem plates for mutagenesis
A cDNA fragment containing the DNA region to be mutated was isolated, cloned 
into pUCl 19 phagemid vector (Vieira and Messing, 1987) and transformed into E. coli 
strain XL-1 cells. A single colony was picked and inoculated into 2 ml of 2 x YT broth 
containing 70 pg/ml of ampicillin and 5xl07 pfu/ml of helper phage M13K07 to make 
single stranded DNA templates. Following 1-2 hr shaking at 37°C, kanamycin was 
added to 70 pg/ml and incubation was continued for 14-20 hr.
Bacterial cells were pelleted by centrifugation for 5 min in a microcentrifuge, 1.25 
ml of the supernatant were transferred to a fresh tube, mixed with 200 pi of 20% 
PEG/2.5M NaCl and incubated at RT for 15 min followed by centrifugation for 5 min. 
The supernatant was removed by aspiration and following a brief spin, all the residual 
supernatant was carefully removed. The PEG precipitation was repeated by resuspending 
the pellet in 0.5 ml of TE buffer and mixing with 100 pi of 20% PEG/2.5 M NaCl. The 
phage pellet was resuspended in 300 pi of 0.3 M NaOAc and extracted with 
phenol/chloroform. DNA was precipitated by adding 0.8 ml of ethanol and incubated on 
dry ice for 10 min. After centrifugation, the pellet was washed with 70% ethanol, dried 
and resuspended in 25 pi of water. Ten aliquots of DNA were combined, quantitated by 
OD at 260 nm and the DNA concentration was adjusted to 1 pg/pl.
31.2. O ligonucleotide-directed i n  v i t r o  mutagenesis
The Eckstein method (Nakamaye and Eckstein, 1986; Sayers, et al., 1988) was 
used for oligonucleotide directed mutagenesis. The method involves a strand specific 
selection step which eliminates the unwanted non-mutant DNA sequence. Selective 
removal of the nonmutant strand is made possible by the incorporation of a thionucleotide 
(e.g. dCTPaS) into the mutant strand during in vitro synthesis. As certain restriction 
enzymes (e.g. Nci I) can not cleave phosphorothioate substituted DNA, single strand 
nicks are generated in DNA containing one phosphorothioate and one non- 
phosphorothioate strand. Such nicks present sites for exonuclease III to digest away 
most of the non-mutant strand. This avoids host mediated repair which can remove the 
mutant sequence resulting in poor yields of mutated DNA. The commercial 
oligonucleotide-directed in vitro mutagenesis kit (version 2, Amersham LKB Ltd.) was 
used for the mutagenesis reaction according to the manufacturer's instruction.
The synthetic oligonucleotides were phosphorylated by incubating 100 pmol of 
oligonucleotide with 5 units of polynucleotide kinase in a total volume of 30 pi containing
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1 mM ATP, 100 mM Tris-HCl, pH 8.0, 10 mM MgCl2 and 7 mM DTT at 37°C for 10 
min. The enzyme was inactivated by heating at 70°C for 10 min. The phosphorylated 
oligonucleotide was used immediately or stored at -20°C. Phosphorylated oligonucleotide 
(1.75 jxl) was annealed to 2 pg of DNA template in a total volume of 8.5 pi by heating at 
70°C for 3 min followed by incubating at 37°C for 30 min.
The extension reaction was carried out by replacing dCTP with dCTPaS in the 
presence of 3 units of Klenow fragment and T4 DNA ligase at 16°C for 16-20 hr. 
Sodium chloride was then added to final concentration of 0.5 mM and the solution filtered 
through 2 sheets of nitrocellulose filters by centrifugation at 1,500 rpm for 10 min. The 
filters were washed by centrifuging 100 pi of 0.5 M NaCl through the filters and the 
filtrates pooled. The combined filtrates were ethanol precipitated and half of the DNA 
was digested with 4 units of Nci I at 37°C for 90 min followed by incubating with 50 
units of exonuclease III at 37°C for 20 min. The enzymes were inactivated by heating at 
70°C for 15 min. The gapped DNA was repaired by polymerization and ligation in the 
presence of the 4 dNTPs, ATP, MgCl2,1.25 units of DNA polymerase I and 1.5 units of 
T4 DNA ligase at 16°C for 3 hr. Five to twenty pi of the reaction were used to transform 
E. coli strain XL-1 cells which were plated on agar plates containing 100 pg/ml of 
ampicillin. Single colonies were picked, grown in the presence of helper phage M13K07 
and single stranded DNA prepared for sequencing. The bacterial pellets were saved for 
preparing dsDNA for subcloning the desired mutant DNA fragments back into plasmids 
containing the Bunyamwera virus full length L gene cDNA.
32. Computing
Computer analysis of DNA and protein sequence were performed on the Micro 
VAX 11 and PDP11/14 computers in this Institute, using primarily the University of 
Wisconsin Genetics Computer Group package.
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Chapter 3
Production of monospecific antisera to the 
L protein
3.1. Introduction
Virus specific antibodies arc a principle means of defence against infection and have 
also been used as important reagents in the serological classification of viruses and in the 
study of aspects of virus replication. An andserum against purified Bunyamwera virus 
had been raised in rabbits by Watret (1985) in this Institute. However, the production of 
monospecific antibodies against the L protein was required for the future characterization 
of recombinant L protein molecules. The recent determination of the complete nucleotide 
sequence of the Bunyamwera virus L genome segment from cloned cDNA (Elliott, 
1989a) made it possible to produce L protein specific antisera by a genetic engineering 
approach.
To obtain the L protein antigen, I expressed five fusion proteins in E. coli. Out of 
five antisera raised against the fusion proteins, I obtained two potent monospecific 
antisera against both the N- and C-termini of the L protein.
3.2. Construction of recombinant plasmids containing 
portions of the L gene cDNA in pUEX
To obtain suitable L protein antigens, the pUEX bacterial expression vector series, 
constructed by Brcssan and Stanley (1987), was used (Fig.3.2). The pUEX vectors, 
transformed into DH5 cells, are capable of expressing cro-B-galactosidasc fusion proteins 
at high levels when induced by temperature shift to 42 °C. It had been reported previously 
that it was difficult to express a protein fragments larger than 130 residues in the pEX
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Fig.3.2. Nucleotide sequence analyses of pUEX-L constructs. Panel A. Map of 
plasmid pUEXl/3 showing the unique restriction enzyme sites and reading frames of 
6 -galactosidase through the cloning linker. 'Stop is the sequence containing stop 
codons in all reading frames. Panel B: Portions of sequencing S ej s  Rowing the 
correct sequence across the insertion point. The alkaline denatured DNA derived 
from pUEX-L 1 to pUEX-L5 was sequenced by the dideoxy chain termination method
and the order of the lanes is G, A, T, and C.
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vectors, from which the pUEX series was derived (Stanley & Luzio, 1984). Thus, only 
small L gene cDNA fragments were considered for cloning into the vector. To choose 
cDNA fragments for making fusion proteins, the hydropathy profile of the L protein was 
analysed (Fig.3.1). However, it was still difficult to determine which regions might be 
antigenic. Thus, five cDNA fragments spanning different regions of the L protein were 
removed from the L gene cDNA subclones, largely due to the convenience of suitable 
restriction enzyme sites, and were inserted into either pUEXl or pUEX3 so as to 
maintain the reading frame when fused to B-galactosidase (Fig.3.1 and 3.2).
The LI cDNA fragment was removed from the L gene subclone pBUN357 by 
digestion with EcoR V and ligated into the Sma I site of pUEX3; L2 was removed from 
subclone pBUN357 by digestion with Pvu II and Stu I and ligated into the Sma I site of 
pUEX3; L3 was removed from subclone pBUN347 by digestion with Bgl II and ligated 
into the BamH I site of pUEXl; L4 was taken from subclone pBUN347 by digestion 
with Hae III and Pst I and inserted between the Sma I and Pst I sites of pUEXl; and L5 
was removed from pBUN347 by Hpa I and Dra I double digestion and subsequently 
cloned into the Sma I site of pUEX3 (Table 3.1). The recombinant plasmids were 
transformed into E. coli strain DH5 cells and the correct orientation of the inserts were 
determined by nucleotide sequence analysis of denatured plasmid DNA using a primer 
complementary to nucleotides 4101-4121 of the pUEX vector (Fig.3.2). Cultures 
carrying recombinant plasmids were then assayed for their ability to express fusion 
proteins.
3.3. Expression of the L fusion proteins
Cultures of E. coli transformed with recombinant plasmids were grown to mid- 
logarithmic phase at 30°C and transferred to 42°C for 2 hr to induce synthesis of B- 
galactosidase fusion proteins. The protein profiles of total cell lysates were analysed on 
10% polyacrylamide-SDS gels. A comparison of the profiles obtained at 30°C and 42°C 
(Fig.3.3) showed that at 30°C no B-galactosidase fusion proteins were produced, 
whereas after 2 hr of induction at 42°C each culture carrying a recombinant plasmid 
induced a fusion protein larger than B-galactosidase produced by the parental pUEXl or 
pUEX3. The migration differences of the fusion proteins correlated closely with those 
predicted by the size of each inserted L gene cDNA fragment. In one case (pUEXl-L3, 
Fig.3.3. lane 8), a protein that comigrated with B-galactosidase was also produced dunng 
the induction period, which may have resulted from specific degradation of the L3 fusion
protein product.
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The level of the fusion proteins expressed was similar to that of the B-galactosidase 
produced by pUEXl or pUEX3, and was high enough for purification. Large scale 
bacterial cultures (100 ml) were induced at 42 °C, the cells collected by centrifugation and 
the insoluble fusion proteins were separated from bacterial soluble proteins (see chapter
2). The fusion proteins were partially purified by electrophoresis on 10% 
polyacrylamide-SDS preparative gels as described in chapter 2, and ar\aliquot of each 
preparation was analysed on a 10% polyacrylamide-SDS gel. As can be seen from 
Fig.3.4, the fusion proteins composed the major protein components of the preparations. 
The quantity of each fusion protein was estimated by comparison with known amounts of 
standard B-galactosidase protein by Coomassie blue staining of the gel. Two rabbits 
were immunized with each fusion protein following the schedule given in chapter 2 .
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Fig.3.3. Fusion protein expression in E. coli transformed with recombinant plasmids^ 
Cultures were grown at 30 °C (lanes 1-6) and induced at 42 C for 2 hr (lanes 7-18) and 
the bacteria were collected by centrifugation. Proteins were separated on 10% 
polyacrylamide-SDS gels and stained with Coomassie bnlliant blue. pUEXl Janes 1, 
and 7); pUEXl-L3 (lanes 2, 8 and 16); pUEX3 (lanes 3 ,9 and 13); pUEX3-Ll 0anes4 
10 and 14); pUEX3-L2 (lanes 5, 11 and 15); pUEX3-L4 (lanes 6 , 12 and 17) and
pUEX3-L5 (lane 18).
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Fig.3.4. Partially purified fusion proteins analysed on a 10% polyacrylamide-SDS 
gel. L1-L4 fusion proteins are shown in lanes 2-5. Lane 1 is protein size markers 
and lane 6 shows purified B-galactosidase.
3.4. Characterization of the antisera raised against the L 
fusion proteins
Antisera raised against portions of the Bunyamwera virus L protein fused with B- 
galactosidase were characterized by Western blotting and immunoprecipitation. The L 
protein present in intracellular nucleocapsids, which were purified from Bunyamwera 
virus infected cells by CsCl gradient centrifugation (see chapter 2), were used as the 
antigen for Western blotting. The nucleocapsid proteins were separated by 
electrophoresis on a 10% polyacrylamide-SDS gel and the L and N proteins were 
detected by Coomassie brilliant blue staining (Fig.3.5A). Of the antisera raised against 
four fusion proteins (LI-4) which were initially screened, two antisera which were made 
against the fusion proteins produced in pUEXl-L3 and pUEX3-L4 transformed bacterial 
cells reacted with the L protein (Fig.3.5B. lanes 3-4). Anti-Ll and anti-L2 did not react 
with the L protein (lanes 1-2). In an independent assay, the anti-L4 serum reacted with 
the L protein bound on the nitrocellulose filter strongly (lane 6), which is not seen with 
the preimmune serum (lane 5).
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As the L protein separated on the SDS-polyacrylamide gels is a denatured antigen 
and because denaturation may have changed the antigenicity and hence affected its 
reactivity with the sera, I then performed immunoprecipitation assays to test each serum.
A. B.
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Fig.3.5. Immunodetection of the Bunyamwera virus L protein by Western blotting.
A. Analysis of Bunyamwera virus nucleocapsids. Bunyamwera virus nucleocapsids 
were purified from the infected BHK cells by CsCl gradient centrifugation, separated 
on a 10% polyacrylamide-SDS gel and stained with Coomasie brilliant blue (lane 2). 
The positions of the L and N proteins are indicated and the protein size markers are 
shown in lane 1. B. Characterization of the test sera response to the L protein by 
Western blot assay. Bunyamwera virus nucleocapsids were separated on a 10% 
polyacrylamide-SDS gel and transferred to a nitrocellulose filter. The strips of the 
filters were incubated with 1:50 diluted anti-Ll (lane 1), anti-L2 (lane 2), anti-L3 (lane 
3), anti-L4 (lanes 4 and 6), or preimmune serum Qane 5), the bound antibodies were 
detected by their reaction with goat anti-rabbit antibody conjugated with horseradish 
peroxide (1:80 dilution) which produced a blue-black colour by reaction with 
Chloronaphthol. The L protein derived from intracellular nucleocapsids was 
specifically detected by anti-L3 (lane 3) and anti-L4 (lanes 4 and 6), but not by anti-Ll 
(lane 1), anti-L2 (lane 2) or preimmune serum (lane 5).
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35s-methionine labelled Bunyamwera virus infected cell extracts were reacted with each 
individual serum followed by analyses on a 10% polyacrylamide-SDS gel. As shown in 
Fig.3.6, two sera raised against the L4 and L5 fusion proteins, which represent the C- 
and N-termini of the L protein, specifically precipitated the L protein; no reaction was 
observed with the preimmune serum control. More L protein was precipitated by anti-C 
L protein antiserum than by the anti-N antiserum. The other three antisera, which were 
against LI, L2 or L3, did not show reactivity with the L protein. The characterization of 
the antisera against the five fusion proteins is summarized in Table 3.1.
Table 3.1. Summary of the L protein antisera raised against fusion proteins
Fusion protein Residues 
of L protein
Cloning site in pUEX Antiserum reactivity
Western Blotting IP
LI 110(44-154) pUEX3-Sma I -
L2 50 (722-772) pUEX3-Sma I -
L3 199(1440-1639) pUEXl-BamHI +
L4 217 (2017-2233) pUEX3-Sma I/Pst I + +
L5 340 (82-422) pUEX3-Sma I ND +
ND: not determined
It was noted that in Fig.3.6, a protein migrating slower than the G2 protein was 
also immunoprecipitated by both positive antisera against the L protein and this band was 
not clearly shown in the lane which was precipitated with anti-Bunyamwera virus serum. 
The origin of this protein band is unclear and might be a nonspecific precipitation, which 
has never been seen on other occasions. Minor amount of the N protein was also 
precipitated by the L specific antisera. The more L protein precipitated, the more N 
protein could be seen (Fig.3.6). As the cytoplasmic extracts were prepared for 
immunoprecipitat ion under essentially nondenaturing conditions, the antisera against the 
L protein might have reacted with the L associated with the nucleocapsid and thus 
precipitated the nucleocapsid-associated N protein. The precipitation of the L protein by 
anti-Bunyamwera virus serum may have resulted from precipitation of the N protein on
the nucleocapsid with which the L is associated.
The two positive antisera against either the N- or C-terminus of the L protein were 
also characterized by their reactivity with an N-termmal half L protein which was
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Fig.3.6. Characterization of the test sera response to the Bunyamwera virus L protein 
by immunoprecipitation. Bunyamwera virus infected cells were labelled for 4 hr at 
16 hr postinfection and cytoplasmic extracts were immunoprecipitated with sera 
against fusion proteins (anti-Ll to anti-L5) and anti-Bunyamwera virus (anti-v) or 
preimmune serum (pre) as indicated, followed by electrophoresis on 10% 
polyacrylamide-SDS gels. Two antisera (anti-L4 and anti-L5) precipitated the L 
protein; no reaction was seen with the preimmune serum. More L protein was 
precipitated by the anti-L4 antiserum. Minor amounts of N protein were also 
precipitated by these two anti sera with more N precipitated by anti-L4. Antiserum 
against LI, L2 or L3 did not react with the L protein. Lane BUN is Bunyamwera 
virus infected cells examined without immunoprecipitation. Lanes anti-v are 
immunoprecipitation of Bunyamwera virus infected cell extracts with the anti- 
Bunyamwera virus serum and the Bunyamwera virus proteins L, Gl, G2, and N are 
indicated; these lanes were overexposed to visualize the L protein.
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transiently expressed in CV-1 cells (see chapter 4). This truncated L protein only 
contained amino acids 1-1271 of the L protein. It was immunoprecipitated by the anti-N 
L protein antiserum but not by the anti-C L protein antiserum (Fig.3.7), con firming the 
specificity of the two L protein antisera.
3.5. Discussion
Hitherto, specific antisera to the Bunyamwera virus L protein were unavailable. 
The major reason was the lack of suitable amounts of antigen because there is very little L 
protein present within each virus particle. It has been estimated that there are 25 
molecules of L protein compared to 2100 molecules of N protein in each virus particle 
(Obijeski et a l., 1976). Therefore, it is very difficult to get enough L protein antigen 
from the virus to elicit antibodies. Expression of the protein via a bacterial vector could 
overcome the problem, but it has not been possible to express the full-length 
Bunyamwera virus L protein in E. coli (see chapter 4). Thus, the bacterial expression 
vector series pUEX were used for expression of fusion proteins, with portions of the L 
protein fused to bacterial B-galactosidase. B-galactosidase confers insolubility on the 
hybrid protein and thus protects the protein against proteolysis and facilitates its 
purification (Stanley & Luzio, 1984). As expected however, fusion proteins are not 
always successful immunogens. Initially I expressed four fusion proteins (L1-L4), but 
only one antiserum, that raised against the C-terminal part of the L protein (anti-L4), was 
screened positive by immunoprecipitation. As it would be useful to obtain an antibody 
which specifically reacted with the N-terminus of the L protein for future work, I then 
went on to clone a bigger fragment removed from the 5' end of a cDNA subclone. The 
antiserum raised against this fusion protean (L5) recognized the virus L protein 
specifically as tested by immunoprecipitation analysis. Thus, two antisera which 
represent the anti-C and anti-N termini of the L protein have been characterized.
Western blotting and immunoprecipitation assays were used to test the antisera 
since these two methods use different forms of antigen. The fusion protein immunogens 
were made as the denatured form by electrophoresis on SD S-polyacrylamide gels. The 
antigen in a Western blotting assay is presented as the denatured form and the antibodies 
should recognize the protein more efficiently. Therefore, the antiserum against fusion 
protein L3 showed its reaction with the L protein by Western blotting (Fig. 3.5), but 
failed to recognize the L protein by immunoprecipitation (Fig.3.6). The antiscra against 
fusion protein LI and L2 did not react with the L protein in either assay; whether this was
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because of the relatively small size of the fragment fused to B-galactosidase or because the 
regions were not antigenic is not known.
Fig.3.7. Reactivity of the anti-C and anti-N terminal L protein antisera with a C- 
terminal truncated L protein by immunoprecipitation. The N terminal half of the L 
protein which contained residues 1-1271 (lanes 3 and 6) and full-length L protein 
(lanes 4 and 7) were transiently expressed in CV-1 cells (see chapter 4) and the 
proteins were labelled with 35s_methionine. The cytoplasmic extracts were 
immunoprecipitated with the anti-N (lanes 1-4) or anti-C (lanes 5-8) specific L 
protein antisera followed by electrophoresis on a 12% polyacrylamide-SDS gel. 
Immunoprecipitation of Bunyamwera virus infected cytoplasmic extracts (Lanes 1 
and 8) and cell extracts without transient expression (lanes 2 and 5) by either sera are 
also shown. The N terminal half of the L proton was only precipitated by the anti-N 
terminus of L protein antiserum but not by the anti-C terminus of L protein 
anti serum.
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The specific reaction of the antisera with the Bunyamwera virus L protein provides 
further evidence that the L RNA genome segment encodes the L protein, which had 
previously been determined by genome reassortment experiments (Endres et a i , 1989; 
Elliott, 1989a). This work also demonstrated that in addition to the N protein, 
nucleocapsids also contain L protein as revealed by Western blot analysis of the 
nucleocapsids purified from the Bunyamwera virus infected cells, and by the fact that 
some N protein was also precipitated by the monospecific L protein antisera.
The monospecific antisera raised against the L protein should be useful probes in 
determining the localization of the L protein in infected cells, e.g. by immunofluorc^ent 
staining, and in virus nucleocapsids, e.g. by immune electron microscopy. They will 
also be helpful for the functional analysis of the L protein.
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Chapter 4
Expression of the Bunyamwera virus L 
protein
4.1. Introduction
The L protein of Bunyamwera virus is presumed to be the virion associated 
transcriptase or RNA polymerase, but direct proof of this is lacking. Little is known 
about its role in viral RNA synthesis and it is considered that the L protein is 
multifunctional. Expressing the L protein from cloned cDNA would be the first 
important step towards defming the functional domains within the bunyavirus L protein.
Over the past decade several systems for heterogeneous gene expression have been 
established. Each system has its own advantages and disadvantages over the others. To 
obtain biologically functional L protein, it was considered prudent to evaluate more than 
one expression system. Three systems were tried to express the L protein: in vitro 
translation of in vitro synthesized mRNA; the bacterial T7 expression system described 
by Studier et al. (1990); and the construction of recombinant vaccinia viruses.
4.2. Construction of a full-length cDNA to the 
Bunyamwera virus L gene.
An intact copy of the Bunyamwera virus L gene coding region was constructed 
from existing cDNA clones (Elliott, 1989a) and synthetic oligonucleotides. The major 
part of the gene was built from the unique Hind III site just downstream of the ATG 
initiation codon for the L protein by using three subgenomic cDNA clones (Fig.4.1 A). 
A 1.67 kb Hind III-Sph I fragment isolated from pBUN357 and a 2.07 kb Sph I-Pst I 
fragment isolated from pBUN367 were ligated together with Hind III- and Pst I-doubly 
digested pUC18 DNA. The resulting plasmid, pUC18 357/367, was digested with Pst 
I, treated with alkaline phosphatase, and then ligated to a 3.06 kb Pst I fragment isolated
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I________I________ I________I_______ I________I________I_______ I
L cDNA -| | | |
Hind\\\ Sph I PsM Pst l(G/C)
pBUN357 J______________ I__________ ,
pBUN367 J __________________I_________ i
pBUN363 i____________ I__________________________ I
B
Sma
Hind III Kpn I Hind III
AGCTTGGT ACCCGGGT AGG AGT ATGG AGG ACC A
ACCATGGGCCCAT CCT CATACCT CCTGGTTCGA
Pst I Sma I Kpn
Hind III
pUCl8 357/367/363
Fie.4.1. Construction of a full-length Bunyamwera virus L gene cDNA. A. 
Relationship of the three subgenomic cDNA clones and relevant resmcuon enzyme 
sites used in the construction. Pst I(G/C) indicates a Pst I site created by GC tail ng 
during the initial cDNA cloning of the L RNA. The major part of the L gene coding 
region comprised the Hind III-Sph I fragment of pBUN357, the p - st ^ e"f 
of pBUN367, and the Pst I-Pst I fragment of pBUN363 B. Inse" ‘° " °  
complementary synthetic oligonucleotides, containing Hind III, Kpn 
restriction enzyme sites and nucleotides 43 to 65 of the L gene c ( '
including the ATG translational start codon, to complete the L gene coding sequence. 
The shaded box represents the L gene cDNA (not to scale), and relevant resmcuon 
sites at the 3 ' end of the insert are indicated.
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Fig.4.2. Dideoxy chain termination sequencing gels of alkali-denatured DNA derived 
from pUC-BUNL and pTZ-BUNL, showing multiple copies of linkers were 
introduced in pUC-BUNL and the correct sequence after subcloning Sma I digested 
insert into pTZ18R to give pTZ-BUNL. The order of the lanes is G, A, T, and C. 
Positions of Sma I and Hind III restriction enzyme sites and the ATG translational 
start of the L protein are indicated.
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from pBUN363. The correct orientation of this latter fragment was confirmed by 
digestion with appropriate restriction enzymes. This plasmid (pUC18 357/367/363) was 
digested with Hind III, treated with phosphatase, and ligated together with two 
complementary synthetic oligonucleotides which contained the ATG start codon and 
missing bases of the L gene, flanked by Hind III restriction sites (Fig. 4.IB). The 
oligonucleotides also contained sequences for Kpn I and Sma I restriction enzymes to 
facilitate subcloning of the full-length L gene cDNA: these enzymes do not cleave the L 
gene cDNA, and hence the gene may be removed as a Kpn I or Sma I fragment, the 3' 
sites being derived from the polylinker region of the vector. Direct nucleotide sequence 
analysis of plasmids after ligation of the synthetic oligonucleotides revealed that multiple 
copies of the linker had been cloned; however, digestion with Smal and ligation of the
6.83 kb fragment into Sma I cleaved pTZ18R DNA yielded a cDNA containing the 
correct 5' end sequence (Fig.4.2). This plasmid was designated pTZ-BUNL.
4.3. I n  v i t r o  transcription and translation of the L gene
The L gene cDNA cloned under control of the T7 promoter (pTZ-BUNL) was 
linearized at the 3' end of the L gene coding sequence by digestion with Sal I (Fig.4.3). 
Full length L RNA was transcribed by T7 RNA polymerase in vitro and analysed by 
agarose gel electrophoresis followed by ethidium bromide staining (Fig.4.4A). The
6.83 kb full-length L RNA (lane 2) was observed to migrate slightly faster than the 6.6
Cla I Xba I PstI SailPst I BamH I
6.83 (kb)0.79 2.0
T7
pTZ-BUNL
Fig.4.3. Positions of the restriction enzyme sites used to linearize the L gene cDNA 
cloned under control of the T7 promoter in PTZ-BUNL. The linearized pTZ-BUNL 
was transcribed in vitro to synthesize mRNA by T7 RNA polymerase for in vitro 
translation. The 3.81 kb RNA transcribed from a recombinant plasmid which has 
nucleotides 41-3810 of the L gene sequence cloned under control of the T7 promoter 
followed by a T7 terminator in pTF7-5 (see later).
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kb DNA size marker which probably reflects the migration difference between DNA and 
RNA species. The 6.83 kb RNA band appeared rather smeared, which might have been 
due to degradation of the RNA or because some incomplete transcripts were made 
during the in vitro transcription. This RNA was then translated in a message dependent 
reticulocyte lysate (NEN). No full-length L protein was detected; a number of smaller 
polypeptides were seen below the position where L should migrate (Fig.4.4B. lane 3). 
Therefore, RNA transcripts truncated from the 3' end of the L were made to examine the 
possible translational attenuation of the L gene. Digestion of pTZ-BUNL with Cla I, 
Xba I and BamH I produced RNAs of 0.87 kb, 2.0 kb and 4.28 kb in length 
respectively (Fig.4.4A. lanes 7-5). The digestion of pTZ-BUNL with Xba I was not 
complete and a bigger RNA band was also seen (lane 6 ). Translation of these RNAs 
was performed and only the 0.87 kb RNA (Fig.4.4B. lane 4) synthesized a protein of 
the expected size (34.8K); the other two RNAs (Fig.4.4B. lanes 5 and 6) produced 
proteins shorter than the predicted species of 80K and 170K. These experiments 
indicated that most probably correct translation initiation of the L protein occurred, but 
no full-length L protein could be synthesized in vitro.
Since translational activity of reticulocyte lysates produced by different companies 
might be different, I then repeated the L gene in vitro translation experiment using the 
Amersham reticulocyte lysate. As can be seen from Fig.4.5, both the 0.87 kb (lane 1) 
and the 3.8 kb (lane 2) RNA transcripts were translated to give proteins which correlated 
with their estimated size (34.7K and 150K). These polypeptides were also 
immunoprecipitated by a mixture of the monospecific antisera against the C- and N- 
termini of the L protein (lanes 5 and 6). No L protein was clearly detected in the in vitro 
translation reaction which was supplemented with the 6.83 kb full-length L RNA (lane
3), but a protein of the same size as the authentic L was detected in an independent 
experiment (Fig.4.5. right panel). However, the level of this L sized protein was not 
high enough to be immunoprecipitated by the antisera against the N- or C-termini of the 
L protein. Many smaller polypeptides were made during the in vitro translation of the 
full length L gene and some of them were precipitated by the antiserum against the N- 
terminus of the L protein. The smaller proteins produced were considered to be 
premature termination products of the in vitro translation of the L messenger RNA or 
else possibly resulted from degradation of larger polypeptides. The experiment 
suggested that there was a strong translational attenuation during the in vitro translation 
of the L.
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Fig.4.4A. Agarose gel analysis of the in vitro synthesized RNA. About 10% of the 
RNA synthesized in vitro by 77 RNA polymerase (see chapter 2) was fractionated on 
a 1% agarose gel containing 5 mM methylmercuric hydroxide and stained with 
ethidium bromide. The Sal I linearized 9.6 kb pTZ-BUNL DNA (lane 3) and the
6.83 kb full length L RNA (lane 2) were visualized in the gel. Lane 1 shows the 
DNA size markers which are designated on the side of the gel. Lane 4 shows lkb 
ladder DNA size markers. The 4.28 kb RNA generated by transcription of pTZ- 
BUNL linearized with BamH I (lane 5), 2.0 kb RNA from Xba I linearized pTZ- 
BUNL (lane 6) [the bigger band was probably derived from uncut plasmid], 0.87 kb 
RNA transcribed from Cla I linearized pTZ-BUNL (lane 7) were clearly seen in the 
gel. It appeared that the bigger the RNA size, the more smearing of the RNA band 
occured, indicating some degradation of the RNA occurred or incomplete transcripts 
were produced.
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Fig.4.4B. In vitro translation of RNA transcripts in the NEN reticlulocyte lysate. 
The in vitro transcribed RNA was translated in the NEN reticulocyte lysate as 
described in chapter 2. The 35s-methionine labelled proteins were analysed in a 10% 
polyacrylamide-SDS gel (left) or 12% polyacrylamide-SDS gel (right). The full- 
length 6.83 kb RNA (lane 3) did not produce a protein of 259K but some smaller 
polypeptides were observed. The 0.87 kb RNA produced a protein of the expected 
size which was about 34.8K (lane 4), whereas the 2.0 kb RNA (lane 5) and 4.28 kb 
RNA (lane 6) did not synthesize proteins of the expected size (80K and 170K). 
Lanes 2 and 7 were in vitro translation reactions supplemented with the Maguari S 
RNA in vitro transcribed from pTZ-MAGS (Elliott and McGregor, 1989), which was 
translated into the N protein as a system control. Lanes 1 and 8 show products of 
reactions which had no RNA added.
Fig.4.5. In vitro  translation of the L gene in the Amersham reticulocyte lysate. In 
vitro  tanslations performed according to the manufacturer's instructions as described 
in chapter 2 and two independent experiments are shown in this figure. The 35s - 
methionine labelled in vitro  synthesized proteins were assayed directly on the gel 
(lanes 1-4 and L), or after immunoprecipitation with a mixture of anti-N and anti-C L 
protein specific antisera (lanes 5-6) or with anti-Bunyamwera virus antiserum (lane 7) 
or with the serum indicated. The 0.87 kb RNA (lane 1) was translated into a protein 
which correlated with the estimated size (34.8K) and also a larger protein which was 
probably translated from RNA derived from partially digested DNA; both were 
precipitated by the L protein specific antisera. The 3.81 kb RNA (lane 2) synthesized 
a protein of the expected size (150 K) which was also precipitated by the mixed 
antisera against the L protein Qane 6). Lane 4 is Maguari S RNA control with the N 
protein synthesized and precipitated by the anti-Bunyamwera virus antiserun (lane 7). 
Lane BUN shows the Bunyamwera virus protein L, G l, and N markers. Note that 
the mobility of the Maguari virus N protein is slower than the Bunyamera virus N 
protein. Translation of the full-length L RNA did not show production of a full length 
L protein in lane 3 of the left gel, but it was observed in the right gel that a protein of 
the same size as the L protein produced in Bunyamwera virus infected cells was 
detected, although it was not shown to be immunoprecipitated by the anti-C or anti-N 
L protein antiserum.
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4.4. Attempts to express the L protein by the bacterial 
T7 system.
The bacterial T7 RNA polymerase expression system in E. coli (Studier and 
Moffatt, 1986; Studier e t aL> 1990) has been used to express a number of proteins in 
high yields. To construct a recombinant plasmid with the L gene cDNA under control of 
the T7 promoter suitable for expression in E. coli, two complementary oligonucleotides 
were synthesized for inserting the L gene cDNA into the plasmid vector pET8c, which 
contains the T7 promoter followed by a T7 terminator. The synthetic oligonucleotides 
contained the ATG start codon of the L protein, nucleotides 43-65 of the L gene 
sequence between the ATG and the Hind III site, and Hind III and Kpn I sites for 
insertion of the L gene cDNA (Fig.4.6). Plasmid pET8c was digested with Nco I and 
BamH I, treated with phosphatase and ligated with the two complementary 
oligonucleotides. The resulting plasmid pET8c(H/K) was digested with Hind III and 
Kpn I, and ligated with the Hind HI and Kpn I cDNA fragment which had been removed 
from pTZ-BUNL; the recombinant plasmid was designated pET-BUNL. The 5' end of 
the L gene sequence inserted into the vector was examined by dideoxynucleotide 
sequencing of the alkaline denatured pET-BUNL and the correct ligation of the insert 
was confirmed (Fig.4.6B). pET-BUNL was then transformed into E. coli strain 
BL21(DE3) for analysis of expression.
The lysogen BL(DE3) contains a single copy of the gene for T7 RNA polymerase 
in the chromosome under control of the lacUV5 promoter which is inducible by IPTG. 
BL(DE3) transformed with pET-BUNL was grown at 37 °C for 5 hr until the culture 
reached an OD600 of 0.6-1. To induce expression, IPTG was added to 0.4 mM and 
incubation was continued for 2 hr at 37 °C. BL21(DE3) transformed with pET-65K, 
obtained from Dr. C. Preston, was used as positive expression control. The herpes 
simplex virus 65K protein was shown to be expressed in both uninduced and induced 
(Fig.4.7a), indicating that some T7 RNA polymerase was synthesized in uninduced 
cultures. No L protein was synthesized in BL21(DE3) cells transformed with pET- 
BUNL (b). As it was possible that the basal level of T7 RNA polymerase in BL21(DE3) 
cells may have induced L protein expression which might have been toxic to the cells, £. 
coli strains BL21(DE3)pLysS and BL21(DE3)pLysE were transformed with pET- 
BUNL and then used for the L expression. BL21(DE3)pLysE carries a plasmid 
containing the lysozyme gene cloned under the tet promoter and BL21(DE3) pLysS has 
the lysozyme gene cloned in the plasmid in the opposite orientation and accumulates
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A. B.
Nco I Hind ID Kpn I BamHI
5 ' CAT GGAGG ACCAAGC1 '1 ATOg TACCcGG
CT CCTGGTTGGAATAOC ATGGGCCCTAG
i S
Hind HI 
Kpn I
T7
r * :
T0
pET-BUNL
pTZ-BUNL
I Hind III 
|  Kpn I
I----- T
ATG | . Nco I
Fig.4.6. Construction of the recombinant plasmid for expression of the L protein in 
the bacterial T7 system. A. Insertion of a complementary synthetic oligonucleotide 
linker between the Nco I and BamH I sites of the vector pET8c. The linker contained 
the ATG translational start codon of the L protein in the Nco I site, nucleotides 43-65 
of the L gene cDNA, and Hind III and Kpn I sites for insertion of the L gene 
fragment. The resulting vector pET8c(H/K) was digested with Hind m  and Kpn I 
and ligated with the L gene cDNA (not to scale) which was removed from pTZ- 
BUNL by Hind III and Kpn I double digestion, and the recombinant plasmid was 
designated pET-BUNL. The restriction enzyme sites created in the linker and the 
ATG translational start site are indicated. B. Dideoxy chain termination sequencing 
gel of pET-BUNL, showing the correct sequence inserted by the L cDNA. The 
orders of the lanes is G, A, T, and C. The positions of the ATG start codon and 
Hind III site are indicated.
Hind III
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Fig.4.7. SDS-polyaciylamide gel analysis of proteins produced in the bacterial T7 
system. A. Expression by IPTG induction. Cultures of different E. coli strains 
transformed with pET-65K (a) and pET-BUNL (b-e) were grown in YT broth 
containing 50 pg/ml ampicillin, and the production of T7 RNA polymerase was 
induced by adding IPTG to 0.4 mM. For BL21(DE3) transformants, after 30 min 
induction rifampicin was added to the cultures at 200 pg/ml for 10 min to inhibit host 
protein synthesis. Bacterial cells were collected by centrifugation and an amount equal 
to 100 |il of culture were radiolabelled with ^^S-methionine (20 pCi/ml) in PBS for 
60 min in the presence of IPTG. The labelled proteins were analysed by gel 
electrophoresis. The cultures of E. coli were BL21(DE3) (a and b), HMS174(DE3) 
(c), HMS174(DE3)pLysS (d) orHMS174(DE3)pLysE (e) and were uninduced (U) or 
induced (I) by IPTG. The 65K protein was produced in both uninduced and induced 
E. coli cells containing pET-65K (a), but no L protein was observed in cells 
containing pET-BUNL (b-e).
B. CE6 phage directed expression. Cultures of HMS174 carrying pET-BUNL were 
grown in M9 medium containing 50 jig/ml ampicillin and infected with bacteriophage 
CE6 at moi of 1, 5, or 10 pfu/cell. Immediately after 2 hr of infection, 100 pi of the 
cultures were radiolabelled with ^^S-methionine (20 pCi/ml) for 20 min at 37 °C. The 
cells were collected by centrifugation and the proteins subjected to electrophoresis in a 
10% polyacrylamide-SDS gel. No L protein was detected.
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lower levels of lysozyme than in BL21(DE3)pLysE. The production of the T7 lysozyme 
in these cells would inhibit the basal level of T7 RNA polymerase activity. However, no 
L protein was detected in these cells transformed with pET-BUNL. Meanwhile, pET- 
BUNL was also transformed into E. co li K12 strains HMS174, HMS(DE3), 
HMS(DE3)pLysS and HMS(DE3)pLysE to examine whether these strains would be 
better for L expression. Again, none of these cells established with pET-BUNL showed 
any expression of the L protein (Fig.4.7c-e).
In further experiments, attempts were made to express the L protein by providing 
T7 RNA polymerase through CE6 phage infection of HMS174 cells transformed with 
pET-BUNL. The cells were grown at 37 °C overnight in M9 medium and then infected 
with CE6 phage at moi of 1,5, or 10 pfu/cell, followed by continued incubation at 37 °C 
for 2 hr. The infected cells were labelled with ^^S-methionine and proteins separated on 
an SDS-polyacrylamide gel (Fig.4.7). However, no L protein was detected in the gel.
4.5. Expression of the L protein by recombinant vaccinia 
viruses
Two approaches were used to express the Bunyamwera virus L protein by 
recombinant vaccinia viruses. The first employed the classical method in which the L 
gene was inserted in lieu of the vaccinia virus TK gene, under control of the vaccinia 
virus P7.5 promoter, by using the plasmid transfer vector pSCll; this vector includes 
the E. coli B-galactosidase gene under control of the PI 1 promoter so that recombinant 
vaccinia viruses produce blue plaques when stained with X-Gal (Chakrabarti et a l., 
1985). The second approach again used the TK locus as the site for recombination of 
the L gene, but in this case the L gene was under control of the bacteriophage T7 
promoter and terminator by using the transfer vector pTF7-5 (Fuerst et a l., 1987). 
Expression of the Bunyamwera virus gene should occur only when T7 RNA 
polymerase, supplied by a second, coinfecting recombinant vaccinia virus, vTF7-3, was 
present in the cell (Fuerst et al., 1987; 1986).
4.5.1. Construction and characterization of recombinant 
vaccinia virus vSCl 1-BUNL
The Bunyamwera virus L gene was removed from pTZ-BUNL by digestion with 
Sma I and cloned into Sma I site in pSCll (Fig.4.8). The correct orientation of the 
insert was ascertained by restriction enzyme digestion and the recombinant plasmid was 
designated pSCl 1-BUNL. pSCl 1-BUNL was then recombined by standard procedures
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Fig.4.8. Construction of recombinant plasmid pSCl 1-BUNL for making recombinant 
vaccinia virus vSCl 1-BUNL. A 6.83 kb Sma I fragment (not to scale) containing the 
entire L gene coding sequence was removed from pTZ-BUNL and inserted into the 
unique Sma I site of the vaccinia virus transfer vector pSCl 1. The L gene is under 
control of the vaccinia virus P7.5 promoter and the chimaeric gene is flanked by the 
left (TKl ) and right (TKr ) vaccinia virus TK gene sequences. Plasmid DNA was
transfected into CV-1 cells infected with wild type vaccinia virus (WR strain) and TK* 
recombinants were selected by plaque isolation in TK" cells in the presence of BUdR.
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Fig.4.9. Plaque selection of TK' recombinant vaccinia virus vSCl 1-BUNL, showing 
the blue plaques produced in TK' cells after staining with X-Gal.
(see chapter 2) into the TK locus of vaccinia virus WR strain, and TK' viruses were 
selected by plaque assay on TK" 143 cells in the presence of 5-bromodeoxyuridine 
(BUdR). TK ' blue plaques were picked after addition of X-Gal to the overlay 
(Fig.4.9). The TK" plaques were grown up in TK" 143 cells and the cells were lysed 
and total cellular DNA dot blotted onto a nitrocellulose filter. Hybridization with an L 
gene cDNA probe revealed a possible signal with DNA from a blue plaque (Fig.4.10A. 
lane 1), but not in a colourless plaque (lane 2). The blue plaque was then further plaque- 
to-plaque purified, and finally confirmed by analysis of the restriction enzyme profile of 
vaccinia virus DNA. Total cellular DNA extracted from the vaccinia virus infected cells 
(Fig.4.10B. lanes 1 and 3) and plasmid pSCl 1-BUNL DNA (lanes 2 and 4) was 
digested with BamH I or EcoR I, fractionated on an agarose gel, transferred to a 
nitrocellulose filter, and hybridized to 32p-iabelled L gene cDNA. The 2.55 kb and
4.28 kb BamH I L cDNA restriction fragments were detected for both vSCl 1-BUNL 
and pSCl 1-BUNL DNA (lanes 1-2); the 3.7 kb, 1.5 kb and 0.9 kb EcoR I fragments 
were present in each pair of DNAs (lanes 3-4), indicating that the L gene cDNA was 
recombined into the vaccinia virus. The recombinant virus obtained was then designated 
vSCl 1-BUNL.
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Fig.4.10. Characterization of recombinant vaccinia virus vSCll-BUNL. A. DNA 
dot blot analysis. A TK" blue plaque (lane 1) and a colourless TK" plaque (lane 2) 
were used to infect small monolayer cultures of TK” cells and after 2 days the cells 
were lysed and total cellular DNAs prepared. The DNA was dot blotted onto a 
nitrocellulose filter and hybridized with 32p-labelled pTZ-BUNL DNA. An L gene 
signal was detected in the DNA from the blue plaque infected cells (lane 1), but not in 
the colourless plaque infected cells (lane 2). B. Southern blot analysis. DNA was 
extracted from the recombinant vaccinia virus (vSC 11-BUNL) infected cells and 
digested with either BamH I (lane 1) or EcoR I (lane 3), transferred to nitrocellulose 
filter, and hybridized with 32p-iabelled pTZ-BUNL DNA. Plasmid pSCll-BUNL 
DNA was also digested with either BamH I (lane 2) or EcoR I Qane 4). The L cDNA
4.28 and 2.55 kb BamH I fragment was detected in both vSCll-BUNL infected 
cellular DNA and plasmid pSCl 1-BUNL DNA (lanes 1 and 2). The L cDNA 3.7 kb,
1.5 kb and 0.9 kb EcoR I fragments were also present for both DNAs (lanes 3 and 
4) The 0.9 kb EcoR I fragment was visible in the original film.
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4.5.2. Construction and characterization of recombinant 
vaccinia virus vTF7-5BUNL
The Bunyamwera virus L gene was removed from pTZ-BUNL by digestion with 
Sma I and cloned into the end-filled BamH I site in vaccinia virus transfer vector pTF7-5 
(Fig.4.11 A). The correct orientation of the insert was ascertained by restriction enzyme 
digestion and the resulting recombinant plasmid was designated pTF7-5BUNL. The 
correct insertion of the L gene in pTF7-5BUNL was further examined by 
dideoxynucleotide sequencing of the alkali denatured DNA (Fig.4.1 IB). pTF7-5BUNL 
was then recombined by standard procedures (see chapter 2) into the TK locus of 
vaccinia virus WR strain, and TK- viruses were selected by plaque assay on TK* 143 
cells in the presence of 5-bromodeoxyuridine.
The plasmid pTF7-5 does not contain the LacZ gene to allow for colour selection 
of recombinant plaques. Therefore to screen for true recombinant TK* vaccinia viruses 
against spontaneous TK* mutants, about 80 TK* plaques were picked. The plaques 
were grown up in TK" cells and total cellular DNA screened for the L gene signal by dot 
bot hybridization. After a first round of screening, 10 TK* plaques were picked and 
replicated in TK* cells. Total cellular DNA from the 10 virus infected monolayers were 
dot blotted onto nitrocellulose filters. Hybridization with both ^P-labelled L gene DNA 
and the vaccinia virus TK gene DNA revealed that six plaques contained the L gene 
sequence (Fig.4.12A). Thus, these six plaques were used to infect TK" cells and the 
presence of the L gene was confirmed by another round of dot blot analysis 
(Fig.4.12B). Finally, these vaccinia virus DNAs were characterized by Southern blot 
analysis. DNAs extracted from vaccinia virus infected cells were digested with Pst I and 
fractionated in an agarose gel (Fig.4.12C). Hybridization of the DNAs with 32p. 
labelled L gene cDNA showed that all of the six viruses contained an L gene cDNA 3 kb 
Pst I fragment, indicating that the L gene was recombined into the vaccinia virus. The 
resulting recombinant vaccinia virus was designated vTF7-5BUNL.
Further characterization of recombinant vaccinia virus vTF7-5BUNL by Southern 
blot analysis is shown in Fig.4.13. pTF7-5BUNL (lanes 3 and 6), vTF7-5BUNL 
(lanes 1 and 4), and vaccinia virus WR strain (lanes 2 and 5) DNAs were analysed using 
EcoR V and EcoR I digestion followed by Southern blotting. It was shown that no 
hybridization occurred with the WR strain DNA, whereas the pattern of EcoR V bands 
(3.0 kb and a bigger DNA) for vTF7-5BUNL and pTF7-5BUNL was the same; and the 
pattern of EcoR I bands was also consistent for the expected structure of a recombinant 
vaccinia virus vTF7-5BUNL.
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Fig.4.11. Construction of recombinant plasmid pTF7-5BUNL for making 
recombinant vaccinia virus vTF7-5BUNL. A. Insertion of the L gene cDNA into 
vaccinia virus transfer vector pTF7-5. A 6.83 kb Sma I fragment containing the entire 
L  gene coding sequence (not to scale) was inserted into the end-filled BamH I site of 
PTF7-5. The recombinant plasmid pTF7-5BUNL has the L gene under control of the 
bacteriophage T7 promoter and T7 terminator. The chimaeric gene is also flanked by 
vaccinia virus TK gene sequences. The plasmid was transfected into CV-1 cells 
which had been infected with wild type vaccinia virus (WR strain). TK* recombinants 
(vTF7-5BUNL) were selected by plaque isolation in TK* cells in the presence of 
BUdR. B. Dideoxynucleotide chain termination sequencing gel, showing the correct 
5' end sequence of the L gene inserted into the filled BamH I site in pTF7-5. The 
insertion site and the ATG start codon of the L protein are indicated.
Chapter 4 Expression o f the Bunyamwera virus L protein 110
A.
1 2 3 4 5 6 7 8 9 10
• • #
•
B.
2 4 5 7 9 10
• •  • t •  •t.
C. •  •
2 4 5 7 9 10
A1
A2
B1
B2
3.0kb
Fig.4.12. Screening of recombinant vaccinia virus vTF7-5BUNL. A. and B. DNA 
dot blot analysis. Total cellular DNA from small monolayer cultures infected with 
TK" vaccinia virus plaques (1-10) were dot blotted onto nitrocellulose filters and the 
DNA probed with 32p-labelled pTZ-BUNL DNA (Al) or 32P-labelled pTF7-5 DNA 
for detection of the TK gene (A2). Six plaques which showed strong signals on both 
blots (2 ,4 ,5 ,7 ,9 , and 10) were amplified in TK" cells and the DNA dot blotted onto 
nitrocellulose filters for another round of screening. The blots were either hybridized
with 32P-labelled pTZ-BUNL (Bl) or 32P-labelled pTF7-5 (B2). The L gene was 
shown to be recombined into the vaccinia viruses. C. Southern blot analysis. DNAs 
were extracted from the six recombinant vaccinia virus infected cells and digested with 
Pst I. After fractionation on a 1% agarose gel, the DNAs were transferred to a 
nitrocellulose filter, and hybridized with 32p_iabelled pTZ-BUNL DNA. All the
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viruses had the same pattern of DNA bands. The L cDNA diagnostic 3 kb Pst I 
fragment band is indicated.
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Fig.4.13. Characterization of recombinant vaccinia virus vTF7-5BUNL by Southern 
blot analysis. DNA from cells infected with vTF7-5BUNL (lanes 1 and 4) or from 
the transfer vector pTF7-5BUNL (lanes 3 and 6) was digested with either EcoR V 
(lanes 1 to 3) or EcoR I (lanes 4-6), fractionated on an agarose gel and transferred to 
nitrocellulose. Hybridization with 32p-iabelled pTZ-BUNL DNA indicated the 
expected genetic structure for vTF7-5BUNL; no hybridization occurred with the 
vaccinia virus parental DNA (lanes 2 and 5). The size of the L gene cDNA restriction 
fragments is designated on the side of the gel.
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Analysis of RNA synthesized in recombinant vaccinia virus-infected cells was 
performed by Northern blotting using an L gene cDNA probe (Fig.4.14). The level of 
the L gene-specific RNA in cells infected with vSCl 1-BUNL was barely detectable by 
the standard procedure (lane 5). In cells dually infected with vTF7-3 and vTF7-5BUNL 
(lane 3), an RNA transcript about the same size as that detected in Bunyamwera virus- 
infected cells was easily detected (lanes 2 and 6). No L gene-specific RNA was detected 
in mock-infected cells Oane 1) or in cells infected with vTF7-5BUNL alone (lane 4).
1 2 3 4 5 6
Fig.4.14. Northern blot analysis of vSCl 1-BUNL and vTF7-5BUNL infected cell 
RNA. Total cellular RNA was extracted from mock-infected cells (lane 1), or from 
cells infected with Bunyamwera virus (lanes 2 and 6), vTF7-5BUNL and vTF7-3 
(lane 3), vTF7-5BUNL alone (lane 4), or vSCl 1-BUNL Oane 5), and fractionated on 
a 1%  agarose gel containing methyl mercuric hydroxide. After transfer to 
nitrocellulose filters, hybridization was performed with 32p_iabeiied pTZ-BUNL 
DNA. An L segment specific RNA, similar in size to that observed in the 
Bunyamwera virus infected cells (lane 2), was detected in the cells infected with 
VTF7-5BUNL and vTF7-3 (lane 3). No hybridization was observed in mock-infected 
(lane 1) or vTF7-5BUNL singly infected cells (lane 4). Barely detectable L RNA was 
observed in vSCl 1-BUNL infected cells Qane 5).
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4.5.3. Analyses of proteins synthesized by recombinant vaccinia 
viruses.
To investigate the proteins made by the recombinant vaccinia viruses, CV-1 cells 
were infected with the various recombinants at moi of 5 pfu/cell and pulse-labelled at 22 
to 24 hr postinfection with 35S-methionine; the cell lysates were fractionated on SDS- 
polyacrylamide gels (Figs.4.15 and 4.16). The cells infected with vSCl 1-BUNL 
produced a high molecular weight protein of the same electrophoretic mobility as the L 
protein identified in Bunyamwera virus-infected cells (Fig.4.15), which was not seen in 
cells infected with the parental vaccinia WR virus. In vSCl 1-BUNL infected cells, a 
band corresponding to B-galactosidase was also clearly evident and comigrated with the 
G1 protein of Bunyamwera virus. Other bands specific to the vSCl 1-BUNL infected 
lysate were seen migrating between the positions of 6-galactosidase and the L protein, of 
which one (labelled X in Fig.4.15) is considered in more detail later.
Cells dually infected with vTF7-5BUNL and vTF7-3 (expressing T7 RNA 
polymerase) also contained a protein which comigrated with the Bunyamwera virus L 
protein (Fig.4.16). This band was not seen in cells infected with either virus singly. In 
cells infected with vTF7-5BUNL only, a band having the same mobility as the X band 
seen in vSCl 1-BUNL infected cells was observed, but this band was not seen in the 
dually infected cells.
Thus, both systems synthesized a protein corresponding in size to the L protein; in 
the T7 system, the amount of the expressed protein was similar to that in Bunyamwera 
virus-infected cells, whereas more L protein was synthesized by vSCl 1-BUNL.
Expression of the L protein by the T7 system was further studied by varying the 
multiplicity of infection of both vTF7-3 and vTF7-5BUNL (Fig.4.17). It was observed 
that the level of the L protein was increased at moi of 5 pfu/cell of both vTF7-3 and 
vTF7-5BUNL (lane 14) as compared to 1 pfu/cell of each vaccinia virus Oane 13) and 
decreased at moi of 20 pfu/cell (lane 17). This result suggests that infection with 5 
pfu/cell of vTF7-3 was sufficient to supply adequate T7 RNA polymerase for maximal 
expression. Increasing the amount of T7 RNA polymerase produced by vTF7-3 did not 
appear to significantly enhance the level of the L protein synthesized. Since less vaccinia 
virus proteins, especially the T7 RNA polymerase, were produced in dual vaccinia virus 
infected cells (lanes 13-18) compared with singly vTF7-3 infected cells (lanes 1*6), it 
was possible that higher moi of vaccinia virus inhibited the protein synthesis ability of 
the cells.
To confirm the identity of the protein made in the recombinant vaccinia virus- 
infected cells, immunoprecipitation experiments were performed with the monospecific
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Fig.4.15. Protein synthesis in recombinant vaccinia virus vSCl 1-BUNL infected 
cells. CV-1 cells were mock infected or infected with the WR strain of vaccinia 
virus, the recombinant vSCl 1-BUNL, or with Bunyamwera virus (BUN) as 
indicated. The cells were labelled with 35s-methionine at 22 to 24 h after infection and 
the proteins separated by electrophoresis on a 10% acrylamide-SDS gel. The 
Bunyamwera virus proteins L, G l, and N are designated on the right, and a band 
corresponding to L protein is observed in the vSCl 1-BUNL lane but not in the 
parental vaccinia virus lane. The position of the X protein (see text) is also noted. 
vSCl 1-BUNL synthesizes B-galactosidase which has a mobility similar to that of Gl.
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Fig.4.16. Protein synthesis in recombinant vaccinia viruses vTF7-5-BUNL/vTT7-3 
infected cells. CV-1 cells were mock infected or infected with vTF7-3, vTF7- 
5BUNL, vTF7-3 and vTF7-5BUNL (dual), or Bunyamwera virus (BUN) as 
indicated. The cells were labelled with ^^S-methionine at 22-24 hr after infection and 
the proteins separated on a 10% acrylamide-SDS gel. The Bunyamwera virus L, G l, 
and N proteins are indicated, and a band corresponding to L protein is observed in the 
dual-infected lane. L protein is not seen in cells infected with vTF7-5BUNL alone, 
but the X protein is present. The position of T7 RNA polymerase, synthesized by 
vTF7-3, is indicated.
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antiserum against the C-terminus of the L protein. As shown in Fig.4.18 the protein, 
which was similar in length to the L protein observed in Bunyamwera virus infected 
cells (lanes 2 and 3), synthesized by dual infection with vTF7-3 and vTF7-5BUNL 
Qanes 6 and 9) or infection with vSCl 1-BUNL (lanes 7 and 10) was precipitated by the 
L protein specific antiserum. No proteins were precipitated from cells infected with 
vTF7-3 alone (lanes 4 and 8), and no proteins were precipitated by preimmune serum 
Oane 1). Of interest is the X protein, which was immunoprecipitated from cells infected 
by vTF7-5BUNL alone (lane 5) and by vSCl 1-BUNL Oane 7). This result suggests 
that the X protein is a carboxy terminal fragment of the L protein, but its genesis was not 
investigated.
The time course of the L protein synthesis by the two different vaccinia virus 
systems was compared (Fig.4.19). In cells infected with vSCl 1-BUNL, the L protein 
(and the X protein) could be detected at 6-8 hr postinfection and the synthesis of L 
declined by 24 hr of postinfection. In contrast, using the dual vaccinia virus system L 
protein could not be detected before 10 hr postinfection and its synthesis was greater 
by 24 hr of postinfection. Therefore, the optimal times for expression of the L protein 
by the two vaccinia virus systems were different
4.6. Transient expression of the L protein by plasmid 
transfection
Bacteriophage T7 RNA polymerase, expressed in the cytoplasm of cells infected 
with the recombinant vaccinia virus vTF7-3, can be used to transcribe transfected 
plasmid DNAs that contain target genes placed downstream of T7 RNA polymerase 
promoter (Fuerst e t a l., 1986,1987). As described above the Bunyamwera virus L gene 
cDNA had been cloned into different plasmid vectors under the T7 RNA polymerase 
promoter: pET-BUNL, pTZ-BUNL, and pTF7-5BUNL. Transient expression of the L 
protein by these recombinant plasmids were then investigated.
Recombinant plasmid DNAs pET-BUNL, pTZ-BUNL, or pTF7-5BUNL (Fig. 
4.20. lanes 2-4) were transfected into vTF7-3 infected-CV-1 cells and after 6 hr of 
transfection the cells were labelled with ^S-methionine for 4 hr. Cytoplasmic extracts 
were prepared and immunoprecipitated with the anti-C terminus L protein antiserum 
followed by gel electrophoresis. The results showed that a protein, which comigrated 
with the authentic L protein synthesized in Bunyamwera virus infected cells (lane 1) and 
was recognized by the specific L protein antibody, was expressed in pTF7-5BUNL 
(lane 2), pTZ-BUNL (lane 3) or pET-BUNL DNA (lane 4) transfected cells. This 
protein was not observed in cells without plasmid transfection (lane 5).
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Fig.4.18. Immunoprecipitadon of the L protein expressed by recombinant vaccinia 
vims. Two independent experiments are shown in this Figure. Recombinant vaccinia 
virus infected cells were labelled with 35s-methionine for 2 hr at 22 to 24 hr 
postinfection, and cell lysates were prepared for immunoprecipitadon. The samples 
were precipitated with preimmune serum (lane 1) or a monospecific L protein 
antiserum (anti-C) in lanes 2 and 4 to 11 or with an anti-Bunyamwera vims serum in 
lane 3. Cells were infected with Bunyamwera vims (lanes 1-3 and 11), vTF7-3 (lanes 
4 and 8), vTF7-5BUNL (lane 5), vTF7-3 and vTF7-5BUNL (lanes 6 and 9), or 
vSCl 1-BUNL (lanes 7 and 10). Lane 3 shows Bunyamwera vims protein markers 
L, G l, G2, and N. The monospecific L protein antisemm precipitated L protein and 
minor amounts of N protein from Bunyamwera virus-infected cells (lane 2) but not 
from vTF7-3-infected cells (lane 4). L protein was precipitated from cells dually 
infected with vTF7-3 and vTF7-5BUNL (lanes 6 and 9) or with vSCl 1-BUNL (lanes 
7 and 10). The fusion protein andbody also precipitated 6-galactosidase from vSCl 1- 
BUNL infected cells. The X protein was precipitated by this antibody from cells 
infected by vTF7-5BUNL alone Oane 5) or vSCl 1-BUNL Oane 7). No proteins were 
precipitated by preimmune serum Oane 1).
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Fig.4.19. Comparison of the time course of the L protein synthesis by the different 
recombinant vaccinia viruses. Cells were infected with either vTF7-5BUNL and 
yTF7-3 or with vSCl 1-BUNL, radiolabelled with ^^S-methionine for 2 hr at the 
indicated times^ (hr) of post infection, and cell extracts prepared for 
immunoprecipitation with the monospecific L antiserum (anti-C). The positions of L, 
X and B-galactosidase proteins are indicated. L protein expression by vSCl 1-BUNL 
was detected by 6 hr postinfection, whereas L protein could not easily seen before 10 
nr with the 77 system. Some vaccinia virus proteins were also precipitated in vSCl 1- 
BUNL infected cells in this experiment.
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Fig.4.20. Transient expression of the L protein. Subconfluent monolayers of CV-1 
cells in 35 mm dishes were infected with vTF7-3 at moi of 5 pfu/cell (lanes 2-5) and 
then transfected with 20 pg recombinant plasmid DNA pTF7-5BUNL (lane 2), pTZ- 
BUNL Qane 3), pET-BUNL Qane 4), or were not transfected (lane 5). Lane 1 is the 
extract from cells infected with Bunyamwera virus. The cells were labelled with 3$S- 
methionine for 16 hr at 6 hr ^ transfection. Cytoplasmic extracts were prepared, and 
the proteins were immunoprecipitated with a specific L protein antiserum (anti-C) and 
analysed by electrophoresis in a 12% polyaciylamide-SDS gel. A protein which was 
similar in size to the L observed in Bunyamwera virus infected cells Oane 1) was 
detected in cells transfected with each of the plasmids Oanes 2-4).
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The RNA species in vTF7-3 infected cells which had been transfected with 
recombinant plasmids were also examined. pET-BUNL DNA (Fig.4.21. lane 1) and 
pTF7-5BUNL (lane 2) were transfected into vTF7-3 infected CV-1 cells, total cellular 
RNA was extracted and Northern blotted with 32P-labelled L gene cDNA. An L 
specific RNA transcript about the same size as that observed in Bunyamwera virus- 
infected cells (lane6) or Bunyamwera virus nucleocapsids (lane 5) and vaccinia virus 
dually infected cells Oane 4) was detected in the plasmid transfected cells Oanes 1 and 2), 
which was not seen in cells without plasmid transfection (lane 3). However, no L 
specific RNA was detected in pTZ-BUNL transfected cells (data not shown).
The amount of the transiently expressed L protein did not increase significantly as 
the multiplicity of vTF7-3 infection was increased from 5 to 20 pfu/cell and it appeared 
that an adequate amount of T7 RNA polymerase was synthesized from vTF7-3 at moi of 
5 pfu/cell, which correlated with the result of recombinant vaccinia virus dual infection 
(see Fig.4.17). In order to examine the quantitative relationship between the level of the 
expressed L protein and the amount of the recombinant plasmid DNA transfected, CV-1 
cells were infected with vTF7-3 at moi of 5 pfu/cell and subsequently transfected with 
various amounts (10 pg, 20 pg, and 30 pg) of pTF7-5BUNL DNA (Fig. 4.22A, lanes 
1-3). The cells were labelled with ^^S-methionine for 16 hr after 6 hr of transfection 
and cytoplasmic extracts were immunoprecipitated with the monospecific L protein 
antiserum (anti-C) followed by gel electrophoresis. The result showed that transfection 
with the increased amounts of pTF7-5BUNL resulted in the synthesis of the increased 
levels of the L protein. Some of the vaccinia virus proteins, smaller than the L protein, 
were also precipitated in this experiment (Fig.4.22A).
I then determined how soon after DNA transfection the L protein could be 
detected, and monitored the time course of L protein synthesis by transient expression. 
pTF7-5BUNL was transfected into vTF7-3 infected CV-1 cells and the cells were 
radiolabelled with 35s-methionine for 2 hr at the indicated times shown in Fig.4.22B. 
Cytoplasmic extracts were immunoprecipitated with the antiserum against the C-terminus 
of the L protein. The L protein was shown to be synthesized as early as 4-6 hr after the 
DNA was first added to the cells. The level of the L protein decreased at 11 hr post­
transfection and was hardly detectable at 22-24 hr. This result indicates that the transient 
expression of the L protein occurs much earlier than in the cells dually infected with 
vTF7-3 and vTF7-5BUNL recombinant vaccinia viruses.
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Fig.4.21. Northern blot analysis of the RNA transcribed from plasmid vectors. 
Total cellular RNA was extracted from vTF7-3 infected cells which were transfected 
with pET-BUNL (lane 1), pTF7-5BUNL (lane 2), or were not transfected (lane 3), 
or infected with vTF7-5BUNL (lane 4). Lane 5 is RNA extracted from purified 
intracellular nucleocapsids and Lane 6 is RNA extracted from Bunyamwera virus 
infected cells. The RNA was fractionated on a 1% agarose gel containing 5 mM 
methyl mercuric hydroxyde and transferred to nitrocellulose. Hybridization with 
32p-iabelled L gene cDNA showed that an RNA species, similar in size to that 
observed in the Bunyamwera virus infected cells (lane 6) and dual vaccinia virus 
infected cells (lane 4), was detected in both pET-BUNL and pTF7-5BUNL 
transfected cells (lanes l and 2), but not in cells without plasmid transfection.
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Fig.4.22. Characterization of the transient expression system for expression of the L 
protein. A. Dose response of the L protein synthesis. CV-1 cells were infected with 
vTF7-3 at moi of 5 pfu/cell and transfected with 10 pg Oane 1), 20 pg Qane 2), or 30 
pg (lane 3) pTF7-5BUNL DNA. The cells were labelled overnight at 6 hr post 
transfection and cytoplasmic extracts were precipitated with a monospecific L protein 
antiserum (anti-C). Increased levels of the L protein were produced following 
transfection of increased amount of pTF7-5BUNL DNA. Some vaccinia virus 
proteins were also precipitated. Lane 4 is the immunoprecipitation of the 
Bunyamwera virus infected cells with the L protein anti serum. B. Time course of the 
L protein expression. CV-1 cells were infected with vTF7-3 at moi of 5 pfu/cell and 
transfected with 20 pg pTF7-5BUNL DNA. Cells were labelled for 2 hr at the 
indicated times post transfection. The cytoplasmic extracts were immunoprecipitated 
with the L protein antiserum (anti-C) followed by electrophoresis on a 10% 
polyacrylamide-SDS gel. Lane BUN/IP is Bunyamwera virus infected cell extract 
immunoprecipitated with the L protein antiserum. Lane BUN shows Bunyamwera 
virus proteins L, G l, G2, and N, which are designated on the right. L protein 
expression was detected by 4 hr of posttransfection, but declined as early as 10 hr.
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4.7. Discussion
As a prelude to mapping the functional domains within the L protein, I sought to 
express the L protein in various expression systems to obtain L protein suitable for 
further functional analysis. Firstly a cDNA containing the full-length L gene coding 
sequence was constructed and subcloned into various plasmid vectors. Efforts were 
then made to express the L protein in various systems.
(1). In vitro transcription and translation of the L gene could be a simple way to 
assay the functionality of the L protein in vitro by coupling the translation of the L 
protein with its transcriptase activity analysis. Patterson et al. (1984) demonstrated LAC 
bunyavirus virion-associated RNA polymerase and endonuclease activites in an in vitro 
transcription assay and the RNA synthesis ability was increased when reticulocyte lysate 
was added to the reaction. Since the in vitro system is saturated only with the 
supplemented mRNA, the expressed protein could be assayed directly in vitro without 
purification. Thus it was considered that if the L protein could be expressed in the in 
vitro translation system, it might be possible to analyse the polymerase activity of L by 
replication of a suitable RNA template or to assay the endonuclease activity by analysing 
the processing of a capped mRNA. However, initial attempts to translate the L protein 
in a messenger dependent reticulocyte lysate were not successful. The experiment was 
repeated using a reticulocyte lysate which was produced by a different company; a 
protein which was the same size as the L protein was detected. However the level of 
this protein produced in vitro was very low and could not be precipitated by the specific 
L protein antiserum. Whether this protein really was L is therefore questionable. These 
results also reflect the difficulty of translating a protein larger than 60K in vitro 
(Clements, 1986).
(2). The bacterial T7 expression system established by Studicr and his colleagues 
(1986 and 1990) is a practical means to obtain large amounts of protein expressed from 
the cloned cDNA in E. coli. However, considering the large size of the Bunyamwera 
virus L protein, it is probably very difficult to synthesize it in^bacterial system. Efforts 
were made to use this system for the expression of the L protein, but the data provided 
here showed that the L protein was not produced in the bacterial T7 system.
(3). Vaccinia virus is a useful vector for expressing genes within the cytoplasm of 
eukaryotic cells and recombinant vaccinia viruses have been used to synthesize a number 
of biologically active proteins and further to analyse successfully the structure-function 
relations of protein molecules in various fields (Moss, 1991). Therefore, I cloned the 
Bunyamwera virus L gene cDNA into two vaccinia virus transfer vectors to make 
recombinant vaccinia viruses. Two vaccinia virus expression systems, the constitutive
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system and the "inducible" vaccinia virus/bacteriophage T7 promoter vector system, 
were chosen for the expression experiment. These two systems were used in parallel in 
case "constitutive" expression of L by the vaccinia virus P7.5 promoter was detrimental 
to vaccinia virus replication: it was reported that the VSV M protein was toxic to vaccinia 
virus in making a recombinant based on pSCl 1 (Li et a/., 1988). The use of the T7 
RNA polymerase system would have overcome this problem. In fact both systems 
expressed full length antigenically authentic Bunyamwera virus L protein. Apparently 
more L was synthesized using vSCl 1-BUNL than with vTF7-3 and vTF7-5BUNL, 
even though the level of L mRNA was considerably higher in cells infected with the 
latter. In their characterization of the vaccinia virus-T7 polymerase system, Fuerst and 
Moss (1989) also observed much higher levels of mRNA compared to the level of 
protein made, and suggested that the apparent inefficient translation of the T7 
polymerase transcribed RNAs was because only 5-10% contained terminal cap 
structures.
In addition to full-length L, other proteins apparently specific to the recombinant 
vaccinia viruses were observed (Figs.4.15-4.19). In particular, the protein designated 
X is worthy of mention as this was immunoprecipitated by the monospecific L antibody, 
suggesting it to be a carboxy-terminal fragment of L. Although the genesis of this 
protein has not been investigated, this protein may be the translation product of an RNA 
transcribed by the vaccinia virus polymerase recognising a cryptic vaccinia virus-like 
promoter sequence in the L cDNA. This is not unreasonable as the L cDNA is relatively 
AT-rich (67%; Elliott, 1989a) and so are vaccinia virus promoters (Davison and Moss, 
1989a and 1989b); vaccinia virus late promoters contain the highly conserved sequence 
TAAAT (Davison and Moss, 1989b) and this sequence is found 49 times in the L cDNA 
(considering both strands).
(4). In addition to expressing the L protein by the two recombinant vaccinia 
viruses, the L was also synthesized by transient expression. The L gene cDNA, under 
control of the T7 promoter in different plasmids, such as pTZ18R, pET8c, and pTF7-5, 
was transfected into cells infected with a recombinant vaccinia virus vTF7-3 expressing 
the T7 RNA polymerase, and L protein was synthesized. In contrast to pTF7-5 and 
pET8c vectors, pTZ18R does not have the T7 terminator sequence and no L specific 
RNA was detected in pTZ-BUNL transfected cells. However, it appeared that there 
must be some functional L RNA transcripts made in the pTZ-BUNL transfected cells 
which were used to translate the 259 K L protein. Expression of the L protein by 
plasmid transfection may be very useful for future assays. The transient expression 
system may have the advantage for expressing large numbers of L gene constructs so 
that the functionality of a number of the mutated L genes could be screened directly
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without having to recombine into vaccinia virus. It may also be useful in that the levels 
of the L protein expressed can be controlled by the amount of the plasmid DNA 
transfected. The ability of controlling the protein expression level in the transfected cells 
may provide flexibility in defining the requirements for optimal RNA replication in 
functional analyses of the L protein, since it has been reported that high levels of 
expressed L protein are inhibitory to RNA replication in some other negative-strand 
RNA viruses, such as Sendai virus and VSV (Gotoh et a/., 1989; Meier et a/., 1987). 
The transient expression system may also be used to determine the requirements for 
individual virus proteins in the virus replication processes.
In summary, a protein which is similar in size to the Bunyamwera virus L protein 
was synthesized in an in vitro translation system; L could not be expressed from the 
bacterial T7 system; antigenically authentic L protein has been successfully produced in 
vaccinia virus systems, either through recombinant vaccinia viruses or by transfection of 
the plasmids containing the L gene cDNA under the T7 promoter into the T7 RNA 
polymerase producing cells.
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Chapter 5
Functional analysis of the L protein 
expressed by recombinant vaccinia viruses
5.1. Introduction
The L protein is a multifunctional protein. It is presumed to have RNA-dependent 
RNA polymerase activity and some other functions, such as endonuclease activity 
(Patterson e t al.> 1984). Study of the L protein of bunyavirus has been limited and 
mostly confined to the virion-associated enzyme protein. To date, attempts to synthesize 
the large polymerase protein of other negative-strand RNA viruses in vitro in a suitable 
form have not been very successful, and since it is difficult to obtain a functional 
synthetic RNA template (in a nucleocapsid form) for the functional assays of the 
expressed protein in vitro. This has hindered the advancement of our
understanding of the L protein and hence the viral RNA synthesis process. Thus, 
alternative in vitro systems have to be developed.
In the previous chapter, I demonstrated that the full-length L gene cDNA was 
assembled, and that antigenically authentic 259K L protein was expressed by 
recombinant vaccinia viruses and by the transfected plasmid system. In order for the 
expressed L protein to be useful for domain mapping, it was necessary to demonstrate 
that the expressed L protein had RNA synthesis ability.
To determine the funtionality of the L protein expressed from the recombinant 
vaccinia virus, several assay systems were investigated: complemen tadon of bunyavirus 
L gene ts mutants; in vitro  transcription assays; and the ability of the L to replicate an 
RNA template in vivo.
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5.2 Complementation of bunyavirus ts mutants
On discussion I recognized that the difference between the yields of Bunyamwera virus
at 31 C and 38.5 °C was too great to allow critical conclusions to be drawn from the 
complementation data.
Complemen tation of ts mutants with defects in the L gene by the L protein 
expressed from recombinant vaccinia viruses was first explored. It was suggested that 
the Group I ts mutants of Bunyamwera virus may be L mutants (C. R. Pringle, personal 
communication). The ts mutants BUN ts5 (Bunyamwera virus) and MAG ts7 (Maguari 
virus) were chosen to be the candidates for the experiment because they grew relatively 
better than the other Group I ts mutants at the permissive temperature (31 °C). It was 
considered that if the L protein was functional, superinfection with recombinant vaccinia 
viruses should increase the released virus yield from the ts mutant infected cells at the 
nonpermissive temperature.
Before carrying out the complementation experiment, I examined whether vaccinia 
virus infection would interfere with bunyavirus growth. CV-1 cells were infected with 
vaccinia virus WR strain at 5 pfu/cell and incubated at 31 °C for 60 min, the cells were 
washed once with the medium (5% DMEM) and superinfected with wild type 
Bunyamwera virus at 0, 2,10, or 20 pfu/cell at 37 °C for 30 min. The cells were then 
washed twice with medium and further incubated at either 31 °C or 38.5 °C for 24 hr.
The supernatants were harvested and Bunyamwera virus yields were assayed by plaque 
titration in the presence of phosphonoacedc acid, which is inhibitory to vaccinia virus
Table 5.1. Effect of vaccinia virus infection on Bunyamwera virus growth
BUN (wt) 
(pfu/cell)
WR
Bunyamwera virus yields
31°C (x lO 8 ) 38.5°C (x lO 6 )
5 0 1.0 4.6
5 2 2.0 1.9
5 10 1.1 0.9
5 20 1.2 1.1
CV-1 cells were infected with each virus at moi indicated and the parallel 
dishes were incubated at the permissive (31 *fc) or the restrictive temperature 
(38.5 *fc) for the bunyavirus ts mutants. After 48 hr of infection, the culture 
fluids were titrated for the Bunyamwera virus yields in the presence of 250 
pg/ml phosphonoacedc acid.
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growth but allows Bunyawera virus to form plaques. As can be seen from Table 5.1, 
vaccinia virus showed little interference on Bunyamwera virus replication. The titre of 
Bunyamwera virus did not vary significantly in the absence or presence of vaccinia virus 
WR strain when the cells were incubated at the same temperature. However, it was about 
100 fold lower when incubated at 38.5 °C than that at 31 °C, which might be because 
some of the released virus became noninfectious during the incubation or some slight 
temperature sensitivity of the Bunyamwera virus. Using vaccinia viruses carrying the L 
gene, similar results were also observed.
The protocol of the complementation assay is shown in Fig.5.1, and the result of a 
typical complementation assay is shown in Table 5.2. For bunyavirus ts mutants, BUN 
ts5 and MAG ts7, no significant difference was observed between the virus yields 
released from CV-1 cells infected with ts mutants alone and the cells superinfected with 
recombinant vaccinia viruses expressing the L protein. Thus, the L protein expressed 
from the recombinant vaccinia viruses did not show ability to complement these two ts 
mutants. The more well-characterized snowshoe hare (SSH) bunyavirus ts mutants, 
obtained from Prof. DHL Bishop, were also used for the complementation experiment. 
The incubation of the CV-1 cells infected with SSH ts mutants and recombinant vaccinia 
viruses was carried at 39.5 °C for 2 days. However, again no complementation of these 
ts mutants by the L protein was demonstrated (data not shown).
Infect CV-1 cells with ts mutant 
at 31° C for 60 min; then wash
I
Superinfect with recombinant vaccinia virus 
at 31°C for 30 min; then wash
I
Incubate at 38.5° C or 39.5 °C 
for 24 hr or 48 hr
I
Harvest medium
I
Titrate at 31 °C in the presence of 
phosphonoacetic acid (250 M-g/ml)
Fig.5.1. Protocol of the L gene complementation assay.
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Table 5.2. Complementation assay
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Virus
Virus yields
BUN ts5 ( x 103 ) MAGts7 (x  102 )
Mutant 7.5 1.25
+ VTF7-5BUNL 6.7 3.5
+ vTF7-5BUNL/vTF7-3 3.7 3.0
+ vSCl 1-BUNL 4.2 2.5
The moi of each virus was 5pfu/cell and the released virus yields of ts mutants titrated 
by plaque assay at 31 °C in the presence of 250 ug/ml of phosphonoacetic acid.
5.3. I n  v i t r o  transcriptase analysis of the L protein
The functional RNA template for RNA synthesis of negative-strand RNA viruses is 
not naked RNA, but the nucleocapsid or RNP i.e. RNA complexed with the N protein. 
To date, we do not have a method to reconstruct this template in vitro. Therefore, 
Bunyamwera virus nucleocapsids were purified from infected BHK cells to determine if 
they could be used as the templates for in vitro transcriptase activity assay of the L 
protein. As a prerequisite, the polymerase activity associated with the RNP was 
examined by in vitro transcription of the preparation; the polymerase activity in vinons 
was used as a comparison. Intracellular nucleocapsids were purified by CsCl gradient 
centrifugation, and Bunyamwera virus was purified and disrupted with NP-40 by the 
method described in Chapter 2. The RNP or the detergent disrupted virions were added 
to the in vitro transcription reaction and incubated in the presence of 32p-GTP at 30 C 
for 60 min under the conditions described in Chapter 2. The in vitro synthqized, labelled 
RNA was analysed by electrophoresis in a 1% agarose gel containing 5 mM 
methylmercuric hydroxide. As can be seen from Fig.5.2, the virion associated RNA 
polymerase activity was much higher than that of the RNP preparation and the L, M, and
S RNA species were clearly observed.
Since lower polymerase activity in the RNP preparation was detected, it was
thought possible that the RNP could be used as templates by the supplemented L protein 
in cytoplasmic extracts prepared from lysolecithin pcrmeabilized cells infected with the 
recombinant vaccinia viruses. To ensure that the lysolecithin method (see chapter 2) 
would release the L protein efficiently, immunoprecipitation of the L protein with the L
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Fig.5.2. Agarose gel analysis of the Bunyamwera virus RNA polymerase products. 
Bunyamwera virus Qane 1) and nucleocapsids (lane 2) were purified and polymerase 
reactions were carried out in the presence of 32p_GTP under the condition described 
in chapter 2. RNA labelled with 32p_GTP during the in vitro reaction was resolved in 
a 1 % agarose gel containing 5 mM methylmercuric hydroxide. The L, M, and S RNA 
species are clearly seen in the detergent-di srupted virion programmed reaction Qane 1) 
but are barely detected in RNP programmed reaction flane 2).
Methylmercuric hydroxide would minimize possiblility that the labelled bands were hybrids
between template and ^^P-labelled partial products.
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specific antiserum was performed. As shown in Fig.5.3A, the L protein was released 
efficiently. Immunoprecipitation of the cytoplasmic extracts infected with vSCll-BUNL  
(lane 3) or vTF7-3 and vTF7-5BUNL (lane 2) detected L protein, but not in cells infected 
with vTF7-3 alone (lane 1). More L was produced in
vSCl 1-BUNL infected cells (lane 3). Unlabelled extracts were prepared and added to 
the RNP programmed in vitro transcription reaction in the presence of 32p_GTP, the 
RNA products were fractionated on a 1% agarose gel containing 5 mM methylmercuric 
hydroxide, and the labelled RNA visualized after exposure to X ray film. It was 
observed that the vTF7-3 infected cell extract slightly stimulated the RNP associated 
RNA polymerase activity and the labelled S, M, and L RNA species were detected 
(Fig.5.3B. lane 2) as compared to the reaction without supplementation (lane 1). The L 
protein present in vTF7-3 and vTF7-5BUNL (lane 3) infected cell extract did not 
increase polymerase activity significantly. However, it appeared that slightly more 
RNAs were synthesized in vitro by the addition of vSCl 1-BUNL infected cytoplasmic 
extract (lane 4), which had more L protein produced as detected by immunoprecipitation 
(Fig.5.3A. lane 3). It is also possible that cytoplasmic extract prepared from vSCll- 
BUNL infected cells had some other protein components which stimulated the RNA 
polymerase. More RNA was made in the reaction supplemented with Bunyamwera virus 
infected cell extract (lane 5), which presumeably also contained active virus RNA 
templates and the L protein. The above results indicated that it was difficult to determine 
the functionality of the L protein by an in vitro transcription assay using the intracellular 
RNP as templates.
5.4. Attempts to reconstruct a synthetic RNA for 
replication assay
The template recognized by the Bunyamwera virus L protein is the RNA 
encapsidated with the N protein. Attempts to encapsidate a synthetic RNA in cultured 
cells were made to synthesize this kind of template. To obtain the N protein for 
encapsidation^the Bunyamwera virus S cDNA, cloned under control of the T7 promoter 
in pTF7-5 (pTF7-5BUNS), obtained from A. McGregor, was used for transient 
expression of the N protein. pTF7-5BUNS DNA was transfected into vTF7-3 infected 
cells and the cells were radiolabelled with ^ S - m e t h i o n i n e  for 4 hr at 6 hr after 
transfection to examine the N protein transiently expressed. Cytoplasmic extracts were 
immunoprecipitated with anti-Bunyamwera virus antiserum and the proteins analysed by 
gel electrophoresis. As can be seen from Fig.5.4A, the N protein was expressed from 
the transfected pTF7-5BUNS DNA; the more recombinant plasmid transfected, the more
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Fig.5.3. Analysis of the transcriptase activity of the L protein expressed from 
recombinant vaccinia viruses. A. Analysis of the L protein synthesis in recombinant 
vaccinia virus infected cytoplasmic extracts prepared by the lysolecithin 
permeabilization method. CV-1 cells were infected with vTF7-3 (lane 1), vTF7- 
5BUNL and vTF7-3 (lane 2), vSCl 1-BUNL Qane 3), or Bunyamwera virus (lane 4) 
and radiolabelled with ^^S-methionine at 20-22 hr post infection. The cells were then 
treated with lysolecithin and the extracts immunoprecipitated with the monospecific L 
protein antiserum (anti-C). The L protein was observed in extracts from cells infected 
with vTF7-5 and vTF7-5BUNL (lane 2) or vSCl 1-BUNL, but not in vTF7-3 
infected cells. B. In vitro ^^P-labelled RNA synthesized from purified RNP template 
(lane 1) and supplemented with unlabelled cytoplasmic extracts from cells infected 
with vTF7-3 (lane 2), vTF7-3 and vTF7-5BUNL pane 3), vSCl 1-BUNL (lane 4), or 
Bunyamwera virus (lane 5). Very weak transcriptase activity was detected in the 
reaction without supplementation with cytoplasmic extract (lane 1); more -^^P-labelled 
L, M, and S RNA were detected in other reactions supplemented with cytoplasmic 
extracts. The vSCl 1-BUNL (lane 4) infected cytoplasmic extract had slightly more 
activity in stimulating the RNA synthesis than vTF7-3 (lane 2) or dual vaccinia vinis 
(lane 3) infectecf extracts. Much stronger activity was seen in the reaction 
supplemented with Bunyamwera virus infected cell extract (lane 5).
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Fig.5.4A. SDS-polyacrylamide gel analysis of transiently expressed Bunyamwera 
virus N protein. CV-1 cells were infected with vTF7-3 (lanes 1-3 and 5-7) at moi of 
5 pfu /cell and transfected with 5 pg or 25 pg pTF7-5BUNS DNA (lanes 1,2, 5 and
6) as indicated. The cells were labelled with 3*S-methionine and aliquots run on the 
gel (lanes 1-3) or the labelled extracts were prepared for immunoprecipitation with 
anti-Bunyamwera virus antiserum (lanes 5-7). The N protein was only clearly shown 
by immunoprecipitation (lanes 5-6), and more N was made in cells transfected with 25 
pg pTF7-5BUNS DNA (lane 6) compared to 5 pg DNA (lane 5). The L and G1 
proteins were not seen in lane 4 - immunoprecipitation of Bunyamwera virus infected 
cell extract with anti-Bunyamwera virus antiserum as the gel was only exposed for 4 
hr, but were seen on longer exposures.
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N protein was produced (compare lanes 5 and 6). To examine if the N protein could also 
be expressed in cells expressing the L protein, pTF7-5BUNL and pTF7-5BUNS were 
transfected together, the result showed that both the L and N proteins could be expressed 
simultaneously (Fig.5.4B. lanes 7-9). The dose response of the N protein expression to 
the amount of the plasmid transfected was less apparent when transfecting 10 pg, 20 pg 
or 30 pg of pTF7-5BUNL DNA (B. 4-6) as compared to 5 pg or 25 pg of pTF7- 
5BUNS DNA transfected (Fig. 5.4A. lanes 5-6). It was likely that 10 pg pTF7-5BUNS 
DNA had saturated the expression system. The L protein dose response was not 
obvious when transfected together with pTF7-5BUNS DNA (Fig. 5.4B. lanes 7-9) 
compared with pTF7-5BUNL DNA transfection alone (Fig. 5.4B. lanes 1-3), which 
might be due to competition for the T7 RNA polymerase produced by vTF7-3.
The recombinant plasmid pUC-BUNS292 obtained from A. McGregor, contains 
the 3' and 5' terminal untranslated sequences of the Bunyamwera virus S RNA segment 
but has the most of the internal coding region deleted (Fig.5.5A). The end sequences 
were considered to contain the (promoter) sequence recognized by the RNA polymerase, 
and should be replicated by the RNA polymerase. The 292 base S cDNA was under 
control of the T7 promoter, digestion with Xba I to linearize the plasmid would allow 
synthesis of an RNA transcript with the exact 3’ end of the S segment. CV-1 cells were 
infected with vTF7-3 and transfected with the linearized plasmid to synthesize the 292 
base long (+) sense S RNA. The cells were also transfected with pTF7-5BUNS for 
transient expression of the N protein, or were infected with Bunyamwera virus to supply 
the N protein for encapsidation of the 292 base S RNA. Any encapsidated 292 base S 
RNA should then act as a template for replication by the L protein present in 
Bunyamwera virus infected cells or by the L protein transiently expressed in the cells.
pUC-BUNS292 DNA linearized by the digestion with Xba I was transfected into 
vTF7-3 infected cells which had also been transfected with pTF7-5BUNL and pTF7- 
5BUNS (Fig.5.5. lane 2) or infected with Bunyamwera virus (lane 3). Total cellular 
RNA was extracted and fractionated in a 1% agarose gel containing 5 mM 
methylmercuric hydroxide, and transferred to a nitrocellulose filter (B) or the RNA was 
dot blotted onto a nitrocellulose filter directly (C). However, hybridization with ^2p. 
labelled S gene cDNA could not detect S RNA of 292 bases in vTF7-3 infected cells 
(lane 4), indicating that transcription of pUC-BUNS292 by T7 RNA polymerase did not 
occur. The S RNA produced in pTF7-5BUNL transfected cells appeared as a doublet. 
The reason for this is not clear.
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pTF7-5BUNL (pg) 10 20 30 10 20 30 0
pTF7-5BUNS (pg) 10 20 30 10 20 30 0
1 2 3  4 5 6 7 8 9  10
Fig.5.4B. Transient expression of the N protein together with the L protein. CV-1 
cells were infected with vTF7-3 (lanes 1-10) and transfected with different amounts of 
pTF7-5BUNL or pTF7-5BUNS DNA as shown above the lanes. The cells were 
labelled with ^^S-methionine and immunoprecipitated with anti-Bunyamwera virus 
antiserum Qanes 4-10) or the anti-C terminal of the L specific antiserum (lanes 1-3 and 
7-9). The L and N proteins were expressed individually (lanes 1-3 or 4-6) or 
simultaneously (lanes 7-10) in the cells transfected with recombinant plasmids, but 
were not detected in cells without plasmid transfection (lane 10). The dose response 
of the L protein was obvious in lanes 1-3, but not evident in lanes 7-9 which had also 
been transfected with pTF7-5BUNS DNA. The N protein dose response was not 
obvious in either singly transfected cells (lanes 4-6) or when transfected together with 
pTF7-5BUNL DNA (lanes 7-9). The top of the gel was exposed longer (48 hr) than 
the lower part of the gel (4 hr) to visualize the expressed L protein.
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Fig.5.5. Attempts to replicate a synthetic Bunyamwera virus S RNA by recombinant 
L protein. A. A map of the internally deleted Bunyamwera virus S cDNA plasmid 
(pUC-BUNS292) which was used to make a synthetic RNA template. Bunyamwera 
virus S segment nucleotides 99 to 768 had been removed from the full-length S 
cDNA, which had been cloned under control of the T7 promoter in plasmid pUC9. 
Digestion with Xba I linearized pUC-BUNS292 and produced the exact 3' end 
sequence of the S segment. (B) Northern blot and (C) dot blot analysis of RNA 
extracted from cells transfected with linearized plasmid pUC9-BUNS292. The cells 
were mock-infected (lane 1), infected with vTF7-3 (lanes 2-4) following transfection 
with pTF7-5BUNS and pTF7-5BUNL (lane 2), or infection with Bunyamwera virus 
(lane 3). Total cellular RNA was extracted, fractionated on a 1% agarose gel 
containing 5 mM methylmercuric hydroxyde and transferred to a nitrocellulose filter 
(B), or dot blotted onto a nitrocellulose filter (C). Hybridization with ^ P - la b e l l e d  
pTZ-BUNS did not detect the synthesis of a 292 base RNA. The 961 base full-length 
S RNA was observed in Bunyamwera virus infected cells (lane 3); a doublet of S 
RNA bands were observed in pTF7-5BUNS transfected cells Qane 2).
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Attempts were made to produce "committed" pUC-BUNS292 transcription 
complexes by incubating pUC-BUNS292 DNA with T7 RNA polymerase in vitro and 
then transfecting the pUC-BUNS292 DNA/T7 RNA polymerase complex into cells. 
Again, however, no 292 base S RNA transcripts were detected. Thus it was considered 
that the linearized plasmid was not stable in the transfected cells. To confirm this 
suggestion, the protein synthesis ability of the linearized full-length S cDNA in pUC 
vector (pUC-BUNS) was examined. pUC-BUNS DNA linearized by digestion with 
Xba I was transfected into vTF7-3 infected cells, the cells were labelled with 35S- 
methionine and the extracts immunoprecipitated with anti-Bunyamwera vims anti serum. 
No N protein was detected. However, intact circular pUC-BUNS DNA was shown to 
express the N protein in the same experiment (data not shown). Thus, it seemed that 
transfection of linearized plasmid DNA was unsuitable for making either RNA or 
protein, and that other alternative approaches should be developed.
5.5. Replication of S RNA supplied in RNP form
The use of Bunyamwera vims intracellular nucleocapsids (RNP) was considered 
for the functional analysis of the expressed L protein in the recombinant vaccinia vims 
infected cells. Purified Bunyamwera vims RNP contained both the N and L proteins 
(Chapter 3, Fig.3.5A) and hence should be capable of synthesizing RNA if transfected 
into cells. Thus the initial aim was to determine the effect of recombinant vaccinia vims 
infection on the levels of Bunyamwera virus-specific RNA in cells transfected with 
purified RNP. I expected to see a background level of RNA after transfection of RNP 
and hoped to see an amplification after infection with the vaccinia vims expressing the L 
protein.
The protocol for the RNP transfection assay using the calcium phosphate 
transfection method, is shown in Fig.5.6. Preliminary dot blot analysis of RNA 
extracted from the RNP transfected CV-1 cells indicated that no Bunyamwera virus- 
specific S RNAs could be detected in either mock infected cells (Fig.5.7. lane 1) or cells 
infected with vTF7-3 (lane 4) at 24 hr after transfection. However, in the RNP 
transfected cells which had been infected with vTF7-3 and vTF7-5BUNL (lane 2) or 
infected with vSCl 1-BUNL (lane 3), or infected with vTF7-3 and transfected with 
pTF7-5BUNL (lane 5), Bunyamwera vims S RNA signals were clearly detected. These 
data indicated that the L protein expressed by the recombinant vaccinia viruses, or by the 
transfected plasmid pTF7-5BUNL DNA, had amplified the S RNA introduced into the 
cells through RNP transfection.
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Infect CV-1 cells with recombinant 
vaccinia viruses, lhr, 37 °
I
Wash cells with TBS+ and add nucleocapsid 
transfection mix for 30 min, RT
I
Add medium and incubate 4 hr, 37°
I
Shock cells with 10% glycerol in TBS+ 
for 1-2 min; wash twice with TBS+
I
Add medium and incubate 20 hr, 37°
I
Radiolabel cells for protein analysis 
or
extract RNA for Northern blot.
Fig.5.6. Protocol of the nucleocapsid transfection assay. (TBS+ = 25 mM Tris-HCl, 
pH 7.4, 135 mM NaCl, 50 mM KC1,0.01% CaCl2,0.01% MgCl2).
1 2 3 4 5 6
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Fig.5.7. Dot blot analysis of RNA from cells transfected with Bunyamwera virus 
nucleocapsids following infection with recombinant vaccinia viruses. CV-1 cells 
were mock-infected (lane 1), or infected with vTF7-3 and vTF7-5BUNL (lane 2), 
vSCl 1-BUNL (lane 3), vTF7-3 (lane 4-6) and transfected with pTF7-5BUNL (lane 
5) or transfected with pTF7-5BUNL and pTF7-5BUNS Qane 6). Twenty hours later 
total cellular RNA was extracted, dot blotted onto nitrocellulose filters and hybridized 
with 32P-labelled puC-BUNL DNA, or 32P-labelled pTZ-BUNS DNA. S RNA 
signals were detected in cells expressing L (lanes 2, 3 and 5), but were not observed 
in mock (lane 1) or vTF7-3 (lane 4) infected cells.
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The RNA was then analysed by Northern blojting. Total cellular RNA was 
extracted from cells which had been infected with vTF7-3, vTF7-3 plus transfected with 
pTF7-5BUNL, vTF7-3 plus vTF7-5BUNL, or vSCl 1-BUNL, and then transfected 
with RNP (Fig.5.8. lanes 1-4); RNA obtained from Bunyamwera virus-infected cells 
was used as a specific marker (lane BUN). The RNAs were fractionated on agarose gels 
containing methylmercuric hydroxide, transferred to nitrocellulose filters, and hybridized 
with 32p_iabelled pUC-BUNS DNA. Again, no hybridization was detected with RNA 
from cells infected with vTF7-3 alone (lane 1) post transfection; however, specific 
signals corresponding to the S RNA segment observed in the Bunyamwera virus infected 
cells (lane BUN) were detected in cells expressing the L protein either from vaccinia 
viruses or by the transient T7 system (lanes 2-4). It was concluded that the expressed L 
protein was capable of synthesizing Bunyamwera virus S RNA in the RNP transfected 
cells.
In order to determine the polarity of the S RNA replicated, strand-specific 
riboprobes were synthesized and used for the detection of the RNA amplified by the 
recombinant L protein. Maps of the recombinant plasmids for making S and M RNA 
riboprobes are shown in Fig.5.9A. Plasmids containing full-length S cDNAs, which had 
been cloned under control of the T7 promoter in pUC9 in either direction, were obtained 
from A. Mc^fregor. Digestion with Xba I linearized the plasmid (pUC-BUNS+) and the 
RNA synthesized by T7 RNA polymerase in vitro should only hybridize to (-) sense 
RNA; in vitro transcription of Sma I linearized plasmid (pUC-BUNS-) should produce 
RNA which only detects (+) sense RNA. S mall amounts of 32p_GTP labelled S 
riboprobes were analysed by agarose gel electrophoresis and full-length both (-) and (+) 
S detecting riboprobes were observed (Fig.5.9B). Specific M gene riboprobes were also 
synthesized, using a recombinant plamid containing the full-length M gene under control 
of T7 and T3 promoters (pT3T7-BUNM) obtained from G. Nakitare. Transcription of 
Sma I linearized plasmid with T7 RNA polymerase produced M RNA which detects (+) 
M RNA, and transcription of Hind ID linearized plasmid produced M RNA which would 
hybridize to the (-) M RNA. A mixture of the S and M probes was then used to detect 
either positive- or negative-sense RNA species. L segment probes were not included, as 
these would have detected the recombinant vaccinia virus-derived L transcript. No 
hybridization
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Fig.5.8. Northern blot analysis of RNA from cells transfected with RNP following 
infection with recombinant vaccinia viruses. CV-1 cells were infected with Bunyamwera 
virus (lane BUN), vTF7-3 (lane 1), vTF7-3 and transfected with pTF7-5BUNL (lane 2), 
vTF7-3 and vTF7-5BUNL (lane 3), vSCl 1-BUNL (lane 4), and subsequently 
transfected with RNP (lanes 1-4). Total cellular RNA was extracted at 25 hr post 
transfection, separated on a 1% agarose gel containing 5 mM methyl mercuric hydroxide, 
transferred to nitrocellulose filters and hybridized with ^^P-labelled pUC-BUNS DNA. 
The S RNA signal was detected in the RNP transfected cells which expressed the L 
protein (lanes 2-4), but not in RNP transfected cells which had been infected with vTF7- 
3 alone (lane 1).
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Fig.5.9. In vitro synthesis of 32p_GTP labelled riboprobes. A. The Bunyamwera 
virus S cDNA was cloned under the control of the T7 promoter in either direction in 
pUC9. The recombinant plasmid DNA was linearized by the enzymes indicated and 
subjected to in vitro transcription to produce full-length ^^P-labelled riboprobes for 
detection of (+) or (-) strand S RNA. The Bunyamwera virus M cDNA cloned in 
pT3T7 vector (pT3T7-BUNM) was used for making M gene specific riboprobes. The 
recombinant plasmid was linearized by the enzymes indicated and transcription with 
T3 RNA polymerase produced a riboprobe detecting (-) sense M RNA. Transcription 
of the lineari zed pT7T3-BUNM with T7 RNA polymerase produced a riboprobe 
detecting (+) sense M RNA. B. 32p_iabelled S riboprobes detecting (+) or (-) strand 
S RNA were transcribed in vitro using T7 RNA polymerase and aliquots were 
analysed on an agarose gel containing 5 mM methylmercuric hydroxide, showing that 
the full-length S riboprobes of both senses were made.
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was detected with RNA from cells infected with vTF7-3 (Fig.5.10. lane 2); weak but 
specific signals corresponding to positive- and negadve-sense Bunyamwera virus S 
RNA were detected in cells infected with vTF7-3 and vTF7-5BUNL (lane 4). Much 
stronger signals to both senses of RNA were detected in the RNA extracted from cells 
infected with vSCl 1-BUNL (lane 3). Note that with this gel system the full-length 
positive-sense S RNA and the shorter S mRNA were not separated. No M RNA signal 
was detected in RNAs from the nucleocapsid-transfected cells using either probe, though 
both sense M RNAs were detected in the Bunyamwera virus-infected cell sample (lane 
1).
These experiments demonstrated that the L protein expressed by the recombinant 
vaccinia viruses was able to transcribe both positive- and negative-sense S nucleocapsids 
(RNP obtained from infected cells contain RNAs of both polarities) and was thus 
functional for RNA synthesis. The difference in the levels of amplification seen between 
infection with vSCl 1-BUNL and dually infected with vTF7-3 and vTF7-5BUNL was 
reproducible, and so far I have been unable to detect amplification of the M segment 
RNA.
This RNP amplification system was further characterized by analyzing the 
synthesis of Bunyamwera virus proteins. Two independent experiments are shown in 
Fig.5.11. After infection with recombinant vaccinia viruses and transfection with RNP, 
the cells were pulse-labelled with 35s_methionine, and then cell lysates were 
immunoprecipitated with the specific (anti-C) L protein antiserum (lanes 5,7, and 9) or 
anti-Bunyamwera virus antibody (lanes 6, 8, and 10) or a mixture of these two antisera 
(lanes 1-3). No Bunyamwera virus proteins were detected in vTF7-3 infected and RNP 
transfected cells (Fig.5.11. lanes 1, 5 and 6). Both the L and N proteins were detected 
in RNP-transfected cells which had also been infected with either vSCl 1-BUNL (lanes 
2, 7 and 8), or vTF7-3 and vTF7-5BUNL (lanes 3,9 and 10). A consistent observation 
was that much less N protein was detected in the dual vaccinia virus-infected cells than in 
cells infected with vSCl 1-BUNL. It was also observed that minor amounts of N protein 
were detected in vSCl 1-BUNL infected cells which had been transfected with RNP and 
immunoprecipitated by the antiserum against the L protein (lane 7). This suggested that 
some of the newly synthesized N protein might have encapsidated the amplified S RNA 
and formed nucleocapsid structures in the RNP transfected cells, or that the N had 
complexed with the L protein. Further experiments are required to confirm this 
suggestion. The major glycoprotein G1 was not detected in the RNP-transfected cells 
but was observed in the Bunyamwera virus-infected control (lanes 4 and 11). The
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Fig. 5.10. Northern blot of RNA from RNP transfected cells following
infection with recombinant v^ec ir*v virus using strand specific riboprobes. CV-1 cells 
were infected with recombinovfr'^ccinia virus vTF7-3 (lane 2), vSCl 1-BUNL (lane 
3) or both vTF7-3 and vTF7- fctt/JTL (lane 4). The vaccinia virus infected cells were 
subsequently transfected with f i /0  and total RNA was extracted and separated on an 
agarose gel containing methylmwaeuric hydroxide. The filters were hybridized with a 
mixture of full length 32p-iabelicd riboprobes specific for the M and S segment (+) or 
(-) strand RNAs as indicated. The positions of the M and S segment RNAs are 
indicated, using the Bunyamwera virus infected cell sample as markers (lane 1). Both 
(+) and (-) sense S segment RNAs were detected in RNP transfected cells which 
expressed the L protein (lanes 3 and 4), but not in cells which had been infected with 
v'lhV-3 alone Qane 2).
1 2  3 4
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Fig.5.11. Immunoprecipitation of cells infected with recombinant vaccinia viruses and 
transfected with Bunyamwera virus nucleocapsids. Two independent experiments are 
shown in the figure. CV-1 cells were infected with vTF7-3 (lanes 1, 5 and 6), 
vSCl 1-BUNL (lanes 2, 7 and 8), vTR-3 and vTF7-5BUNL (lanes 3, 9 and 10), or 
Bunyamwera virus (lanes 4 and 11). The cells were then transfected with 
Bunyamwera virus nucleocapsids (lanes 1-3 and 5-10) and radiolabelled cell extracts 
prepared 20 hr later. The cytoplasmic extracts were precipitated with a mixture of the 
monospecific L and Bunyamwera virus antisera (lanes 1-4), or with the L specific 
antiserum (lanes 5,7, and 9) or anti-Bunyamwera virus antiserum (lanes 6, 8,10 and 
11). The positions of the Bunyamwera virus proteins L, G1 and N are indicated in 
lanes 4 and 11, which were cut from one side of the same gels as the other lanes to 
prepare the figure. The N protein was detected in cells expressing the L protein from 
recombinant vaccinia viruses and transfected with Bunyamwera virus nucleocapsids 
(lanes 2, 3, 8 and 10) by immunoprecipitation of anti-Bunyamwera virus antiserum. 
Minor amounts of N protein were also detected in vSCl 1-BUNL infected and RNP 
transfected cells by immunoprecipitation with the (anti-C) L specific antiserum (lane
7).
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results of the proteinanalysis are entirely consistent with the previous RNA analysis: 
more N protein was detected in vSCl 1-BUNL infected and RNP transfected cells, in 
which more S RNA was made.
The supernatants from the RNP transfected cells which had been infected with the 
recombinant vaccinia viruses were titrated by plaque assay to examine if infectious 
Bunyamwera virus could be rescued; however, I could not demonstrate the production of 
infectious Bunyamwera virus rescued from the transfected RNP.
In order to define whether the expressed L protein was able to transcribe and 
replicate Bunyamwera virus genomic RNA, Bunyamwera virions were purified by 
gradient centrifugation as described in chapter 2 and the RNP was released from virus 
particles by disruption with 1% NP-40. The released RNP (vRNP) was then purified by 
CsCl gradient centrifugation. The S RNA in the vRNP preparation was detected by (-) 
sense-detecting S riboprobe, but not by the (+) sense-detecting riboprobe, showing that 
the vRNP only contained negative-sense RNA. The vRNP was transfected into cells 
which had been infected with vaccinia viruses expressing the L, and total cellular RNA 
was extracted and analysed by Northern blot. The blots were probed with (+) and (-) 
sense detecting S riboprobes. However, no replication of the vRNP was detected either 
in mock-infected cells or in cells expressing the L protein. Protein analysis of the vRNP 
transfected cells which had the L protein expressed also failed to detect the N protein 
synthesis. The reasons for this are not clear and will be discussed later.
Elliott & Wilkie (1986) and Scallan & Elliott (1991) had observed the generation of 
Bunyamwera virus DI particles from Bunyamwera virus persistently infected mosquito 
cells. These DI particles appeared to package only the Bunyamwera virus S segment. I 
considered to exploit these DI parades to further characterize the functionality of the L 
protein. BHK cells were infected with DI particles (Fig.5.12. lanes 1-3) and 
superinfected with vTF7-3 and vTF7-5BUNL (lane 2) or vSCl 1-BUNL (lane 3). Total 
cellular RNA was extracted after 24 hr of infection, separated on 1% agarose gels, 
transferred to nitrocellulose filters and hybridized with 32p-iabelled L gene cDNA (left 
panel) or 32p_iabelled S gene cDNA (right panel). No L RNA signal was detected in 
cells infected only with DI particles (left, lane 1) and no S RNA was observed either 
(right, lane 1). However, significant S specific signal was detected in cells infected with 
vSCl 1-BUNL (right, lane 3) and relatively less S was detected in dual vacdnia viruses 
infected cells (right, lane 2). This was entirely consistent with the RNP amplification 
data which has been described previously. More L RNA was synthesized in dual 
vaccinia virus infected cells (left, lane 2) than in vSCl 1-BUNL infected cells (lane 3). 
These results further confirmed that the recombinant L protein expressed from
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recombinant vaccinia viruses was functional by showing its ability to replicate or amplify 
Bunyamwera virus S RNA in DI particles.
A. B.
1 2  3 1 2  3
Fig.5.12. Replication of Bunyamwera virus DI particle RNA by the expressed L 
protein. BHK cells were infected with DI particles generated from Bunyamwera virus 
persistently infected mosquito cells, followed by superinfection with vTF7-3 and 
vTF7-5BUNL (lane 2) or vSCl 1-BUNL (lane 3). Total cellular RNA was extracted at 
24 hr after infection and fractionated on agarose gels containing 5 mM methylmercuric 
hydroxide, transferred to nitrocellulose filters and hybridized with 32p_iabelled pTZ- 
BUNL DNA (panel A) or 32P-labelled pTZ-BUNS DNA (panel B). No L RNA was 
detected in DI infected cells alone (Panel A, lane 1). The S RNA of the DI preparation 
was detected in cells expressing the L protein from the recombinant vaccinia viruses 
(Panel B, lanes 2 and 3), but was not observed in the DI infected BHK cells (lane 1).
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5.6. Discussion
To test the fundonality of the L protein expressed from recombinant vaccinia 
viruses, three systems have been explored:
(1). Complementation of ts mutants with defects in the L gene by the expressed L 
protein was invalidated by the experimental approach used. To date, there have been 
no reports on the complementation of ts mutants in cells expressing the polymerase
of any negative-strand RNA virus by recombinant vaccinia viruses. The only report which 
concerns the complementation of ts mutants is the L protein of VSV expressed in COS 
cells by transfection of recombinant plasmid DNA (Schubert et al., 1985). It was shown 
that only cells which synthesized low levels of the L protein were able to complement the 
ts mutants (Schubert e t al., 1985; Meier e t al., 1987). Gotoh e t al. (1989) rescued 
infectious virus from cells transfected with Sendai virus RNP by supplying the L and 
P/C proteins expressed from recombinant vaccinia viruses. They found that high levels 
of the Sendai virus L protein were much less efficient in rescuing the infectious virus 
from the transfected RNP and even diminished Sendai virus replication. Thus it 
appeares that it is difficult to assay the functionality of the expressed Bunyamwera virus 
L protein by a complementation assay. It is possible that the level of the L protein 
expressed is important in determining its functionality. In recombinant vaccinia virus 
and ts mutant infected cells, the expressed L protein and the defective L together might 
accumulate to a protein level which might be inhibitory to virus replication.
(2). The investigation of the in vitro  transcriptase activity of the recombinant L 
protein was not successful, mainly due to the lack of a suitable synthetic RNA template. 
Transcriptase activity was demonstrated in the detergent-disrupted Bunyamwera virion 
preparation but only weak activity in the RNP preparation. However, the RNA 
polymerase activity was increased when the vTF7-3 infected cytoplasmic extract was 
added to the RNP programmed in vitro transcription. This could be due to stimulation 
by cellular primers used for priming bunyavirus mRNA synthesis, as it has been 
reported for the LAC (Patterson et a l., 1984), since the L protein is still associated with 
nucleocapsids after the purification procedure. Although it was observed that the 
vSCl 1-BUNL infected cytoplasmic extract, which contained more expressed L protein 
(Fig.5.3A. lane 3), showed higher activity in stimulating the RNA polymerase reaction 
(Fig.5.3B. lane 4), it could not be demonstrated that the increased enzyme activity was 
due to the L protein present in the extract. Since it is difficult to differentiate the activity 
of the authentic L protein with that of the expressed L protein, a synthetic nucleocapsid 
devoid of the L protein is needed for performing this experiment.
Chapter 5 Functional analysis o f the L protein 149
(3). A nucleocapsid transfection assay was then developed based on a previous 
report by Gotoh et al. (1989) who studied Sendai virus. They showed that they could 
enhance the yield of Sendai virus obtained from transfected nucleocapsids by supplying 
Sendai virus L and P/C gene products through recombinant vaccinia viruses. Here, I 
demonstrated that the Bunyamwera virus L protein expressed by the vaccinia virus 
systems, as well as by the transient expression system, was able to amplify markedly the 
level of S segment RNA in CV-1 cells. After transfection of cells with the Bunyamwera 
virus intracellular nucleocapsids, which contained both negative- and positive-sense 
genomes, no viral RNA was detected. This result was somewhat surprising, since the 
preparations of nucleocapsids contain the N and L proteins, and were expected to be 
capable of initiating RNA synthesis. However the in vitro  transcription assay (Fig. 5.2) 
showed the nucleocapsids contained minimal enzymatic activity. The transfected 
nucleocapsids do provide an appropriate template for the synthesis of both polarities of at 
least the S segment RNA by the recombinant L protein. Thus far it has not been possible 
to demonstrate synthesis of the M segment RNA. Whether this reflects a relative lower 
abundance of the M segment, as the RNA extracted from nucleocapsid is rarely 
equimolar and S usually predominants (Rossier e t a l.y 1988), a lower efficiency of 
transfection of the M segment RNP or a lower stability of the M segment RNP is not 
known. Using defective interfering (DI) particles generated from Bunyamwera virus 
persistently infected mosquito cells, I was able to confirm the functionality of the 
expressed L protein by showing its ability to replicate the DI particle RNA.
The expressed L protein has transcriptase activity as the synthesis of S RNA of 
both polarities was observed, and the positive-sense S RNA was translated to the N 
protein. It is not clear whether the recombinant L protein is also able to replicate the 
virus genomic RNA template since the intracellular RNP contains the RNA of both 
polarities. It was not possible to determine if the negative-sense S RNA was transcribed 
from the positive-sense RNA in the RNP preparation or from the newly replicated 
positive-sense RNA. Since RNP were purified from the infected cells and might have 
associated with some other proteins, it is unclear if the L protein alone performed the 
polymerase function or whether some other protein components contained in the 
nucleocapsid also participated. This should have been clarified by using nucleocapsids 
(vRNP) purified from virions which only contained the negative-sense viral genomic 
RNA. However, attempts to replicate vRNP have not been successful. As this 
experiment was only performed twice, it is unclear if the failure was due to some aspects 
of the technique or if the purified virion RNP lacked some protein components required 
for the RNA synthesis. The role played by the NSs protein, which has been detected in
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infected cells, is not known yet. Overton et al. (1987) reported that the NSs protein of 
PT phlebovirus was detected in the purified intracellular RNP and virion preparations. 
However, it is not known if the NSs of Bunyamwera virus is also associated with 
Bunyamwera virus RNP, and hence might have some role in viral RNA synthesis. In 
order to analyse the individual viral protein requirements for Bunyamwera virus RNA 
replication, a reconstituted system should be established using synthetic RNA templates 
and individually defined virus proteins.
The association of the N protein translated from the newly synthesized positive S 
RNA with the S RNA has not been further investigated due to the time limitations. 
However, it was observed that immunoprecipitation with the L protein specific antiserum 
of extracts of vSCl 1-BUNL infected celb which had been transfected with RNP showed 
that minor amounts of the N protein were immunoprecipitated (Fig.5.11). It was 
previously noted that some of the N protein in Bunyamwera virus infected cells was 
immunoprecipitated by the L protein antisera (see chapter 3). It is possible therefore that 
the N protein synthesized in the RNP transfected cells was able to associate with the 
newly replicated RNA and form a nucleocapsid structure. Alternatively, newly 
synthesized N protein could have complexed with the L protein.
Since no M segment RNA was produced and no M RNA gene products were 
synthesized, it was not possible to demonstrate the production of infectious Bunyamwera 
virus. In contrast, Gotoch et al. (1989) working on the unsegmented Sendai virus were 
able to rescue infectious virus from transfected RNP. Notwithstanding this point, the 
system described above should be exploitable to dissect the functions and functional 
domains of the complex L protein encoded by Bunyamwera virus.
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Chapter 6
Site-specific mutagenesis of the L protein
6.1. Introduction
The recent identification of four conserved motifs among the RNA dependent RNA 
polymerase encoding elements (Poch e t  a l ., 1989) provides possible targets for 
mutagenesis of the RNA polymerase proteins. Although the functions of the conserved 
regions in the putative RNA polymerase proteins are not well understood, they are 
predicted to be well-ordered and may have a structural role in the polymerization activity. 
By sequence analysis of the Bunyamwera virus L protein, Elliott (1989a and personal 
communication) identified the polymerase motifs in the central region of the L protein, 
which are embeded in a large domain of 190 amino acids (see Fig. 1.8 in chapter 1).
In the previous chapter, I demonstrated that the L protein expressed by recombinant 
vaccinia virus had polymerase function in an RNP transfection assay. It was thus 
possible to probe the RNA polymerase domain within the multifunctional L protein by 
site-directed mutagenesis experiments. To study the functional role of the conserved 
amino acids in the predicted motifs in relation to RNA polymerase activity of the L 
protein, the conserved amino acids in the predicted RNA polymerase domain of the L 
protein were selected to make specific amino acid substitutions by site-directed 
mutagenesis of the L gene cDNA. The L gene mutants were then expressed and their 
functionality was determined by the RNP transfection assay.
6.2. Generation of the defined amino acid substitutions 
in the L protein
The predicted RNA polymerase domain of the L protein is located in the central 
region of the L protein between amino acid residues 1020 and 1210 (see Fig. 1.8 in
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chapter 1). The four conserved amino acid residues in each motif were selected as the 
initial targets for amino acid substitution. The positions of these residues in the L protein 
and their possible substitutions are shown in Fig.6.1. The sequence alignment data 
indicated that the L protein of Bunyamwera virus shares a feature of RNA polymerase 
proteins of the segmented RNA viruses which have the SDD span in motif C, whereas 
the similar sized L proteins of nonsegmented RNA viruses have GDN at this position. 
On the other hand, the RNA polymerase proteins of plus-strand RNA viruses have the 
conserved GDD span in this motif (Poch et a l., 1989 and 1990). Therefore the initial 
attempt was to determine if changing the SDD span to SDN in the Bunyamwera virus L 
protein was detrimental to the polymerase function of the L. The second D (1165) residue 
was thus selected as the target for making specific mutagenesis in motif C. It was also of 
interest to know the effect of the substitution of this D with a chemically opposite amino 
acid (R) or with a residue of neutral property (A) on the functionality of the L protein. 
Based on these considerations, a degenerate oligonucleotide (Table 6.1) was designed to 
cover the three desired changes so that by one mutagenesis reaction, all the three 
substitutions should be obtained. This degenerate oligonucleotide should also produce 5 
additional amino acid substitutions.
A, G, H, N, P, R, S, T
ALKLEINA^MSK 
__________1037
t
NYVQIKR0 WLQGNFNYISS 
_________ 1119____________
NH2 B C D COOHr t
0 400 800 1200 1600 2000 2238
s w v h s d [d ]n q t s
1^65
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TFG CGANM K0TY
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I
A, E, G, S, T
Fig.6.1. Positions of mutations in the polymerase motifs in the L protein. The L 
protein is represented as a linear molecule with amino acid residue numbers as 
indicated below. Polymerase motifs A, B, C, and D are shown as solid bands with 
expanded sequences in the single-letter code for amino acids. Single amino acid 
substitutions to be introduced in the regions are indicated.
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The most conserved D (1037) residue in motif A was also chosen for substitution 
with three chemically different amino acids using a degenerate oligonucleotide (Table 
6.1), which should also produce 5 additional amino acid substitutions. The K (12Q5) 
residue in motif D was chosen for substitution with an A residue and four other residues 
using a degenerate oligonucleotide (Table 6.1). The N residue at position 1119 in the L 
protein was found to align best with the most conserved G residue in motif B which had 
been identified in all the other RNA polymerase proteins analysed to date (Poch et al., 
1989). The importance of this N was also addressed by its conservation in the L proteins 
of Hantaan virus and TSWV (de Haan et al., 1991). It was not known if this N (1119) 
residue would be an important amino acid in motif B of the Bunyamwera virus L protein. 
Hence I determined to substitute this N with a G residue to clarify this experimentally.
Table 6.1. Synthetic oligonucleotides used for introducing the specific changes in the L 
Position Sequence of oligonucleotide
D-1037 5'-GGAAATAAATGCAG[A/C]A[C/G]CATGTCAAAATG-3'
N-1119 5'-CCAAATTAAAAGAGGCTGGCTC-3'
D-1165 5’-GGTGCATTCAGATG[A/C]A[C/G]r \ATCAAAC-3’
K-120 5  5'-GGCAAACATGAAAA[G]A[C/G]A[T]ACATATATTAC-3'
Degenerate positions are shown in bracket.
The scheme for site-directed mutagenesis of the L gene cDNA is shown in Fig.6.2. 
To make site-specific mutations in the L, it was considered that a small cDNA fragment 
containing the RNA polymerase motifs should be cloned into a vector to make single 
stranded DNA for the mutagenesis reactions. This fragment should also be easily cloned 
back into the full-length cDNA after mutagenesis. By searching of the restriction enzyme 
sites in the L cDNA, the EcoR I (nt 2877) to Pst I (nt 3811) fragment was convenient for 
removal from the L gene cDNA, but it would be difficult to clone this fragment back into 
the L gene cDNA in the right position after mutagensis because of three other EcoR I sites 
in the L. Therefore, I decided to make a silent mutation first to introduce a unique Xho I 
site into the L cDNA at the position of nucleotide 3145 so that the resulting Xho I/Pst I 
fragment of the L could be replaced with the mutated fragment in a one step ligation.
Recombinant plasmid pTZ-BUNL was digested with EcoR I and Pst I, and the 1 kb 
EcoR I/Pst I fragment was isolated and inserted between the EcoR I and Pst I sites of 
M Bm p 19 to give MP19-L(E/P). Mutagenesis was performed using Eckstein’s method
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(chapter 2) and the DNA samples in each mutagenesis reaction were monitored by 
agarose gel analysis (Fig.6.3). The final DNA reaction sample (S4) was transformed into 
E. coli TGI cells and dsDNA was prepared, digested with Xho I and Pst I and analysed 
by agarose gel electrophoresis. Plasmids containing the 0.6 kb Xho I/Pst I fragment were 
obtained and the correct sequence of the 0.6 kb insert was confirmed by 
dideoxynucleotide termination sequencing using a primer complementary to nucleotides 
3079-3097 of the L gene. The EcoR I/Pst I fragment containing the Xho I site was then 
removed from MP19-L(E/P) and recloned into pTF7-5BUNL (Fig.6.2). The same Xho I 
containing fragment was also inserted into pUC119 [pUC119-L(E/P)] for other site- 
directed mutagenesis reactions since it was found that pUC119 was much better than 
M13mpl9 for making template DNA for oligonucleotide-directed mutagenesis and for 
recovering the dsDNA fragment.
Four oligonucleotide-directed mutagenesis reactions were performed using 
pUC119-L(E/P). The DNAs were transformed into E. coli DH5 cells and single 
stranded DNA templates were prepared (see chapter 2). The mutants were screened by 
sequence analysis which involved termination with only ddATP and/or ddGTP. Fig.6.4
op
is an example of a screening gel showing location of mutations by a half set/sequencing 
reaction* which were terminated with ddGTP and ddATP. All of the 8 possible amino 
acid substitutions of 1037 D residue in motif A and 1165 D residue in motif C, as well as 
one substitution of 1119 N residue in motif B, were obtained. These mutations were 
confirmed by the full set of sequence reaction analysis (Figs.6.5-6.7). The mutant (L-G- 
1119) was found later to have a one base deletion in the oligonucleotide used for the site- 
directed mutagenesis, which changed the protein reading frame (Fig.6.6). The 
mutagenesis reaction to change 1205 K residue in motif D was unsuccessful. This most 
conserved K residue resides in a sequence containing 7 A bases. About 120 colonies 
were screened by A-track sequencing analysis; two deletion mutants in the region were 
obtained (Fig.6.8) but none of the DNAs contained the desired mutations. It appeared 
that the degenerate oligonucleotide was unsuitable for the mutagenesis in this A-rich 
region. The designations of the obtained mutations in motifs A, B, and C are 
summarized in Table 6.2.
Each mutated Xho I/Pst I fragment was then removed from pUCl 19-L(E/P) to 
substitute the wild type Xho I/Pst I fragment in pTF7-5BUNL, which had been 
digested with Xho I and partially digested with Pst I (Fig.6.2). The Pst I site at the 3' 
end of the cDNA created by GC tailing during the initial cloning of the L RNA was 
apparently more resistant to digestion, so that only a one step cloning procedure was 
required.
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Fig.6.2. Scheme for the generation of site-specific mutations in the L gene cDNA. 
pTZ-BUNL was digested with Pst I and EcoR I, the 1 kb EcoR I/Pst I fragment 
cloned into similarly digested M13mpl9 and the resulting construct designated MP19- 
L(E/P). Site directed mutagenesis was performed using the oligonucleotide shown in 
the figure to create a Xho I site, which does not affect the amino acid sequence of the L 
protein. The EcoR I/Pst I fragment carrying the Xho I site (nt 3145) was then inserted 
into EcoR I and Pst I digested pUCl 19 for the required mutagenesis reactions. This 
fragment was also used to replace the EcoR I/Pst I fragment in pTF7-5BUNL by a 
series of subclonings for future use. Mutagenesis was carried out on pUCl 19-L(E/P) 
using Eckstein’s method (see chapter 2). The mutated Xho I/Pst I fragment was then 
ligated with the Xho I and Pst I partially digested pTF7-5BUNL DNA from which the 
0.6 kb wild type Xho I/Pst I fragment had been removed. To insert the mutated L 
gene cDNA into the vaccinia virus transfer vector pS C ll, pSCl 1-BUNL was 
digested with Sph I and Sal I, and the L cDNA Sph I/Sal I fragment in pSCl 1-BUNL 
was replaced with the mutated restriction fragment from pTF7-5BUNL mutants.
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(DNA pol /  Ligase)
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SI Remove unwanted ssDNA by filtration
SI S2 S3 S4 ss ds marker
Fig.6.3. Protocol for making site-directed mutagenesis by Eckstein's mutagenesis 
method. The mutant oligonucleotide was annealed with the single stranded DNA 
template MP19-L(E/P) or pUC119-L(E/P) and the polymerization reaction was 
performed at 16 °C overnight. The samples (SI) were filtered to remove unwpted 
remaining ssDNA and the dsDNA was nicked by digestion with Nco I. The nicked 
DNA (S2) was further digested with Exo III (S3), which was then repolymerized by 
DNA polymerase I and ligated by T4 DNA ligase (S4). The DNA (S4) was then 
transformed into E. coli TGI [MP19-L(E/P)] or DH5 [pUCl 19-L(E/P)] cells and the 
desired mutants were screened by dideoxynucleotide termination sequence analysis. 
The DNA samples (SI, S2, S3, and S4) taken during each step of the mutagenesis 
protocol were analysed by electrophoresis on an agarose gel. The single stranded and 
double stranded DNA of pUCl 19-L(E/P) and the Hind III digested lambda DNA size 
markers are indicated.
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Fig.6.4. An example of a screening gel showing the identification of mutations by a 
half set sequencing reactions which were terminated with ddGTP and ddATP. The 
order of the lanes is G and A, and the position of mutations is indicated.
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Fig.6.5. Sequencing gel showing the mutations in motif A. The changed nucleotide 
sequence of each mutant, the position of the mutations and the created Xho I site by 
silent mutation are indicated. The order of the lanes is G, A, T, and C.
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1119$ wt
Fig.6.6. Sequencing gel showing the mutations in motif B. The mutated nucleotide 
sequence (GGC) and the witct type nucleotides (AAC) are indicated. The positions 
of the mutations and the one base deletion in the synthetic oligonucleotide are also 
indicated. The order of the lanes is G, A, T, and C.
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Fig.6.7. Sequencing gel showing the mutations in motif C. The mutated nucleotide 
sequence of each mutant and the position of mutations are indicated. The order of 
the lanes is G, A, T, and C.
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Fig.6.8. Sequencing gel showing the mutations in motif D. Single stranded DNA 
templates were prepared and the sequencing reactions terminated with only ddATP to 
determine the changes among the 7 As (as indicated) in the mutagenesis region. Only 
two deletion mutants were detected and none of the desired changes were obtained.
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The pTF7-5BUNL mutants obtained were further confirmed by direct nucleotide 
sequence analysis using alkaline denatured plasmid DNAs.
Table 6.2. Mutations in RNA polymerase motifs of the L protein
Designation Nucleic acid sequence Amino acid sequence
Mutagenesis in Motif A:
L-D-1037 (wt) GACGAC ATG ADN
L-A-1037* GCC A
L-G-1037 GGC G
L-H-1037 CAC H
L-N-1037* AAC N
L-P-1037 CCC P
L-R-1037* CGC R
L-S-1037 AGC S
L-T-1037 ACC T
Mutagenesis in Motif B:
L-N-1119 (wt) AGA^AgTGG RNW
L-G-1119* G
Mutagenesis in Motif C:
L-D-1165 (wt) TCA GAT G AC SDD
L-A-1165* GCC A
L-G-1165 GGC G
L-H-1165 CAC H
L-N-1165* AAC N
L-P-1165 CCC P
L-R-1165* CGC R
L-S-l165 AGC S
L-T-l165 ACC T
The mutated L genes indicated with * were cloned into recombinant vaccinia viruses.
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6.3. Expression of the L protein mutants.
In the previous analysis of the L protein by the RNP transfection assay, it was 
consistently observed that the L protein expressed by vSCl 1-BUNL had greater activity. 
Therefore, the six initially designed mutations in the L (1037 D and 1165 D replaced with 
A, N, or R, and 1119 G to N substitution) were cloned into the vaccinia virus transfer 
vector pSCl 1 to make recombinant vaccinia viruses. These pTF7-5BUNL mutants were 
digested with the Sph I and Sal I, and the mutated Sph I/Sal I fragment was ligated with 
Sph I and Sal I digested pSCl 1-BUNL DNA from which the wild type Sph I/Sal I 
fragment had been removed. The resulting pSCl 1-BUNL mutant DNAs were then 
transfected into vaccinia virus WR strain infected CV-1 cells to generate recombinant 
vaccinia virus vSCl 1-BUNL mutants (see chapter 2). TK' blue plaques were obtained 
after staining with X-Gal and the recombinants were characterized by Southern blot 
analysis. The DNAs extracted from blue plaque infected TK' cells were fractionated on a 
1 % agarose gel and transferred to nitrocellulose. Hybridization with -^P-labelled pTZ- 
BUNL DNA indicated that all the vSCl 1-BUNL mutants had the expected genetic 
structures (Fig.6.9A).
To determine the effect of the amino acid substitution on the L protein activity, the 
expression of the L protein mutants were first analysed. CV-1 cells were infected with 
vSCl 1-BUNL mutants and labelled with 35s-methionine overnight after 6 hr of 
infection. Cell extracts were prepared and immunoprecipitated with the L specific antisera 
(anti-C plus anti-N) followed by gel electrophoresis (Fig.6.9B). Except for L-G-1119, 
which had a one base deletion, all the mutants synthesized an antigenically authentic 
protein having the same size as the L protein observed in Bunyamwera virus infected 
cells.
Expression of the other nine L protein mutants generated, which had been cloned 
into pTF7-5 under control of the T7 promoter, was analysed by transfecting plasmid 
DNA into vTF7-3 infected cells and then labelling with 35s-methionine (Fig.6.10). Cell 
extracts were prepared and immunoprecipitated with the L specific antisera (anti-C plus 
anti-N) followed by gel electrophoresis. L protein was detected in pTF7-5BUNL mutants 
(L-G-1037, L-H-1037, L-P-1037, L-S-1037, L-T-1037, L-G-1165, L-P-1165, L-S- 
1165, and L-T-l 165) transfected cells; no L was seen in the cells infected with vTF7-3 
alone (lane 0). The pTF7-5BUNL mutant with 1119 N substituted with G produced a 
polypeptide about the half size of the L in the transfected cells due to a base deletion in the 
synthetic oligonucleotide which resulted in the early termination of the translation.
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Fig.6.9. Characterization of recombinant vaccinia virus vSCl 1-BUNL mutants. A. 
Southern blot analysis. The seven mutated L cDNA fragments(L-A-1037, L-N-1037, 
L-R-1037, L-A-l 165, L-N-l 165, L-R-l 165, L-G-l 119) were cloned into pSCl 1 and 
recombinant vaccinia virus vSCl 1-BUNL mutants were selected (see chapter 2). 
CV-1 cells were infected with vSCl 1-BUNL mutants and total cellular DNA extracted 
at 24 hr postinfection. The DNA was digested with Xho I and Pst I, fractionated on 
a 1 % agarose gel and transferred to a nitrocellulose filter. Hybridization with 32p_ 
labelled pTZ-BUNL showed that all the mutants had the expected genetic structure, 
which is not seen in the parental (WR) virus. The position of the 0.6 kb Xho I/Pst I 
fragment band is indicated.
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Fig.6.9 B. Expression of L protein by vSCl 1-BUNL mutants. CV-1 cells were 
infected with vSCl 1-BUNL mutants and the cells labelled with 35s-methionine 
overnight after 6 hr of infection. Cytoplasmic extracts were immunoprecipitated with 
the specific antisera against the L protein (anti-C plus anti-N) followed by 
electrophoresis in a 12% polyacrylamide-SDS gel. Except for L-G-l 119, L protein 
was detected in each recombinant vaccinia virus vSCl 1-BUNL mutant and vSCl 1- 
BUNL (wt) infected cells. The positions of L, G l, G2, N, and B-galactosidase are 
indicated.
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Fig.6.10. Transient expression of the mutant L proteins by transfection of the pTF7- 
5BUNL mutant DNAs. The mutant pTF7-5BUNL DNAs (20 pg) were transfected 
into vTF7-3 infected CV-1 cells and the cells labelled with ^^S-methionine overnight 
after 6 hr of transfection. Cytoplasmic extracts were immunoprecipitated with the 
specific L protein antisera (anti-C and anti-N). Except for L~<3f-1119, the L protein 
was expressed in cells transfected with each mutant pTF7-5BUNL DNA as indicated 
above the lanes. L- £-1119 had a one base deletion in the oligonucleotide used for 
mutagenesis and thus created a premature termination, producing a polypeptide 
which is about the half size of the L protein (indicated as LNH2). Lane 0 is the cells 
without plasmid transfection.
Chapter 6 Site-specific mutagenesis o f the L protein 167
I also made a deletion mutant, which had the 3' end Nde I fragment (nt 6021-6519) 
of the L cDNA removed, to determine the effect of deleting the C-terminal 166 residues 
on the functionality of the L protein. This deletion mutant was also cloned into the 
vaccinia virus (vSCl 1-BUNLAN) and a protein slightly smaller than the L was produced 
in recombinant vaccinia virus infected cells (see later).
6.4. Functional analysis of the mutant L proteins
The functionality of the L protein mutants were then assayed by the Bunyamwera 
virus RNP transfection assay as described in chapter 5. Both N protein synthesis and the 
S RNA amplification were analysed in the RNP transfected cells, which also had the L 
protein expressed, to determine the functionality of the mutants.
The functionality of the six vSCl 1-BUNL mutants was firstly determined by protein 
analysis. RNP were transfected into the cells which had been infected with the six 
vSCl 1-BUNL mutants and the cells were labelled with ^-m ethionine overnight after 6 
hr of transfection. Immunoprecipitation of the extracts with a mixture of anti- 
Bunyamwera virus antiserum and the specific antiserum against the L protein revealed that 
the N protein was detected in the vSCll-BUNL-A 1037 mutant infected and RNP 
transfected cells (Fig.6.11A), indicating that this mutant maintained the RNA polymerase 
activity. The other two substitutions in 1037 D residue by R or N in the L protein 
reduced the enzyme activity. The substitution of 1165 D in motif B with N, A or R 
made greatly reduced level of N. The activity of vSCl 1-BUNL-A 1037 mutant was also 
confirmed by Northern blot analysis. Total cellular RNA was extracted from the RNP 
transfected cells (Fig.6.1 IB. lanes 1-3) which had been mock-infected (lane 1), infected 
with vSCl 1-BUNL-A 1037 mutant (lane 2), or vSCll-BUNL(wt) (lane 3), and 
fractionated on an agarose gel containing methylmercuric hydroxyde. Hybridization with 
3 2 p - l a b e l l e d  pTF7-5BUNS DNA showed that the S specific RNA signal was detected in 
vSCl 1-BUNL-A 1037 mutant (lane 2 )  and vSCl l-BUNL(wt) ( l a n e  3) infected cells, but 
not in the mock-infected cells (lane 1). Preliminary Northern blot analysis of RNA from 
the other 5 vSCl 1-BUNL mutants (L-R-1037, L-N-1037, L-A-1165, L-R-1165, and L- 
N-1165) infected cells did not show S RNA amplification, indicating that these 5 
substitutions in the L reduced . the RNA polymerase activity.
Some pTF7-5BUNL mutants with mutations in motif B and C were also assayed by 
the RNP transfection assay. pTF7-5BUNL mutant DNAs (L-G-1037, L-H-1037, L-P- 
1037, L-S-1037, L-T-1037, L-A-1165, L-H-1165, L-P-1165, L-S-1165, or L-T-1165), 
together with the RNP, were transfected into vTF7-3 infected CV-1 cells and the cells
Chapter 6 Site-specific mutagenesis o f the L protein 168
Fig.6.11. Functional analysis of the L proteins expressed by vSCl 1-BUNL mutants. 
A. Immunoprecipitation analysis of the proteins synthesized in cells infected with 
vSCl 1-BUNL mutants following transfection with the Bunyamwera virus RNP. The 
transfected cells which had been infected with the vSCl 1-BUNL mutants as indicated 
were labelled with ^^S-methionine overnight after 6 hr of transfection. Cytoplasmic 
extracts were immunoprecipitated with a mixture of anti-Bunyamwera virus antiserum 
and the specific antiserum aeainst the L Drotein (anti-C). The N protein was detected in 
the cells infected with vSCl l-BUNL(wt) and A-1037, but only very slightly, if at all, in the cells
infected with the other mutants. Except for L-A-1165, the levels of the L protein 
produced in other mutants infected cells were similar to that of L-A-1037. B. Northern 
blot analysis of RNA from the RNP transfected cells (lanes 1-3) which had been mock- 
infected (lane 1), infected with vSCl 1-BUNL-A 1037 (lane 2), or vSCl 1-BUNL (lane
3). Total cellular RNA was extracted after 20 hr of transfection, fractionated on a 1% 
agarose gel containing methylmercuric hydroxide and transferred to nitrocellulose. 
Hybridization with pUC-BUNS DNA showed that the S signal was
detected in the RNP transfected cells which had been infected with vSCl 1-BUNL-A 
1037 (lane 2) and vSCl 1-BUNL Qane 3), but not in the mock infected cells (lane 1).
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were labelled with ^^S-methionine. The extracts were immunoprecipitated with a 
mixture of anti-Bunyamwera virus antiserum and the specific anti serum against the L 
protein followed by gel electrophoresis. As can be seen from Fig.6.12, the L protein 
was synthesized in the RNP transfected cells which had been transfected with the mutant 
recombinant plasmid DNAs, but no N protein was clearly detected. This suggests that 
those mutants may have lost the enzyme activity. The functionality of L-G-l 165 mutant 
was not determined.
The functionality of one deletion mutant, vSCll-BUNLAN, was also analysed by 
analysis of N protein synthesis in the mutant infected and the RNP transfected cells 
(Fig.6.13). A protein migrating slightly faster than the L protein was detected in the 
vSCll-BUNLAN infected cells (lane 1), but no N protein synthesis was observed. In 
contrast, both the L and N proteins were detected in the wild type vSCl 1-BUNL infected 
cells (lane 2). Thus, the C-terminal 166 residues deletion generated by removing 498 
bases between nucleotides 6021 and 6519 of the L cDNA, made a truncated L protein 
which was inactive in the RNP transfection assay. This indicated that the intactness of the 
L protein may be important for its functionality.
In summary, among the 16 mutant L proteins generated by site-directed 
mutagenesis, one mutant L-A-1037 was shown to still have the polymerase activity; and 
other mutations in 1037D and 1165D of the L had no activity in the RNP transfection 
assay.
6.5. Discussion
Site-directed mutagenesis experiments were performed on the central region of the 
Bunyamwera virus L protein which encompasses the four conserved predicted RNA 
polymerase motifs. Two conserved amino acids (1037 D and 1165 D) were substituted 
by 8 different amino acid residues. Interestingly, one mutant (L-A-1037) still exhibited 
polymerase function in the RNP transfection assay, suggesting it may maintain the 
similar structure as the wild type L protein. The replacement of the 1037 D by other 
residues (G, H, N, P, R, S, or T) rendered the L protein^inactive. Bordo and Argos 
(1991) have suggested that A substitution is a "safe" residue substitution in site-directed 
mutagenesis. Larder et al. (1987) also noted that not all conserved amino acids are 
essential for the enzyme function since some of the mutations they generated in HIV 
reverse transcriptase (RT) (D and A in position 12 and 13 of motif A, respectively) had 
no apparent effect on the biochemical properties of the enzyme.
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Fig.6.12. Functional analysis of the mutant L proteins by transient expression. 
CV-1 cells were infected with vTF7-3 at moi of 5 pfu/cell and transfected with RNP 
and pTF7-5BUNL mutant DNA as indicated. The cells were radiolabelled with 35S- 
methionine overnight after 6 hr of transfection and the extracts were 
immunoprecipitated with a mixture of anti-Bunyamwera virus antiserum and the 
specific antiserum against the L protein. The vTF-7-5BUNL (wt) DNA transfected 
cells did not produce high levels of the N protein in this experiment. Therefore, the 
determination of the functionality of these mutants remained to be investigated.
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Fig.6.13. Functional analysis of a deletion L protein mutant expressed by vSC ll- 
BUNLAN. CV-1 cells were infected with vSCll-BUNLAN (lane 1), vS C ll- 
BUNL(wt) (lane 2) and transfected with RNP (lanes 1-2). The cells were labelled 
with ^S-m ethionine overnight after 6 hr of transfection and the extracts were 
immunoprecipitated with a mixture of anti-Bunyamwera virus antiserum and the 
specific antiserum against the L protein (anti-C) followed by electrophoresis on a 
15% polyacrylamide-SDS gel. A protein which migrated faster than the L protein 
was observed in vSCll-BUNLAN infected cells, but no N protein was detected. 
Both L and N proteins were detected in vSCl 1-BUNL (wt) infected cells. The 
positions of L, G l, N and B-galactosidase are indicated.
The minor band in lane 1 migrating slightly faster than N is a vaccinia virus protein.
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The second D (1165) in the SDD span in motif C was chosen as a target for 
mutagenesis, since the SDD span is unique to the polymerase proteins of the segmented 
negative-strand RNA viruses analysed to date (See Fig. 1.8 in chapter 1). For 
unsegmented negative-strand RNA viruses, the most conserved amino acid residues in 
motif C are GDN (Poch et a l.t 1989, 1990). Therefore, it appeared that SDD residues 
might be important for the segmented RNA virus replication. My initial aim was to 
determine if changing SDD to SDN is detrimental to the functionality of the L protein and 
the preliminary result showed that the SDD to SDN change abolished the activity of the L 
protein in the RNP transfection assay, indicating this DD doublet is essential for 
maintaining the L protein activity. Larder et al. (1987) substituted the first D of the 
conserved MDD residues in motif C with H in the reverse transcriptase of HIV and the 
resulting mutant lost reverse transcriptase activity. This suggests the importance of the 
DD doublet in motif C. Motif C has been suggested to be at or near the enzyme active 
centre (Poch e t a l., 1989, Jablonski et a/., 1991). Jablonski e t al. (1991) studied the 
conserved YGDD span in motif C of the poliovirus RNA-dependent RNA polymerase by 
site-directed mutagenesis of the poliovirus cDNA. They replaced the G residue in the 
YGDD span with A, C, M, P, S, or V and found that the mutant RNA polymerase with A 
or S substitution, exhibited the enzymatic activity in vitro.
The S (1163) residue in SDD span is only conserved in the polymerase proteins of 
segmented negative-strand RNA viruses; it would be of interest to determine the role of 
this S residue in the future by changing this S to G which is conserved in polymerase 
proteins of plus-strand RNA viruses and unsegmented negative-strand RNA viruses. 
Attempts to change the 1119N with G residue were not successful due to a one base 
deletion in the synthetic oligonucleotide (Fig.6.6). Since this N residue is conserved in 
the L protein of Hantaan virus (Schmaljohn, 1990) and TSWV (de Haan et a l., 1991) and 
aligned with the most conserved G residue in motif B which has been detected in all the 
other RNA polymerase proteins analysed to date (Poch et a l., 1989 and 1990), the 
experiment should be repeated in the future to asses the role of this conserved N residue.
One deletion mutant which had 166 residues deleted at the C-terminus of the L lost 
polymerase activity, indicating the deletion could have destroyed the secondary structure 
of the protein or affected other functions of the L protein. This implies that the intactness 
of the L protein is required for its functionality in the RNP transfection assay.
More site-directed mutagenesis is obviously necessary to study the functional role of 
the conserved amino acids systematically. The amino acids adjacent to the four most 
conserved amino acids have been selected as the targets for making more L mutants and
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the oligonucleotides have been synthesized. However, due to time limitations on the 
project, these further mutations have not yet been done. For the functional analysis of the 
mutants, it is also important to develop a more sensitive assay. This might have to await 
success in reconstituting synthetic RNA templates so that it would be possible to measure 
the polymerase activity of the generated L mutants more precisely. It would also be very 
useful if the desired L gene mutants could be introduced into an infectious virus genome 
to investigate their role in virus replication more fully.
Chapter 7
Outlook
The aims of the project have been achieved by demonstrating the success of: (1) 
construction of a cDNA representing the full-length Bunyamwera virus L gene (chapter
4); (2) expression of the L protein by vaccinia virus systems and exploration of the L 
gene expression in other systems (chapter 4); (3) production of monospecific antisera 
against the L protein in order to identify the antigenicity of the expressed L protein 
(chapter 3); (4) demonstration of the RNA polymerase activity of the expressed L 
protein (chapter 5). In addition, preliminary data on mapping the polymerase domain 
within the multifunctional L protein by site-directed mutagenesis of the L cDNA were 
presented in chapter 6.
Expression of functional L protein of Bunyamwera virus provides a very useful 
vehicle for detailed dissection of the functions of the different viral proteins involved in 
transcription and replication. A similar type of expression system has been described by 
Pattnaik & Wertz (1990) working with VSV, which has enabled them to identify the 
protein requirements for replication of the genome of a VSV DI particle. They 
transfected plasmids containing cDNAs for the L, N and NS genes of VSV, under 
control of the T7 promoter, into VSV DI infected cells which had also been infected with 
vTF7-3 (producing T7 RNA polymerase). Replication and amplification of the genome 
of DI particle were entirely dependent on the expression of the L, N and NS proteins 
driven by vaccinia virus-T7 polymerase; omission of any one of the proteins abolished 
replication. Furthermore, the degree of RNA replication depended on the relative ratios 
of the proteins; maximal levels were achieved at molar ratios of L:N:NS of 1:200:200, 
and were eight- to ten-fold higher than those achieved by wild type VSV as a helper 
virus.
The Bunyamwera virus RNP transfection assay developed in this project indicates 
that the L protein alone is required for transcription of the S RNA supplied from the
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transfected RNP. Note that unlike the DI particle of VSV, which lacks genetic 
information (including the N gene) necessary for its genes to be replicated, the 
transfected Bunyamwera virus RNP contain intact viral genomes. Thus the N protein 
was synthesized from the plus-sense S RNA which had been transcribed by the 
expressed L protein in the RNP transfected cells, and hence it is difficult to assess the 
role of the N protein in the RNA transcription process. Similarly, the Bunyamwera 
virus DI particles also contained full length S RNA and were replicated by the expressed 
L protein. A synthetic RNA template is therefore a must for future experiments aimed at 
identifying the protein requirements for bunyavirus RNA transcription or replication.
The corijtruction of synthetic RNA templates of influenza virus has been reported 
recently (Luytjes et a l , 1989; Parvin et a l., 1989; Enami et al., 1990). Parvin et al.
(1989) constructed synthetic RNA templates which were transcribed from plasmid- 
encoded sequences and encapsidated with NP protein purified from virions. The 
synthetic templates, which contained 3-terminal sequences of genomic RNA could be 
transcribed by the purified authentic influenza virus polymerase; sequences not specific 
for influenza virus were not copied. Using this system, they were able to demonstrate 
that the promoter sequence of influenza virus lies within the 15 nucleotides at the 3’- 
terminus. Similarly, Moyer et al. (1991) also assembled functional RNA templates of 
VSV by encapsidating in vitro synthesized sequences representing the 5' end of both the 
negative- and positive-strand VSV genome RNAs with purified N protein. The 
assembled nucleocapsids could function in vitro  as templates for transcription by the 
VSV RNA polymerase. They showed that as few as 19 nucleotides from the 5' end of 
VSV RNA allowed maximal encapsidation.
Luytjes et al. (1989) exploited the system developed by Parvin e t al. (1989) to 
package a foreign gene into influenza virions and to support transcription of a synthetic 
influenza virus RNA. A plasmid was constructed containing the chloramphenicol 
acetyltransferase (CAT) gene flanked by the 3 - and 5-terminal untranslated sequences 
from influenza virus genome segment 8. RNA was synthesized in vitro using T7 RNA 
polymerase, equivalent to the negative strand of the CAT gene, and this was mixed with 
the influenza virus polymerase preparation and then transfected into MDCK cells. 
Following superinfection with a helper virus, CAT activity was detected in the 
transfected cell extracts. In addition, the recombinant influenza virus gene was found to 
be packaged into virus particles: when the supernatant from these cells was used to infect 
other cells, CAT activity was again detected. In this way, they have shown that the 5'- 
terminal 22 nucleotides and the 3'-terminal 26 nucleotides of the viral RNAs contain all 
the signals necessary for transcription, replication and packaging of the influenza virus 
RNAs. Yamanaka e t al. (1991) reported a similar system for the analysis of the 
promoter structure of the influenza virus RNA genome. They confirmed that in vitro
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synthesized RNA must be complexed with viral RNA polymerase and NP to form active 
templates prior to transfection.
Progress towards the propagation of negative-strand viral genomes in the absence 
of homologous helper virus has also been developed for influenza virus. Huang et al. 
(1990) used a vaccinia virus vector-driven system for replication of a synthetic NS-like 
gene. The NS-like gene contains the CAT gene (reporter gene) in place of the antisense 
coding regions for the NS proteins (NS1 and NS2). This was transfected into cells 
which had previously been infected with vTF7-3 and transfected with a mixture of 
plasmids expressing the three polymerase proteins (PB1, PB2 and PA), the NP protein, 
NS1 and/or NS2 proteins. The replication of the synthetic RNP was assayed by 
analyzing cells for CAT activity. By this approach, they were able to identify that the 
minimum subset of influenza virus proteins needed for specific replication is the three 
polymerase proteins (PB1, PB2 and PA) and the NP protein.
The source of N protein used for reconstituting functional synthetic nucleocapsids 
of VSV and influenza virus is from purified virions. However it is difficult to obtain 
enough N protein from a bunyavirus for in vitro encapsidation of a synthetic RNA, since 
bunyavirus yields in infected cells are low. Other alternative approaches have to be 
developed. The Maguari virus N protein has been successfully expressed in a 
recombinant baculovirus by Elliott and McGregor (1989), and has been purified to 
homogeneity by chromatography (McGregor and Elliott, unpublished data). If this 
recombinant N protein can bind to viral RNA transcripts in vitro  and form a functional 
nucleocapsid structure, it would provide an alternative template for functional analysis of 
the RNA polymerase in vitro or in intact cells.
Bunyamwera virus DI particles generated from persistently infected mosquito cells 
(Elliott & Wilkie, 1986; Scallan & Elliott, 1991) were appropriate templates for the 
polymerase activity assay as described in chapter 5. More work is required to 
characterize these DI particles in order to fully understand their protein composition and 
structure of the defective genome. It may be possible to rescue Bunyamwera virus DI 
particles by expressing all the viral structural proteins (L, G l, G2, and N) of 
Bunyamwera virus from cloned cDNA. Similar work has been achieved for the DI 
particle of VSV (Pattnaik & Wertz, 1991). The DI particles of VSV were successfully 
replicated, assembled and budded from the cells expressing all five VSV proteins (L, N, 
NS, G, and M) from the vaccinia virus/T7 system. Omission of either M or G protein 
expression resulted in no DI particle budding.
The protein requirements for Bunyamwera virus RNA replication have not been 
defined due to the lack of a synthetic RNA template. The function of the NSs protein 
encoded by the S segment is not known yet. Expression of the NSs protein by a cloned 
cDNA should help to unraval its role in the RNA synthesis process. It is known that the
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NS protein of VSV is required for replication of the VSV genome (Pattnaik & Wertz, 
1990; 1991). However, using a similar system, the NS1 and NS2 proteins of influenza 
virus were shown not to be essential in the replication of a NS-like synthetic RNA 
(Huang et a l., 1990). As has been discussed in chapter 5, the protein components in the 
transfected RNP were not characterized and it is not known if minor amounts of NSs 
were also present in the RNP preparations. The expressed L protein has not been shown 
to replicate the S RNA from the transfected vRNP; therefore it is possible that the 
expression of NSs cDNA in the vRNP transfected cells might aid the L protein activity. 
The NSs protein of bunyavirus has been suggested to play a role in the switch from viral 
transcription to genome replication (Bishop, 1985), which should be studied in the 
future.
The study of negative-strand RNA viruses in general has suffered from the lack of 
a method for recovering viable virus from molecularly cloned cDNA copies of genomic 
sequences to allow genetic manipulation of the virus genomes. Such systems have been 
available for positive-strand RNA viruses, such as picomavirus (Omata e t al., 1984; 
Mizutani & Colonno, 1985) for some time. For positive-strand RNA viruses, the RNAs 
from full-length cDNAs are infectious upon transfection, and no additional factors or 
proteins are required. In contrast, negative sense RNA genomes have to be first 
transcribed into mRNA by the viral specific RNA polymerase. This difficulty has been 
overcome for influenza virus (Luytjes e t al., 1989; Enami et al., 1990),
which represents a significant step towards genetic 
manipulation of negative-strand RNA viruses.
Enami et al. (1990) succeeded in rescuing infectious influenza virus by transfecting 
cells with RNAs derived from specific cDNAs. They constructed a recombinant plasmid 
containing the complete NA gene of influenza WSN virus downstream of a T3 promoter 
to make a faithful RNA copy identical in length to the genomic NA RNA. This RNA 
was then incubated with purified RNA polymerase proteins and the complexes 
transfected into MDBK cells. Superinfection with helper WSN-HK virus resulted in the 
release of virus containing the WSN NA gene. The use of helper virus WSN-HK was 
important in this experiment to provide a strong selection for the NA rescued viruses, 
because WSN-HK virus cannot foim plaques in MDBK cells in the absence of protease 
due to the defect in its NA gene. When five point mutations were introduced into the 
WSN NA gene by cassette mutagenesis of the plasmid DNA, the desired mutations 
were revealed in the NA gene of the rescued viruses. The transfection efficiency of 
influenza virus transfectants has been much improved by coupling the in vitro  
transcription of cDNA with the actual assembly of the RNP to allow cDNA-derived 
RNA to be introduced into the genome of influenza virus more efficiently (Emini and 
Palese, 1991). More recently, Muster et al. (1991) demonstrated that a chimaeric
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influenza virus could be produced by transfecting engineered RNA into MDBK cells 
infected with the helper virus. The hybrid influenza A/B virus gene contained the coding 
region of the A/WSN NA flanked by terminal sequences derived from influenza B/Lee 
virus; and this virus had reduced virulence in mice. The recognition of the end sequences 
derived from influenza B virus by the influenza A virus RNA polymerase was less 
efficient, suggesting that the end sequences may be responsible for the altered phenotype 
of the chimearic virus.
For measles virus, Ballart et al. (1990) claimed to have rescued infectious virus 
entirely from cloned cDNA by microinjecting committed cDNA/RNA polymerase 
complexes into the helper virus infected cells. However there are doubts on the validity 
of this claim and a follow up report has been retracted (/. Virol. 65:5656,1991).
It is also worthwhile to mention the approach established by Roner e t al. (1990) in 
establishing a productive infection by transfecting reovirus RNA. Reoviras contains 10 
segments of double-strand RNA ranging in length from 196 to 3916 nucleotides and the 
virion also contains a transcriptase complex. The reovirus genome has been shown to be 
noninfectious by simply transfecting the 10 virus RNA species into the cells. The 
conditions described by Roner et al. are complex: the optimal transfection mixture 
comprised ssRNA (plus-strand) and ds RNA of serotype 3 (ST3) as well as reticulocyte 
lysate in which all 10 reovirus ST3 mRNAs had been translated. Eight hours after the 
introduction of this mixture into mouse L929 fibroblasts by the "Lipofectin" transfection 
method, the cells were superinfected with a helper virus, ST2, and virus was harvested 
23 hr later. ST2 helper virus only forms plaques after 10-12 days of incubation whereas 
ST3 forms plaques in as short as 2 days, which provided selection for ST3 progeny 
virus. The yield of ST3 virus from the transfected RNAs was 0.1-0.2 pfu/cell and 
contained virus with only a homogeneous ST3 genome type. Reassortants were 
generated when a mixture of ST2 and ST3 dsRNAs, together with reticulocyte lysate 
primed with both ST2 and ST3 ds RNAs, were translated. Although the roles of the 
various components in the transfection mixture are not understood, this advancement 
may provide a useful approach for making infectious Bunyamwera virus entirely from 
the cloned cDNAs. The three RNA segments of Bunyamwera virus have been cloned 
and full length cDNAs are available; efforts could be made by transfecting the in vitro  
transcribed three RNA species (S, M, and L) together with the in vitro produced virus 
proteins (L, N, G l, G2, NSs and NSm) and assaying for the production of the 
infectious virus.
By transfecting the purified Bunyamwera virus RNP into the cells expressing the L 
protein, I was not able to detect infectious virus recovered from the transfected RNP 
(chapter 5). In contrast, Gotoh et al. (1989) were able to rescue infectious Sendai virus 
from cells transfected with RNP by supplying the Sendai virus L and P/C gene products
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expressed from recombinant vaccinia viruses. Since M RNA amplification and M RNA 
gene products were not detected, it was speculated that the efficiency of transfecting M 
RNA (and L RNA) segment nucleocapsids might be lower. Unlike Sendai virus which 
has^unsegmented RNA genome, Bunyamwera virus has three RNA segments and it is 
therefore more difficult to transfect all three nucleocapsids into a single cell. More 
investigation is required to overcome this.
The L protein is presumed to have endonuclease activity, which has been indicated 
by the in vitro transcription assay (Patterson et a l., 1984) and by analysis of viral mRNA 
species in infected cells (Bishop et al., 1983; Eshita et al., 1985; Collett, 1986; Bouloy et 
al., 1990). The endonuclease activity is considered to be involved in a cap-snatching 
initiation of viral mRNA synthesis. The identification of the endonuclease activity and 
further mapping of its domain in the L protein should provide more information on the 
viral RNA synthesis mechanism. It may be difficult to use the L protein expressed from 
recombinant vaccinia virus for the endonuclease assay, since a similar activity might be 
present in some of the vaccinia virus proteins. In chapter 4, a protein which was the 
same size as the Bunyjmwera virus L protein was produced in vitro by translation of an L 
gene mRNA. Due to time limitations this system has not been further explored. It 
would be worthwhile characterizing further the in vitro synthesized protein and to assay 
for polymerase activity. In vitro transcription reactions could be performed using the in 
vitro  synthesized L protein and a synthetic RNA template to detect cap endonuclease- 
primed RNA synthesis. A similar assay system using authentic RNA polymerase 
protein has been described for influenza virus which employs a similar initiation 
mechanism for viral RNA synthesis (Parvin et a l., 1989). It would also be possible to 
incubate the expressed L protein with a capped mRNA to determine specific digestion of 
the cap containing sequence.
The agarose gel system used for detecting the S RNA synthesis in the RNP 
transfected cells did not separate the full-length S RNA and the shorter S mRNA. This 
should be overcome by using an alternative gel system. The 5' end sequences of the 
amplified S RNA could be analysed by a PCR technique to determine if the positive- 
sense S mRNA contains host derived primers. This should help us to understand the 
viral RNA initiation mechanism in an artificial system.
In summary, the results presented in this thesis demonstrated that the Bunyamwera 
virus L protein is an RNA polymerase, which opens a new approach for further 
structural and functional studies. These may also provide some insights into the 
mechanism of the RNA synthesis process, such as identification of the promoter 
sequences in the viral RNA, endonuclease function of the L and further protein 
requirements for viral RNA synthesis. Preliminary data on mapping the RNA 
polymerase domain of the L protein presented in this thesis indicated the importance of
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some conserved amino acids in the predicted polymerase motifs. It would be very
• •important to incorporate the L gene mutants into an infectious virus and/determine their 
functions in virus replication. More mutagenesis of the L gene cDNA is required to 
identify the crucial amino acids within the enzyme active site of the polymerization 
reaction, which may provide possible targets for antiviral chemotherapy. Based on the 
results achieved in this project some work of immediate interest, which has been 
discused as above, is summarized as follows:
(1) reconstitution of RNA templates for RNA polymerase assay;
(2) determination of the protein components involved in bunyavirus genome replication 
using a synthetic RNA template;
(3) rescue of an infectious virus from cloned cDNA;
(4) domain mapping of the L protein: continuation of the RNA polymerase domain 
mapping and establishment of an endonuclease assay for identification of the 
endonuclease region in the L protein.
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A cDNA containing the complete coding sequence of the Bunyamwera virus (family Bunyaviridae) L genome 
segment has been constructed and cloned into two recombinant vaccinia virus expression systems. In the first, 
the L gene is under control o f vaccinia virus P I.5 promoter; in the second, the L gene is under control of the 
bacteriophage T7 <J>10 promoter, and expression of the L gene requires coinfection with a second recombinant 
vaccinia virus which synthesizes T7 RNA polymerase. Both systems express a protein which is the same size as 
the Bunyamwera virus L protein and is recognized by a monospecific L antiserum. The expressed L protein was 
shown to be functional in synthesizing Bunyamwera virus RNA in a nucleocapsid transfection assay: 
recombinant vaccinia virus-infected cells were transfected with purified Bunyamwera virus nucleocapsids, and 
subsequently, total cellular RNA was analyzed by Northern (RNA) blotting. No Bunyamwera virus RNA was 
detected in control transfections, but in cells which had previously been infected with recombinant vaccinia 
viruses expressing the L protein, both positive- and negative-sense Bunyamwera virus S segment RNA was 
detected. The suitability of this system to delineate functional domains within the Bunyamwera virus L protein 
is discussed.
Bunyamwera virus is the prototype o f the family Bunya­
viridae (for a review, see reference 11) and has a tripartite 
negative-sense RNA genom e. The three genom e segm ents 
have been cloned as cD N A , and their com plete sequences 
have been determined; the sm allest segm ent, S, is 961 
nucleotides in length and encodes the nucleocapsid protein 
N and a nonstructural protein termed N Ss (9); the middle- 
sized segm ent, M, is 4,458 bases long and encodes the two  
virion glycoproteins (G1 and G2) and a second nonstructural 
protein called NSm (22); and the largest RNA segm ent, L, 
which contains 6,875 nucleotides, encodes a high-molecular- 
weight protein also termed L (10). The L protein (259,000 
Da) is presumed to be the virion-associated transcriptase or 
RNA polym erase, though direct proof o f this is lacking. The 
Bunyamwera virus L protein does not show extended re­
gions o f hom ology with other negative-strand virus tran­
scriptases (10) but does contain the polymerase motifs 
identified in all RNA-dependent RNA polym erases (29).
Transcriptase activity has been detected in detergent- 
disrupted preparations o f a number o f bunyaviruses (2, 16, 
27), though the activity was low compared with that o f other 
negative-strand viruses, such as vesicular stomatitis virus, 
which has hampered detailed biochem ical analyses. H ow ­
ever, Patterson et al. (27) demonstrated that La Crosse 
bunyavirus polym erase was stimulated by dinucleotides 
(e .g ., ApG), cap analogs (e .g ., mGpppAm), and natural 
mRNAs (e .g ., alfalfa m osaic virus RNA 4) and detected an 
endonuclease activity which cleaved methylated capped 
mRNAs in vitro. These results are consistent with the notion 
that bunyavirus mRNA synthesis is primed by RNA se­
quences cannibalized from host cell capped mRNAs; further 
evidence stem s from the observation that heterogeneous 
nonviral sequences are present at the 5' ends o f bunyavirus 
m RNAs (1, 3, 12, 18, 28). Thus, bunyavirus transcription 
resembles that o f influenza virus (for a review, see reference 
21), but in contrast to that of influenza virus, bunyavirus
* Corresponding  author.
transcription is not inhibited by actinomycin D or a-amanitin 
(32) and occurs in the cell cytoplasm  (20, 31). Additionally, 
whereas influenza viruses em ploy three proteins (the P 
proteins) to catalyze the various enzym atic events in tran­
scription and replication, bunyaviruses most probably use 
just one, the L protein.
With the long-term aim o f  defining the functional domains 
within the bunyavirus L protein, we have exploited the 
available cloned cD N A s to establish a system  in which the L 
protein is expressed by recombinant vaccinia viruses. We 
show here that the expressed protein is functional by dem­
onstrating its ability to amplify an appropriate RNA tem­
plate, supplied in the form o f purified nucleocapsids.
MATERIALS AND METHODS
Viruses and cells. Bunyamwera virus was grown in BHK  
cells as described previously (33). Vaccinia virus WR strain 
was obtained from A. Patel, and the recombinant vTF7-3, 
which expresses T7 RNA  polym erase (15), was obtained 
from B. M oss. Vaccinia viruses were grown in CV-1 cells 
and purified as described by Mackett et al. (25). CV-1 
monkey kidney cells were grown in D ulbecco’s modified 
Eagle’s medium (DMEM) containing 5% fetal calf serum. 
Human thymidine kinase-negative (T K - ) 143 cells were 
grown in DMEM supplemented with 5%  fetal ca lf serum and 
25 p.g o f 5-bromodeoxyuridine per ml.
Plasmids. Recombinant plasmids containing cD N A  de­
rived from the Bunyamwera virus L R NA  segm ent, cloned  
into pBR322, were described by Elliott (10). The vaccinia 
virus transfer vectors pTF7-5 (13) and p S C ll (5) were 
obtained from B. M oss and L. Whitton, respectively.
The procedures for cloning in plasmids, transformation of 
bacteria (Escherichia coli  DH5; Bethesda Research Labora­
tories), and purification by CsCl-ethidium bromide centrifu­
gation were as described by Maniatis et al. (26).
The construction o f the full-length cD N A  (pTZBU N L) is 
described in the Results section. Enzym es involved were 
obtained from Bethesda Research Laboratories, N ew  En­
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gland Biolabs, or Boehringer-Mannheim and used according 
to the manufacturers’ recommendations.
Construction and characterization of recombinant vaccinia 
virus. A 6.8-kb S m a l  fragment containing the com plete L 
gene coding sequence was isolated from pTZBU N L and 
cloned into the S m a l  site o f p S C ll or the filled-in B a m H l  
site o f pTF7-5, and the correct orientation o f the insert was 
determined by restriction endonuclease analysis and nucle­
otide sequencing.
Recombinant vaccinia viruses were prepared essentially  
as described by Mackett et al. (25): 80 to 90% confluent 
monolayers o f CV-1 cells in 35-mm dishes were infected with 
the WR strain o f  vaccinia virus (multiplicity o f infection,
0.05) and then transfected with 5 p.g o f plasmid D N A  by the 
calcium phosphate method. T K -  recombinants were iso­
lated by plaque assay o f transfected cell lysates on T K -  143 
cells by using a 1% low-melting-point agarose gel overlay  
containing 25 p.g o f 5-bromodeoxyuridine per ml, and for 
p S C ll derivatives, 300 p.g o f  X-Gal (5-bromo-4-chloro-3- 
indolyl-p-D-galactopyranoside; BRL) per ml. The plaques 
were screened by filter hybridization (25) with 32P-labelled 
pTZBU N L D N A , and plaques positive for the L gene were 
purified by three rounds o f plaque-to-plaque passage. Fi­
nally, the genom es o f the recombinant viruses were analyzed  
by restriction enzym e digestion and Southern blotting.
Radiolabelling, immunoprecipitation, and polyacrylamide 
gel electrophoresis. M onolayers o f cells in 50-mm dishes 
were radiolabelled with [35S]m ethionine (75 p.Ci/ml), and 
extracts were prepared for immunoprecipitation or poly­
acrylamide gel electrophoresis essentially as described pre­
viously (33). Immunoprecipitation em ployed either an anti- 
serum prepared against purified Bunyamwera virus (33) or a 
chimeric protein comprising the carboxy-terminal 217 amino 
acids o f  the L protein fused in-frame to bacterial p-galactosi- 
dase (19) by using the pU EX  expression system  (4). Radio­
labelled proteins were analyzed by sodium dodecyl sulfate 
(SDS)-polyacrylam ide gel electrophoresis as described by 
Watret et al. (33).
Extraction of cellular RNA and Northern (RNA) blotting. 
Total cellular RNA was extracted from phosphate-buffered 
saline-washed cells by the acid phenol-guanidinium thiocy- 
anate procedure o f  Chomczynski and Sacchi (6). The R N A s 
were fractionated on 1% agarose gels containing 5 mM 
methyl mercuric hydroxide and transferred to nitrocellulose 
filters, as described by Maniatis et al. (26). The filters were 
hybridized with 32P-labelled Bunyamwera virus-specific 
cD N A  or riboprobes, w ashed, and exposed  to X-ray film 
according to standard procedures (26).
Nucleocapsid isolation and transfection assay. Intracellular 
nucleocapsids were prepared by CsCl gradient fractionation 
o f cytoplasm ic extracts o f Bunyamwera virus-infected BH K  
cells by the method o f Leppert et al. (23). The nucleocapsid  
band was recovered with a syringe, diluted with N TE (0.1 M 
NaCl, 10 mM Tris-HCl [pH 7.5), 1 mM EDTA ), and pelleted  
at 40,000 rpm for 2 h at 4°C with the TST41 rotor. The 
preparation from 6 x  108 cells was resuspended in 0.5 ml o f  
NTE buffer and used either immediately or after storage at 
~70°C in the presence o f  10% glycerol.
For the transfection assay, CV-1 cells (106 per 35-mm  
dish) were infected with recombinant vaccinia virus at a 
multiplicity o f 5 PFU per cell for 1 h at 37°C and then washed  
once with T B S + (25 mM Tris-HCl [pH 7.4], 135 mM NaCI, 
50 mM KC1, 0.01% CaCl2, 0.01% MgCl2). The nucleocapsid  
transfection mix was then added and com prised, in a volume 
of 250 jjlI, purified nucleocapsids (10 p.1), 140 mM NaCl, 5 
mM KC1, 0.75 mM N a2HPQ4 • 2H zO, 6 mM dextrose, 25
mM V -2-hydroxyethylpiperazine-V'-2-ethansulfonic acid 
(HEPES; pH 7.05), and 125 mM CaCl2. After 30 min at room 
temperature, 2 ml o f DMEM containing 5% fetal calf serum  
(5% DMEM) was added, and incubation was continued at 
37°C for 4 h. The supernatant fluid was then rem oved, and 
the cells were shocked with T B S + containing 10% glycerol 
for 1 to 2 min. After tw o further washes with T B S + , 2 ml o f  
5% DMEM was added, and incubation was continued at 
37°C for 20 h. Cell monolayers were then radiolabelled with 
[35S]m ethionine, or total cellular RNA was extracted as 
described above.
RESULTS
Construction of a full-length cDNA of the Bunyamwera 
virus L gene. An intact copy o f the Bunyamwera virus L 
gene coding region was constructed from existing cD N A  
clones and synthetic oligonucleotides. The major part o f  the 
gene was built from the unique ///m ilII site just downstream  
o f the ATG initiation codon for the L protein by using three 
subgenom ic cD N A  clones (Fig. 1A) (10). A 1.67-kb H in d l l l -  
S p h l  fragment isolated from pBUN 357 and a 2.07-kb S p h l-  
P s t \  fragment from pBUN 367 were ligated together with 
H in d l l l -  and /\sfI-doubly digested pUC18 D N A . The result­
ing plasmid, pUC18 357/367, was digested with P s/I , treated 
with alkaline phosphatase, and then ligated to a 3.06-kb P s t l  
fragment isolated from pB U N 363. The correct orientation o f  
this latter fragment w as confirmed by digestion with appro­
priate restriction enzym es. This plasmid (pUC18 357/367/ 
363) was digested with / / /n d l ll ,  treated with phosphatase, 
and ligated together with tw o complementary synthetic  
oligonucleotides which contained the ATG start codon and 
missing bases o f  the L gene, flanked by H in d l l l  restriction 
sites (Fig. IB ). The oligonucleotides also contained se­
quences for K p n l  and Sm al restriction enzym es to facilitate 
subcloning o f  the full-length L gene cD NA : these enzym es 
do not cleave the L gene cD N A , and hence the gene may be 
removed as a K p n l  or Sm al fragment, the 3' sites being 
derived from the polylinker region o f  the vector. Direct 
nucleotide sequence analysis o f  plasmids after ligation o f 
the synthetic oligonucleotides revealed that multiple copies 
o f the linker had been cloned; how ever, digestion with 
Sm al and ligation o f  the 6.8-kb fragment into S m a l-  
cleaved pTZ18R D N A  yielded a cD N A  containing the cor­
rect 5' end sequence (Fig. 1C). This plasmid was designated  
pTZBU N L.
Construction and characterization of recombinant vaccinia 
viruses. T w o approaches w ere used to express the Bunyam­
wera L protein by recombinant vaccinia viruses. The first 
em ployed the classical method in which the L gene was 
inserted in lieu o f  the vaccinia virus TK gene, under control 
o f the vaccinia virus P I .5 promoter, by using the plasmid 
transfer vector p S C ll;  this vector includes the E. coli  
(3-galactosidase gene under control o f the P l l  promoter so  
that recombinant vaccinia viruses produce blue plaques 
when stained with X-Gal (5). The second approach again 
used the TK locus as the site for recombination o f  the L 
gene, but in this ca se , the L gene was under control o f the 
bacteriophage T7 <[>10 promoter and terminator by using the 
transfer vector pTF7-5 (13). Expression o f the Bunyamwera 
virus gene should occur only when T7 RNA polym erase, 
supplied by a second, coinfecting recombinant vaccinia 
virus, vTF7-3, was present in the cell (13, 15).
The Bunyamwera virus L gene was rem oved from 
pT ZB U N L  by digestion with Sm al and ligated into the 
unique S m a l  site in p S C ll or the filled-in B a m H l  site in
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FIG. 1. Construction o f a full-length Bunyamwera virus L gene cDNA. (A) Relationship o f the three subgenOmic cDNA clones and 
relevant restriction enzyme sites used in the construction. Pstl(G/C) indicates a Pstl  site created by GC tailing during the initial cDNA cloning 
of the L RNA (10). The major part o f the L gene coding region comprised the Hindlll-Sphl  fragment o f pBUN357, the Sphl-Pstl  fragment 
o f pBUN367, and the Pstl-Pstl  fragment o f pBUN363. (B) Insertion o f complementary synthetic oligonucleotides, containing //m d lll, Kpn I, 
and Smal restriction enzyme sites and nucleotides 43 to 65 o f the L gene cDNA (underlined), including the ATG translational start codon, 
to complete the L gene coding sequence. The shaded box represents the L gene cDNA (not to scale), and relevant restriction sites at the 3' 
end of the insert are indicated. (C) Dideoxy chain termination sequencing gel o f alkali-denatured DNA derived from pTZBUNL, showing the 
correct sequence inserted by the synthetic oligonucleotides. The order o f the lanes is G, A, T. and C. Positions o f the Smal and //m d lll 
restriction enzyme sites and the ATG translational start o f the L protein are indicated.
pTF7-5. The correct orientation o f  the insert w as ascertained  
by restriction enzym e digestion and confirmed by nucleotide  
sequencing. The recombinant plasmids were then recom ­
bined by standard procedures into the TK locus o f vaccinia  
virus WR strain (see Materials and M ethods), and T K -  
viruses were selected by plaque assay on T K -  143 cells in 
the presence o f 5-bromodeoxyuridine; in the case o f  the 
pSC ll-derived  recombinants, blue plaques were picked after 
staining with X-Gal. Recombinant viruses were identified 
initially by hybridization with an L gene cD N A  probe, then 
further plaque-to-plaque purified, and finally, confirmed by 
analysis o f the restriction enzym e profile o f vaccinia virus 
D N A  (Fig. 2A and B). Recombinant viruses were obtained  
from both system s and designated v S C ll-B U N L  and vTF7- 
5B U N L . In Fig. 2A , p S C ll-B U N L  and v S C ll-B U N L  
D N A s were digested with Bam H l or EcoRI, fractionated on 
agarose gels, transferred to nitrocellulose filters, and hybrid­
ized to 32P-labelled L gene cD N A . The same pattern of 
bands was detected for each pair o f D N A s. Figure 2B show s 
analysis o f  pTF7-5BU N L, vT F7-5B U N L , and vaccinia virus 
(WR strain) D N A  using E coRV  and EcoRI by Southern  
blotting; no hybridization occurred with the WR strain
D N A , w hereas the pattern o f  bands for vT F7-5BU N L  was 
consistent for the expected structure o f  a recombinant 
containing the L gene.
A nalysis o f  RNA synthesized in recombinant vaccinia  
virus-infected cells was performed by Northern blotting. The 
level o f L gene-specific RNA in cells infected with v S C ll-  
B U N L  was barely detectable by our standard procedure 
(data not show n). H ow ever, in cells dually infected with 
vTF7-3 and vT F7-5B U N L , an R N A  transcript about the 
sam e size as that detected in Bunyamwera virus-infected  
cells w as easily  detected (Fig. 2C, lanes 2 and 3). N o L 
gene-specific R N A  w as detected in m ock-infected cells (lane
1) or in cells infected with vT F7-5BU N L  alone (lane 4).
Analyses o f proteins synthesized by recombinant vaccinia 
viruses. T o investigate the proteins made by the recombinant 
vaccinia v iruses, CV-1 cells were infected with the various 
recombinants and pulse-labelled at 22 to 24 h postinfection  
with [35S]m ethionine; the cell lysates were fractionated on 
SDS-containing polyacrylamide gels (Fig. 3). Cells infected 
with v S C ll-B U N L  produced a high-molecular-weight pro­
tein o f the sam e electrophoretic mobility as the L protein 
identified in Bunyamwera virus-infected cells (Fig. 3A),
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FIG. 2. Characterization o f recombinant vaccinia virus. (A) 
Southern blot analysis o f vSC ll-B U N L . DNA was extracted from 
recombinant vaccinia virus-infected cells (25) and digested with 
BamH\  (lane 1) or EcoRI (lane 3). The transfer vector plasmid DN A, 
pSC ll-B U N L , was also digested with either B a m \\ \  (lane 2) or 
EcoRI (lane 4). After fractionation on agarose gels and transfer to 
nitrocellulose, the filters were hybridized with 32P-labelled 
pTZBUNL DNA. The pattern of bands is similar for both DNAs 
with each enzyme. (B) Southern blot analysis o f vTF7-5BUNL. 
DNA from cells infected with vTF7-5BUNL (lanes 1 and 4) or 
vaccinia virus WR strain (lanes 2 and 5) or from the transfer vector  
pTF7-5BUNL (lanes 3 and 6) were digested with either EcoRV  
(lanes 1 to 3) or EcoRI (lanes 4 to 6), fractionated on agarose gels, 
and transferred to nitrocellulose. Hybridization with 32P-labelled 
pTZBUNL DNA indicated the expected genetic structure for vTF7- 
5BUNL; no hybridization occurred with the vaccinia virus parental 
DNA (lanes 2 and 5). (C) Northern blot analysis o f  infected cell 
RNA. Total cellular RNA was extracted from mock-infected cells 
(lane 1), Bunyamwera virus-infected cells (lane 2), cells infected 
with vTF7-5BUNL and vTF7-3 (lane 3), or cells infected with 
vTF7-5BUNL alone (lane 4) and fractionated on a 1% agarose gel 
containing methyl mercuric hydroxide. After transfer to a nitrocel­
lulose filter, hybridization was performed with 32P-labelled 
pTZBUNL DNA. An L segment-specific RNA, similar in size to 
that observed in the Bunyamwera virus-infected cells, was detected  
in the cells infected with vTF7-5BUNL and vTF7-3. No hybridiza­
tion was observed in mock-infected or VTF7-5BUNL singly infected 
cells.
FIG. 3. Protein synthesis in recombinant vaccinia virus-infected 
cells. CV-1 cells were labelled with [35S]methionine at 22 to 24 h 
after infection. (Left panel) Cells were mock infected or infected 
with the WR strain of vaccinia virus, the recombinant v S C ll-  
BUN L, or with Bunyamwera virus (BUN) as indicated. The Bun­
yamwera virus proteins L, G l, and N are designated on the right, 
and a band corresponding to L protein is observed in the v S C ll-  
BUN L lane but not in the parental vaccinia yirus lane. The position 
of the X protein (see text) is also noted. vSC ll-B U N L  synthesizes 
P-galactosidase, which has the same mobility as G l. (Right panel) 
Cells were mock infected or infected with vTF7-3, vTF7-5BUNL, 
vTF7-3 and vTF7-5BUNL (dual), or Bunyamwera virus (BUN). The 
Bunyamwera virus L. G l. and N proteins are indicated, and a band 
corresponding to L protein is observed in the dual-infected lane. L 
protein is not seen in cells infected with vTF7-5BUNL alone, but the 
X protein is present. The position of T7 RNA polymerase, synthe­
sized by vTF7-3, is indicated.
which was not seen in cells infected with the parental 
vaccinia W R virus. In vS C ll-B U N L -in fected  cells, a band 
corresponding to {3-galactosidase w as also clearly evident 
and comigrated with the G l protein o f  Bunyamwera virus. 
Other bands specific to the vS C ll-B U N L -in fected  lysate 
were seen migrating between the positions o f  p-galactosi- 
dase and the L protein, o f  which one (labelled “ X ” in Fig. 
3A) is considered in more detail later.
Cells dually infected .with vTF7-3 (expressing T7 R N A  
polym erase) and vT F7-5BU N L  also contained a protein 
which comigrated with the Bunyamwera virus L protein  
(Fig. 3B). This band was not seen in cells infected with either 
virus singly. In cells infected with vT F7-5BU N L  on ly , a 
band having the sam e mobility as the X band seen  in 
vS C ll-B U N L -in fected  cells was observed, but this band 
was not seen  in the dually infected cells. Thus, both system s  
synthesize a protein corresponding in size to the L protein; 
in the T7 system , the amount o f the expressed protein was 
similar to that in Bunyamwera virus-infected cells, w hereas 
considerably more L protein was synthesized by v S C ll-  
B U N L .
To confirm the identity o f the protein made in the recom ­
binant vaccinia virus-infected ce lls, immunoprecipitation 
experim ents w ere performed with a m onospecific antiserum  
to the carboxy-terminal 217 amino acids o f the Bunyamwera 
virus L protein (19). A s shown in Fig. 4 , the proteins 
synthesized by dual infection with vTF7-3 and vTF7- 
5B U N L  (lane 6) and with v S C ll-B U N L  (lane 7) were 
precipitated by the L protein-specific serum; this serum  
recognizes authentic L protein made in Bunyamwera virus- 
infected cells (compare lanes 2 and 3). N o proteins were 
precipitated by preimmune serum (lane 1) or ce lls  infected  
with vTF7-3 alone (lane 4). O f interest is the X  protein, 
which was immunoprecipitated from cells infected by vTF7- 
5B U N L  alone (lane 5) and by v S C ll-B U N L  (lane 7). This 
result suggests that the X protein is a carboxy-terminal 
fragment o f  the L protein, but its genesis has not been  
investigated.
Functional assay of the recombinant vaccinia virus L pro­
tein. The above experim ents indicated that antigenically  
authentic Bunyamwera virus L protein was produced by the 
recombinant vaccinia viruses, but in order for this protein to 
be useful for mapping domains within the L protein, it was 
necessary to demonstrate that the expressed L protein had
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Infect CV-1 cells with recombinant 
vaccinia viruses , 1 hr. 37°.
t
Wash cells with TBS+ and add 
nucleocapsid transfection mix for 30min, 
room temperature.
t
Add medium and incubate 4hr, 37°.
t
Shock cells with 10% glycerol in TBS+ 
for 1-2min; wash twice with T BS+.
t
Add medium and incubate 20hr, 37°
Radiolabel cells for protein analysis 
OR
extract RNA for Northern blot.
FIG. 5. Protocol of the nucleocapsid transfection assay.
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FIG. 4. Immunoprecipitation o f the recombinant vaccinia virus- 
expressed L protein. Infected cells were labelled with [35S]methio- 
nine at 22 to 24 h postinfection, and cell lysates were prepared for 
immunoprecipitation. The samples were precipitated with preim- 
mune serum (lane 1) or a monospecific L protein antibody (fi- 
galactosidase fusion with the 217 carboxy-terminal amino acids o f L 
protein) in lanes 2 and 4 to 7 or with an anti-Bunyamwera virus 
serum in lane 3. Cells were infected with Bunyamwera virus (lanes 
1, 2, and 3), vTF7-3 (lane 4), vTF7-5BUNL (lane 5), vTF7-3 and 
vTF7-5BUNL (lane 6), or vSC ll-B U N L  (lane 7). Lane 3 shows 
Bunyamwera virus protein markers L, G l, G2, and N. The mono- 
specific L protein antiserum precipitates L protein and minor 
amounts o f N protein (19) from Bunyamwera virus-infected cells 
(lane 2) but not from vTF7-3-infected cells (lane 4). L protein was 
precipitated from cells dually infected with vTF7-3 and vTF7- 
5BUNL (lane 6) or with vSC ll-B U N L  (lane 7). The fusion protein 
antibody also precipitates p-galactosidase from vSC ll-B U N L -in- 
fected cells. The X protein is also precipitated by this antibody from 
cells infected by vTF7-5BUNL alone (lane 5) or vS C ll-B U N L  (lane 
7). No proteins were precipitated by preimmune serum (lane 1).
RNA synthesis capability. The tem plate for RNA  synthesis 
employed by negative-strand viruses is the nucleocapsid,
i.e ., viral RNA com plexed with viral proteins. At present, 
we do not have a method to reconstitute this tem plate in 
vitro, but we can purify nucleocapsids from Bunyamwera 
virus-infected cells by cesium  chloride centrifugation by 
established procedures (23, 30). Purified Bunyamwera virus 
nucleocapsids contain N and L proteins (19) and therefore 
should be capable o f synthesizing RNA if transfected into 
cells. Thus, our initial aim was to determine the effect of 
recombinant vaccinia virus infection on the levels o f  Bun­
yamwera virus-specific RNA in cells transfected with puri­
fied nucleocapsids. We expected to see a background level 
of RNA after transfection o f nucleocapsids and hoped to see 
an amplification after infection with the vaccinia viruses 
expressing L protein. In fact, preliminary experim ents indi­
cated that no Bunyamwera virus-specific R N A s could be 
detected in cells 24 h after transfection with nucleocapsids 
(data not shown). Undaunted by this result, w e proceeded  
with the experiment using recombinant vaccinia viruses 
according to the schem e outlined in Fig. 5, and the results 
are shown in Fig. 6. Total cellular R NA  w as extracted from 
cells which had been infected with vTF7-3, vTF7-3 plus 
vT F7-5BU N L, or v S C ll-B U N L  and transfected with nucle­
ocapsids; RNA  was obtained from Bunyam wera virus-in­
fected cells to  act as specific markers. The R N A s were 
fractionated on agarose gels containing methyl mercuric 
hydroxide, transferred to nitrocellulose filters, and hybrid­
ized with strand-specific probes derived from cloned full- 
length Bunyamwera virus M and S segm ent cD N A s to detect 
either positive- or negative-sense RNA species. L segment 
probes were not included, as these would have detected the 
vaccinia virus-derived transcripts, at least in the case o f  
vT F7-5BU N L. N o hybridization was detected with RNA  
from cells infected with vTF7-3 (Fig. 6 , lane 2), whereas 
weak but specific signals corresponding to positive- and 
negative-sense Bunyamwera virus S R N A  w ere detected 
from cells infected with vTF7-3 and vT F7-5B U N L  (lane 4). 
Much stronger signals to the positive- and negative-sense S 
R NA s were detected in the R NA  extracted from cells 
infected with v S C ll-B U N L  (lane 3). N ote that with this gel 
system , the full-length positive-sense S R NA  and the shorter 
S mRNA are not separated. N o M RNA signal was detected  
in RNAs from the nucleocapsid-transfected cells by using 
either probe, though both positive- and negative-sense M 
RNA s were detected in the Bunyamwera virus-infected cell 
sample (lane 1). These experim ents dem onstrate that the L 
protein expressed by the recombinant vaccinia viruses is 
able to transcribe both positive- and negative-sense S nucleo­
capsids (nucleocapsids obtained from infected cells contain 
RNAs o f  both polarities) and is thus functional in RNA  
synthesis. The difference in the levels o f amplification seen 
between infection with v S C ll-B U N L  and dual infection 
with vTF7-3 and vT F7-5BU N L  is reproducible, and so far 
we have been unable to detect amplification o f the M 
segment R NA .
We have further characterized this nucleocapsid amplifi­
cation system  by analyzing the synthesis o f  Bunyamwera 
virus proteins (Fig. 7). After infection with recombinant
V o l . 65, 1991 EXPRESSION OF BUNYAMWERA VIRUS L PROTEIN 4187
+  — 
1 2 3  4  1 2  3 4
FIG. 6. Northern blot analysis o f RNA from cells transfected 
with Bunyamwera virus nucleocapsids after infection with recom­
binant vaccinia viruses. CV-1 cells were infected with Bunyamwera 
virus (lanes 1), vTF7-3 (lanes 2), vS C ll-B U N L  (lanes 3), or both 
vTF7-3 and vTF7-5BUNL (lanes 4). The vaccinia virus-infected 
cells were subsequently transfected with Bunyamwera virus nucleo­
capsids by the calcium phosphate method (lanes 2 to 4). Twenty 
hours later, total cellular RNA was extracted, separated in agarose 
gels containing methyl mercuric hydroxide, transferred to nitrocel­
lulose filters, and hybridized with a mixture o f full-length 32P- 
labelled riboprobes specific for the M and S segment positive (+ ) or 
negative ( - )  strand RNAs as indicated. The positions of the M and 
S segment RNAs are indicated by using the Bunyamwera virus- 
infected cell sample as markers (lanes 1). Both positive- and 
negative-sense S segment RNAs could be detected in nucleocapsid- 
transfected cells which expressed the L protein (lanes 3 and 4), but 
no Bunyamwera virus RNA was detected in transfected cells which 
had been infected with vTF7-3 alone (lane 2).
vaccinia viruses and transfection with nucleocapsids, the 
cells were pulse-labelled with [35S]m ethionine, and then cell 
lysates were immunoprecipitated with a mixture o f the 
m onospecific L protein antiserum (19) and an antiserum  
prepared against purified Bunyamwera virus (33). N o  Bun­
yamwera virus proteins w ere detected in vTF7-3-infected, 
nucleocapsid-transfected cells (Fig. 7 , lane 1). Both L and N  
proteins were detected in nucleocapsid-transfected cells 
which had also been infected with either v S C ll-B U N L  (lane
2) or vTF7-3 and vT F7-5B U N L  (lane 3). Much less N  
protein was detected in the dual vaccinia virus-infected cells  
than in cells infected with v S C ll-B U N L . The major g lyco­
protein G l w as not detected in the nucleocapsid-transfected  
cells but was observed in the Bunyamwera virus-infected 
control (lane 4). The results o f  the protein analysis are 
entirely consistent with the previous R NA  analyses.
DISCUSSION
As with other negative-strand viruses, transcription and 
replication o f the bunyavirus genom e involve the L protein. 
The large size o f the L protein suggests it is multifunctional 
and most probably catalyzes initiation, elongation, and ter­
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FIG. 7. Immunoprecipitation o f cells infected with recombinant 
vaccinia viruses and transfected with Bunyamwera virus nucleocap­
sids. CV-1 cells were infected with vTF7-3 (lane 1), vSC ll-B U N L  
(lane 2), both vTF7-3 and vTF7-5BUNL (lane 3), or Bunyamwera 
virus (lane 4). Cells infected with the vaccinia viruses were then 
transfected with Bunyamwera virus nucleocapsids (lanes 1 to 3), and 
radiolabelled cell lysates were prepared 20 h later. The lysates were 
precipitated with a mixture o f the monospecific L protein and 
Bunyamwera virus antisera. The positions o f the Bunyamwera virus 
proteins L, G l, and N from the control cells are shown in lane 4, 
which was cut from one side o f the same gel as the other tracks to 
prepare the figure. The N protein was detected in cells expressing L 
protein from vaccinia viruses and transfected with Bunyamwera 
virus nucleocapsids (lanes 2 and 3) but not in cells infected with 
vTF7-3 alone prior to nucleocapsid transfection (lane 1).
mination o f  R N A  synthesis and perhaps also plays a role in 
events which generate the host-derived primers for tran­
scription, such as cap-binding and endonuclease activities. 
A s a prelude to mapping the individual domains within the L 
protein, we sought to express functional L  protein in a 
eukaryotic vector, namely vaccinia virus. In this article, we 
have described the reconstruction o f  a cD N A  containing the 
com plete L gene coding region and its subcloning into two  
vaccinia virus expression system s. W e chose to investigate 
both system s in parallel in case constitutive expression o f  
the L gene by the vaccinia virus P I .5 promoter w as detri­
mental to vaccinia virus replication; e .g ., Li et al. (24) 
reported that the vesicular stom atitis virus M protein was 
toxic to vaccinia virus when they attempted to make a 
recombinant based on p S C ll. The use o f  the T7 RNA  
polym erase system  would have overcom e this problem. In 
fact, both system s expressed full-length antigenically au­
thentic Bunyamwera virus L protein. Apparently, more L 
protein was synthesized with v S C ll-B U N L  than with 
vTF7-3 and vT F7-5B U N L , even though the levels o f L 
protein m RNA were considerably higher in cells infected
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with the latter. In their characterization o f  the vaccinia 
virus-T7 polym erase system  Fuerst and M oss (14) also 
observed much higher levels o f m RNA compared with the 
level o f  protein made and suggested that the apparent 
inefficient translation o f  the T7 polymerase-transcribed 
RNA s was because only 5 to 10% contained terminal cap 
structures.
In addition to full-length L protein, other proteins appar­
ently specific for the recombinant vaccinia viruses were 
observed (Fig. 3 and 4). In particular, the protein designated  
X is worthy o f mention because this was immunoprecipi- 
tated by the m onospecific L protein antibody, suggesting it 
to be a carboxy-terminal fragment o f  L protein. Although we 
have not established the genesis o f this protein, we suggest 
that it may be the translation product o f an RNA  transcribed 
by the vaccinia virus polym erase recognizing a cryptic 
vaccinia virus-like promoter sequence (7, 8) in the L gene 
cD N A .
T o test the functionality o f  the expressed L protein, we 
developed a nucleocapsid transfection assay on the basis of 
a previous report by Gotoh et al. (17), w ho studied Sendai 
virus. T hese workers show ed that they could enhance the 
yield o f  Sendai virus obtained from transfected nucleocap­
sids by supplying Sendai virus L and P/C gene products 
through recombinant vaccinia viruses. We demonstrated 
that Bunyamwera virus L protein expressed by both vac­
cinia virus system s was able to amplify markedly the level o f  
S segm ent R N A s in CV-1 cells. After transfection o f  cells 
with the Bunyamwera virus intracellular nucleocapsids, 
which contain both negative- and positive-sense genom es, 
w e could not detect any virus R N A . This result was som e­
what surprising; since our preparations o f  nucleocapsids 
contain the N  and L  proteins (19), w e expected  these to be 
capable o f  initiating R N A  synthesis. We suspect therefore 
that the L  protein must becom e damaged during the nucleo­
capsid purification schem e. H ow ever, the transfected nucleo­
capsids do provide an appropriate template for the synthesis 
o f both polarities o f  at least the S segm ent R N A . Thus far we 
have been unable to demonstrate synthesis o f  M segment 
R N A . W hether this reflects a relative lower abundance 
(R NA  extracted from nucleocapsid is rarely equimolar, and 
usually S predominates [11]), lower efficiency o f transfection 
or lower stability o f  M segm ent nucleocapsids is not known, 
and experim ents to address this question are in progress. 
Since no M segment R N A  is produced and no M R NA  gene 
products are synthesized, w e have been unable to dem on­
strate the production o f  infectious Bunyamwera virus, in 
contrast to the results o f  Gotoh et al. (17) using the unseg­
mented Sendai virus. Notwithstanding this point, we have 
described a system  which w e think will be exploitable to 
dissect the functions and functional domains o f  the com plex  
L protein encoded by Bunyamwera virus.
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1 M E D Q A Y D Q Y L H R I Q A A R
1 AGTAGTGTACTCCTACATATAGAAAATTTAAAAATATAACCAGTAGGAGTATGGAGGACCAAGCTTATGATCAATACCTGCACAGAATCCAAGCAGCTAG
18 T A T V A K D  I S A D I L E A R H D Y F G R E L C N S L G  I E Y K
101 AACAGCTACAGTTGCTAAAGACATCAGTGCTGATATCCTTGAGGCAAGGCATGACTATTTTGGTCGGGAGCTTTGTAACTCTTTAGGAATTGAATACAAA
5 1 N N V L L D E I I L D V V P G V N L L N Y N I P N V T P D N Y I W D  
2 0 1  AATAATGTTCTTTTGGATGAAATCATCCTTGATGTTGTGCCAGGTGTTAACTTGTTAAACTATAACATACCCAATGTGACACCAGACAACTATATATGGG
8 5  G H F L I  I  L D Y K V S V G N D S S E  I  T Y K K Y T S L  I  L P V M  
3 0 1  ATGGTCACTTCTTGATAATTCTTGATTACAAAGTCTCAGTTGGGAATGATAGTAGTGAAATCACATATAAGAAATACACCAGTTTGATTCTCCCAGTGAT
1 1 8  S E L G I D T E  I A I  I R A N P V T Y Q I S I  I G E E F K Q R F P
4 01  GTCTGAATTGGGTATAGATACAGAAATAGCTATTATTAGGGCAAATCCTGTTACATATCAGATATCTATAATTGGAGAAGAATTCAAACAAAGATTCCCA
1 5 1  N I P I Q L D F G R F F E L R K M L L D K F A D D E E F L M M I A H  
5 0 1  AATATACCTATACAATTAGATTTTGGTAGGTTCTTTGAACTGAGAAAAATGTTGCTGGACAAGTTTGCTGATGATGAGGAATTTCTGATGATGATAGCAC
1 8 5  G D F T L T A P W C T S D T P E L E E H E I F Q E F I N S M P P R
60 1  ATGGAGATTTCACTTTGACAGCACCATGGTGCACATCTGACACCCCTGAGCTAGAGGAGCATGAAATATTTCAAGAGTTTATTAATTCCATGCCACCAAG
2 1 8  F V S L F K E A V N F S A Y S S E R W N T F L Y R A R A E T E V D  
7 0 1  ATTTGTATCACTTTTCAAAGAAGCAGTCAATTTTAGTGCATACTCTTCAGAAAGATGGAATACATTCTTATATAGAGCCAGAGCAGAGACAGAGGTGGAT
2 5 1  Y N Q F L S D K A H K I F M L E G D Y M R P T Q A E I D K G W E L M  
80 1  TATAATCAATTTCTATCAGACAAGGCACATAAGATTTTCATGCTAGAAGGAGACTATATGAGACCAACACAAGCTGAAATCGATAAGGGTTGGGAGCTAA
2 8 5  S Q R V Y T E R E I  I T D V T K Q K P S  I  H F I W V K N A D R K L
90 1  TGAGTCAGAGAGTTTACACAGAGAGAGAAATTATAACAGATGTGACAAAACAGAAGCCTTCTATCCATTTTATTTGGGTAAAGAATGCAGATAGAAAGCT
31 8  I G S T A K L I Y L S N S L Q S I T E Q S T W T D A L K A I G K S  
10 0 1  AATAGGTTCAACAGCAAAATTAATATACCTATCTAATAGTTTACAAAGTATCACTGAACAGTCAACTTGGACAGATGCACTAAAAGCAATAGGAAAGAGT
35 1  M D  I D G K V G Q Y E T L C A E R K M I A R S  T G K K V D N K R L E  
1 1 0 1  ATGGATATTGATGGTAAAGTAGGGCAATATGAAACCTTATGTGCTGAAAGAAAAATGATTGCCAGGTCAACTGGCAAAAAGGTAGATAACAAGAGATTGG
3 8 5  A V K I G N A L V L W E Q Q F I L A N D L F K N Q E R Q K F M K N  
1 2 0 1  AAGCGGTTAAGATTGGCAATGCACTTGTGTTATGGGAACAACAATTCATCTTAGCAAACGACTTATTTAAAAATCAAGAAAGGCAGAAGTTCATGAAAAA
4 1 8  F F G I G K H K S F K D K T S S D I E T D K P K T L D F N N T I V  
1 3 0 1  CTTCTTTGGCATAGGAAAGCATAAGAGTTTTAAAGATAAGACATCTAGCGACATTGAAACGGATAAGCCTAAAATCTTAGATTTCAATAATACTATAGTC
4 5 1  L M A A R T M V N K N K A L L A K D N T L Q D L H P  I I M Q Y A S E  
1 4 0 1  CTGATGGCTGCAAGAACAATGGTTAATAAAAACAAAGCTCTGTTAGCTAAGGATAACACATTGCAAGACCTACATCCTATTATCATGCAGTATGCTTCAG
4 8 5  I K E A S K D T F D A L L K I S K T C F W Q C I V D V S T I M R N  
1 5 0 1  AAATAAAAGAGGCATCTAAAGACACATTTGATGCGCTACTAAAAATTTCCAAAACTTGCTTCTGGCAATGTATAGTAGATGTTTCAACAATAATGAGGAA
5 1 8  I  L A V S Q Y N R H N T F R V A M C A N D S V Y A L V F P  S S D  I
1 6 0 1  TATATTAGCTGTGTCACAATATAATAGACATAATACATTTAGAGTTGCAATGTGTGCTAATGACTCTGTTTATGCATTAGTATTTCCTTCATCTGACATA
V
5 5 1  K T K R A T V V F S I V C M H K E K N D L M D A G A L F T T L E C K  
1 7 0 1  AAAACAAAGAGAGCAACAGTAGTCTTTAGTATAGTTTGCATGCACAAGGAAAAAAACGACCTGATGGATGCAGGTGCATTATTCACTACTTTAGAATGTA
5 8 5  N K E Y  I  S I  S K A I R L D K E R C Q R I V S S P G L F  I  L S  S M
18 01 AAAATAAAGAATATATATCTATAAGTAAAGCAATTAGATTAGATAAAGAGAGGTGCCAAAGGATTGTATCATCACCTGGGCTTTTCATATTAAGTTCTAT
6 1 8  L L Y N N N P E V N L V D V L N F T F Y  T S L S  I T K S M L S  L T
1 9 0 1  GTTACTTTATAATAATAATCCAGAAGTAAATTTAGTAGACGTTCTAAATTTTACATTCTATACTAGCTTGTCTATAACAAAAAGTATGCTTTCGCTGACT
6 5 1  E P S R Y M I M N S L A I S S H V R D Y I A E K F S P Y T K T L F S  
2 0 0 1  GAGCCATCTAGATATATGATAATGAATTCGCTTGCCATTTCAAGCCACGTTAGAGATTATATAGCTGAGAAATTCTCTCCTTACACCAAAACACTTTTCA
6 8 5  V Y M V N L I K R G C A S A N E Q S S K  I Q L R N  I  Y L S D Y  D I
2 1 0 1  GTGTATACATGGTCAATTTGATAAAGAGAGGATGCGCATCCGCAAATGAGCAATCATCGAAGATCCAGCTGAGAAATATATATCTTTCAGATTATGATAT
7 1 8  T Q K G V N D G R N L D S I W F P G K V N L K E Y I N Q I Y L P F
2 2 0 1  TACACAAAAAGGTGTTAATGATGGTAGGAACTTAGACTCTATTTGGTTCCCTGGTAAAGTTAATTTAAAAGAATATATAAACCAAATATATCTACCATTT
7 5 1  Y F N A K G L H E K H H V M  I D L A K T V L E  I  E M N Q R S D N  L G  
2 3 0 1  TACTTCAATGCAAAAGGCCTTCATGAGAAACATCACGTAATGATTGACTTAGCAAAGACTGTTCTGGAAATAGAGATGAACCAAAGAAGTGATAATTTAG
7 85  I W S K A E K K Q H V N L P  I L  I  H S  I A K S L I  L D T S R H N H
2 4 01  GTATATGGTCTAAAGCAGAAAAGAAACAACATGTCAATCTACCAATATTAATACACTCTATAGCAAAATCTTTGATATTGGATACATCAAGACACAATCA
8 1 8  L R N R V E S R N N F  ■' R R S I T T I S T F T S S K S C I K I G D F
2 5 0 1  CTTGCGAAACCGTGTAGAAAGTAGAAATAATTTTAGAAGAAGCATCACAACAATAAGCACTTTTACAAGCTCTAAATCTTGTATAAAGATTGGTGATTTC
8 5 1  R E ,  I K D K E T E K S K K S T E K F D K K F R L S N P L F L E D E E  
2 6 0 1  AGAGAAATTAAAGATAAAGAAACAGAAAAATCAAAAAAATCAACTGAGAAATTTGATAAAAAGTTCAGACTTTCAAATCCATTATTCTTAGAAGATGAGG
8 8 5  A N L E V Q H C N Y R A L  I  Q K  I  P N Y K D Y  I S V K V F D R L Y
2 7 0 1  AAGCCAATCTTGAAGTTCAACATTGCAATTATAGGGCTCTGATACAAAAAATTCCTAATTATAAAGACTATATTTCAGTAAAGGTGTTTGATCGTCTATA
S 1 8 E L L K N G V L T D K P F I E L A M E M M K N H K E F S F T F F N
2 8 0 1  t g a g t t g c t a a a a a a t g g a g t c t t a a c a g a c a a a c c t t t c a t t g a a t t a g c t a t g g a a a t g a t g a a g a a t c a c a a g g a a t t c t c t t t c a c a t t c t t t a a t
9 5 1  K G Q K T A K D R E I F V G E F E A K M C M Y V V E R I  s k e r c k  
2 9 0 1  AAGGGCCAAAAGACAGCTAAAGATAGAGAGATATTCGTTGGAGAATTTGAAGCTAAAATGTGTATGTATGTAGTGGAGAGAATATCAAAAGAGAGATGTA
9 8 5  L N T D E M I  S E P G D S K L K  I L E K K A E E E  I R Y  I V E R T
3 0 0 1  AGCTGAACACGGACGAGATGATAAGTGAACCAGGTGATTCAAAATTGAAAATATTGGAAAAGAAAGCAGAAGAGGAAATCCGCTATATTGTTGAGAGAAC
1 0 1 8  K D S  I  I K G D P S K A L K L E I N A D M S K W S A Q D V F Y K Y  
3 1 0 1  AAAAGACAGTATAATTAAAGGAGACCCATCAAAAGCATTGAAACTGGAAATAAATGCAGACATGTCAAAATGGAGTGCTCAAGATGTATTTTACAAATAT
1 0 5 1  F W L  I A M D P  I  L Y P A E K T R I  L Y F M C N Y M Q K L L I L P D  
3 2 0 1  TTTTGGCTGATAGCAATGGACCCTATACTTTATCCAGCAGAAAAAACACGTATTCTGTATTTTATGTGCAATTATATGCAAAAACTATTAATACTTCCAG
1 0 8 5  D L  I A N  I  L D Q K R P Y N D D  L I  L E M T N G L N Y N  Y V Q  I  K
3 3 0 1  ATGATTTAATTGCAAATATCTTAGATCAGAAAAGACCTTATAATGATGATTTGATCCTTGAGATGACTAATGGTCTAAATTATAATTATGTCCAAATTAA
1 1 1 8  R N W L Q G N F N Y I S S Y V H S C A M L V Y K D I L K E C M K L  
3 4 0 1  AAGAAACTGGCTCCAGGGCAATTTCAATTACATTTCTAGTTATGTGCATAGTTGTGCAATGCTTGTTTACAAAGATATCCTCAAAGAATGTATGAAGTTA
1 1 5 1  L D G D C L I N S M V H S D D N Q T S L A I I Q N K V S D Q I V I Q  
3 5 0 1  CTAGACGGAGACTGCTTGATTAACTCAATGGTGCATTCAGATGACAATCAAACATCGTTAGCAATTATCCAAAATAAAGTCTCTGATCAAATAGTAATTC
1 1 8 5  Y A A N T F E S V C L T F G C Q A N M K K T Y I T H T C K E F V S
3 6 0 1  AATATGCAGCAAACACATTTGAGTCTGTTTGTTTGACATTTGGATGTCAGGCAAACATGAAAAAAACATATATTACTCATACATGCAAAGAATTTGTCTC
1 2 1 8  L F N L H G E P  L S V F G R F L L P  S V G D C A Y  I  G P Y E D L A  
3 7 0 1  ACTTTTCAATTTACATGGAGAACCACTATCTGTCTTTGGCAGATTTTTATTGCCTAGTGTAGGTGATTGTGCTTACATTGGGCCATATGAAGATTTAGCC
1 2 5 1  S R L S A A Q Q S L K H G C P P S L V W L A I S C S H W I T F F T Y  
3 8 0 1  AGCCGTTTATCTGCAGCACAACAGAGCTTAAAGCATGGGTGCCCTCCAAGTCTAGTTTGGTTAGCAATAAGCTGTAGCCACTGGATAACATTTTTCACTT
1 2 8 5  N M L D D Q I N A P Q Q H L P F N N R K E  I  P V E L N G Y L N A P
3 9 0 1  ACAACATGCTGGATGATCAAATTAATGCACCACAGCAGCATTTGCCATTCAATAATCGGAAGGAAATACCAGTTGAGTTAAATGGGTACTTGAATGCACC
1 3 1 8  L Y L I A L V G L E A G N L W F L I N I L K K L V P L D K Q K E T  
4 0 0 1  ATTATATTTGATAGCATTAGTCGGCTTGGAAGCTGGGAACTTATGGTTTTTAATAAATATATTGAAAAAATTGGTGCCATTGGATAAACAGAAAGAAACT
1 3 5 1  I Q S Q C L H L C N S I D K L T E S E K F K L K I L R Y L T L D T E  
4 1 0 1  ATACAAAGCCAATGTTTACACTTATGCAATTCAATTGATAAGCTGACAGAATCAGAAAAGTTCAAATTAAAAATATTGAGATATCTTACTCTTGACACTG
1 3 8 5  M S V D N N M G E T S D M R S R S L L T P R K F T T L ; : G S L N K L
4 2 0 1  AGATGTCAGTTGATAACAACATGGGAGAAACAAGTGATATGCGAAGTAGATCACTCTTAACGCCTCGCAAATTTACAACATTGGGATCCTTAAATAAACT
1 4 1 8  V S Y N D F R S S L D D Q R F T D N L N F M L N N P E L L V T K G  
4 3 0 1  AGTTTCCTATAATGACTTTAGATCTTCTTTAGACGACCAGAGATTTACTGATAATTTGAACTTCATGCTTAATAACCCAGAATTGTTAGTTACTAAAGGT
1 4 5 1  E N K E Q F M Q S V L F R Y N S K R F K E S L S  I Q N P A Q L F  I E  
44 0 1  GAAAATAAAGAGCAGTTCATGCAATCTGTCCTTTTCAGATATAATTCAAAAAGATTTAAAGAAAGCCTTTCCATCCAAAA^pCAGCACAATTATTTATTG
1 4 8 5  Q I L F S H K P I I D Y S S I F D K L T S L A E A D I I E E L P E
4 5 0 1  AGCAGATACTGTTTTCCCATAAACCAATCATAGATTACAGCAGTATATTTGATAAATTAACCTCACTTGCAGAAGCGGATATCATTGAAGAGCTACCAGA
1 5 1 8  I I G R V T F P Q A Y Q M I N R D I G Q L P L D I D D I K L I F R  
4 6 0 1  GATCATTGGAAGAGTTACATTTCCTCAGGCATACCAGATGATAAATAGAGATATTGGCCAACTACCTTTAGATATAGATGATATTAAGTTAATATTCCGG
1 5 5 1  Y C I L N D P L M I T A A N T S L L C V K G T P Q D R T G L S A S Q  
47 01  TATTGTATATTGAATGATCCACTAATGATCACAGCTGCAAACACTTCCTTATTATGTGTTAAAGGAACACCACAAGATAGAACTGGCCTCAGTGCAAGTC
1 5 8 5  M P E F R N M K L I H H S P A L V L K A F S K G T S D I P G A D P
4 8 0 1  AAATGCCTGAATTTAGAAATATGAAACTTATTCACCATTCCCCTGCTCTAGTTCTTAAGGCGTTTAGCAAAGGGACATCAGATATTCCTGGGGCTGATCC
1 6 1 8  I E L E K D L H H L N E F V E T T A I K E K I  L H N  I D N P P K H  
4 9 0 1  TATAGAATTGGAAAAAGATCTTCATCACTTAAATGAATTTGTTGAAACAACAGCAATTAAAGAAAAGATTTTGCACAACATAGACAATCCTCCTAAGCAT
1 6 5 1  L I G N E I L I Y R I R E M T K L Y Q V C Y D Y V K S T E H K V K I  
5 0 0 1  TTAATAGGGAATGAAATCCTAATTTATAGAATCAGAGAGATGACCAAACTCTATCAGGTTTGTTATGATTATGTTAAATCTACAGAGCATAAGGTTAAAA
1 6 8 5  F I L P M K S Y T A I D F C T L I Q G N T I S D N K W Y T K H Y L
5 1 0 1  TATTTATATTACCAATGAAATCTTATACTGCAATTGACTTTTGCACATTGATTCAGGGCAACACTATCTCTGATAATAAATGGTACACAATGCATTATTT
1 7 1 8  K Q I A S G S I K G N I V T T S T S E Q I I A N E C F R V L C H F  
5 2 0 1  AAAACAGATTGCTAGCGGATCTATCAAAGGGAATATAGTAACAACTAGTACAAGCGAGCAAATAATAGCAAATGAGTGTTTTAGAGTGCTCTGCCACTTT
1 7 5 1  A D S F V E E A S R L S F I N E V L D N F T Y K N I S V N S L F N T  
5 3 0 1  GCTGATTCCTTTGTGGAAGAGGCAAGCAGATTGAGCTTTATTAATGAaGTTCTTGATAATTTCACATATAAAAACATAAGTGTTAACTCCTTATTTAACA
1 7 8 5  L L A S T T R L D F I P L L F R L K V L T Q T D L N R F D A L K T  
54  0 1  CTCTATTAGCCAGCACTACAAGGTTAGACTTTATTCCTCTATTATTTAGACTCAAAGTTTTAACTCAGACAC-ATTTAAATAGATTTGATGCCCTTAAAAC
1 8 1 8  N E R V S W N N W Q T N R S L N S G L I  D L T  I S G Y L R S  I R V
5 5 0 1  TAATG AAAGAGTTTCATGGAATAACTGGCAGACAAACCGTTCCTTAAATTCAGGTCTGATTGATTTGACAATATCCGGCTATTTAAGATCAATAAGGGTT
1 8 5 1 V G E D N K L K I A E L T I P N F Y P N T V F H A G N K L L N S R H  
5 6 0 1  GTG GGG GAAG ATAATAAACTCAAAATTGCTGAACTAACAATACCTAATTTCTATCCAAATACAGTGTTCCA7GCAGGGAACAAACTTCTAAATTCTAGAC
1 8 8 5  G L K F E Y M E E I V L D E K Y N Y Y  I T Y  Q K K R A H  I Y T Y Q
5 7 0 1  ATGGATTAAAATTTGAATACATGGAGG AAATTGTTCTAG ATG AAAAATATAACTATTATATAACATACCAAAAAAAG AG GGCTCATATTTATACATATCA
1 9 1 8  V S T I E H I L R R N N E G L Q S R G P R Y N K M V P V C P V V L  
5 8 0 1  AGTATCTACAATAGAACATATTTTGAGAAGGAATAATGAAGGATTACAATCCAGAGGCCCTAGGTATAACAAAATGGTTCCTGTCTGTCCAGTTGTTTTA
1 9 5 1  S V R D E L F R M S L E N V F S L N M T N F S M S R L F V S P D E V  
5 9 0 1  AGTGTCAGGGATGAATTATTTAGAATGTCTCTAGAAAATGTTTTTAGTTTAAACATGACAAACTTTAGCATGTCTAGATTATTTGTTTCACCTGACGAAG
1 9 8 5  A T V K K A H M S K M M F F S G P T I K A G I I N L T S L M R T Q  
6 0 0 1  TTGCTACTGTAAAGAAAGCTCATATGTCCAAAATGATGTTCTTTTCCGGGCCAACAATAAAAGCAGGAATTATTAATTTAACATCTTTAATGAGGACCCA
2 0 1 8  E L L T L N Y D N L C K S S  I V P F C R I  L E C N G D E Q G E L I
6 1 0 1  AGAGCTTTTAACATTGAATTATGATAATCTATGCAAATCTAGCATTGTCCCGTTTTGTAGAATATTAGAATGTAATGGCGATGAGCAAGGAGAACTAATA
2 0 5 1  F L S D E V M D F T I  S E E  I  E S M P L F T  I R Y Q K R G T E  I M T  
6 2 0 1  TTTCTTTCAGATGAAGTCATGGATTTCACAATTTCTGAGGAGATAGAATCTATGCCATTATTTACAATAAGGTATCAGAAAAGAGGTACTGAAATTATGA
2 0 8 5  Y K N A I M K L V S A G V D E  I K E V F D F  S K Q G F Y  S K K N L
6 3 0 1  CTTATAAAAATGCTATAATGAAGTTAGTTTCAGCAGGGGTAGATGAGATCAAAGAAGTTTTTGATTTTTCAAAACAAGGGTTCTATTCAAAGAAAAACTT
2 1 1 8  G l  I N T  I C S  I  I N I L E T N E W S T  I L Y N S F H I A M L L E
64 0 1  AGGTATAATAAATACAATTTGTTCTATAATAAATATACTAGAGACAAATGAGTGGTCCACAATTCTATACAATTCCTTCCATATAGCAATGTTATTAGAG
2 1 5 1  S M D R E F H M F T L P E A F F  I  N V A G G V V N W T K L L K F  I K  
6 5 0 1  TCTATGGATCGAGAATTCCATATGTTCACATTACCCGAAGCCTTTTTCATAAATGTGGCAGGTGGTGTTGTTAATTGGACTAAGCTGCTAAAATTTATAA
*
2 1 8 5  S L P V I E Q E P W S M M M S R F V E K T V Y L I E R E M N K D V
6 6 0 1  AGTCATTGCCAGTGATAGAGCAAGAGCCTTGoTCAATGATGATGTCAAGATTTGTAGAAAAAACTGTGTATTTGATAGAAAGAGAAATGAACAAAGATGT
2 2 1 8  D F T D F L D E L E F S S G K S L F T F F  2 2 3 8
6 7 0 1  TGACTTCACTGATTTCTTAGATGAGTTAGAATTTAGTTCAGGAAAGTCTCTATTTACCTTTTTCTGAAACATATCTTCATTGGTTTATTTAATTGGACAT 
6 8 0 1  TCCAAAAGCACTATGTGGCAAAAATGATAACAGCATTCAAAAAAGTACAATTTTCTTATGTAGGAGCACACTACT 6 8 7  5
V
(Linear) MAPPLOT ofI Bun.L ck! 686* 1 to! 6875 October 9, 1991 16105*
Enzyme Data! Enzyme.Dat
1000 2000 3000 4000 5000 6000
AccI ----------
Aflll ----------
AfIIII ----------
Alul 4 H ---1— H
Alwl ----------
AlwNI ----------
ApaLI ---------h
Asel —  I
Avail H---------
Avrll ----------
Ball ----------
BamHl ----------
BanI ----------
BanII ----------
Bbvl — I--------
BcefI
Bell -+■ 
B glll —
BpulQI
Bsal
BsaAI
BsaBI
BsaJI
BsmI
BsmAl
Bfepl286I
BspCI
BspGI
BspHI
BspMI
BsrI
BstYI
Bsu36I
Clal
CvTJI
Dctel
Dpnl
Dral
Dralll
Drdll
Dsal
Eael
H— H-
H-
-H-
1— I llll l— h H— h Httf
-H-Hf
2 6T'mk_AC 
1 C'TTAA_G
3 A'CryG.T 
30 AG'CT
8 GGATCmnn'n_
1 CAG_nm‘CTG 
1 G'TGCA_C 
7 AT'TA_AT
4 G'GwC_C 
1 C'CTAG_G 
i TGG'CCA
1 G'GATC.C
3 G’frxC.C
2 G_r&y'C
7 GCAGCnrrrrrinn1 mn
1 NOQSCrnrrrnrrrnrn
4 T'GATC.A
2 A'GATC.T
3 CC'TnAGC
2 GGTCTCn ‘ nmn_
2 uAC'GTr
6 GATm'mATC
7 C'CmG_G
4 GAATG_Cn'
11 GTCTCn' m m _
7 G_dGCh'C
8 GCm'mGC
1 CTGGAC
2 T'CATG_A
3 ACCTGCnmn1 rmn_
12 ACTG_Gn'
5 r'GATC_y 
1 CC'TnA_GG 
1 AT'CG_AT
60 rG'Cy 
23 C'TnA_G 
19 GA'TC 
8 TTT'AAA 
1 CAC_nm' GTG 
3 GAACCA 
1 C'CryG_G 
1 y'GGCC_r
(Linear) MAPPLOT of! Bu"i.L ok! 686* i to! 6875 October 9, 1991 16!09.
Enzyme Data! Enzyme.Dat
1000 2000 3000 4000 5000 6000
Ecrl
Eco57I
EcoAI
EcoDI
EcoDXXI
EcoKI
EcoNI
Eco0109I
EcoPI
EcoP15I
EcoRI
EcoRII
EcoRV
Flnl
Fnu4HI
FokI
FspIfoul
Hael
Haelll
HglAI
flhal
HlrcII
HTndlll
HTnfl
Mao II 
MaoIII 
MboII 
Mfol 
Mlyl
Mmolfoil
fool
MspI
fool
NcTI
Ncol
Ndel
fool
++■
-Hk
-hh- ■i— k H kH—H—1 k
H k
-1— kH (k
l i  I I
H k
-h+« i l i m n  i i i
5 CTCTTCn‘nm_
2 CTGAAGrrTrrinnrnrn.
1 GAGnrrnnnnGTCA
2 TTArrrrinnnGTCu
3 TCAmmnnnATTC 
1 AACnrmmGTGC
1 OCTm'n_nnAGG
2 rG'GnC_Cu
4 AG ACC 
4 CAGCAG
4 G'AATT_C 
7 'CCwGG_
5 GAT'ATC 
1 GTCCC
7 GC'n_GC
11 GGATGrrvinrnrinn'rn. 
1 TGC'GCA
1 CTGGAGrTTYTYTTnnrri.
3 mGG'CCm 
7 GG'CC
4 G_*»GCw' C
2 G.CG'C
5 GTu'rAC
1 A'AGCT.T 
17 G'AnT.C
2 GTT'AAC
7 GGTGArrrinnnr»_n1 
21 C'TA_G 
4 A'CG.T 
11 'GTnAC_
15 GAAGArnnnrrrL.n'
2 CAATTG 
7 GAsTC
1 TCCrACnrrYTnrnrnnn. 
26 (XTGrrrrrrin'
59 T’TA_A
3 C'CG.G
11 GCrrunm'nnGC 
1 CC's_GG 
1 C'CATG.G 
3 CA'TA_TG 
1 G'CTAG_C
NloIII - 
NlalV - 
Net I - NepI -  
tepBII - 
Plel " 
PpuMI - 
Pstl - 
PvuII - 
RleAI - 
Rsal k 
Sau96I H 
Sau3AI - 
ScrFI - 
SfaNI - 
Sfel - 
Snal - 
Spel ~ 
SphI - 
SpTI - 
SspI - 
StuI - 
StuI -  Bt^ -Tl - 
StuBBI -  stuSPi - 
TaqI - 
TaqII-2 - 
TfTI -  
Tsp45I 
TspEI 
Tthlllll 
Uball05I 
Xbal 
Xcml 
XmnI
(Linear) MAPPLOT of! Bun.L ck! 686» 1 to! 6875 October 9. 1S&1 16! 12.
Enzyme Data! Enzyme.Dat
1000 2000 3000 4000 5000 6000
+H-
-k+
+—k
++
-H k
111 -M IHIt
-H-
H k
H  l i l t  II I— H
-kH+k
-t-k
H k
-H—k
- 28 _CATG1
- 9 GGn'nCC
- 2 A_TGCA'T 
~ 6 r_CATG1y
- 2 CmG'CkG
- 7 GAGTCmm' n_
~ 1 rG ‘ G*^ C_Cy
- 1 CLTGCA'G
- 2 CAG'CTG
-  1 (XXACArYrrrirnnn_n. 
k 8 GT'AC
- 8 G'GhC.C
- 19 'GATC_
- 8 CC'n_GG
------------ 8 GCATCnrmn1 m m _
------------ 7 C'TryA_G
-----------  1 GTATAC
-----------  2 A'CTAG_T
------------ 1 G_CATG'C
------------ 2 CCGC
— H---------  9 AAT'ATT
------------ 1 AGG'CCT
--------1--- 3 C'CwwG.G
------------ 12 CAGAG
------ 1 1 GAGnmnmrTAuG
------------ 1 AACrrrnrnGTrC
------ 1----- 3 T'CG_A
------------ 1 CACCCArrrrinnnnn_n.
 1--------- 10 GAwTC
------------ 4 GTsAC
-H— H— kH-H— kkk 84 AATT
------------ 12 CAArCArrrrrinnnn_n.
------------ 1 6ACm_n' mGTC
------------ 5 T‘CTAG_A
------------ 2 0CArrm_n' nrmTGG
------------ 4 GAAm1 rmTTC
Enzymes that do not cut:
Aatll Agcl Ahall Apal Aval BbvII Bcgl Bgll BsTI BspMII BssHII BstBI
BstEII BstXI CfrlOI CfrAI DrdI EcTI Eco47III EcoBI EcoEI EcoR124I EcoR124/3I
EspI Esp3I Foul Fsel Gdtll Haell Hgal HgTEII HTnflll Kpnl Mcrl Mlul
Noel Nani Notl Nrul PflMI Pmll PshAI Pvul RsrII SacII Sail Seal
SftI S^AI Smal SnaBI SplI SstI StySJI StySOI TaqII-1 Thai Tthllll Uball08I
Xhol Xmalll
Enzymes excluded? MtnCuts: 1 MaxCuts: 350000
notc
